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Abstract 
Escherichia coli 0157: 1-17 is a significant human pathogen that persists in asymptomatic 
animal hosts. It forms a characteristic attachment, the attaching-effacing (AE) lesion, on cell 
monolayers in vitro and in the intestine in some animal models. Cattle and sheep are 
asymptomatic carriers of E. coli 0157: H7 and sources of the organism for humans. The 
present studies examined the persistence of several strains of E. coli 0157: H7 in orally 
inoculated sheep, and attempted to correlate persistence with features of the strains in vitro 
and in vivo. A particular hypothesis tested was that adhesion of the bacterium to the 
intestinal mucosa is a significant mechanism for persistence in animal hosts. 
Host- and strain-dependent variation in the persistent excretion of E. cola 0157: H7 was 
observed. Correlations could not be discerned between the persistence of the various 
bacterial strains and the results of a range of phenotypic tests. The ability of E. coli 0157: H7 
to form AE attachments to the large intestinal mucosa in sheep of up to six months of age 
was demonstrated. No consistent site of persistence of E. coli 0157: H7 within the ovine 
alimentary tract was found, and AE lesions were not detected in sheep which were 
persistently excreting the organism. However, commensal bacteria, including E. coli 026, 
were seen to have formed AE attachments on the large intestinal mucosa. 
It was concluded that the attachment of E. coli 0157: H7 to the large intestinal mucosa by 
AE lesion formation may have a role in persistent carriage, but that persistence of the 
bacterium in the ovine intestine is probably influenced by additional bacterial and host 
factors. The potential value of interference in the formation of AE lesions, to reduce the 
prevalence of E. coli 0157: H7 excretion by sheep and other ruminants, merits further 
investigation. 
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Chapter 1- GENERAL INTRODUCTION 
1.1 Escherichia coli 
1.1.1 Essential features of Escherichia coil 
Escherichia coli (E. coli) is a small to medium-sized (2-6 gm long) Gram-negative rod, 
classified in the family Enterobacteraceae. Enterobacteraceae are facultative anaerobes that 
ferment sugars to acids. The family includes saprophytes as well as animal and plant 
parasites, some of which are pathogenic. The normal habitat of E. coif is the large intestine 
and lower small intestine of warm-blooded animals, although survival outside the host is 
possible for weeks to months. Generic information on E. cola has been reviewed by 
VanDemark and Batzing 1987, Timoney et al. 1988 and Quinn et al. 1994. 
E. coif has a typical Gram-negative prokaryote cell wall structure (VanDemark and 
Batzing 1987). The phospholipid bilayer cytoplasmic membrane is covered externally by 
cross-linked peptidoglycan with an intervening periplasmic space. External to the 
peptidoglycan layer is the outer membrane, which also has a phospholipid bilayer structure. 
Proteins involved in pore formation, transport and adhesion, collectively termed'outer 
membrane proteins' (OMP), and lipopolysaccharides are present in the outer membrane. The 
latter comprise fatty acid chains (lipid A) lying within the membrane and attached to a'core' 
polysaccharide at the external surface. Branching polysaccharide chains are attached to this 
core and extend away from the membrane surface; these form the '0' (somatic) antigens and 
are variable between strains but identical over the surface of any one cell. Some E coli 
strains additionally have a surface polysaccharide capsule. 
E. coli has filamentous appendages known as flagella, fimbriae and pili, reviewed by 
VanDemark and Batzing 1987, Krogfelt 1991 and Smyth et al. 1994. Flagella are 
approximately 17 nm in diameter and up to 200 µm long. They are helical protein multi-unit 
structures, which are associated with the cytoplasmic membrane at their base. Their function 
is to confer motility upon the cell body, which is achieved by rotation of the flagellum. 
Common usage has tended to prefer the terms'fimbriae' for adhesive organelles and'pili' for 
sexual appendages, although this is not a strictly observed terminology, and the function of 
many observed appendages is unclear. Pili and fimbriae arise from the cytoplasm or 
cytoplasmic membrane and genetic encoding of these structures varies between strains. 
Expression is often dependent on environmental conditions and stage of growth. They are 
composed of repeating protein subunits and are of 2 to 8 nm diameter and 0.2 to 20 µm 
length. Type-I fimbriae cause mannose-sensitive haemagglutination and are functionally 
heterogeneous (Sherman et al. 1985). Morphologically, fimbriae may be divided broadly into 
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three classes: rigid 7 nm diameter structures, flexible 2-4 nm diameter fibrillar structures, 
and bundle-forming pili (BFP) which form tangled rope-like structures composed of many 4 
to 7 nm diameter fimbriae (Giron et al. 1991; Nataro and Kaper 1998). There is a further 
class of 2 nm diameter, coiled, fimbrial-type organelles termed 'curl i' which bind to tissue 
matrix proteins (Olsen et al. 1989) and major histocompatibility complex class I molecules 
(Olsen et al. 1998). 
The E. coli chromosome is a double-stranded, circular DNA molecule of about 4 mega 
base pairs (Mbp). In addition to the chromosome, E. coli may contain plasmids of circular 
double-stranded DNA, varying in number from one to II and in size from 0.3 to 
approximately 60 Megadaltons (Mda; Hard and Dykhuizen 1984). Genes associated with 
pathogenic subtypes are located on both the chromosome and plasmids (VanDemark and 
Batzing 1987). 
Transfer of genes may occur between plasmids and the chromosome within an E. coli 
cell, between different cells of the same or different strains, or between different bacterial 
species. Genetic exchange is accomplished by F-pilus conjugation, bacterial virus 
(bacteriophage) transduction and DNA-uptake transformation (VanDemark and Batzing 
1987). Transposable elements are genetic sequences which can move, and sometimes 
replicate, independently within the genome. These comprise: insertion sequences (IS), 
transposons and some prophages of bacteriophages (Madigan et al. 1997a). IS encode only 
the genes required for their mobility, and their locations in the genome may be used to type 
strains. Transposons encode additional genes which can, for example, include antibiotic 
resistance-conferring elements. Bacteriophages (phages) may be virulent, where successful 
infection leads always to production of virus particles and lysis of the bacterium, or 
temperate, where the viral genome may be integrated into the bacterial genome as a 
prophage following infection, in a process called lysogeny (Madigan et al. 1997b). 
Lysogenised bacteria copy the viral prophage with the rest of the bacterial genome during 
replication. Prophages in lysogenised bacteria may become de-repressed and enter a lytic 
phase, when mature virus particles are produced and the host cell is lysed. If a prophage 
becomes damaged, it may lose the ability to enter the lytic phase and will then persist as a 
defective bacteriophage, possibly encoding genes which are expressed by the bacterium. 
Prophages may encode certain bacterial virulence factors, for example the Shiga toxin 
produced by certain strains of E. coli (Section 1.3.2). 
1.1.2 E. coli subclassification schemes of relevance to the present 
studies 
E. coli isolates may be classified and grouped according to diverse features, some of 
which are related to their capacity to cause disease, as reviewed (Hart) and Dykhuizen 1984; 
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Nataro and Kaper 1998). Pathogenic strains may be divided into pathotypes according to 
their associated diseases, as discussed in Section 1.1.3. 
Kauffmann (1946) proposed a serological typing system based on surface antigens, 
utilising heat-stable cell wall ('0'), heat-labile surface and heat-stable capsular (`K'), and 
flagellar (`H') antigens. Modern serotyping defines the serogroup in terms of the single 0 
antigen and the serotype in terms of the single 0 and H antigens present on any one isolate. 
K denotes capsular antigen (usually polysaccharide) when present. Fimbrial (`F') antigens, 
originally designated `K', may also be typed when present; in common usage they are often 
referred to by K number (e. g. K88, K99) or using a designation related to their type strain, 
e. g. 987P (Krogfelt 1991). Strains without 0 antigen are designated `rough' due to their 
colonial morphology, and strains without flagella are designated'H ' or'non-motile'/'NM'. 
The term `serovar' refers to any serologically-determined grouping. There is no strong 
relationship between serotype and genotype, as closely related strains may be of different 
serotype. 
The total genome size of E. coli varies by up to 23 % between strains, indicating 
substantial genetic variation. Gene probes are available for some characteristics associated 
with virulence, such as Shiga toxin production. Strains may also be genotyped in terms of 
plasmid content, restriction fragment patterns, IS, phage sequences, metabolic enzyme 
sequences, and other features of the genome such as strand-biased eight base-pair 
chromosomal DNA sequences termed octamers (Kim et al. 1999). 
E. coli produces several identified exotoxins, allowing typing on the basis of toxin 
production. Identification of the toxin may be attempted from culture medium or clinical 
specimens by in vitro or in vivo assays. For example, Shiga toxin produces a characteristic, 
progressive shrivelling effect on Vero (African green monkey kidney) cells (Konowalchuk et 
al. 1977) and HeLa (human cervical carcinoma) cells (O'Brien et al. 1982b). Cytotoxic 
necrotising factor (CNF) produces a multinucleating cytopathic effect on hamster ovary, 
Vero and HeLa cells, plus a necrotising lesion when injected intradermally into rabbits 
(Caprioli et al. 1983). Gene probes for known toxin genes may also be used, and serological 
evidence of toxin exposure can also be sought (Nataro and Kaper 1998). 
Biotypes, biogroups and biovars are distinguished on the basis of metabolic capabilities. 
Generally these tests have few advantages over other typing techniques, but some tests of 
high discrimination between closely related strains are in use. Metabolic variation can be of 
use in the detection and isolation of strains, as in the case of E. coli 0157: H7 which is 
distinguished from most other E. coli by its inability to ferment sorbitol, allowing the use of 
sorbitol-containing indicator media to help identify its presence. 
The specificity of a particular phage for E. coli strains depends on surface properties, and 
on prior lysogeny of strains with a related phage (Madigan et al. 1997b). A lysogenised 
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bacterium with, by definition, a repressed phage genome will similarly repress the genome of 
another phage of the same type if it is introduced into the cell. Phage typing is used in 
epidemiological research, for example comparing veterinary- and human-derived strains. A 
bias in the phage types of E. coli 0157: H7 found in different animal species has been noted 
(Paiba et al. 2002). 
1.1.3 Pathogenic E. coli 
E. coli typically are bowel commensals, with the persistence of strains varying over days 
to months in an individual animal (Hard and Dykhuizen 1984). Pathotypes are defined in 
terms of bacteriological and clinical features. Apart from opportunist infections following 
surface damage or implantation of bacteria into the body, E. coli which cause disease possess 
virulence factors that enable them to colonise mucosal surfaces, evade defence mechanisms, 
multiply and cause damage (Nataro and Kaper 1998). Virulence attributes identified so far 
include: a capsule (antiphagocytic), endotoxin (toxic, complement-defeating), fimbriae 
(adhesive), haemolysins (membrane-damaging, nutrient-releasing), siderophores (iron- 
binding for growth), exotoxins (variety of effects), attaching-effacing (AE) phenotype 
(intimate adherence) and acid tolerance (Quinn et al. 1994; Lin et al. 1996). Pathotypes of 
E. colt affecting the gastrointestinal tract of humans include: enteropathogenic (EPEC), 
enterohaemorrhagic (EHEC), enterotoxigenic (ETEC), enteroinvasive (EIEC) and 
enteroaggregative (EAEC, EAggEC), as reviewed by Nataro and Kaper (1998) and Levine 
(1987). Extra-intestinal infections occur also (Hartl and Dykhuizen 1984). Some strains, for 
example E. coli 0157: H7, are pathogenic in one species (Section 1.4.2.3), but are generally 
considered to be commensal organisms in others (Section 1.4.2.6). 
1.1.3.1 E. coli 0157: H7 and related pathotypes in humans 
Enteropathogenic E. coli (EPEC) 
Since the original serological definition of EPEC, which were associated with infant 
summer diarrhoea, other pathotypes have been defined and important virulence factors and 
pathological mechanisms have been identified. The modern definition of EPEC (Nataro and 
Kaper 1998) is non-serological and depends on the presence of the AE phenotype in vitro 
(Section 1.2) in the absence of Shiga toxins (Section 1.3). 
Clinical features of EPEC diarrhoea have been reviewed (Nataro and Kaper 1998). EPEC 
are now mainly associated with infant diarrhoea in the developing world. EPEC colonise the 
small and large intestine (Ulshen and Rollo 1980; Rothbaum et al. 1982) and the hallmark 
lesion is intimate adhesion to the enterocyte brush border with effacement of microvilli, the 
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so-called AE lesion (Section 1.2). Initial non-intimate attachment is followed by intimate 
attachment, with the latter mediated by a cluster of genes called the locus of enterocyte 
effacement (LEE), which includes the eaeA (E. coli attaching and effacing) gene encoding 
intimin (Section 1.2.3.2C). 
On HeLa or HEp-2 epithelial cell cultures, both cervical carcinoma lines (Chen 1988), 
EPEC strains show an initial distinctive, clustering, non-intimate adherence (Scaletsky et al. 
1984; Nataro et al. 1985) termed 'localised adherence' (LA). The LA as originally described 
is seen after a three hour incubation (strong LA), but a second, weak LA pattern is seen with 
some EPEC only after six hours (Scaletsky et at. 1999). Isolates showing the former pattern 
are termed'typical EPEC' and the latter 'atypical EPEC' (Nataro and Kaper 1998). A 50 to 70 
MDa plasmid encoding an uncharacterised'EPEC adherence factor' (EAF) has been 
described in EPEC which exhibit strong LA (Baldini et al. 1983) and its role in conferring 
the strong LA phenotype has been confirmed (Levine 1987). An EAF probe derived from 
this plasmid may be used to discriminate between typical and atypical EPEC. EAF probe 
sequences have occasionally been found on the chromosome (Nataro et al. 1985). The 
clinical significance of EAF has been shown in a human volunteer study which demonstrated 
a significant reduction of the diarrhoeagenic effect in EAF-negative strains derived from 
control EAF-positive EPEC isolates (Levine et al. 1985). The existence of EAF-positive 
strains in which strong LA has been abolished following mutations on the chromosome 
suggests that regulatory chromosomal genes are involved in the LA phenotype (Donnenberg 
et al. 1990). 
The EAF plasmid has been found to contain a gene cluster encoding the production and 
expression of BFP (Stone et al. 1996). These have been shown to mediate microcolony 
formation in culture and strong LA on HEp-2 cells, with inter-bacterial and bacterial-host 
cell connections via BFP evident under scanning electron microscopy (SEM; Giron et al. 
1991). The role of BFP in vivo is still unclear, as adhesion of EPEC to human duodenal and 
jejunal organ cultures appeared to be independent of EAF or BFP (Knutton et al. 1991; 
Hicks et al. 1998). Furthermore, non-intimate adhesion has been shown to require the eaeA 
gene (Hicks et al. 1998). Recently the complete DNA sequence of an EAF plasmid (pB171) 
was determined (Tobe et al. 1999). It contains operons for BFP production, enhancement of 
bfp gene expression and the Per global regulator (see below). The role of atypical EPEC in 
diarrhoea is not well defined, but epidemiological evidence for its significance is 
accumulating (Scaletsky et al. 1999). 
The eaeA gene, crucial to the full expression of the AE phenotype, has been shown to be 
an EPEC virulence factor in a human volunteer study (Donnenberg et al. 1993a), however 
pathogenicity was not completely abolished by the removal of eaeA. 
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An additional property of EPEC, of uncertain significance, is the ability to invade host 
epithelial cells that has been observed in vivo (Fagundes-Neto et al. 1995) and in vitro 
(Miliotis et al. 1989). Invasiveness appears to be influenced by EAF, AE phenotype and 
other, largely undetermined, attributes. The relationship between in vitro cell culture 
invasion assays and in vivo behaviour remains to be clarified (Donnenberg et al. 1990; 
Fletcher et al. 1992). 
A regulatory gene cluster, termed plasmid-encoded regulator (Per) is present on the EAF 
plasmid. It influences expression of certain genes of the AE phenotype-encoding LEE 
(Section 1.2.3), including eaeA, plus the bfp gene cluster (Nataro and Kaper 1998). Per 
appears to be a global virulence regulator which also may affect host tissue tropism as it has 
been shown to confer human tropism upon a rabbit E. coli pathogen (Tesh and O'Brien 
1992). 
The diarrhoeagenic mechanisms operating in EPEC infection are not well understood, but 
observation and experiment have revealed several potentially significant effects occurring in 
parallel and on varying timescales. These include: increased chloride secretion by 
enterocytes, increased intestinal permeability associated with decreased transepithelial 
electrical resistance, maldigestion and malabsorption associated with effacement of 
microvilli and villus atrophy, and inflammation (Donnenberg et al. 1997). 
EPEC strains show more genetic similarity to each other than to other members of their 
respective serotypes, i. e. there is evidence that EPEC are clonally-derived from a common 
ancestor (Donnenberg and Kaper 1992). EPEC may be divided into two clonal groups on 
the basis of multilocus enzyme electrophoresis (Donnenberg and Whittam 2001), which are 
reflected in the H antigen type (Frankel et al. 1998b) and the chromosomal location of the 
LEE (Kaper 1998). 
Enterohaemorrhagic E. coli (EHEC) 
The EHEC pathotype of E. coli was identified following two observations in the early 
1980s. A distinctive gastrointestinal illness was recognised which was termed haemorrhagic 
colitis (HC) and which was associated with a previously rare E. coli serotype, 0157: H7 
(Riley et al. 1983). Karmali et al. (1983; 1985) noted the clinical connection between HC, 
haemolytic-uraemic syndrome (HUS, Section 1.3.4.2), and faecal Shiga (Vero-) toxin or 
Shiga toxin-producing E. coli (STEC, including serotype 0157: 117) isolated from stools. 
'EHEC' was first defined in 1987 (Levine 1987). The definition currently rests on clinical, 
phenotypic and genotypic features. 'Typical' EHEC cause HC and HUS, produce Shiga 
toxins, have an AE phenotype in standard in vitro assays and possess a 60 MDa plasmid, 
termed pOl57 or EHEC plasmid. 'Atypical' EHEC lack either or both of the AE phenotype 
and pO157 plasmid. Important differences from EPEC include: Shiga toxin production, the 
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absence of EAFBFP, the nature and variable presence of the AE lesion, and the site of 
lesions in humans and animal models, this being limited to the large intestine and lower 
ileum in EHEC infection (Nataro and Kaper 1998). 
EHEC are a heterogeneous group, including some non-AE strains (Willshaw et al. 1992), 
and although the EHEC pathotype is a clinically helpful concept, many workers prefer to use 
the broader category of STEC (or Verocytotoxigenic E. coli, VTEC). This is better-defined 
when dealing with strains from any source, including non-clinical isolates, and reflects the 
evidence that Shiga toxin is an essential element in the clinical disorders associated with 
EHEC. 
1.1.3.2 E. coli causing enteric disease in the veterinary species 
Veterinary pathotypes are classified similarly to human E. coli. In particular ETEC 
(Barker et al. 1993), and EPEC- and EHEC-like strains, are recognised. There is substantial 
variation in the serotypes causing disease in different species (Taylor 1961), and few human 
pathogenic serotypes are represented (Nataro and Kaper 1998). 
Attaching-effacing E. cola (AEEC), EPEC and EHEC 
AEEC not producing Shiga toxin or enterotoxin may be termed EPEC, and have been 
reported in association with diarrhoea in the calf (Pospischil et al. 1987; Pearson et al. 1989; 
Janke et al. 1990), dog, (Broes et al. 1988; Drolet et al. 1994a), rabbit, pig, lamb (Barker et 
al. 1993; Finlay and Abe 1998), goat (Drolet et al. 1994b) and cat (Pospischil et al. 1987). 
Rabbit EPEC (REPEC) have been extensively studied. REPEC have been found in 
several serogroups, and two subtypes have been identified. One affects suckling rabbits, with 
AE lesions throughout the intestinal tract, and the other affects weanling rabbits, with AE 
lesions restricted to the lower ileum and large intestine (Cantey and Blake 1977; Prescott 
1978). The weanling subtype appears to be of low virulence in the neonate (Peeters et al. 
1984a) and vice versa (Peeters et al. 1984b). RDEC-1 is a REPEC affecting weanlings and 
older rabbits, expressing a plasmid-encoded fimbrial adhesin (AF/Rl; Berendson et al. 1983) 
which mediates specific non-intimate adherence to the rabbit intestinal brush border 
(Sherman et al. 1985; Wolf et al. 1988), and which increases virulence and AE lesion 
formation in vivo (Wolf et al. 1988). Another fimbrial adhesin, AF/R2, is expressed by 
REPEC 0103 (Nougayrede et al. 1999). A gene cluster homologous with the LEE of human 
EPEC has been found in RDEC-1 (Deibel et al. 1998). 
AEEC are isolated frequently from both healthy and sick calves, and there is evidence of 
a particular association between calf diarrhoea and the presence of the beta subtype of 
intimin (China et al. 1998; China et al. 1999). In several reports, EPEC-like organisms have 
been associated with AE lesions in the large and small intestines of diarrhoeic calves (Janke 
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et al. 1989; Janke et al. 1990; Holland et al. 1999), although only in one case has a positive 
identification of the organism in situ been made (Pearson et al. 1989). A natural HC-like 
disease in calves has been reported in association with several E. coli serotypes (Hall et al. 
1985; Schoonderwoerd et al. 1988; Johnson et at. 1996), some of which have been shown to 
produce AE lesions experimentally in calves (Chanter et al. 1984; Moxley and Francis 1986; 
Schoonderwoerd et al. 1988; Wray et al. 1989) and to be Shiga toxin-producers (Moxley and 
Francis 1986; Hall et al. 1988; Schoonderwoerd et al. 1988; Wray et al. 1989). Diagnostic 
investigations have revealed AE lesions associated with STEC, including 026: H11, in 
diarrhoeic calves with and without dysentery (Iijima et al. 1990; Janke et al. 1990; Gunning 
et al. 2001). Isolates of E. coli 026: H II hybridising with eacA and EHEC plasmid probes 
but lacking Shiga toxin have also been isolated from diarrhoeic calves (Saridakis et al. 
1997). Haemorrhagic diarrhoea with AE lesions has been reported in an adult cow (Wada et 
al. 1994) and an eight-month old heifer (Pearson et al. 1999). In the latter, Shiga toxin and 
other EHEC genes were detected in an associated 026: H ii strain isolated from a 
symptomatic in-contact animal. In summary, bovine EHEC-type strains causing diarrhoeal 
disease have been identified but there is significant variation in the virulence attributes 
identified between strains and information is patchy. The human EHEC serotypes 026: H11 
and 0111: H- have been implicated, but not 0157: H7. No HUS-like disease is reported in 
calves, but this may be difficult to identify in the f ield, as dehydration and acidosis of 
diarrhoeic calves may obscure and preclude assessment of haematological abnormalities. 
AE lesions have been seen in a few cases of postweaning diarrhoea in pigs (Section 
1.1.3.2), associated with E. coli (Janke et al. 1989), including serogroup 045 (Helie et al. 
1991). Experimentally, E. coli 0116 has been associated with AE lesions in weaned pigs 
(Neef et al. 1994). In pigs and sheep, Shiga toxin-producing E. coli (STEC) have not been 
associated with AE lesions in vivo, and no association with haemorrhagic colitis has been 
made. However, a colostrum-deprived lamb inoculated orally with a bovine EHEC strain did 
develop dysentery and die (Moxley and Francis 1986). 
Oedema disease and postweaning diarrhoea in pigs 
Oedema disease of swine is associated with E. coli producing a subtype of Shiga toxin 
(Stx2e) which causes a systemic angiopathy leading to death from vascular leakage. 
Outbreaks are often associated with postweaning diarrhoea (PWD) within the affected group. 
Oedema disease and PWD strains occur in serogroups 0138,0139, and 0141, plus 0149 in 
some cases of PWD. Some oedema 
disease strains produce an enterotoxin. PWD strains are 
enterotoxigenic and some additionally produce 
Shiga toxin. The F 18 fimbrial adhesin is 
implicated in colonisation of the small intestine in both diseases (Gyles 1998), but typically 
AE lesions are not found. 
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1.2 The Attaching-Effacing (AE) Lesion 
1.2.1 Morphology 
The AE lesion is characterised by intimate adherence between the bacterium and the 
epithelial cell membrane with an intervening gap of about 10 nm, plus effacement of 
enterocyte microvilli. The lesion was first described in rabbits (Polotsky et al. 1977; 
Takeuchi et al. 1978). Beneath the adherent bacterium a cytoskeletal rearrangement, 
including the accumulation of filamentous actin (F-actin), is seen. The bacteria often sit upon 
a pedestal-like structure, which can extend up to 10 gm away from the epithelial cell surface 
(Kaper et al. 1998). 
1.2.2 Animal and in vitro models 
Young rabbits and gnotobiotic or caesarean-derived colostrum-deprived (CDCD) piglets 
have proved convenient and useful models for studying AE lesions. They are susceptible to 
human AEEC and, in the case of the rabbit, there are well-characterised AEEC adapted to 
the model species. Piglets are usually inoculated at one to two days of age and develop AE 
lesions in the distal ileum and the large intestine when inoculated with EPEC, EHEC, bovine 
EHEC-like and REPEC strains (Moon et at. 1983; Tzipori et al. 1985; Hall et al. 1988; 
Tzipori et at. 1989). The susceptibility of piglets to AE lesions appears to decline with 
increasing age (Moon et al. 1983). 
Rabbits exhibit AE lesions with REPEC, EPEC and EHEC (Moon et al. 1983; Sherman et 
al. 1988a), and EPEC-induced AE lesions have been observed with in vitro organ culture 
(IVOC) of the rabbit ileum (Batt et al. 1987). 
Studies in mice with EHEC have not revealed AE lesions (Wadolkowski et al. 1990), but 
Citrobacter rodentium, which encodes a LEE, does induce AE lesions in murine 
transmissible colonic hyperplasia (Adu-Bobie et al. 1998). 
IVOC using AEEC-inoculated human tissues has shown AE lesions (Knutton et al. 1987; 
Phillips and Frankel 2000a; Phillips et at. 2000b; Fitzhenry et al. 2002). Common human cell 
lines on which AE lesions are formed include HEp-2, HeLa, Henle (Int) 407 (all cervical 
carcinoma derivatives; Gey et al. 1952; Lavappa 1978; Chen 1988), Caco-2 (colon 
carcinoma), T84 (colon), HCT-8 (ileocaecum) and HEL 229 (human embryonic lung 




1.2.3.1 The locus of enterocyte effacement (LEE) 
The LEE pathogenicity island has been found in all tested bacterial strains which express 
the AE phenotype (McDaniel et al. 1995). In EPEC 0127: H6 It is a 35.6 kbp chromosomal 
insertion, encoding 41 predicted open reading frames (orf), which have a distinct C and G 
nucleotide percentage (38.3 %) when compared with the rest of the E. coli genome (50.8 %), 
indicating an origin outside the species (Elliott et al. 1998). The EPEC LEE is necessary and 
sufficient for expression of the AE phenotype in vitro (McDaniel and Kaper 1997), but the 
EHEC 0157: H7 LEE is larger (approximately 41 kbp) and appears to be insufficient on its 
own for that function (Section 1.4.2.2B; Elliott et al. 1999). Differences between the LEE 
genes of EHEC and EPEC are most marked among the proteins which interact directly with 
the host (Perna et al. 1998), which possibly contributes to the different disease patterns 
observed. 
For both EPEC and EHEC there are four operons (LEE 1-4) which encode secreted 
proteins and a type III secretion apparatus (Section 1.2.3.2B, part ii), plus an operon (Tir) 
encoding the Tir and intimin proteins (Section 1.2.3.2C). Within LEE I is an orf termed Ler 
(LEE-encoded regulator) which is under the positive influence of the Per regulator found on 
the EAF plasmid of EPEC, and which upregulates expression of LEE operons 2 to 4 (Mellies 
et al. 1999). Additionally, Ler promotes expression of the Tir operon and of other non-LEE 
secreted proteins of EPEC and EHEC, suppresses novel fimbriae in EPEC and EHEC, and 
alters adherence patterns in vitro (Elliott et al. 2000). It therefore appears to act as a global 
regulator. 
Investigations into regulation mechanisms have revealed that the EPEC and EHEC LEE, 
including Ler, is under the influence of a quorum-sensing mechanism, mediated by the 
autoinducer product of the luxS gene which is found in many E. coli and is released into 
supernatant (Sperandio et al. 1999). It has been hypothesised that quorum sensing is to some 
extent responsible for the upregulation of virulence determinants, such as the LEE, in an 
intestinal environment, using signals from the intestinal flora (Sperandio et al. 2001). EPEC, 
which colonise the relatively bacteria-poor small intestine, may compensate for the low 
signal from the surrounding flora via the Per promoter (Sperandio et al. 1999), whereas this 
may be an unnecessary mechanism for EHEC, which lack Per and which colonise the 
bacteria-rich large intestine. In addition, another quorum sensing system, involving the SdiA 
regulator, appears to act as a late-stage repressor of LEE expression in EHEC 0157: H7, but 
not in EPEC (Kanamaru et al. 2000). 
There is one report of a plasmid-borne REPEC AE determinant (Fletcher et al. 1990). It 
was not possible to identify any LEE genes on subsequent investigation of the plasmid, nor 
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was any single gene from the plasmid able to confer the AE phenotype (Fletcher et al. 1992). 
The possibility of a plasmid-borne regulatory gene cluster could not be excluded and the 
presence of a chromosomal LEE was not determined. 
1.2.3.2 Development of the AE lesion 
A three-stage model for the AE process has been proposed (Donnenberg et al. 1997), 
although a final invasion stage may be included (Tesh and O'Brien 1992). 
A. Initial non-intimate attachment 
An early non-intimate attachment appears to be necessary for initial signalling leading to 
development of the lesion, but the mediators of this attachment are poorly understood. 
Studies have shown a potentiating effect of suspected adhesive factors, such as EAF and the 
REPEC-associated AF/Rl, on AE lesion formation in vitro and on AEEC virulence in vivo. 
Several putative E. coli 0157: H7 adhesins have been identified in vitro (Section 1.4.2.2D), 
but their roles in promoting AE lesion formation are unknown. EspA filaments (Section 
1.2.3.2B) may act as an adhesin for EPEC (Knutton et al. 1998; Daniell et al. 200lb) and for 
E. coli 0157: H7 (Tatsuno et al. 2000). Intimin and Tir, which are directly involved in 
intimate attachment, appear to be important for the primary adhesion and microcolony 
formation of E. coli 0157: H7 (Section 1.4.2) in vitro and for detectable adherence in vivo 
(Marches et al. 2000), but intimin-deficient mutants may still adhere diffusely in vitro 
(Tatsuno et al. 2000). 
B. Signal transduction leading to cytoskeletal reorganisation and microvillus 
effacement. 
AEEC use a type III secretory apparatus, which functions to deliver bacterial proteins into 
the cytosol of the host eukaryotic cell (Hueck 1998). The type III apparatus is encoded on the 
LEE by sep and esc genes (Elliott et al. 1998), and another LEE gene (pas) is necessary for 
its function in EHEC 0157: H7 (Kresse et al. 1998). The LEE encodes several proteins 
secreted by the type III apparatus, termed SPEC-secreted proteins (Esp), which are induced 
in eukaryotic cell culture medium and in vivo. Three Esp (A, B and D) are essential for 
normal AE lesion formation. EspA forms filaments on the bacterial surface, in an EspD- 
dependent manner (Knutton et al. 1998), which adhere to host cells (Shaw et al. 2002). There 
is evidence that EspD participates in forming pores in the host cell membrane also (Daniell 
et al. 2001 a). EspD from an 0157: H7 EHEC has been localised to the membrane of the 
target cell (Kresse et al. 1999) and certain AE diffusely-adhering E. coli (Nataro and Kaper 
1998) insert EspD into the host cell membrane (Wachter et al. 1999). EspB is translocated to 
the host cell in an EspA-dependent manner (Ebel et at. 1998; Knutton et al. 1998), and is 
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distributed in the plasma membrane and the cytosol of the host cell (Wolff et at. 1998). 
Although EspB binds EspA and is co-localised with it, EspB is not necessary for EspA 
interaction with host cells (Hartland et al. 2000). An Esp -A, -B and -D -dependent 
haemolytic action of EPEC has been reported, suggesting that all three of these proteins may 
be involved in pore formation in eukaryotic cell membranes (Warawa et al. 1999). 
A current model proposes that a bacterial transmembrane structure, encoded by escC, 
links with a hollow EspA filament to form a bi-functional organelle which has adhesive and 
protein-translocating roles (Daniell et al. 2001b). Esp -B and -D may create a eukaryotic cell 
membrane pore-forming structure. Connected together, these elements could form a 
molecular'syringe' for the introduction of bacterial macromolecules into the host cytosol 
(Frankel et al. 1998b). The distribution of EspB within the host cell membrane plus cytosol 
(Taylor et al. 1998; Wolff et al. 1998) and the importance of EspB in the phosphorylation of 
Tir (see below) suggests that EspB may have other functions instead of, or in addition to, 
that proposed. Significant differences in the roles of the Esp proteins of EPEC and EHEC are 
becoming apparent, with the adhesion of mutants of EHEC 0157 in EspA and EspD being 
more profoundly affected than that of similar mutants of EPEC (Kresse et al. 1999). 
Two secreted proteins, EspC (110 kDa) and EspF (21 kDa) are not essential for the AE 
phenotype (Donnenberg et al. 1997; Frankel et al. 1998b). EspF appears to have a role in 
disrupting the intestinal epithelial barrier function (McNamara et al. 2001), and EspC is 
secreted independently of the type III mechanism and has an enterotoxic activity (Mellies et 
al. 2001). 
AEEC translocate a LEE-encoded 72 to 80 kDa receptor for the eaeA gene product 
(intimin), termed the translocated intimin receptor (Tir), into the host cell (Rosenshine et al. 
1992; Kenny et al. 1997b; Deibel et al. 1998; DeVinney et al. 1999). This translocation is 
dependent on the type III secretion system. Tir undergoes an apparent increase in molecular 
mass within the host cell, from 72 kDa to 88 kDa in the case of E. coli 0157: H7 (DeVinney 
et al. 1999). With EPEC 0127: H6 the shift is from 78 kDa to 85 kDa and involves serine 
residue phosphorylation (Warawa and Kenny 2001). The alteration in apparent mass may be 
due to conformational changes, which may in turn be required for a functional conformation 
within the host cell membrane (Warawa and Kenny 2001). Tir is thought to adopt a hairpin- 
loop conformation when in situ in the host cell membrane, with the C- and N-terminals 
located on the cytoplasmic side of the plasma membrane and an externally-presented loop 
forming the Tir-intimin binding area (Hartland et al. 1999; Kenny 1999). 
Kenny (1999) has shown that additional phosphorylation of tyrosine 434 of EPEC Tir is 
required for filamentous actin focusing (see below), but this modification is not required for 
membrane insertion and does not contribute to shifts in apparent molecular mass. Tyrosine 
phosphorylation does not occur with E. cola 0157: H7 Tir (DeVinney et al. 1999), where 
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tyrosine 434 is replaced by serine (Kenny 1999), but the molecule remains associated with 
filamentous actin nucleation. Phosphorylation of proteins at the site of the lesion appears to 
be dependent upon EspB secretion (Ismaili et at. 1998). 
At the site of intimate attachment, considerable eukaryotic cytoskeletal reorganisation 
occurs, with depolymerisation of actin, the formation of filamentous actin (F-actin) and the 
accumulation of a-actinin, myosin light chain, talin and ezrin (Donnenberg et at. 1997). a- 
actinin cross-links actin, and talin and ezrin are believed to link actin with transmembrane 
proteins such as integrins (Finlay et at. 1992). These cytoskeletal changes are associated with 
effacement of microvilli and disruption of the intestinal barrier function of enterocytes 
(Simonovic et al. 2001). The F-actin may be detected in vitro by virtue of its specific affinity 
with the fungal toxin phalloidin, or by antibody labelling. Fluorescein-conjugated phalloidin 
forms the basis of the filamentous actin staining (FAS) test, by which AE lesions may be 
detected and characterised in vitro (Knutton et al. 1989) on a variety of cell lines, including 
HeLa, HEp-2, Caco-2, and HEL 229 (human embryonic lung fibroblast). 
The mechanisms by which cytoskeletal elements are dissolved and reaggregated are 
unclear. Current theories implicate translocated bacterial proteins such as EspB and Tir, 
which are co-localised at the site of cytoskeletal reorganisation, plus activation of host cell 
protein kinase activity (Frankel et at. 1998b). 
C. Intimate attachment 
Intimin is a 94 kDa bacterial surface-exposed outer membrane protein which is the 
product of the eaeA gene (Jerse and Kaper 1991; Louie et al. 1993). Tir binds intimin 
(Rosenshine et al. 1996; DeVinney et al. 1999; Hartland et al. 1999); both proteins are 
necessary for the development of the mature AE lesion (Donnenberg et at. 1993b; 
Rosenshine et al. 1996; Kenny et al. 1997b) and both are virulence factors for REPEC 
in vivo (Marches et at. 2000). Examination of eaeA-negative mutants in vitro reveals a 
'shadow' FAS phenotype demonstrating a dim, diffuse FAS reaction (Jerse et at. 1990), 
indicating that intimin is required for intimate adhesion but is not necessary for the earlier 
stages of signal transduction. Cells bearing EPEC 0127: H6 Tir appear to form normal AE 
lesions with EHEC 0157: H7, but AE lesions between EPEC 0127: H6 and cells bearing 
EHEC Tir are attenuated (DeVinney et at. 1999). This indicates that there is a limited degree 
of functional interchangeability between intimin and Tir from different pathotypes of E. coli. 
Intimin/eaeA has protein and gene sequence homology with the invasin molecule which 
promotes invasion of host cells by Yersinia (Isberg and Leong 1990), but it is significantly 
different in the protein C-terminal domain, which is the part responsible for binding to host 
cells (Frankel et at. 1994). Five principal subtypes of intimin (a, ß, y, S and s) are currently 
recognised, based on antigenic and amino acid sequence differences at the C-terminal 
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domain (Adu-Bobie et at. 1998; Oswald et al. 2000). The occurrence of intimin subtypes 
parallels the clonal groupings established for EPEC and EHEC. Thus, most EPEC express 
either a-intimin (clonal group 1) or ß-intimin (clonal group 2), and most EHEC express 
either ß-intimin (clonal group 2) or y-intimin (clonal group 1, including 0157: H7). 
A Tir-independent c-lectin-like binding site has been found in the C-terminal domain of 
intimin, which has been shown to be necessary for expression of the AE phenotype (Frankel 
et al. 1998a; Hartland et al. 1999). Speculation that intimin subtype may confer tissue 
tropism upon AEEC, reflected in differing zones of gut affected by EPEC and EHEC 
(Tzipori et at. 1995) was discounted following the observation that EPEC Tir binds multiple 
intimin subtypes (Hartland et at. 1999). The finding of another binding site on intimin which 
is necessary for AE lesions once again raises this possibility, although detailed analysis of 
EPEC intimin has shown that binding of c-lectins by intimin in the conventional manner is 
unlikely (Luo et at. 2000). Experiments using piglets and EHEC eaeA-negative mutants 
complemented with EPEC and EHEC eaeA genes have produced conflicting results. In one 
experiment, EPEC eaeA in EHEC O 157: H7 produced an EPEC-type (distal half of the small 
intestine plus large intestine) lesion distribution (Tzipori et at. 1995), whilst in another, a 
similar manipulation produced an EHEC-type (large intestine and occasionally terminal 
ileum) distribution (Donnenberg et at. 1993b). 
Intimin has been shown also to bind f 1-integrins (Frankel et at. 1996). The significance of 
this is unknown, as intimin-bearing EPEC cannot bind intimately to host cells in the absence 
of Tir (Rosenshine et at. 1996). 
D. Invasion 
The tendency for EPEC invasion of host cells is promoted by EAF and eaeA (Francis et 
al. 1991), plus other unknown determinants (Fletcher et at. 1992). EHEC show less tendency 
to invade in vitro but co-incubation with EPEC increases the invasiveness of 0157: H7 on 
HEp-2 cells (Ismaili et al. 1998). 
1.2.4 Attaching-effacing lesions in clinical specimens 
1.2.4.1 Human 
AE lesions have been reported in intestinal tissues from several diarrhoeic infants (Ulshen 
and Rollo 1980; Rothbaum et al. 1983). Despite forming AE lesions in vitro, E. coli 
0157: H7 has not yet been observed to cause AE lesions in vivo in human intestine. 
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1.2.4.2 Veterinary species 
AE lesions were first illustrated, incidentally, in piglets inoculated with a human EPEC 
serotype (Staley et al. 1969). Field cases of AE lesions have been reported or illustrated from 
veterinary species, initially in rabbits in 1978 (Takeuchi et al. 1978), and subsequently in 
calves (Moon et al. 1979; Hall et al. 1985), cats (Pospischil et at. 1987), lambs, pigs and 
young dogs (Janke et al. 1989), goats (Drolet et al. 1994b) and chickens (Fukui et al. 1995). 
1.2.5 Detection 
FAS is considered to be a definitive test for AE lesions in vitro, but adhesion 
characteristics of AEEC vary, particularly among EHEC (Karch et al. 1987; Knutton et al. 
1989; Tesh and O'Brien 1992). AEEC which do not adhere to the particular test cell line may 
give a false negative result. Amongst animal pathogens the sensitivity of assays on 
commonly-used cell lines may be low. For example, REPEC 0103 is AE and FAS-negative 
on HeLa cells, but FAS-positive on a rabbit cell line (Nougayrede et al. 1999), and bovine 
LEE-positive STEC are more commonly FAS-positive on a bovine cell line than on HEp-2 
cells (Wieler et al. 1998). Interpretation of the FAS test requires care as there is a'shadow', 
unfocussed, lesion which occurs when signal transduction is not followed by full lesion 
formation (Jerse et al. 1990). 
The characteristic morphology of AE lesions may be seen using transmission electron 
microscopy (TEM) on intestine or cell culture sections. 
1.3 Shiga Toxins 
1.3.1 Introduction 
A parallel terminology exists with Shiga toxin nomenclature, relating to source (Shigella) 
and effect (Verocytotoxicity). The following terminology and abbreviations will be used in 
the present thesis: 
'Shiga toxin' meaning any of the Shiga toxin family (Shiga toxin, Shiga-like 
toxin) 
'Stx' meaning Shigella dysenteriae serotype I toxin 
'Stxl' meaning E. coli Shiga (like) toxin I/ Verotoxin I/ VTl 
'Stx2' meaning E. coli Shiga (like) toxin 2/ Verotoxin 2/ VT2 
'STEC' meaning Shiga (like) toxin-producing E. coli / Verocytotoxin- 
producing E. coli / VTEC 
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Konowalchuck et al. (1977) were the first to report an E. coli toxin or toxins lethal to 
Vero cells and distinct from enterotoxin. These toxins are related to Stx, and two 
antigenically non cross-reactive groups, Stx/Stxl and Stx2, are recognised (Scotland et al. 
1985). Both are cytotoxic for Vero and HeLa cells (Griffin and Tauxe 1991). 
1.3.2 Shiga toxin structure, subtypes and genetics in E. coli 
Shiga toxins have a subunit structure consisting of a single A subunit plus five B subunits 
(Melton-Celsa and O'Brien 1998a). Stxl is neutralised by anti-Stx antiserum (O'Brien et al. 
1982b), appears to be antigenically homologous to Stx and differs from it by one amino acid 
in the A subunit (Strockbine et al. 1988). Expression of both Stx and Stxl is regulated by 
environmental factors including temperature and the presence of iron (O'Loughlin and 
Robins-Browne 2001). Stx2 comprises an antigenically related family of subtypes including 
Stx2, Stx2c, Stx2d and Stx2e which are not neutralised by anti-Stx/Stxl antiserum (Marques 
et al. 1986) and which apparently are not environmentally regulated (O'Loughlin and 
Robins-Browne 2001). The genes encoding Stxl and Stx2 (sal and stx2) are chromosomally 
located and are inserted by temperate toxin-converting bacteriophages (Scotland et at. 1983; 
Williams Smith et at. 1983; O'Brien et al. 1984; Strockbine et al. 1986), with the exception 
of Stx2e (Williams Smith et al. 1983; O'Brien and Holmes 1987). Shiga toxin production 
may occur at a late stage in the lytic phase of the bacteriophage cycle (Plunkett et al. 1999), 
but some Shiga toxin genes may be associated with defective bacteriophages (O'Brien et al. 
1989). STEC may produce either or both Shiga toxin subtypes and multiple copies of stx2 
are found in some STEC (Lindgren et at. 1993). Stx2 cytotoxicity appears to be more 
strongly associated with culture supernatant than Stxl, which is more cell-associated and is 
released in larger amounts following lysis of bacterial cultures (Nataro and Kaper 1998). 
Shiga toxin production is usually assayed by antibody neutralisation of the characteristic 
cytotoxicity on HeLa or Vero cells. This technique has demonstrated high, medium and low 
degrees of cytotoxicity, with neutralising titres varying by up to ten thousand-fold (O'Brien 
et al. 1982b; Hall et al. 1988) and which appear to be related to the amount of Shiga toxin 
produced (O'Brien and Laveck 1982a). E. coli demonstrating low-level cytotoxicity on cell 
assays include RDEC-1, some ETEC and EIEC and the laboratory strain K-12 (O'Brien et at. 
1982b; Marques et at. 1986). Such cytotoxicity appeared to be entirely bacterial cell- 
associated in one study (Marques et al. 1986). When probed for Shiga toxin genes, low-level 
Verocytotoxic E. coli are found to be negative, and are now considered not to be STEC 
(Nataro and Kaper 1998). Some non-0157: H7 E. coli strains associated with haemorrhagic 
colitis were found to be low level Shiga toxin producers (Marques et al. 1986), although the 
possibility of concurrent infection with undetected high-level STEC in these clinical cases 
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cannot be excluded. Strains which contain Shiga toxin genes and which do not produce 
detectable Shiga toxin have been found (Bonardi et al. 1999). 
1.3.3 Mechanisms of toxicity and target tissues 
1.3.3.1 Animal models 
A. Rabbit 
Oral inoculation of infant rabbits with EHEC 0157: H7 produced diarrhoea with AE 
lesions in the large intestine. Oral dosing with cell-free Shiga toxin extracts from the same 
strain produced colitis with diarrhoea (haemorrhagic in one animal) without AE lesions (Pai 
et al. 1986). Histology revealed widespread epithelial apoptosis in the colon. Thus, 
haemorrhagic colitis was shown to be induced by Shiga toxin without AE lesions in this 
case. A dilating effect of Shiga toxin in ileal loops has been demonstrated in rabbits 
(Williams Smith et al. 1983). Intravenous inoculation of Stxl produces non-bloody diarrhoea 
and neurological signs in adult rabbits (Richardson et al. 1992), associated with localisation 
of Stxl in the intestinal and central nervous system (CNS) microvasculature. Intravenous 
inoculation of STEC culture supernatants, including Stx2e-like toxin, induced caecal oedema 
and paralysis (Williams Smith et al. 1983). Adding the stxl gene to RDEC-1 potentiated the 
diarrhoeagenic effect of the pathogen (Sjogren et al. 1994). In the rabbit, therefore, Shiga 
toxin has an intrinsic diarrhoeagenic effect by oral and parenteral routes. Shiga toxin 
globotriaosylceramide receptors (Gb3, Section 1.3.3.2) have been detected at the rabbit 
intestinal brush border, but not before 16 days of age (Mobassaleh et al. 1988). The secretory 
(gut loop dilating) response to Shiga toxin parallels the development of Gb3 in this location. 
B. Pig 
In contrast to the rabbit, reports concerning piglets do not show any diarrhoea- 
potentiating (Tzipori et al. 1987) or ilea] loop-dilating (Williams Smith et al. 1983) effects of 
Shiga toxin. Oedema of the mesocolon was noted in piglets experimentally infected with 
STEC 0157: H7, and intravenous inoculation of older pigs with an Stx2e-like Shiga toxin 
produced oedema disease-like effects (Williams Smith et al. 1983). Neurological signs and 
CNS pathology have been reported in orally inoculated piglets using eaeA-negative STEC 
(Tzipori et al. 1995, also Section 1.4.2.7). 
C. Mouse 
Parenteral (intravenous or intraperitoneal) administration of Shiga toxin has produced a 
variety of effects. Renal tubular necrosis, epithelial or full-thickness necrosis of the colon, 
intestinal vascular damage, hindlimb paralysis and death have been reported (Williams 
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Smith et al. 1983; Beery et al. 1984). Stx2 has a far lower lethal dose than Stxl. An oral 
infection model has been developed using streptomycin-resistant STEC in animals, in which 
the commensal gut flora is suppressed by streptomycin treatment. The ability to colonise the 
murine distal small intestine and to grow in small intestinal mucus were found to be 
important for virulence in this model (Wadolkowski et al. 1990; Lindgren et al. 1993). 
Lethality is apparently due to Stx2-induced renal tubular necrosis, and colonic mucosal 
lesions are mild or absent (Lindgren et al. 1993). Stx2d is activated by murine or human 
colonic mucus, and strains producing this subtype are far more virulent than other STEC in 
mice (Melton-Celsa et al. 1998b). The streptomycin-treated mouse model has also 
demonstrated an acute, fatal encephalomyelopathy associated with damage to CNS myelin 
sheaths and vasculature (Fujii et al. 1994). 
D. Baboon 
Intravenous administration of StxI to baboons induced necrosis of the intestinal mucosal 
epithelium and the renal proximal tubule epithelium. Renal glomerular cell swelling and 
detachment plus thrombosis were observed. Myelin sheath damage was observed in the 
CNS. Clinicopathological changes reminiscent of HUS were observed (Taylor et al. 1999). 
E. Greyhound 
There is a striking similarity between HUS and a condition of greyhounds associated with 
STEC called idiopathic cutaneous and renal glomerular vasculopathy (CRGV; Fenwick and 
Cowan 1998), but reports are limited. 
1.3.3.2 Current understanding 
The Shiga toxin B subunits form a pentamer (Melton-Celsa and O'Brien 1998a) which 
binds a eukaryotic glycolipid receptor which is typically Gb3, but in the case of Stx2e it is 
globotetraosylceramide (Gb4; Gyles 1998). Following endocytosis of the toxin and receptor, 
the A subunit is enzymatically nicked, releasing an Al subunit which binds the 60S 
ribosome and inhibits protein synthesis (Melton-Celsa and O'Brien 1998a). Other receptors 
or binding sites may also be involved (Cooling et al. 1998; Devenish et al. 1998). The 
varying distribution of Gb3 between tissues and species is believed to explain some of the 
differences in susceptibility and lesion patterns. The human microvascular endothelium, 
particularly in the intestine and kidney, is sensitive to Shiga toxin (Louise and Obrig 1995; 
Ohmi et al. 1998; Jacewicz et al. 1999). Murine renal tubules are targeted, in contrast to 
human renal tissue where glomeruli are affected (Lindgren et al. 1993). In the baboon, both 
tubular and glomerular renal tissues are affected (Taylor et al. 1999). 
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1.3.4 Clinical entities associated with STEC 
1.3.4.1 Haemorrhagic colitis 
The clinical features of HC are described in Section 1.4.1. An epidemiological association 
between STEC and HC was first made in 1983 (Karmali et al. 1983). A human volunteer 
study using Stx-positive and negative Shigella dysenteriae 1 found that the Stx-negative 
strain induced less severe dysentery (O'Brien and Holmes 1987). This evidence plus clinical 
histopathology and the fact that human enterocytes lack Gb3 receptors (O'Loughlin and 
Robins-Browne 2001) supports the involvement of a Shiga toxin-induced vasculopathy in 
HC. 
1.3.4.2 Haemolytic-uraemic syndrome (HUS) and Thrombotic- 
thrombocytopaenic purpura (TTP) 
HUS was first described in 1955 and is defined by the triad of microangiopathic 
haemolytic anaemia, renal failure and thrombocytopaenia. It is associated with intravascular 
platelet and fibrin thrombosis, particularly in the kidney. Patients with TTP additionally 
show fever and neurological signs and have a wider distribution of thrombi in organs, 
although the renal signs may be less severe (Morrison et al. 1986; Griffin and Tauxe 1991). 
Either may be caused by a variety of factors, but the principal association currently is with 
EHEC infection in children and the elderly, following the acute, diarrhoeic phase of the 
illness (Griffin and Tauxe 1991). 
The association between HUS and EHEC infection (Karmali et al. 1983; Karmali et al. 
1985), reversed a previous belief that HUS caused gastrointestinal signs (Whitington et al. 
1979). Evidence for the causal link between Shiga toxin and HUS/TTP includes the 
observation that the only bacteria-associated HUS involves Shiga toxin-producing organisms 
(including Shigella dysenteriae 1) and the observed sensitivity of the human microvascular 
endothelium to Stx2, particularly in the target organ of the kidney (Louise and Obrig 1995). 
A risk factor for HUS in EHEC infection is the presence of Stx2, particularly if it is not 
accompanied by StxI. There is good evidence that, in humans, circulating Shiga toxin is 
bound to polymorphonuclear neutrophils (PMN) and this is a primary route of delivery of the 
toxin to target organs (Loo et al. 2001). 
HUS/TTP is thought to result from systemic Shiga toxin damage to the vascular 
endothelium, but additional factors are probably involved, such as the binding of Shiga toxin 
to platelets (Cooling et al. 1998). Some cell cultures lack Gb receptors and are insensitive to 
the effects of Shiga toxin, but nonetheless do internalise and transport the toxin, suggesting a 
possible enterocyte-mediated route of delivery of the toxin from the intestinal lumen into the 
circulation (O'Loughlin and Robins-Browne 2001). 
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1.3.4.3 Oedema disease of swine 
Oedema disease (Section 1.1.3.2) is associated with Stx2e STEC (Gyles 1998) and an 
angiotoxic effect of the toxin seems likely. Stx2e is frequently found in STEC from cattle 
(Suthienkul et al. 1990), but a disease association has not been reported in this species. 
1.3.4.4 Idiopathic cutaneous and renal glomerular vasculopathy 
Associations have been made between CRGV (Section 1.3.3.1 E) and STEC in the diet 
and faeces, faecal Shiga toxin and diarrhoea. Injected Shiga toxin has produced similar 
clinical effects in greyhounds (Fenwick and Cowan 1998). 
1.3.5 Occurrence of STEC in veterinary species and food 
STEC are isolated frequently from ruminants, ranging from 1 to 45 % of animals tested 
(Mainil et at. 1987; Blanco et al. 1988; Johnson et at. 1996), with a wide geographical 
variation. Isolation rates are higher from calves than from adult cattle (Wells et al. 1991; 
Cobbold and Desmarchelier 2000). Excretion of STEC by a group of feedlot cattle was 
shown to vary markedly between sampling occasions, suggesting 'spikes' of high prevalence 
between longer periods of much lower prevalence (Midgley et al. 1999). Excretion of STEC 
by sheep was found to be persistent in one study (Asakura et at. 1998). An association 
between bovine STEC and eaeA or the AE phenotype has been reported from several studies 
(Wray et al. 1993; Asakura et at. 1998; Ismaili et at. 1998; Wieler et al. 1998), although most 
veterinary and food STEC isolates are LEE-negative (Kaper 1998). Serogroups (Wray et al. 
1993; Ismaili et al. 1998) and serotypes (Blanco et at. 1993; Hsia et al. 1993) associated with 
human EHEC infection are found frequently in animals. There is evidence for a higher rate 
of STEC excretion among animals at slaughterhouses (Suthienkul et al. 1990). An 
association between STEC and calf diarrhoea has been suggested by one study (Mohammad 
et at. 1985) but not supported by others (Blanco et at. 1993; Holland et al. 1999). STEC of 
EHEC serotypes are found frequently in calves (Blanco et al. 1988; Griffin and Tauxe 1991). 
Monogastric species have a `low' isolation rate of STEC, below 10 % and often below I% 
(Johnson et al. 1996). 
The preponderance of STEC in young ruminants is reflected in isolations from meat, with 
STEC found in 15 to 40 % of minced beef samples in Canadian studies, 63 % of veal and 
lamb samples in a Seattle study, and 17 % of minced beef samples in the UK. Studies in 
continental Europe have shown a lower isolation rate, up to approximately 6% (Johnson et 
at. 1996). 
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1.4 Enterohaemorrhagic E. coli 
1.4.1 Human clinical features 
Haemorrhagic colitis typically has a 3- to 4-day incubation followed by crampy 
abdominal pain and diarrhoea, which starts as non-bloody and becomes bloody (Nataro and 
Kaper 1998). A proportion of cases do not show bloody diarrhoea, but this is difficult to 
assess accurately as many of these cases are not sampled; 10 % (Nataro and Kaper 1998) and 
26 % (Ryan et al. 1986) of cases have been quoted. Vomiting and fever may be present. 
IIUS occurs predominantly in children, with an incidence of 10 % in EHEC patients less 
than 10 years old. It proves fatal in 3 to 5% of affected children, with severe neurological 
and/or renal sequelae in a further 12 to 30 % (Nataro and Kaper 1998). 
1.4.2 Prototype EHEC: E. coli 0157: H7 
1.4.2.1 Lineage and evolution 
EHEC 0157: H7 shows a close association between serotype and pathotype. E. coli 
0157: H7 is not closely related to a reference EPEC strain, other STEC, other non-EHEC 
E. coli O 157 serotypes, or other E. coli associated with bloody diarrhoea (Whittam et al. 
1993; Perna et al. 1998). Phylogenetic studies on metabolic genes support a recent common 
ancestor for E. coli 0157: H7 and EPEC 055: H7, with E. coli 0157: H7 acquiring Shiga 
toxin genes and E. coli 055: H7 acquiring EAF (Kaper 1998). Studies of archival clinical 
E. coli isolates have revealed that E. coli 0157: H7 was a rare serotype before 1983 (Nataro 
and Kaper 1998). The chromosome of E. coli 0157: H7 is, at 5.5 Mbp, 859 kbp larger than 
that of the reference E. coli K12 laboratory strain (Hayashi et al. 2001). Much of the 
additional DNA appears to be the result of horizontal transfer into the genome, although 
many putative genes span junctions between native and inserted sequences (Perna et al. 
2001). 
1.4.2.2 Virulence factors 
Due to the severity of the induced disease, human volunteer studies are not possible for 
evaluation of virulence attributes. Therefore the identification and evaluation of putative 
virulence factors relies on epidemiological observation, animal models and in vitro studies. 
The subject has been reviewed by Nataro and Kaper (1998). 
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A. Shiga toxins 
Shiga toxin is believed to be of primary importance in the pathology of HC and HUS, and 
HUS is most often associated with Stx2. E. coli 0157: H7 usually produces Stx2 alone or 
Stxl plus Stx2 (Griffin and Tauxe 1991), at moderate or high levels (Marques et al. 1986). 
The status of Shiga toxin-converting prophages in E. coli 0157: H7 is variable, i. e. one of 
two in strain EDL933 appears capable of lytic growth (Perna et al. 2001), whereas both in 
strain 0157 Sakai appear defective (Hayashi et al. 2001). This indicates likely variability in 
expression of the toxins between strains. The RecA protease has a role in de-repressing 
phage induction in lysogenised bacteria, and in EHEC 0157: H7 strains EDL933 and 86-24 it 
is associated with a high level of Stx2 production and induction of Stx2 by the DNA 
alkylating agent mitomycin C (Fuchs et al. 1999). This indicates that in those strains, Stx2 
production is closely associated with the lytic cycle of the toxin-converting bacteriophage. 
Recently Shiga toxin-negative E. coli 0157: H7 and E. coli 0157: H- strains have been 
isolated, in the absence of any other STEC, from patients with HUS (Schmidt et al. 1999). 
The significance of this finding is unknown. 
B. Attaching-effacing phenotype 
E. coli 0157: H7 contains the LEE and expresses eaeA-dependent AE lesions in vitro and 
in pig, rabbit, calf and chicken models (Section 1.4.2.7). AE lesions have not yet been 
demonstrated in natural human disease (Nataro and Kaper 1998), which may reflect late or 
infrequent sampling of clinical cases. The E. coli 0157: H7 LEE, at 43.4 kbp, is larger than 
the LEE of EPEC 0127: H6 (Elliott et al. 1998) and is necessary for AE lesions (Donnenberg 
et al. 1993b; Dean-Nystrom et al. 1998). However, in contrast with the EPEC LEE, it is not 
sufficient on its own to induce FAS in the HEp-2 assay or to confer the secretion of Esp 
proteins upon a K-12 laboratory strain into which it was cloned (Elliott et al. 1999). Clear 
differences between EPEC and E. coli 0157: H7 are emerging (Section 1.2.3), specifically in 
respect of quorum-sensing regulation systems involving the LEE (Section 1.2.3.1) and of AE 
lesion mechanisms (Ismaili et al. 1998). One effect of these differences is that signal 
transduction in the EHEC 0157: H7 AE lesion occurs more slowly than in EPEC-induced AE 
lesions (DeVinney et al. 1999). There appears also to be a role for the pO157 virulence 
plasmid in the normal expression of the E. cola 0157: H7 AE phenotype (Section 1.4.2.2E). 
C. Chemical resistance 
Pathogenic and non-pathogenic isolates of E. coli typically demonstrate a high degree of 
acid tolerance (Lin et al. 1996; Small 1998), frequently showing greater than 10 % survival 
in a simulated fasted gastric environment of pH 2.0 for 2 hours (Gorden and Small 1993). 
E. coli 0157: H7 is not exceptional within this group (Benjamin and Datta 1995; Lin et al. 
1996; Duffy et al. 2000). Prior exposure to acid enhances (Benjamin and Datta 1995) but is 
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not necessary (Small 1998) for acid tolerance in E. coll. Acid tolerance is maximal in late 
stationary growth phase, when E. coli cells are physiologically adapted to environmentally 
stressful conditions (Benjamin and Datta 1995). The rpoS gene, encoding the RpoS 
stationary-phase RNA polymerase sigma factor (Lange and Hengge-Aronis 1991) is 
associated with acid, heat and salt tolerance in E. coil 0157: H7 (Cheville et al. 1996). 
Several mechanisms for acid tolerance have been proposed, including acid-induced amino 
acid decarboxylases and an acid-induced oxidative system (Lin et al. 1996; Small 1998). 
Whilst most E. cola 0157: H7 strains isolated from humans are resistant to inorganic acid, a 
small proportion are acid-sensitive with an associated rpoS lesion (Waterman and Small 
1996), suggesting that normal Rpos expression and/or acid tolerance may not be an absolute 
prerequisite for virulence. Weak acids, including volatile fatty acids (VFA) found at 
substantial concentrations in the rumen and intestine, are potent antibacterial agents at low 
pH, possibly due to their ability to penetrate into the bacterial cytoplasm in the undissociated 
state (Benjamin and Datta 1995; Booth et al. 1999). The relative contributions of the proton 
and anion components of the intracellular VFA to bacterial cell damage remains a matter of 
debate (Russell 1992). The induced acid tolerance of E. coif has been shown to have a 
protective effect against VFA, evident even under mildly acidic conditions (Benjamin and 
Datta 1995; Lin et al. 1996). 
The induced acid tolerance mechanisms have been shown to persist for at least 28 days in 
cold storage at 4 °C (Lin et al. 1996). This raises the possibility that E. coli 0157: H7 cells 
which are acid-tolerised in the intestinal tracts of reservoir hosts or during acidic food 
preservation processes may enter the human stomach already demonstrating enhanced acid 
resistance. E. coli 0157: H7 has been shown to survive for weeks in acidic foodstuffs such as 
salami, apple juice and cheese (Meng and Doyle 1998). E. coif 0157: H7 is not exceptionally 
salt tolerant (Meng and Doyle 1998), but the low infectious dose means that salt-preserved 
foods may still pose a risk of transmission. 
D. Non-intimate adhesion 
The initial adhesion of E. coli 0157: H7 to the intestinal epithelium is poorly understood. 
In vitro adhesion assays produce conflicting results, possibly due to differing methodologies 
and bacterial strains. No association has been shown between the possession of pO 157 and 
adherence to rabbit ileum in vitro (Ashkenazi et al. 1992) or to pig large intestine in vivo 
(Tzipori et al. 1987; Tzipori et al. 1989), but the pO157 plasmid has been shown to confer a 
colonisation advantage in streptomycin-treated mice (Wadolkowski et al. 1990). One study 
suggested that p0157 conferred fimbriae, and adhesion to Henle (Int) 407 cells (Karch et al. 
1987), but other studies failed to confirm this (Clausen and Christie 1982; Toth et al. 1990). 
There is a report of a homologue of the irgA-encoded protein of Vibrio cholerae, named Iha, 
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There is a report of a homologue of the irgA-encoded protein of Vibrio cholerae, named Iha, 
associated with adherence of E. coli 0157: H7 to HeLa cells (Tarr et al. 2000). Deletion 
mutants of E. coli 01 57: H7 lacking eaeA do not adhere, or adhere in much smaller numbers, 
to HEp-2 and HeLa cells than do their wild-type counterparts (McKee et al. 1995a; 
DeVinney et al. 1999). The residual adhesion is diffuse rather than microcolonial. These 
effects have also been demonstrated with a Tir-deficient mutant on HeLa cells (DeVinney et 
al. 1999) and with various LEE mutants on Caco-2 cells (Tatsuno et al. 2000). By contrast, 
intimin-deficient mutants of an EAF-positive EPEC retained their ability to form 
microcolonies on HEp-2 cells (Jerse et al. 1990). Adhesion of E. coli 0157: H7 to HEp-2 
cells is low or absent after three hours' incubation (Karch et al. 1987; Tesh and O'Brien 
1992), but reliably present after five or six (Sherman et al. 1987; Tesh and O'Brien 1992; 
Donnenberg and Nataro 1995; McKee and O'Brien 1995b). 
Type-I fimbriae have been shown to be associated with adherence of E. coli 0157: H7 to 
human epithelium and to rabbit ileal brush border in vitro (Dumo et al. 1989), however most 
E. coli 0157: H7 strains contain a 16 base-pair deletion in the fim switch controlling thefimA 
gene, abolishing expression of type-I fimbriae (Enami et al. 1999; lida et al. 2001; Roe et al. 
2001). Analysis of the 0157 Sakai strain of E. coli 0157: H7 has revealed 14 sets of genes 
encoding putative fimbrial biosynthesis systems (Hayashi et al. 2001), four of which have 
only been found in E. coli 0157: H7. However, the expression and significance of these 
sequences are undetermined. Expression of curli fibres by E. coli 0157: H7 is uncommon and 
unstable, but has been reported in some human-derived strains, associated with variations in 
the csgDEFG operon (Uhlich et al. 2001). There is in vitro evidence of an adhesive effect 
due to OMP (Sherman et al. 1987; Sherman and Soni 1988b; Sherman et al. 1991), 
particularly a 94 kDa OMP which is not intimin (Louie et al. 1993) and which is not 
associated with pO157 (Dytoc et al. 1993), and an 8 kDa OMP which also showed adhesive 
qualities in vivo, in chicken caeca (Zhao et al. 1996). Other proposed adhesins borne by 
E. coli 0157: H7 are lipopolysaccharide (Paton et at. 1998) and exopolysaccharide (Junkins 
and Doyle 1992). Furthermore, E. colt 0157: H7 and EPEC appear to adhere, by an unknown 
mechanism, to phosphatidylethanolamine, a surface-exposed phospholipid of the eukaryotic 
cell membrane (Barnett Foster et al. 1999; 2000). There is evidence for an adhesive role for 
EspA filaments (Section 1.2.3.2A), but whether these structures have a primary role in initial 
adherence to mucosal surfaces in vivo is uncertain. 
In summary, there are reports of fimbrial and of non-fimbrial non-intimate adhesins and 
receptors. However, the significance of these putative adhesive mechanisms in vivo is 
undetermined. The marked reduction in adhesion to cell monolayers in vitro of intimin and 
Tir mutants of E. coli 0157: H7 suggests two possibilities. These are that initial adhesion 
may be transient and the formation of AE lesions is necessary for persistent adhesion, and/or 
35 
that these LEE-encoded molecules play a broader role, mediating non-intimate adhesion in 
addition to their established interaction in the AE lesion. 
E. Other putative virulence determinants 
The pO157 plasmid is present in virtually all E. coli 0157: H7 isolates (Levine et al. 
1987) and in many other human-derived STEC where its presence, indicated by detection of 
enterohaemolysin, is associated with the development of HUS (Schmidt and Karch 1996). 
Several putative virulence factors are encoded on the pO157 plasmid (Burland et al. 1998), 
as follows. Enterohaemolysin, encoded by the EHEC-hiyABCD operon, is believed to release 
iron for bacterial growth from host cells by lysis. Two other haemolysins, Ehlyl and Ehly2, 
are encoded on pO157 and are widespread amongst STEC, but their significance is 
unknown. The plasmid contains a 13-gene cluster, termed etpC to etpO, homologous with 
genes encoding a general (type II) protein secretory system in other Gram-negative bacteria 
(Schmidt et al. 1997). A probe for etpD revealed that it is highly prevalent in EHEC 
0157: H7 (100 % of those tested), sporadic in non-Ol57 EHEC (60 %) and uncommon in 
bovine STEC (10 %). It is not known whether the etp genes are functional. Catalase P 
(encoded by katP) is a catalase-peroxidase, which is thought to protect against oxidative 
stress, as induced during phagocytosis by host cells (Brunder et al. 1996; Burland et al. 
1998). An iron-transport OMP is present which may bind iron for bacterial use in low-iron 
environments. EspP, a serine protease, may be associated with increased haemorrhage 
(Burland et al. 1998). Sequencing of pO157 has revealed possible genes for fimbriae, per- 
like regulator sequences (Burland et al. 1998), and a gene (toxB) which appears to have a 
positive, probably post-transcriptional, role in the level of expression of some LEE proteins, 
and in the expression of the normal adherence phenotype in vitro (Tatsuno et al. 2001). 
Finally, pOl 57 has been reported to promote the transcription of the esp operon of the LEE 
(Beltrametti et al. 1999). These last two reports suggest a role for a product or products of 
the plasmid in promoting the formation of the AE lesion. 
Concerning features not associated with pO157, encapsulated isolates have been reported 
from an outbreak (O'Brien et al. 1993), and appear to be common, even typical (Junkins and 
Doyle 1992) but their significance has not been further discussed. Entero-aggregative E. coli 
stable toxin 1 (EAST-1), which has homology to the ETEC stable toxin, is encoded on the 
E. coli 0157: H7 chromosome and is of unknown significance, but may be important in cases 
of non-bloody diarrhoea (Nataro and Kaper 1998). Alpha-haemolysin may be present but it 
is not associated with increased virulence. 
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1.4.2.3 Enteric pathology in humans 
The lack of AE lesions observed in human biopsy and necropsy material may be due to 
sampling late in the disease and/or infrequently (Nataro and Kaper 1998). Colonoscopy and 
biopsy reports from cases of HC reveal a multifocal pattern of damage, and two 
histopathological patterns have been described. One ('ischaemic') suggests an underlying 
vasculopathy and shows mucosal necrosis, plus or minus ulceration, with capillary 
thrombosis and little inflammation (Brownlie and Grau 1967; Griffin et al. 1990; Kelly et al. 
1990). The other ('infectious') shows an acute inflammatory picture with cryptitis and crypt 
abscessation (Griffin et al. 1990). The two patterns may coexist in an individual. 
1.4.2.4 Epidemiology in human infection 
In North America, E. coli 0157: H7 causes 15 to 39 % of bloody diarrhoea cases and is 
the most frequent pathogen isolated from bloody stools (Pai et al. 1984; Remis et al. 1984). 
The incidence is seasonal, with a maximum between June and September in the Northern 
Hemisphere (Boyce et al. 1995; Anon. 2002). Identified sources include beef (particularly 
hamburgers), other meats including sheep meat (Chapman et al. 2001) and preserved meats 
such as salami, water, milk including sheep milk (Rubini et al. 1999), apple juice and raw 
vegetables (Griffin and Tauxe 1991; Nataro and Kaper 1998). Contact with animal faeces 
was a strong risk factor for sporadic E. coli 0157: H7 infection (Locking et al. 2001), and 
traceable links between human infection and ruminant faeces have been made (Licence et al. 
2001; Strachan et al. 2001). Interpersonal spread is frequent, accounting for approximately 
20 % of cases, and consequently a biphasic pattern of disease in outbreaks is often seen 
(Ryan et al. 1986; Cryan 1990). Both outbreaks and sporadic cases occur (Riley et al. 1983; 
Pai et al. 1984; Remis et al. 1984). The duration of excretion is most prolonged in children, 
but does not exceed a few weeks, and long-term asymptomatic carriage is believed to be rare 
or non-existent (Boyce et al. 1995). 
The causal link between E. coli 0157: H7 and HC/HUS is postulated because of the 
association of the serotype with the diseases, the absence of the serotype in unaffected 
individuals, and the consistent presence in isolates of the virulence attributes of Shiga toxin 
and AE phenotype. The low prevalence of E. coli 0157: H7 in food samples compared with 
other STEC implies a high pathogenic potential (Johnson et al. 1996). Investigation of 
sources in outbreaks indicates that the infective dose is very low, of the order of 100-200 
organisms (Nataro and Kaper 1998) or even lower (Meng and Doyle 1998; Strachan et al. 
2001), and it is believed that the infective dose may be below the limit of detection in 
foodstuffs (Tarr and Neill 1996). 
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There is a marked geographical variation in incidence even within the developed world 
(Cryan 1990), and there is growing evidence that E. coli 0157: H7 is prevalent within parts 
of the developing world (Cunin et al. 1999; Gwavava et al. 2001). 
1.4.2.5 Detection in human, veterinary and food samples 
Because of the low infective dose and the presence of commensal E. colt in patients and 
animals, the reliable detection of E. coli 0157: H7 from food, faeces and carcasses requires 
methods with high sensitivity and specificity. E. coil 0157: H7 does not ferment sorbitol 
rapidly, but 80 to 90 % of commensal E. coli do (Boyce et al. 1995), and this permits 
sorbitol-McConkey agar (SMAC) to be used as an indicator medium. Incorporation of 
rhamnose, which E. coli 0157: H7 does not ferment, assists discrimination between 0157: H7 
and other sorbitol-negative E. coll. There is an association between E. cola 0157: H7 and a 
plasmid-borne gene associated with tellurite resistance, which permits the selective 
inhibition of non-0157: H7 E. cola on tellurite agar (Zadik et al. 1993). Sorbitol-MacConkey 
agar supplemented with cefixime and tellurite has proved to be a reliable selective medium 
for the detection of E. coli 0157: H7 (Chapman 2000a). Another distinguishing biochemical 
feature of the bacterium is the lack of ß-glucuronidase, which ferments 4-methyl 
umbelliferyl-p-D-glucuronide (MUG) to a fluorescent product. Therefore, in contrast to most 
E. coli, E. cola 0157: H7 is MUG-negative on fluorescent examination of appropriate media. 
A number of commercial selective solid media are available for the culture of E. cola 
0157: H7, some of which have chromogenic or fluorogenic indicator properties. The various 
media available differ in sensitivity and specificity (Manafi and Kremsmaier 2001), and 
detection protocols involving subculture on more than one medium appear to improve 
detection rates (Wallace and Jones 1996; Wallace et al. 1997). 
For detection by culture, enrichment of samples in broths containing antibiotics or other 
differentially suppressive agents, with or without subsequent immunomagnetic separation 
(IMS) using magnetic beads coated with 0157 antibodies, increases sensitivity. In one study, 
enrichment in buffered peptone water (BPW) with vancomycin, cefixime and cefsulodin 
followed by IMS and culture on CT-SMAC agar was shown to be approximately 100 times 
more sensitive than direct culture on CT-SMAC for the detection of E cola 0157: H7 in 
bovine faeces (Chapman et al. 1994). A similar advantage in sensitivity for IMS over 
enrichment plus direct subculture was demonstrated for minced beef samples in another 
study (Wright et al. 1994) but with poor repeatability at the lowest detectable concentration 
of 2 cfu/g. Using enrichment protocols, in one report IMS proved to be some 100 times less 
sensitive in the detection of 0157 organisms from spiked bovine faeces (requiring around 
100 cfu/g for reliable detection) than from similarly spiked food or milk samples (Illingworth 
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1998). Similarly, another report (Eriksson et al. 1998) showed, using a similar protocol to 
that in the present studies (pre-enrichment in BPW for six hours, IMS and culture on 
CT-SMAC), that the sensitivity of IMS fell below 100 % when the E. coli 0157: H7 
concentration in spiked bovine faeces was less than 100 cfu/g. Sanderson et al. (1995) 
inoculated calves orally with E. coli 0157: H7 and used enrichment of faeces samples in 
tryptone soya broth plus cefixime and vancomycin (TSBcv) followed by either direct 
subculture of the diluted broth on CT-SMAC, or IMS plus subculture on CT-SMAC. No 
significant difference in sensitivity of detection was found between the IMS and non-IMS 
methods, when the enriched direct subculture method was optimised. With either technique, 
it was concluded that reliable detection of less than 100 cfu/g bovine faeces was not possible. 
However a similar comparison in another report (Besser et al. 2001) found IMS to be 
significantly more sensitive than TSBcv enrichment, with final culture on SMAC in both 
techniques. 
The precise methodology used with any approach to detection appears potentially to 
substantially affect the eventual sensitivity. For example, when using broth incubation prior 
either to direct subculture or to IMS, enrichment using antibiotics or other selective agents is 
commonly practised (Chapman 2000a). However, omitting selective agents at this stage (pre- 
enrichment) improves the recovery rate of sublethally damaged E. coli 0157: H7 from 
environmental or food sources (De Boer and Heuvelink 2000), and non-selective pre- 
enrichment using BPW alone has proved more sensitive than enrichment using antibiotics, in 
an IMS protocol using bovine faeces samples (Synge et al. 1998). The type of solid media 
used for final culture also appears to the affect sensitivity of detection, with one group 
concluding that CHROMagar 0157 was most the sensitive of a range of selective media 
tested, using bovine and bird faeces samples (Wallace and Jones 1996; Wallace et al. 1997). 
Some field (Heuvelink et al. 2001) and experimental (Besser et al. 2001) studies suggest that 
IMS, and particularly pre-enriched IMS (Section 1.4.2.6), is the most sensitive cultural 
method of detection of E. coli 0157: H7 from ruminant faeces. 
Sensitive non-culture assays for the detection of E. coli 0157: H7 include polymerase 
chain reaction (PCR) for various elements with specificity for E. coli 0157: H7 (Campbell et 
al. 2001), enzyme-linked immunosorbent assay (ELISA; Kerr et al. 2001), and nucleic acid 
microarrays (Call et al. 2001). Detection of Shiga toxin or Shiga toxin genes may be 
attempted from stool or culture, but the genes may be lost from the organism during 
subculture (Karch et al. 1992). CVD419 is an empirically-derived polynucleotide probe 
which may be used for the detection of the large EHEC plasmid pO157 (Levine et al. 1987), 
which was present in 99 % of E. coli 0157: H7 strains tested. However CVD419, 
subsequently shown to recognise part of the EHEC-hly enterohaemolysin gene cluster 
(Schmidt et al. 1995), lacks specificity for E. coli 01 57: H7 amongst STEC. 
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1.4.2.6 Occurrence and epidemiology in veterinary species 
Cattle 
Very few isolates of E. coli 0157: H7 were reported from cattle before 1982 (Orskov et al. 
1987). The field and experimental reports concerning E. coli 0157: 1-17 epidemiology in 
cattle are summarised in Appendix 4. Due to the concentration of E. coli 0157: H7 excreted 
by healthy cattle, often less than 103 cfu/g faeces (Sanderson et al. 1995) compared with a 
typical density of 106 E. coli per gram of colon contents (Hart) and Dykhuizen 1984), the 
detection method employed is likely to have had a significant effect on prevalence and 
persistence data. In published surveys the detection methods vary, but typically involve broth 
enrichment then subculture on a solid medium, or IMS and culture following pre-enrichment 
or enrichment. Enrichment broths used include: TSB with vancomycin, cefixime and 
cefsulodin added in varying combinations to inhibit the growth of Gram positive organisms, 
Proteus and Aeromonas respectively (Hancock et al. 1994; Sanderson et al. 1995; Hancock 
et al. 1997b; Rice et al. 1997; Hancock et al. 1998b; Van Donkersgoed et al. 2001); modified 
E. coli medium (mEC; Garber et al. 1999), mEC plus novobiocin to inhibit Gram positive 
bacteria (Faith et al. 1996; Dargatz et al. 1997; Shere et al. 1998); TSB with antibiotic(s) plus 
bile salts (Cray and Moon 1995; Garber et al. 1995; Brown et al. 1997; Harmon et al. 1999; 
Cornick et al. 2002) or tellurite (Hovde et al. 1999; Magnuson et al. 2000) or both (Cray et 
al. 1998) as additional selective agents. Enriched mixtures typically have been subcultured 
onto CT-SMAC. IMS has been performed on mixtures pre-enriched in Tris buffered saline 
(TBS; Buchko et al. 2000a; Lahti et al. 2001) or BPW (Nielsen 2001; Synge et al. 2001), or 
following enrichment in antibiotic-supplemented BPW, TSB, or mEC (Sanderson et al. 
1995; Besser et al. 1997; Chapman et al. 1997; Heuvelink et al. 1998a; Richards et al. 1998; 
Akiba et al. 2000; Wray et al. 2000; Chapman et al. 2001; Johnsen et al. 2001). 
The reported prevalence of E. coli 0157: H7 excretion by cattle varies between 0% 
(Hancock et al. 1997a; Mechie et al. 1997; Shere et al. 1998) and 68 % of individuals 
(Mechie et al. 1997). Part of this apparent variability may be attributed to temporal variation 
in excretion (Hancock et al. 1997b), with peak prevalences generally seen during the summer 
months (Chapman et al. 1997; Mechie et al. 1997; Heuvelink et al. 1998b; Conedera et al. 
2001). However, as sampling and detection protocols vary widely (Appendix 4), it is 
difficult to gauge the extent to which a reported difference in prevalence reflects a genuine 
difference in the excretion pattern. The data from Appendix 4 shows that most reported 
prevalences of E. coli 0157: H7 excretion fall within the range 0.5 to 5% for adults and 
calves. Where IMS is employed, values are often higher, for example extensive surveys on 
farms in Scotland (Synge et al. 2001) and at an abattoir in England (Chapman et al. 2001) 
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yielded prevalence rates of 7.9 % and 12.9 % respectively. Geographical variation in 
prevalence may play a role in such observed differences. The reported prevalence of E. coli 
0157: H7-excreting herds is 10 to 75 %. 
Where both calves and older stock have been sampled in the same study, weaned calves 
have generally been found to exhibit a higher prevalence of E. coil 0157: H7 excretion 
(Heuvelink et al. 1998b; Richards et al. 1998; Cobbold and Desmarchelier 2000). 
Prevalences of 2.8 and 0.15 % for calves and adults respectively were determined in one case 
(Wells et al. 1991). The prevalence of excretion of E. coli 0157: H7 increases at the weaning 
period (Garber et al. 1995), and group housing of calves appears to increase the risk of 
excretion (Garber et al. 1995; Shere et al. 1998). The duration of excretion of the organism 
also appears to be more extended in calves when compared with adults (Mechie et al. 1997). 
Identified risk factors for E. coli 0157: H7 excretion include: weaning, group housing of 
preweaned calves, poor calf feeding hygiene, dietary changes and transport to slaughterhouse 
lairage (Suthienkul et al. 1990; Garber et al. 1995; Mechie et al. 1997). Increased excretion 
of the organism following dietary changes is supported by studies showing that starvation 
and irregular feeding greatly increases the E. coif density in the rumen and large intestine of 
cattle and sheep (Brownlie and Grau 1967; Rasmussen et al. 1993). There is no association 
with illness; indeed there was a negative association between diarrhoea and the presence of 
E. coli 0157: H7 in faeces samples received at a diagnostic laboratory (Richards et al. 1998). 
There is no clear evidence of a consistent difference in the prevalence of excretion of 
E. coli 0157: H7 between different types of cattle farming enterprise, although relatively few 
comparative studies have been performed. In one such study, the prevalences of excretion 
from dairy, feedlot and extensive beef farms were 0.33,0.28 and 0.71 % respectively 
(Hancock et al. 1994). 
Longitudinal surveys show that, whilst a herd's E. coli 0157: H7-positive status tends to 
be maintained over time (Hancock et al. 1997a; Hancock et al. 1997b; Nielsen 2001), 
excretion of the organism by individuals typically is of short duration, with only a minority 
of animals found to be excreting on consecutive sampling occasions (Mechie et al. 1997; 
Heuvelink et al. 1998b; Shere et al. 1998; Conedera et al. 2001). Intermittent excretion is 
often seen (Mechie et al. 1997; Conedera et at. 2001) which, it may be hypothesised, in any 
particular instance might arise from: repeated recolonisation of an individual, persistent 
colonisation with bouts of excretion, or continuous excretion around the lower limit of 
detection. In many longitudinal surveys there are animals which appear to excrete 
continuously for prolonged periods, ranging from four weeks (Mechie et at. 1997) to eight 
months (Conedera et al. 2001). Although the temporal resolution of these studies is limited 
by sampling intervals typically of one month, but up to three months in some cases, it 
appears that within herds there may be a few persistently-excreting individuals which can 
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help to maintain E. coli 0157: H7 within the group as a whole. In experimental oral 
inoculation studies with frequent sampling intervals and fewer animals, continuous excretion 
has been seen for 27 weeks in calves (Cray and Moon 1995), 69 days in heifers (Magnuson 
et al. 2000), and 67 days in yearlings (Buchko et al. 2000b). Inter-animal variation in the 
tendency to excrete persistently has been observed experimentally (Grauke et at. 2002). 
Many longitudinal surveys over periods of 11 to 15 months have shown that E. coli 
01 57: H7 tends to persist within a herd (Besser et al. 1997; Hancock et al. 1997a; Mechie et 
at. 1997; Hancock et at. 1998b; Sargeant et al. 2000; Conedera et al. 2001; Galland et al. 
2001). One study has suggested additionally that E. coli 0157: H7-positive herds may have 
an inherent and stable `high' or `low' prevalence (Hancock et at. 1997b). Despite this, the 
prevalence within excreting herds is seen to vary, sometimes widely, between sampling 
occasions (Hancock et al. 1997a; Hancock et al. 1997b; Mechie et al. 1997; Heuvelink et at. 
1998b; Conedera et al. 2001). Herds which have a zero prevalence of E. coli 01 57: H7 
excretion at the beginning of a study have subsequently been observed to convert to 
`excreting' herds (Heuvelink et al. 1998b). 
E. coli 0157: H7 strains present on farm environments have been investigated, principally 
using pulsed-field gel electrophoresis (PFGE) to delineate strains and strain variation over 
time. Some PFGE types appear to be endemic, i. e. persistent, on any one premises, whether 
dairy (Shere et al. 1998; Nielsen 2001) or feedlot (Van Donkersgoed et at. 2001). Other 
strains present are more transient. Identical or very similar PFGE types may show a wide 
geographical distribution in the USA (Rice et al. 1999). The number of PFGE strain types 
present on a premises at any one time may be as many as seven, and does not appear to 
correlate with the degree of animal movements onto the farm (Rice et al. 1999). It is 
uncertain to what extent the PFGE types present on a farm are from different sources, as 
calves experimentally inoculated with E. coli 01 57: H7 showed alterations in the PFGE 
profile of recovered E. coli 0157: H7 over 63 days (Akiba et at. 2000). 
Where evidence of E. coli 0157: H7 in the farm environment has been sought, water 
sources (Faith et al. 1996; Hancock et al. 1998b; Sargeant et al. 2000; Conedera et al. 2001; 
Van Donkersgoed et at. 2001) and feed bunks (Van Donkersgoed et at. 2001) have proved 
positive in a small proportion of cases. Water contamination by E. coli 0157: H7 (Shere et at. 
1998) and the use of water troughs rather than individual drinkers by dairy cattle (Garber et 
al. 1999) were both shown to be risk factors for excretion of the organism. Furthermore, in 
one study PFGE typing has shown that strains from cattle and their environment were of the 
same PFGE type (Hancock et al. 1998b). Oral swabs from yearlings in an E. coli 0157: H7- 
positive group yielded the organism in 30 of 180 cases (Buchko et al. 2000b). Extensive 
surveys have identified housing as a risk factor for the excretion of E. coif 0157: H7 by adult 
cattle (Synge et al. 2001), and a six-month study demonstrated a markedly higher prevalence 
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of E. coli 0157: H7 excretion in a group of indoor-housed calves than in a group at pasture 
(Jonsson et al. 2001). The above evidence strongly suggests a significant role for the farm 
and lairage environment in the maintenance of E. coli 0157: H7 excretion by a herd, 
probably by frequent re-ingestion of the organism. Indeed, the assumed `reservoir' status of 
cattle has been questioned (Hancock et al. 1998b), it being suggested that persistence on a 
farm may be primarily environmental and that cattle are not uniquely or particularly 
susceptible to persistent colonisation. In this scenario cattle, and perhaps other animals, may 
act as transiently-infected 'multipliers' for an environmentally-persistent reservoir of E. coli 
0157: H7. 
E. coli 0157: H7 has been recovered from milk samples in one study but not in another 
(Wells et al. 1991; Mechie et al. 1997), and the screening of bulk milk tank samples and 
slurry has not been found to be sensitive for detection of E. cola 0157: H7 positive herds 
(Garber et al. 1995). Correlations have been noted between the seasonal incidence of herd 
excretion and human disease (Mechie et al. 1997) and between excretion on particular farms 
and human EHEC 01 57: H7 cases (Wells et al. 1991). 
In summary, there is epidemiological evidence for persistent colonisation by E. cola 
0157: H7 of cattle herds, and of more transient groups such as in feedlots. However, at the 
individual animal level, persistent excretion is observed in only a small minority of animals. 
Weaned calves show the greatest prevalence and duration of excretion of the organism, and 
dietary changes and stress appear to promote excretion. The farm environment, and 
particularly the water supply, appears to harbour the organism, and environmental niches 
outside the animal are likely factors in the maintenance of E. coli 0157: H7 on a premises. 
Certain strains of the organism appear to persist on a farm for longer than others, either by 
virtue of adaptation or ubiquity, although several strains may co-exist on premises at any one 
time. Excretion may be higher at the slaughterhouse than on the farm. There is no evidence 
that E. coli 0157: H7 is pathogenic in naturally exposed cattle. 
Other ruminants 
E. coli 0157: H7 has been reported in ovine faeces from a number of studies in the UK 
and USA. Prevalence values are subject to the same influences of sampling protocols and 
detection methods as are those of cattle. The range, from surveys sampling between 325 and 
7200 animals, is 0 to 7.4 % of animals excreting E. coli 0157: H7 (Chapman et al. 1996; 
Chapman et al. 1997; Kudva et al. 1997b; McCluskey et al. 1999; Chapman et al. 2001; 
Heuvelink et al. 2001; Johnsen et al. 2001; Paiba et al. 2002). Where prevalence surveys of 
cattle and sheep E. coli 0157: H7 excretion have been conducted contemporaneously, values 
for sheep have been lower than for cattle (Chapman et al. 1997; Chapman et al. 2001; Paiba 
et al. 2002). A summer/autumn peak in the prevalence of excretion has been found (Kudva et 
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al. 1996; Heuvelink et al. 2001; Paiba et al. 2002). The proportion of animals in a group 
excreting the organism appears to increase with stressful situations, such as long transport or 
prolonged detainment in holding pens (McCluskey et al. 1999). Faecal isolates typically 
possess the normal EHEC 0157: H7 virulence attributes (Heuvelink et al. 2001). 
E. coli 0157: 1-17 has been detected in wild deer faeces (Fischer et al. 2001) and in venison 
(Zhao et al. 1998). 
Pigs 
There is evidence that E. coli 0157: H7 with typical EHEC characteristics is common in 
South American domestic pigs (Borie et al. 1997; Notarin et al. 2000), and the organism has 
been found in European pig herds (Heuvelink et at. 1999; Johnsen et al. 2001). 
Other species 
E. coli 0157: H7 has been isolated from many non-ruminant animals, including flies 
(Hancock et al. 1998; Heuvelink et al. 1998b; Kobayashi et al. 1999), equids (Hancock et al. 
1998b; Heuvelink et al. 1998b; Bauwens et al. 2000; Chapman et al. 2000a) and rabbits 
(Pritchard et al. 2001); in the last case there was evidence of a vector role in human disease. 
1.4.2.7 Experimental studies on E. coli 0157: H7 in animals 
Introduction 
Due to the generally low pathogenicity of E. coli 0157: H7 in non-human species, animal 
models of human disease generally require very high oral doses, in the order of 106 to 1010 
colony-forming units (cfu), in comparison with the human infective dose, plus other features 
such as colostrum deprivation, suppression of the normal intestinal flora, or gnotobiotic 
status. 
Cattle 
Studies using Shiga toxin-producing and eaeA-positive E. coli 0157: H7 strains have 
shown large intestinal AE lesions plus colonic oedema and inflammation in colostrum- 
deprived (CD) calves inoculated orally at less than 12 hours of age, with less marked 
changes in calves inoculated at three days of age (Dean-Nystrom et al. 1997). This age- 
related resistance has been supported by studies using f ive-day old gnotobiotic calves 
(Woodward et al. 1999), three- to 14-week old preweaned calves (Cray and Moon 1995), and 
eight-week old weaned calves (Brown et al. 1997), in which no AE lesions were seen. Some 
mild intestinal inflammation and haemorrhage was seen in the five-day old calves 
(Woodward et al. 1999). Transient non-bloody diarrhoea was seen in several studies even in 
calves without detectable AE lesions. One study of neonatal CD calves reported eaeA- 
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dependent blood-tinged diarrhoea, AE lesions, intestinal oedema and haemorrhage, villus 
atrophy and fibrinous mucosal exudation (Dean-Nystrom et al. 1998). The susceptibility of 
three- to four-month old weaned calves to E. coli 0157: H7-induced AE lesions in the large 
intestine has been demonstrated (Dean-Nystrom et al. 1999), but only in those animals where 
a luminal concentration of the organism in excess of 105'5 cfu/g was achieved, via fasting 
prior to inoculation and sampling within a few days of inoculation. 
Examination of persistence characteristics has revealed that calves experimentally 
inoculated with 1010 cfu of E. coif 0157: H7 excreted the organism for longer and in greater 
quantities than did adult cattle (Cray and Moon 1995). One calf in this study excreted 
consistently for at least 27 weeks. E. coli 0157: H7 was consistently isolated from the rumen 
and large intestine, with additional isolation from the small intestine and gut-associated 
lymphoid tissue in some calves. In the same report, oral doses of 10' and 104 cfu E. coli 
0157: H7 in adults established excretion of E. coli 0157: H7 in only two of 10 animals, 
compared with all 12 adults inoculated with 1010 cfu. That the rumen and large intestine are 
sites of persistence in calves was confirmed by another study of isolated calves inoculated 
with 1010 cfu E. coli 0157: H7 which excreted the organism for at least 20 days and in which 
consistent recovery of the organism was obtained from the rumen, with frequent recovery 
from the large intestine (Brown et al. 1997). A calf study using an oral dose of 5x 108 cfu 
showed excretion times, of about 1 month, preweaning (Sanderson et al. 1999). Re- 
inoculation at 12 and 18 weeks produced reduced excretion times of about 1 week. Whether 
this was due to the altered intestinal flora of the weaned calf or to prior exposure was not 
investigated. Despite the apparent correlation between dose and excretion reported by Cray 
and Moon (1995), Besser et al. (2001) reported that some, but not all, bovine-derived strains 
of E. coli 0157: H7 would establish persistent excretion from some calves, and would 
transmit between calves, following oral doses as low as 210 cfu. Histopathological 
examination of the intestinal tissues of persistently-excreting calves has not yielded proof of 
AE lesion formation (Cray and Moon 1995; Brown et al. 1997; Harmon et al. 1999). Studies 
using eight-week to 12-month old calves (Naylor et al. 2003), reported after completion of 
the work contained in this thesis, have shown that the terminal rectum and anus is a 
preferential site of colonisation by E. coli 0157: H7 in persistently-excreting animals. 0157- 
bearing bacteria formed microcolonies at this site in both experimentally and naturally 
excreting calves, but the nature of the attachment was not determined. 
Studies on the effect of starvation upon the density of E. coli 0157: H7 excreted by 
weaned calves following oral inoculation have shown a positive effect only when starvation 
was applied at the time of inoculation (Cray et al. 1998; Harmon et al. 1999). The effects of 
dietary composition on the excretion of E. coli 0157: H7 by orally inoculated animals have 
been the subject of several reports. In one study (Hovde et at. 1999), yearling steers excreted 
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the organism for longer on a forage-based diet than on a grain-based diet, but two other 
studies using heifers (Magnuson et al. 2000) and calves (Tkalcic et al. 2000) found no such 
difference between grain- and forage-based diets. 
Two studies have examined the excretion of E. coli 0157: H7 by dually-inoculated 
animals. In one, a mutant lacking a functional RpoS global stress response regulator was 
excreted from calves at a significantly lower level than its wild-type parent strain (Price et al. 
2000), although there was no evidence of reduced persistence in the former strain. In the 
other, an intimin-deficient mutant was excreted at a lower level from yearling cattle than was 
its wild-type parent strain (Cornick et al. 2002). 
A study on the clonal variation over time of an inoculated E. coli 0157: 1-17 strain in 
calves (Akiba et al. 2000) has shown changes in PFGE profile and loss of the pO157 plasmid 
over a period of 63 days. 
In summary, age-related eaeA-dependent diarrhoea associated with AE lesions in the 
distal ileum and the large intestine has been observed, and the capacity of E. coli 0157: H7 to 
form AE lesions acutely in calves up to four months old has been demonstrated. Persistence 
has been demonstrated in the rumen and large intestine of calves. Factors involved in 
excretion times include dose and either or both of age and prior exposure, although dose- 
dependence does not appear to apply for all strains and hosts. A likely predilection site for 
persistence has been identified at the terminal rectum. There is evidence that the intestinal 
state in respect of starvation and diet does affect excretion, but the relationship is not 
straightforward. Bacterial factors, including stress responses and intimin may provide a 
competitive advantage in the intestine. Persisting strains show readily detectable genetic 
changes over weeks. 
Sheep and other ruminants 
Experimental studies involving sheep have used similar techniques and oral dosages to 
those of cattle. Fewer studies have been reported for sheep than for cattle. Findings in respect 
of dosage-excretion relationships, the persistence of excretion and the significance of intimin 
are similar to those in cattle. 
One study (Kudva et al. 1995) examined the effects of inoculum dose on excretion by 14- 
day old suckling lambs and two adult rams. A human-derived E. coli 0157: 1-17 was 
inoculated at 105 or 109 cfu to co-housed animals. Those lambs given the lower dose started 
excreting the strain later and continued for a shorter period compared with those given the 
higher dose, although detection was markedly variable amongst both groups. A similar dose 
effect upon excretion was seen with two adult rams, with the high-dose individual excreting 
consistently for 50 days post inoculation (p. i. ). 
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The effects of dietary manipulation and repeated inoculation with E. coli 0157: H7 on 
faecal excretion of E. coli 0157: H7 were also examined by the same group (Kudva et al. 
1997b). Using a 1010 cfu inoculum of either nalidixic acid sensitive or resistant organisms 
(the latter of bovine origin), excretion was detected for the 41 days of the experiment, 
although the proportion of excreting individuals declined over time. Differences in the 
duration of excretion were not observed between the two strains used, but the feeding of a 
concentrate-based diet appeared to reduce excretion times in comparison with a fibre-based 
diet. An effect of previous inoculation upon the duration of excretion was not observed. Of 
five sheep which excreted E. coli 0157: H7 consistently for 41 days in this study, two did not 
yield the organism from any intestinal location when examined post mortem at 53 days p. i. 
(Grauke et al. 2002). From the three remaining sheep, samples of faeces (whether these were 
voided faeces or rectal contents is unspecified) yielded the organism in all three cases, and 
caecal samples were positive in one case. No other (unspecified) gastrointestinal tract tissues 
or contents were culture positive for E. coli 0157: H7, and bacterial lesions were not 
observed in any (unspecified) tissues examined by microscopy. 
Subsequent work by the same group included the oral inoculation of 24 sheep, which 
were six- to seven-months old and group-housed, with 109 cfu of a human-derived strain of 
E. coli 0157: H7 (Grauke et al. 2002). At weekly intervals for six weeks, faecal samples were 
examined from groups of four sheep, which were then examined post mortem. A proportion 
of each group of four were excreting the inoculated organism but, from one week p. i., the 
inoculated organism was frequently not recovered from the large intestine and rumen of 
excreting individuals by enrichment culture (TSBvCT then subculture on CVTM-SMAC; see 
legend, Appendix 4). Indeed, from three to six weeks p. i., only two sites (descending colon 
and rectum) from one of seven excreting animals proved to be culture positive. 
Cornick et al. (2000) examined the persistence of bovine- and human-derived E. coli 
0157: H7 in young adult sheep in comparison with ETEC and EPEC pathotypes of E. coli. 
Doses of 1010,107 and 105 cfu, but not 104 cfu, produced excretion of E. coli 0157: H7 for 
the two months of monitoring. As the initial dose decreased, the proportion of animals 
excreting at two months p. i. decreased also. Culture of the alimentary tissues of two sheep 
excreting E. coli 0157: H7 yielded the organism only in the rectal contents. 
The same research group inoculated six- to 12-month old sheep with 1010 cfu of an 
antibiotic resistance marked human-derived E. coli 0157: H7 strain and its isogenic intimin- 
deficient mutant, singly and in combination (Cornick et al. 2002). Excretion of both strains 
was observed up to 60 days p. i. in some animals, although the intimin-deficient mutant 
appeared to be a poorer coloniser in respect of average duration of excretion. In the same 
study, yearling cattle provided similar results when dually inoculated. 




Another study reported the effects of probiotic feed supplements upon faecal shedding of 
E. coli 01 57: H7 by 12- to 15-month old sheep following oral inoculation of 1010 cfu of the 
bacteria (Lema et al. 2001). All five groups of six inoculated sheep excreted the E. coli 
0157: H7 consistently, at between 10' and 107 cfu/g faeces, over the seven week period of 
the study. However, some of the data in this paper relating to animal weights for age, food 
consumption and feed conversion efficiency appear to be erroneous and the source of the 
E. coli 0157: H7 strain given is incorrect, therefore other experimental results from this 
report might be interpreted with caution. 
Fischer et al. (2001) inoculated white-tailed deer with 108 cfu of a mixed E. coli 0157: H7 
inoculum and observed excretion for the 26 days of the study. Mild non-haemorrhagic 
diarrhoea was seen in a proportion of the animals. The organism was transmitted to an 
uninoculated in-contact animal by two days p. i. At post mortem examination E. coli 
0157: H7 was isolated from the rumen and the small and large intestines, and the deer- 
derived strain in the mixed inoculum appeared to be the most persistent. 
Pigs 
Several studies have been performed using eaeA- or LEE-positive, Shiga toxin-producing 
strains and gene deletion mutants in gnotobiotic or CDCD piglets, usually of one to two days 
of age. AE lesions have been observed in the large intestine plus or minus the distal small 
intestine (Francis et al. 1986; Tzipori et al. 1986; Tzipori et al. 1987). These lesions have 
been shown to be eaeA-dependent and Shiga toxin-independent (Tzipori et al. 1987; 
Donnenberg et al. 1993b). Limited mucosal invasion was observed in one study (Tzipori et 
al. 1986). Associated colonic changes include mesocolonic oedema, gut wall oedema and 
neutrophil infiltration (Francis et al. 1986). Clinically, non-bloody diarrhoea was seen 
(Francis et al. 1986), which was independent of Shiga toxin presence (Tzipori et al. 1987). 
The pO157 plasmid did not appear to affect the AE lesion (Tzipori et al. 1987; Tzipori et al. 
1989). Another study has demonstrated the susceptibility of colostrum-fed piglets to AE 
lesion formation by Shiga toxin-positive and -negative E. coli 0157: H7 strains (Dean- 
Nystrom et al. 2000). Neurological signs have been reported in association with a CNS 
vasculopathy resembling oedema disease (Francis et al. 1989). Similar signs occurred with 
an eaeA-deletion mutant (Tzipori et al. 1987) but not with a Shiga toxin-negative E. coli 
0157: H7 strain (Dean-Nystrom et al. 2000). Surprisingly, the neurological signs were found 
to be more severe in colostrum-fed suckling piglets than in colostrum-deprived individuals 
(Dean-Nystrom et al. 2000). Vaccination of pregnant dams against intimin shows a 
protective effect against intestinal colonisation and the formation of AE lesions in the dam's 
suckling piglets (Dean-Nystrom et al. 2002). 
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In summary, piglets inoculated with E. coli 01 57: H7 demonstrate Shiga toxin- 
independent, eaeA-dependent nonbloody diarrhoea associated with AE lesions in the distal 
ileum and the large intestine. Colostral anti-intiminO157 antibody ameliorates the AE lesions 
and reduces colonisation. Systemic neurological signs and lesions have been induced by 
Shiga toxin-producing strains. No HC-like clinical signs have been induced. 
Rabbit 
In contrast to other species, infant rabbits inoculated orally with E. coli 0157: H7 
demonstrate extensive colonisation of the small intestine in addition to the large intestine. 
AE lesions and nonbloody diarrhoea have been observed (Potter et al. 1985; Pai et al. 1986; 
Sherman et al. 1988a). Weaned rabbits appear much less susceptible to colonisation by 
E. coli 0157: H7 than do infant rabbits (Pai et al. 1986). 
Chicken 
Persistent E. coli 0157: H7 infection of the large intestine-like parts of the chicken caeca 
can be induced by inoculation of one-day old chicks with a high dose (109 cfu) of E. coli 
0157: H7. Caecal oedema and attachment of bacteria to the mucosa and were observed, and 
persistence for up to 88 days p. i. was demonstrated. Clinical signs were not detected (Beery 
et al. 1985). 
1.4.3 Non-0157 STEC 
1.4.3.1 Occurrence, detection and significance 
Non-0157: H7 STEC are frequently found in association with HC and HUS in the 
absence of E. coli 0157: H7, and the detected incidence(] 0% in 1987; Bopp et al. 1987) is 
rising. Indeed, in Australia non-0157: H7 associated HUS cases outnumber those associated 
with E. coil 0157: H7 (Robins-Browne et al. 1998), and this has recently become the case in 
Italy also (Tozzi et al. 2001). Serovars involved include 026: H11,011 I: H-, 0103: H2, 
0113: 1-121,0157: H- and O-rough or untypable (Bopp et al. 1987; Griffin and Tauxe 1991; 
Willshaw et at. 1992). Strains are usually eaeA- and CVD419- (enterohaemolysin) positive 
(Nataro and Kaper 1998) but the range of detected plasmid sizes are diverse compared with 
that of pO157 (Willshaw et at. 1992). The experimental inoculation of rabbits with several 
non-0157: H7 EHEC of diverse serotypes produced diarrhoea with AE lesions (Sherman et 
at. 1988a). Other evidence for the virulence of non-0157: H7 STEC includes the existence of 
clusters of such STEC, detected serologically and microbiologically in the human 
population, plus the detection of Shiga toxin from HUS stools with an accompanying lack of 
evidence of E. coli 0157: H7 as sought by serology, culture or other methods (Tarr and Neill 
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1996). Non-0157: H7 STEC are associated more with sporadic disease than with outbreaks, 
suggesting a lower virulence or transmissibility than for EHEC 0157: 117. The pathogenic 
and epidemiological features of non-0157 STEC have been reviewed (Griffin and Tauxe 
1991; Johnson et al. 1996; Tarr and Neill 1996). 
There is evidence of a veterinary species reservoir of non-0157: H7 STEC (Bettelheim 
2000). Comparison between human non-0157: H7 EHEC and veterinary STEC shows much 
overlap of serogroups between bovine, ovine and human isolates (Gonzalez and Blanco 
1989; Wray et al. 1993). The 05,026 and 0111 serogroups predominate in STEC isolates 
from calves (Holland et al. 1999). Serotypes 026: 1111 and 0111: H-, both prominent among 
human EHEC, are reported as bovine EHEC (Johnson et al. 1996; Pearson et al. 1999). 
1.4.3.2 Pathogenic mechanisms 
Virulence factors in non-0157: H7 STEC strains are more variable than with E. coli 
0157: H7, and only Shiga toxin production is found consistently (Johnson et al. 1996). 
Strains may lack the eaeA gene and these are correspondingly FAS- and AE-negative. Such 
strains have been found in the serovars 091: H21 (McKee et al. 1995a), O-rough (Willshaw 
et al. 1992) and 0113: H21 (Dytoc et at. 1994). Amongst AE EHEC, tyrosine 
phosphorylation of Tir does occur with some serotypes, including 026: H 11 (Kaper 1998), in 
contrast to E. coli 0157: H7. An HC-like disease has been reported in eight-month (Pearson 
et al. 1999) and 19-month (Wada et al. 1994) old heifers, associated with 026: H11 and 015 
serovars respectively. Both cases demonstrated AE lesions in the large intestine. 
E. coli 0111: H- has been reported to cause septicaemic shock in one human patient, and 
this strain caused similar pathology in gnotobiotic piglets, suggesting that a more invasive 
phenotype may be present in some EHEC (Tzipori et al. 1988). 
Non-adherence and LA-like initial adherence in vitro is reported (Willshaw et al. 1992). 
E. coli 0113: H21 demonstrates adhesion in vivo by an unknown mechanism (Nataro and 
Kaper 1998). The presence of pO157, as detected by the CVD419 probe, was verified in 10 
out of 14 non-0157: H7 EHEC (Ashkenazi et al. 1992) and showed no correlation with 
adherence to a rabbit ileal epithelial cell preparation. Another study showed a prevalence of 
pO157 of 77 % in 026: H11 EHEC (Nataro and Kaper 1998). Acid tolerance among non- 
0157: H7 EHEC is variable and not associated with serotype (Benjamin and Datta 1995). An 
adherence-associated gene (efal) is present in many EHEC (and EPEC) strains (Nicholls et 
at. 2000), but it appears to be defective in E. coli 0157: H7 (Janka et al. 2002). 
Thus, there appear to be diverse mechanisms whereby non-0157: H7 EHEC are able to 
survive in the food chain and colonise the human intestinal tract to deliver Shiga toxin to 
local tissues and the blood stream. 
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1.5 Rationale and aims of the present work 
The wide distribution and persistence of E. coli 0157: H7 amongst groups of cattle and 
sheep is well-documented (present chapter, Section 1.4.2.6), as is the epidemiological 
connection between E. cola 0157: H7 in food animals and human disease caused by the 
organism (present chapter, section 1.4.2.4). One important chain of contamination passes 
through abattoirs, where animals excreting E. coli 0157: H7 lead to contamination of 
carcasses and meat (Elder et al. 2000; Gansheroff and O'Brien 2000; Barkocy-Gallagher et 
al. 2001). Whilst hygienic practices at abattoirs are effective at limiting contamination of 
meat (Elder et al. 2000), the low infective dose of E. coli 0157: H7 for humans and the 
possible alternative routes of animal to human infection (present chapter, Section 1.4.2.4) 
make on-farm control of the prevalence of the organism a desirable goal. Several authors 
have suggested that control strategies based upon reducing excretion rates on farms and at 
abattoirs are desirable (Gansheroff and O'Brien 2000; Synge 2000; Hancock et al. 2001), and 
theoretical modelling has indicated that lowering the prevalence of excretion is likely to 
prove fruitful in the further reduction of abattoir-based contamination of meat (Jordan et al. 
1999). 
Epidemiological studies indicate that E. coli 0157: H7 exists apparently as a commensal 
organism in ruminants, being excreted by a minority of individuals at any one time, in a 
background of other flora including other E. coli strains. In addition, E. coli 01 57: H7 is 
found in the farm and lairage environment (Midgley and Desmarchelier 2001), including 
water troughs (Faith et al. 1996; Hancock et al. 1998b; Shere et al. 1998; Sargeant et al. 
2000). Reliable detection of the organism in animal faeces is difficult (present chapter, 
Section 1.4.2.6) and the ecology of the organism on farms and amongst groups of animals is 
poorly understood. Persistence may be primarily based in the environment, as suggested by 
some authors (Hancock et al. 1998a), or the organism may reside principally within the 
intestinal tract of reservoir animals. 
Despite experimental work on E. coli 0157: H7 persistence in the environment (Kudva et 
al. 1998; LeJeune et al. 2001; McGee et al. 2001) and in animals (present chapter, Section 
1.4.2.7), the possible mechanisms of persistence of the organism in animals are still poorly 
understood. Therefore the present studies aimed to investigate which features of E. coli 
0157: H7 may be important in persistence, primarily concentrating upon LEE-mediated 
adherence to the intestinal mucosa. Interventions which target specific mechanisms possibly 
associated with persistence, such as AE adherence, have the potential to reduce the persistent 
excretion of E. coli 0157: H7 with the additional benefit of minimising incidental effects 
upon the rest of the gastrointestinal flora. 
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Chapter 2- MATERIALS AND METHODS 
2.1 General considerations 
2.1.1 Microbiological containment 
STEC are classified as hazard category 3 pathogens in the UK. Therefore, any 
manipulations involving viable STEC were performed within appropriate containment 
facilities. For in vitro characterisation studies, a designated category 3 containment facility at 
VLA Weybridge was used, and applicable Working Procedures were followed. For in vivo 
studies, animal accommodation and procedures were as described in Section 2.6. 
2.1.2 Ethical review and Home Office licensing 
All procedures complied with the UK Animals (Scientific Procedures) Act 1986 and were 
performed under Home Office Licence 70/4987. The Home Office licence was submitted to 
an independent panel of animal model experts on the VLA ethics review board and 
scrutinised prior to submission to the Home Office. Additionally, work performed at The 
University of Bristol, Langford was subjected to ethical review by the University. 
2.2 Bacterial strains, growth and enumeration 
2.2.1 Strains used 
2.2.1.1 E. coli 0157: H7 strains 
The Laboratory of Enteric Pathogens (LEP) of the Central Public Health Laboratory 
(CPHL) provided toxin- and phage-typed E. coli 0157: H7 obtained from human sources, 
with brief clinical details. The VLA provided phage-typed strains from bovine field surveys 
of E. coli 0157: H7 excretion (EC218/94, hereafter referred to as `EC218'; EC222/94, 
hereafter referred to as `EC222'), or from an association between human disease and bovine 
excretion (EC 157). The features of each strain examined are summarised in Table 3-A. 
Strain NCTC 12900, original designation E81186 (Willshaw et al. 1994), was isolated from 
a diarrhoeic child (Cheasty, T., personal communication) and lacked Shiga toxins. It was 
genotypically and phenotypically characterised at VLA Weybridge (Dibb-Fuller et al. 2001), 
when it was shown to encode the following genes: eaeA (intimin); sepABCD (type III 
secretion system components); espA (LEE secreted protein); etpD, katP, h1yA (virulence 
plasmid genes, Section 1.4.2.2E). It did not encode either of the Shiga toxin genes six] or 
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stx2. Studies on HEp-2 and bovine epithelial-like cell monolayers demonstrated that strain 
NCTC 12900 formed dense microcolonies and intense FAS-positive lesions on all cell types, 
when compared with the EPEC strain B171 (0111: NM). A quantitative association assay 
demonstrated similar or greater association of strain NCTC 12900 with all cell types when 
compared with EPEC strain B 171 and with Salmonella Typhimurium, but with little invasion 
(: 50.1 %). 
2.2.1.2 Reference strains 
Four non-0157 E. coli strains were used as reference strains in the studies described 
herein: 
  EPEC 0111: NM, strain B171. This was originally isolated from an outbreak of 
diarrhoea in an infant and toddler centre (Paulozzi et al. 1986; Riley et al. 1987). 
  STEC 026: K60: H11, strain EC1537. This is an AE strain isolated from an eight-month 
old heifer with haemorrhagic diarrhoea, in a group of diarrhoeic animals in which 026 
AE lesions were identified in the large intestine (Pearson et al. 1999). It was flagellar 
antigen typed (Gunning et al. 2001) subsequent to the original report. 
" AEEC 080: NM, strain 85440. This was isolated from a three-week old calf with 
diarrhoea associated with AE lesions in the small and large intestines (Pearson et al. 
1989). The lesional bacteria were positively immunostained with an antiserum raised 
against this strain. Subsequently the strain was serotyped (Wales et al. 2000). 
  E. coli K12, strain DHSa is a plasmid-transformation competent, avirulent, laboratory 
strain supplied by Invitrogen. 
2.2.2 Storage of bacterial strains 
Bacterial strains were stored at room temperature on Dorset's egg medium slopes 
(Appendix 1) in screw-capped bijoux. Subcultures were created by inoculation onto 5% 
sheep's blood agar (Appendix 1), and colonies on this medium were examined for 
uniformity of appearance. New sheep's blood agar subcultures were made from the previous 
sheep's blood agar plate or Dorset's egg slopes at monthly intervals. 
2.2.3 Routine broth culture 
Bacterial strains were grown routinely in Luria-Bertani minus glucose (LB-G, 
Appendix 1) broth. Sterile LB-G broth (1,3 or 20 ml) was inoculated with a small sweep of 
colonies from a sheep's blood agar plate of the strain required. Aerobic stationary-phase 
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broth cultures were generated overnight at 37 °C in a shaking incubator (Innova 4000, 
19 mm circular orbit, 175 rpm). 
2.2.4 Cultures for bacterial protein analysis in vitro 
Strains were grown in l ml LB-G broth overnight. Two protein secretion regimes were 
used: 
A. A 200 µl aliquot of broth culture, containing approximately 2x 108 cfu, was inoculated 
into a tapered 50 ml polythene tube (Falcon) containing 20 ml Dulbecco's modified 
Eagle's medium (DMEM, with sodium bicarbonate and 4500 mg/l glucose, Sigma) which 
had previously been equilibrated at 37 °C in 5% CO2. The DMEM was then incubated at 
37 °C in 5% CO2 for five hours. 
B. A 10 ml aliquot of broth culture was centrifuged for 10 min at 3490 g and the bacterial 
pellet was resuspended in 20 ml phosphate-buffered saline (PBS, pH 7.2, Appendix 1) at 
room temperature. This procedure aimed to achieve a final concentration of 
5x 108 cfu/ml, similar to that in DMEM after 5 hours incubation. The PBS suspension 
was then left at room temperature for one hour. 
2.2.5 Cultures for studies of the effect of pre-incubation conditions 
upon cell association 
Two preparations were made for each strain, one in DMEM and one in PBS. For the 
DMEM preparation, 10 pl of an overnight LB-G broth culture was inoculated into 20 ml of 
DMEM, which had been equilibrated at 37 °C and 5% CO2. The inoculated DMEM was 
incubated for three hours in a 37 °C, 5% CO2 incubator and then I ml of it was added to a 
washed HEp-2 cell monolayer. Alternatively, for the PBS preparation, 150 µl of overnight 
LB-G broth culture was added to 850 µl of PBS and the bacterial cells were washed by 
centrifugation and resuspension in I ml PBS. The bacterial suspension was left for one hour 
at room temperature and was then centrifuged, resuspended in 10 µl of PBS and added to 
990 µl of DMEM on a freshly-washed HEp-2 monolayer. 
2.2.6 Cultures for the intestinal loop experiments 
(Dr. A. Cookson prepared all cultures) 
The strains were grown routinely overnight and I ml of broth culture was harvested by 
centrifugation at 13 400 g on a bench-top centrifuge (Microcentaur, MSE). The bacterial 
pellet was resuspended in 4 ml PBS to give a viable count of approximately 2.5 x 108 to 
5x 108 cfu/ml. Alternatively, 200 µl of a routine overnight broth culture was inoculated into 
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20 ml pre-warmed DMEM and incubated for six hours at 37 °C in 5% CO2 to give a viable 
count approximately equivalent to that in the PBS-suspended preparation. The total viable 
count (TVC) of bacteria in inocula was determined for the final two experiments (lambs 3 
and 4). 
2.2.7 Cultures for oral inoculation experiments 
(Mrs. C. Hayes or Dr. A. Cookson prepared all cultures) 
The four-strain mixed inoculum was made by mixing a 2.5 ml aliquot of an overnight 
LB-G broth culture of each of the four strains together and making the mixture up to 100 ml 
with PBS. 
Single-strain inocula were prepared by one of three methods: 
a) A 10 ml aliquot of an overnight culture was made up to 100 ml with PBS. 
b) An 8-hour LB-G broth culture was given orally without further processing. 
c) A 60 ml overnight LB-G broth culture was sedimented by centrifugation and resuspended in 
50 ml PBS. 
Aliquots of each inoculum preparation were taken for TVC determination. Each animal 
was inoculated orally with 10 ml of the appropriate inoculum. 
2.2.8 Determination of total viable count (TVC) 
A technique based on that described by Miles and Misra (1938) was used for the 
determination of TVC. A 20 µl aliquot was removed from the bacterial suspension to be 
measured and was diluted tenfold by addition to 180 gl of PBS in a polystyrene microtitre 
plate well. A serial tenfold dilution series was prepared in PBS on the microtitre plate. 
Depending upon the likely viable count, dilutions of 104- to 106-fold were prepared. From 
each of the three or four most dilute suspensions, three 20 µl aliquots were plated onto 
labelled, partially-dried nutrient agar plates for overnight culture. After incubation, the least 
dilute suspension for which clear, separated colonies could be counted was used for colony 
counting, and an average number of colonies per 20 µl spot was determined from the three 
spots. The viable count of the original suspension was derived by multiplication using the 
dilution factor. 
2.2.9 Recovery and enumeration of bacteria from experimental 
animals 
Most samples were analysed immediately after being taken, as follows. Faeces and 
intestinal contents (I g) and tissue samples (2.5 g) were collected, placed in 9 and 22.5 ml 
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volumes of BPW (pH 7.2, Oxoid) respectively and homogenised in a stomacher. Rectal 
swabs were placed in 10 ml BPW and vortex-mixed. Samples were weighed in plastic petri 
dishes on a portable balance. Some faecal and intestinal contents samples weighed less than 
1g due to constraints of the sampling procedure. 
A Most Probable Number approach was used to determine, semi-quantitatively, the 
E. coif 0157: H7 count in each sample cultured. Each homogenate was diluted 10- or 100- 
fold serially in BPW and then each dilution was incubated for six hours at 37 °C before 1 ml 
of the supernatant was processed via IMS, according to the manufacturer's instructions. For 
IMS, 20 µl of magnetic beads coated in polyclonal antisera raised against the 0157 
lipopolysaccharide (Dynabeads anti-E. coif 0157, Dynal) were mixed with the 1 ml sample 
in a 1.5 ml microcentrifuge tube (Eppendorf) on an inclined rotator at 30 rpm for 30 min at 
room temperature. Each tube was placed in a magnetic separator rack (Dynal) for 5 min and 
the rack was then gently inverted three times, to concentrate the magnetic beads against the 
side of the tube adjacent to the external magnet. The liquid was removed from the tube with 
a pipette and replaced with 1 ml of PBS containing 0.5 % Tween 20 (Sigma). The tube was 
removed from the magnet, gently inverted four or five times to mix the beads with the PBS- 
Tween, and replaced in the magnetic rack. The beads were washed by this procedure twice 
more and then resuspended in 100 µl PBS. 
In experiments involving the four-strain mixed inoculum, 25 ld aliquots of the final 
suspension of beads were spread onto separate nalidixic acid (nal; 15 µg/ml), rifampicin (rif; 
150 µg/ml), streptomycin (str; 25 pg/ml) or nal (15 µg/ml) plus rif (150 µg/ml) - 
supplemented CHROMagar 0157 (CHROMagar) plates. To differentiate between single and 
double antibiotic resistance marked E. colt 0157: H7 strains, 10 colonies from nal- and rif- 
supplemented plates were subcultured onto rif and nal plates respectively. In the experiments 
using a single inoculum strain, all of the final suspension was spread onto nal- or rif- 
supplemented or antibiotic-free CHROMagar 0157 plates, according to the resistance 
marking of the strain involved. The final suspension volume was 100 µl for the antibiotic 
resistant strains and 200 µl for the unmarked strain. The aim of the increased volume for the 
latter was to spread out the background flora carried over from the IMS procedure, which 
would not be suppressed by the antibiotic-free culture medium. 
Where sample processing was to be delayed, 2.5 g samples were collected into 22.5 ml 
PBS containing 15 % glycerol, frozen and stored on dry ice overnight. The frozen 
preparations were then thawed at room temperature and a 2.5 ml aliquot was mixed with 
22.5 ml BPW. This mixture was then serially diluted, incubated and subjected to the IMS 
and culture procedures described above. 
For pre-inoculation screening of lambs for the excretion of E. coif 0157, the IMS 
procedure described above was used, without the preparation of a dilution series before pre- 
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enrichment. The IMS beads were spread onto a CHROMagar 0157 plate without antibiotic 
supplements. 
2.2.10 Analysis of bacteria cultured from experimental animals 
The serogroup of lilac-coloured colonies recovered on CHROMagar 0157 was checked 
by 0157-specific latex agglutination (LAgg; E. coli 0157: H7 Test, Oxoid), following the 
instructions of the manufacturer. Any lilac colonies which produced a negative result with 
LAgg were subcultured and retested, and persistently negative lilac cultures were stored on 
Dorset's egg medium for further analysis if required. 
Serogroup determination and Verocytotoxicity testing of selected strains was performed 
at the VLA E. coli typing unit using standardised multiwell plate agglutination tests and a 
polymyxin B-Verocell assay respectively. PCR detection of eaeA, stxl and stx2 was also 
performed on selected strains, either at the VLA E. coli typing unit or as described in 
Section 2.3. 
2.3 Genotypic characterisation of experimental strains 
2.3.1 Preparation of genomic DNA 
Template DNA for PCR reactions was prepared by phenol-chloroform extraction 
(Ausubel et al. 1987). Bacteria, grown overnight in 3 ml LB-G broth, were sedimented into 
the bottom of a single 1.5 ml microcentrifuge tube (Eppendorf) by three cycles of 
centrifugation of 1 ml for 3 min at 13 400 gin a bench-top centrifuge: the supernatant was 
discarded and further broth suspension was added after each of the first two spins. The 
bacterial pellet was resuspended in 400 µ1 of Tris-EDTA buffer, pH 8.0 (Appendix 1), to 
which 50 µl of Proteinase K (20 mg/ml, Sigma) was added. The mixture was incubated at 
55 °C for 30 min and then the bacterial cells were lysed by the addition of 50 µl 10 % w/v 
sodium dodecyl sulphate (SDS 99 %, Sigma). Incubation continued at 55 °C until the 
suspension cleared (approximately 2 min). The lysed cell suspension was then added to a 
1.5 ml Phase Lock Gel (PLG) Light tube (5'--º 3') which previously had been centrifuged 
briefly to deposit the PLG at the bottom of the tube. An approximately equivalent (500 µl) 
volume of phenol chloroform mixture (25 phenol : 24 chloroform :I isoamyl alcohol, 
buffered to pH 8.0 with Tris, Sigma) was added to the PLG tube. The fluids were emulsified, 
by gentle inversion until the mixture turned milky white, and were then separated by 
centrifugation as above for 15 min. The aqueous (topmost) layer overlying the PLG/phenol 
chloroform interface was removed to a fresh PLG tube and 600 µl of phenol chloroform was 
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added to this tube. The fluids were mixed and separated by centrifugation as described 
above. 
The aqueous layer (approximately 5001d) was then decanted into a new 1.5 ml 
microcentrifuge tube to which isopropyl alcohol (1 ml, Sigma) was added. The tube contents 
were gently mixed by inversion for I min, until a fluffy white DNA precipitate was formed. 
The precipitate was sedimented by centrifugation as above for 5 min and the supernatant was 
discarded. The DNA pellet was washed with l ml of 70 % ethanol and the tube was 
centrifuged as above for 3 min. The supernatant was discarded and the DNA pellet was 
allowed to partially dry by evaporation of the ethanol at room temperature for 15 min, before 
being gently resuspended in 250 µl double-distilled sterile water and allowed to dissolve 
overnight at 4 °C. 
2.3.2 Polymerase Chain Reaction (PCR) 
PCR primer sequences were obtained from quoted references (Table 2-A), or were 
designed by Dr A. L. Cookson at VLA Weybridge using a DNASTAR computer program, 
from published GenBank sequences (NCBI) using the accession numbers quoted in Table 
2-A. The eaeA primers amplified a fragment from the 5' (non-variable) end of the intimin 
gene. The six! primers amplified a fragment spanning the A- and B-subunit genes and the 
stx2 primers amplified a fragment of the A-subunit gene. The enterohaemolysin primers 
amplified a fragment spanning the EHEC-hlyC and -hlyA genes. Primer sequences and the 
expected product sizes are given in Table 2-A. 
To minimise the possibility of foreign DNA contamination, work surfaces were sprayed 
and wiped with 70 % ethanol and plugged (non-aerosol) pipette tips (Anachem) were used. 
Control negative PCR reactions lacking template DNA and positive reactions containing 
DNA with the target sequence were included in all batches of reactions. 
PCR reactions (Saiki et al. 1985) were carried out in a total volume of 50 µl, in thin- 
walled PCR tubes (Sigma). The Cambio PCR Optimization Kit MasterAmp 2x PCR buffers 
A, B, and C were used. These buffers all contain: 100 mM Tris-HCI (pH 8.3), 100 mM KCl 
and 400 µM of each deoxyribonucleoside triphosphate (Adenine, Thymidine, Cytosine and 
Guanidine). Buffers A, B and C contained 3.0,5.0 and 7.0 mM MgC12 respectively. Three 
reaction mixtures, containing buffer A or B or C, were prepared for each strain tested in 
order empirically to provide the optimal magnesium concentration for each amplification. 
Where previous experience had demonstrated an optimal buffer, or no difference between 
buffers for a particular product, only one buffer was used subsequently. Each reaction 
mixture was prepared on ice by addition of reagents in the following order: 
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i. 17.5 or 21.5 µl double distilled sterile water, depending upon whether the PCR reaction 
was single or multiplex (18.5 or 22.5 µl in negative control tube) 
ii. 25 µl MasterAmpTM 2x PCR buffer A, B, or C 
iii. I }d (40-60 pmol) each of forward and reverse primers for each product, i. e. two primers 
for single PCR, six primers for multiplex PCR 
iv. 0.5 µl Thermus aquaticus (Taq) DNA polymerase (Promega) 
The tube was then vortex-mixed, the entire reaction mixture was relocated to the bottom 
of the tubes by brief centrifugation, and two drops of sterile mineral oil (Sigma) were 
added. 
v. Template DNA (1 µl of preparation) was introduced into the aqueous phase by pipetting 
through the oil. 
The sealed tube was then vortexed and centrifuged briefly, to mix the contents. 
Amplification was then performed in a Trio thermal cycler (Biometra) using a 
'touchdown' program with high early annealing temperatures to optimise specificity. The 
program used was as follows: 
i. Initial denaturing at 94 °C for 5 min (tubes added to pre-heated block) 
ii. High-stringency annealing at 68 °C for I min 
iii. Extension at 70 °C for I min per thousand base-pairs in the product 
iv. Denaturing at 94 °C for I min 
Steps (ii) through (iv) were then repeated six times, reducing the annealing temperature 
by 2 °C each time, to a final 56 °C. This was followed by: 
v. Annealing at 56 °C for I min 
vi. Extension at 70 °C for I min per thousand product base pairs 
vii. Denaturing at 94 °C for I min 
Steps (v) through (vii) were then repeated 28 times, followed by: 
viii. Final holding at 4 °C until products were removed for electrophoresis 
PCR products were separated by electrophoresis within 12 hours. Agarose gels (0.8 %, 
Appendix 1) were cast in horizontal tanks (BioRad) and immersed in TAE buffer. Reaction 
products (10 µl) were mixed with 4 µl of loading buffer (Appendix 1) and the 14 µl mixtures 
were loaded into gel wells. Molecular mass markers (1 Kb Plus Ladder, Life Technologies) 
were loaded into adjacent lanes. Electrophoresis was performed at 160 V until the 
bromophenol blue dye front approached the end of the gel. 
Separated products were rendered fluorescent by soaking the gel in an ethidium bromide 
solution (8 pg/ml in TAE buffer) for 5-10 min. The gel was then rinsed in distilled water and 
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examined for fluorescence on an ultraviolet transilluminator (Syngene). The appearance of 
each gel was recorded photographically via video camera and monochrome printer. 
Table 2-A: PCR primers used for strain characterisation 
Expected Accession Target Primer sequences product no. 
/ ref. 




F: TGC GGC ACA ACA GGC GG 628 Z11541 





F: TGC GGC ACA ACA GGC GG 2135 Oswald et 
R: OCT CAC TCG TAG ATG ACG GCA AGC G al. 2000 
subtype (O 103: H2) 
stxl 
F: GGC AGA TGG AAG AGT CCG TGG GAT TAC GC 178 Z36900 
R: CAC AAT CAG GCG TCG CCA GCG CAC TTG CT (0111: H-) 
stx2 
F: CCA CAT CGG TGT CTG TTA TTA ACC ACA CC 374 X61283 
R: GCA GAA CTG CTC TGG ATG CAT CTC TGG TC (0157: 117) 
X97542 
espP 
F: TTG CGA AAA ATG GCG GAA CTC 1146 Brunder et R: OCT GAC GGG GCA TTG ACT G al. 1996 
(0157: H7) 
F: CTT CCT GTT CTG ATT CTT CTG G Brunder et katP 
R: AAC TTA TTT CTC GCA TCA TCC 2125 al. 1996 (0157: 117) 
hlyA-C F: OCT ATG GGC CTG TTC TCC TCT G 1779 X86087 R: TGT CTT GCG TCA TAT CCA TTC TCA (0157: H7) 
etpD 
F: CGT CAG GAG GAT GTT CAG 1061 Y09824 R: CGA CTG CAC CTG TTC CTG ATT A (0157: H7) 
1019 Waterman et 
rpoS 
F: ATG AGT CAG AAT ACG CTG AAA GTT CAT GATT (entire al. 1996 R: AGA CTG GCC TTT CTG ACA GAT GCT TAC TTA (DH I, non- 
0157) 
F: C GGC GGA TCC* TGG TTT CTA AAA TCA TGA ATA AG Z12295 
bfpA R: C GGC AAG CTTt CTT CAT AAA ATA TGT AAC TTT AT 578 (0127: H6) 
Underlined sequences are non-hybridising extensions incorporating *BamH I and tHind III restriction 
sites. 
2.4 Generation of spontaneous antibiotic resistant mutants 
Antibiotic resistant bacterial mutants were selected, to aid recovery from inoculated 
animals and to permit subsequent identification of strains. Nalidixic acid, streptomycin, 
rifampicin and spectinomycin (spec) were used. Strains were spread-plated (200 µl from 
overnight cultures in LB-G broth) on nutrient agar plates containing nal (15 µg/ml), str 
(25 µg/ml), rif (150 gg/ml) or spec (100 µg/ml). After overnight aerobic culture at 37 °C, 
spontaneous antibiotic resistant colonies present on these plates were subcultured onto the 
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same media three further times, then maintained on Dorset's egg medium slopes at room 
temperature, and subcultured onto sheep's blood agar plates prior to any procedures. 
A double-marked nal`riV strain was generated by sequential culture on nal (15 µg/ml) and 
rif (150 µg/ml) -supplemented nutrient agar plates. 
2.5 Phenotypic characterisation of experimental strains 
2.5.1 Species confirmation and serotyping 
The species of presumptive E. coli was confirmed at the VLA E. coli typing unit by 
growing the isolate in o-nitrophenol-D-galactopyranoside (ONPG) broth to test for 
ß-galactosidase activity, indicating a lactose fermenter, and by growing it on Tryptone Bile 
Agar (TBA) for an indole spot test. If the isolate was a non lactose-fermenter or indole test 
negative or failed to grow on TBA, an API 20E (bioMerieux) strip test for Enterobacteraceae 
identification was performed. 
Somatic antigen ('0') serotyping was done by standard microtitre agglutination tests on 
boiled and autoclaved broth cultures, initially against a panel of 48 antisera raised in rabbits. 
Further antisera were used if necessary. Capsule detection and typing was performed with a 
slide agglutination method using homologous 'O' antisera and test capsular antisera. 
2.5.2 Survival at acid pH 
2.5.2.1 Inorganic acid 
For each strain, the TVC of an overnight LB-G broth culture was determined. A 10 µl 
aliquot of the broth culture, containing approximately 107 cfu, was diluted in 990 Id of PBS, 
and 30 µl of this was added to 2970 µl of LB-G broth which had been acidified to pH 2.5 by 
the addition of concentrated hydrochloric acid. Thus, an initial concentration of 
approximately 105 cfu/ml was present in the acidified broth. The broth was incubated 
aerobically at 37 °C with shaking, (Innova 4000 incubator, 19 mm circular orbit, 175 rpm), 
for 2.5 hours. 
To enumerate the TVC after incubation, the bacterial mass was sedimented into the 
bottom of a single 1.5 ml microcentrifuge tube (Eppendort) by two cycles of centrifugation 
for 3 min at 13 400 g in a bench-top centrifuge, with the supernatant discarded after each 
spin. The bacterial pellet was resuspended in 200 gl of PBS and a TVC determined. Using 
the TVC of the initial inoculum (derived from the overnight broth culture) and of the post- 
incubation acidified broth (derived from the resuspended bacterial pellet), a percentage 
survival was calculated. 
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2.5.2.2 Volatile fatty acids (VFA) 
Acetic, propionic, butyric and valeric acids (Sigma) were mixed in a molar ratio of 
77: 10: 10: 3, to a total VFA concentration in LB-G broth of either 100 mmol/I or 150 mmol/l. 
Three aliquots of each mixture, plus three aliquots of control LB-G broth without added 
VFA, were adjusted to pH 6.0,6.5 and 7.0 respectively, using concentrated aqueous sodium 
hydroxide and hydrochloric acid. Thus, three added VFA concentrations (0,100 and 
150 mmol/I) were prepared at each of three acidity levels. Each VFA plus pH combination 
was filter-sterilised using a 0.2 µm syringe filter (Minisart filter, Sartorius) and equilibrated 
overnight at 37 °C in an anaerobic gas jar (Becton-Dickinson'BBL GasPak' anaerobic 
system with palladium catalyst). 
Each test strain was inoculated singly into each VFA plus pH combination. An initial 
100-fold dilution of an overnight LB-G broth culture of each strain was prepared in PBS, and 
10 µl of this was inoculated into 990 p1 of the VFA mixture, in a 1.5 ml screw-capped 
microcentrifuge tube with a hole in the cap to permit gas exchange. A 20 µl aliquot of the 
inoculated VFA mix was withdrawn immediately and the TVC determined. All inoculated 
microcentrifuge tubes were then placed in anaerobic gas jars and incubated at 37 °C. The gas 
jars were opened at four or five hours p. i. and 20 µl aliquots were taken from all 
microcentrifuge tubes for TVC determinations, then the jars were resealed with fresh 
anaerobic packs and final samples for TVC were taken at eight hours p. i. 
2.5.3 Cross-streaking and growth in broth culture 
(Dr. A. Cookson performed all work) 
The growth of each strain in LB-G broth at 37 °C with shaking, (Innova 4000 incubator, 
19 mm circular orbit, 175 rpm) was examined by monitoring optical density (OD). For each 
antibiotic resistance marked strain, 20 ml of a 106-fold dilution of an overnight stationary 
phase broth culture, approximating 103 cfu/ml, was prepared using fresh, warmed LB-G 
broth. This culture was incubated aerobically in 50 ml plastic tubes (Falcon) at 37 °C with 
shaking. At hourly intervals for nine hours, aI ml aliquot was removed and its OD at 
600 nm was read in a spectrophotometer (Biotec UV 1101, WPA). 
Interactions between strains were assessed by mixed batch culture and cross-streaking. A 
low-density mixed-strain LB-G broth culture (20 ml) was made up from overnight broths of 
each antibiotic resistance marked strain, to a concentration of about 103 efu/ml for each 
strain, as for the single-strain growth curves. The mixture was incubated as described above 
for the single strains. At hourly intervals for nine hours, an aliquot of the culture was 
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removed and TVC were determined for each strain using antibiotic-supplemented culture 
plates. 
For cross-streaking, a nutrient agar plate was inoculated with intersecting lines of each 
antibiotic resistance marked strain, such that each strain intersected every other strain. The 
plate was incubated aerobically at 37 °C overnight. 
2.5.4 Analysis of bacterial proteins 
2.5.4.1 Preparation of concentrated secreted protein solutions 
Bacterial strains grown overnight in LB-G broth were inoculated into DMEM and PBS 
and incubated, as described in Section 2.2.4. AI ml aliquot was removed from each of the 
cultures for processing in the intimin expression assay (Section 2.5.4.2). A 20 µI aliquot was 
removed from this for a TVC determination. The remaining approximately 19 ml of DMEM 
or PBS preparation was centrifuged at 3490 g for 10 min in a refrigerated centrifuge 
(Megafuge 1.0 R, Heraeus) at 4 °C. The supernatant was removed, using a 20 ml syringe, 
and filter-sterilised through a 0.2 µm filter (Minisart filter, Sartorius) into a sterile tapered 
polythene tube (Falcon). To demonstrate sterility before removal from the category 3 
containment laboratory, a 100 µl aliquot of each the filter-sterilised preparations was spread 
onto a sheep's blood agar plate, incubated at 37 °C overnight, and examined for bacterial 
growth. The remaining liquid was stored at 4 °C and, following the demonstration of sterility 
as above, were removed to a hazard category 2 containment laboratory. 
Secreted proteins were concentrated by centrifugal ultrafiltration. Most (17 ml) of each 
sterile DMEM or PBS preparation was pipetted into the upper chamber of a Vivaspin 20 
concentrator (Vivascience) containing an ultrafiltration membrane with a molecular weight 
cut-off (MWCO) of 5000 daltons. The Vivaspin apparatus (upper chamber separated from a 
lower chamber by the membrane) was then centrifuged at 3500g in a refrigerated centrifuge 
for 10-20 min, until the sample in the upper chamber had been reduced in volume to 
approximately 500 µl. This concentrated macromolecule solution was then decanted by 
pipette and either analysed immediately or stored frozen at -20 °C. The secreted proteins 
were separated and detected by SDS-PAGE, silver staining and Western blotting as 
described in Section 2.5.4.3. 
2.5.4.2 Intimin expression preparations 
Two protocols were used: 
A. An overnight LB-G broth culture (200 µl) was inoculated into 20 ml of warmed DMEM 
(4500 mg/l glucose) and incubated for five hours at 37 °C in 50/0 CO2. The culture was 
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sedimented by centrifugation at 3490 g for 10 min, the bacteria were resuspended in 200 91 
of double-distilled sterile water, and heated in a boiling water bath. The protein 
concentration of the lysed samples was assayed using a bicinchoninic acid (BCA) Protein 
Assay Reagent Kit (Pierce), with 10 µl sample volumes in a 96-well polystyrene microtitre 
plate (Nunc), according to the manufacturer's instructions. The absorbance of the reaction 
mixtures (two per strain lysate) was read at 550 nm in a plate reader (Revelation, Dynex). 
The calculated absorbance of each lysate was the mean of the two readings obtained, minus 
the mean of the 10 control negative reaction mixtures. 
B. Intimin expression studies were performed on the same DMEM and PBS preparations that 
were used for the secreted protein studies in Section 2.5.4.1. Following incubation aI ml 
aliquot in a microcentrifuge tube, less 20 µl used for a TVC, was centrifuged at 13 400 gin 
a bench-top centrifuge for 3 min and the supernatant was discarded. The bacteria were 
resuspended in 100 p. 1 of SDS-PAGE loading buffer and heated to 99.9 °C for 5 min in a 
thermal block. The preparations were stored frozen. 
Intimin preparations were separated and analysed by Western blotting as described in 
Section 2.5.4.3 B. 
2.5.4.3 Separation and detection of bacterial proteins 
A. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and dtection by silver or Coomassie staining 
A 12 % polyacrylamide mini-gel with 5% stacking gel (Appendix 1) was prepared and 
immersed in SDS-PAGE running buffer in an electrophoresis tank (BioRad) An aliquot (10 
to 30 µl) of concentrated macromolecule solution (Section 2.5.4.1) was mixed with SDS- 
PAGE loading buffer in a ratio of 1: 1 (buffer i. ) or 4: 1 (buffer ii. ). An aliquot (10 gl for 
silver stained gels, 30 µl for Coomassie stained gels) of each preparation was then loaded 
into a separate well of the stacking gel. A molecular weight marker (Rainbow, Amersham) 
was included as 10 µl of a 1: 50 dilution of the supplied stock mixture. Electrophoresis was 
performed at 60 V until the bromophenol blue dye marker passed into the separating gel, 
then at 100 V thereafter, until the dye marker approached the bottom of the gel. 
The gel was washed in deionised water and then either fixed and silver stained with the 
PlusOne silver staining kit (Amersham) according to the manufacturer's instructions, or 
stained with Coomassie stain. For the latter, the gel was immersed in Coomassie reagent 
(Appendix 1) overnight, followed by immersion in destaining solution (Appendix 1) for 24 
hours, with white tissue paper being used to remove from the destaining solution the stain 
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extracted from the gel. Protein band patterns were scanned in a flatbed scanner and stored as 
digital images. 
B. Western blotting 
SDS-PAGE was performed, loading the gel as described above, but using 20 µl (loading 
buffer i) or 301l (loading buffer ii) of the sample/loading buffer mix and using 10 µl of 
undiluted Rainbow marker mix. In the case of intimin preparations made using Protocol A 
(Section 2.5.4.2), the technique was altered to correct for protein content of the samples such 
that an equal amount of protein was loaded into each well of the gel. This was achieved by 
adding an amount of each lysate preparation in inverse proportion to its protein concentration 
(as determined by the BCA assay) to 10 µl of loading buffer. Thus, the sample with the 
lowest calculated absorbance was added at 10 gl per well, and those with higher absorbances 
were added in lower proportions, as the BCA assay demonstrates a linear relationship 
between protein concentration and absorbance over the assayed protein range of 1-2 mg/ml. 
The sample and loading buffer mix were heated to 99.9 °C in a heating block for 5 min 
before loading. 
Electrophoresis was performed as described for the silver-stained gels. When this was 
completed, the separated proteins were transferred to a nitrocellulose membrane (Sartorius) 
by transfer using an electrophoresis tank (BioRad), using a gel-nitrocellulose sandwich 
suspended in CAPS buffer (Appendix 1). The transfer electrophoresis was run at 300 mA for 
one hour. 
The EspA protein was detected on the nitrocellulose membrane of secreted protein 
preparations using a rabbit anti-EspA polyclonal antibody, raised against HIS-tagged 
recombinant EspA from E. colt 0157: H7 strain EC157 (Table 3-A), produced at VLA 
Weybridge (Appendix 2). The membrane was initially blocked against non-specific protein 
binding sites by incubation overnight in 3% skimmed milk powder (Marvel, Premier 
Brands) in Tris-buffered saline (TBS, Appendix 1). After washing in TBS containing 0.05 % 
Tween 20 (Sigma), the membrane was incubated for 45 min at 37 °C in anti-EspA antibody 
diluted 1: 500 in 3% Marvel in TBS. Following washing in TBS-Tween, the membrane was 
again incubated for 45 min at 37 °C in goat anti-rabbit peroxidase conjugate (Sigma) diluted 
1: 2000 in 3% Marvel in TBS. The bound antibody-peroxidase complex was detected using 
amino ethylcarbazole (AEC) substrate (Appendix 1), yielding a red reaction product after a 
few minutes. The development was monitored by eye and stopped by rinsing with deionised 
water. The dried membranes were scanned on a flatbed scanner and images were stored 
digitally. 
The nitrocellulose membrane of intimin preparations was probed, as described above, 
with an anti-intimin primary antibody raised in a rabbit against the C-terminal of the 
y-intimin molecule from E. coli 0157: H7 strain A84 (Woodward et al. 1999), expressed in a 
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recombinant E. coli as a HIS-tagged protein (Appendix 2). The resultant stained membranes 
were dried and scanned on a flatbed scanner and images were stored digitally. 
2.5.5 Association of bacterial strains with cultured cells 
2.5.5.1 Preparation of cell monolayers 
The HEp-2 (human cervical carcinoma derivative, ECACC; Moore et al. 1955; Chen 
1988) cell line was supplied by the VLA Weybridge tissue culture unit. Cells were 
maintained in 75 cm2 polystyrene flasks with 20 ml complete tissue culture medium 
(Appendix 1), at 37 °C in 5% CO2. They were subcultured every three days by detaching 
and disrupting the cell monolayer using a 10 min incubation with 3 ml of a proteolytic / 
EDTA solution (Accutase, ICT), resuspending the cells and discarding 80 % of the 
suspension. The remaining 20 % of cell suspension was made up to 20 ml with fresh 
complete medium and re-introduced into a new 75cm2 flask. 
Confluent monolayers of cells in 24-well polystyrene plates (Nunc), either with or 
without 13 mm diameter glass coverslips, were prepared from confluent stocks in flasks. The 
flask monolayers were disrupted with 3 ml Accutase as above, and the resulting suspension 
was diluted with 10 ml complete medium. A viable cell count was performed in a Neubauer- 
type counting chamber, using 0.1 % erythrosin B (Sigma) to stain non-viable cells. Complete 
medium was added to adjust the cell suspension to 2x 105 cells/ml and I ml of this 
suspension was added to each well of a 24-well plate. A microscopic check for confluence 
was made after incubation for 48 hours. 
Bovine intestinal cell cultures (ileum, colon and rectum) were obtained from frozen 
stocks prepared by Dr M. Dibb-Fuller from a neonatal calf (Dibb-Fuller et al. 2001). Frozen 
vials containing approximately 107 cells in Cell Culture Freezing Medium (Gibco) were 
retrieved from storage in liquid nitrogen and thawed at room temperature. The cells were 
sedimented by centrifugation at 405 g for 10 min and the supernatant was decanted. The 
cells were resuspended in I ml of complete medium and were grown for 72 hours at 37 °C in 
5% CO2. At this point the cells were subcultured by trypsinisation and sowing, at 2x 105 
viable cells per well, into 24-well polystyrene plates. Cells were grown either on the bottom 
of each well or on a 13 mm diameter glass coverslip within each well, as d%cribed for 
HEp-2 cells. Seeded wells were incubated at 37 °C, 5% C02, for 48 to 72 hours before 
checking for confluence by light microscopy and then their use in assays. 
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2.5.5.2 Quantitative association assay 
The assay was based upon published methods (Sherman et al. 1987). Bacterial strains 
were grown overnight in LB-G broth. Cell monolayers grown in wells without coverslips, as 
described in Section 2.5.5.1, were washed with three changes of 2 ml of Hank's balanced salt 
solution (HBSS, Sigma), warmed to 37 °C. The monolayers were covered with 990 µl 
incomplete medium (Appendix 1) pre-equilibrated in 5% CO2 at 37 °C. Mannose was 
omitted from the incomplete medium in the bovine cell culture assays as E. coli 0157: H7 
does not usually express mannose-sensitive fimbriae (Section 1.4.2.2D). For each strain 
culture a 10 µl aliquot, containing approximately 107 cfu, was added to two to four wells. 
The plates were placed in a humidified 5% CO2 incubator at 37 °C for three hours. The 
incomplete medium was drawn off each well and the monolayers were washed three times 
with warmed HBSS. After the final wash had been removed, I ml of I% Triton X-100 
detergent (Sigma) was added to each well and the monolayers were detached and disrupted 
by placing a magnetic stirring flea in each well and agitating the contents on a magnetic 
stirrer for 10 min. The suspensions resulting from this procedure were used for TVC 
determination. 
2.5.5.3 Giemsa-stained preparations 
Bacterial strains were grown overnight in LB-G broth. Confluent monolayers were grown 
on 13 mm diameter glass coverslips in 24-well plates, as described in Section 2.5.5.1, and 
were washed, covered with 990 ml of incomplete medium and inoculated with 10 µl of broth 
culture, as described in Section 2.5.5.2. Monolayers were incubated at 37 °C in a humidified 
5% CO2 atmosphere for three or six hours. The six-hour monolayers were washed three 
times with HBSS at three hours p. i. and fresh incomplete medium was added subsequently. 
After incubation the monolayers were washed three times with HBSS and then fixed for 
30 min with 3% neutral buffered formalin (Sigma). After washing with double-distilled 
sterile water the cells were stained with 10 % Giemsa stain (Sigma) for one hour, washed 
three times with double-distilled water, and differentiated in 1% acetic acid (Sigma) for 
I min. After a final wash, the coverslips were removed from the wells with forceps, air-dried 
and mounted monolayer-side down on glass microscope slides using DPX mountant (R. A. 
Lamb). Slides were examined by light microscopy using 40x (dry) and 100x (oil immersion) 
objectives. 
2.5.5.4 Fluorescence actin staining (FAS) 
FAS was performed on confluent monolayers grown on 13 mm diameter glass coverslips 
in 24-well plates, as described in Section 2.5.5.1. An aliquot (10 µl) of each strain, grown in 
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LB-G broth, was inoculated into a separate well containing 990 µl incomplete medium, and 
incubated for either three or six hours, with washing in the latter case, as described for 
Giemsa preparations. After incubation each monolayer was washed four times with 2 ml 
warmed PBS and then fixed for 20 min with I ml of 3% neutral buffered formalin (Sigma). 
After washing three times with PBS the cells were permeabilised in 0.1 % v/v Triton X-100 
detergent (Sigma) for 4 min. After three further PBS washes, the cells were covered with 
0.5 µg/ml fluorescein isothiocyanate-phalloidin (Phalloidin-FITC labelled, Sigma) for 
20 min, in the dark. After three final washes in PBS the coverslips were removed from the 
wells, dried and mounted monolayer-side down on glass microscope slides using DPX 
mountant. Slides were stored at room temperature in the dark and examined under incident 
fluorescence illumination with a Zeiss Axiovert 25 fluorescence microscope equipped with a 
FITC fluorescence filter, using a 100x oil-immersion objective. 
Comparison of DMEM- and PBS-prepared strains 
The TVC of both DMEM- and PBS-prepared inocula (Section 2.2.5) were enumerated on 
a 20 µl sample taken from the wells immediately after inoculation of the monolayers. A 
single six-hour incubation, with washing at three hours, was performed and the cells were 
then subjected to FAS. 
2.5.5.5 Inoculation of monolayers for electron microscopy 
Comparison of strains 
Monolayers were inoculated, incubated and washed as described in Section 2.5.5.3. The 
infected monolayers were fixed with I% glutaraldehyde overnight. 
Comparison of culture conditions 
Monolayers were inoculated with bacteria pre-incubated in DMEM or PBS, as described 
in Section 2.2.5, and incubated and washed as described in Section 2.5.5.3. After washing 
with HBSS, the monolayers were fixed with I% glutaraldehyde overnight. 
2.6 In vivo studies 
2.6.1 Housing, workspaces and protection of personnel 
Neonatal lambs inoculated with non Shiga toxin-producing E. coli 0157: H7 (strain 
NCTC 12900) were housed indoors in an experimental animal containment facility at the 
University of Bristol, Langford site. Inoculation, feeding, tissue and faecal sampling, and 
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euthanasia were carried out in the same facility using category 2 disinfection and personal 
protection procedures. 
Neonatal lambs inoculated with STEC 0157: H7 and all six- to 11-week old lambs were 
housed indoors under category 3 containment in the Aerobiology Unit, University of Bristol, 
Langford. This comprised an animal pen linked via a hatch to a chamber and a workstation 
(Figure 2-a, i). The latter two facilities were both located within an isolator, with a half-suit 
permitting manual procedures within the chamber (Figure 2-a, ii) and arm portals for 
manipulations on the table workstation (Figure 2-a, iii). Thus, potentially contaminated 
material or animals could be passed into the chamber and/or workstation and manipulated by 
operators working from outside the isolator. 
Six-month old lambs were housed in a category 3 containment building at VLA 
Weybridge. For tissue sampling they were transferred to a post mortem room for euthanasia 
and dissection. Category 3 containment personal protection, including the use of high- 
efficiency EN 143 Class P3 respirator helmets, plus disinfection procedures using Farm 
Fluid S (Antec) at a 1: 100 dilution and 70 % ethanol, were used. 
Surgical and sampling procedures for intestinal loop experiments were performed in a 
category 3 containment animal house using appropriate protective clothing and disinfection 
procedures, as for the oral inoculation experiments. Respirator helmets were worn during 
times when STEC were potentially present as aerosol, i. e. during inoculation and removal of 
intestinal loops. 
2.6.2 Clean sampling technique 
Two approaches were used to gain access to tissues: 
i. Lambs were euthanased and rapidly dissected, using a primary operator (the Author) and 
several assistants, in an open post mortem room at VLA Weybridge. 
ii. Terminal anaesthesia was used to maintain tissue bloodflow for most intestinal samples 
until removal from the animal. This technique was employed using a single operator (the 
Author) with the isolation facility at the University of Bristol Aerobiology Unit. 
Samples were taken as follows: 
i. The body surface was disinfected using surgical scrub (Hibiscrub, SSL) before opening 
body cavities. Where there was substantial fleece, i. e. in the weaned lambs, this was 
sheared off over the right flank before inoculation. A clean surgical drape was used to 
isolate exteriorised viscera from the external body surface. 
ii. Fresh, sterile surgical instruments (scissors, forceps and scalpels) were used for cutting the 
skin, for cutting the muscular abdominal wall, and for each site sampled for bacteriology. 
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iii. A new pair of clean latex gloves, worn over thicker protective rubber gloves, were used at 
each stage in the process of opening body cavities or dissection, and at each sampling 
site. 
iv. For each intestinal sample a loop, or in the case of the caecum and rumen a pouch, of the 
intestine was isolated using two new plastic, disposable food bag clips (Klippits, 
Lakeland Ltd. ) applied side by side across the intestine. The isolated piece of intestine 
was excised by cutting between the clips, and was then removed immediately for 
processing. The cut ends of intestine remaining in the abdomen were then sealed within a 
clean plastic bag, or the inverted latex glove which had been used to hold the cut ends, 
which was clamped around the intestine using another plastic clip. This process is 
illustrated in Figure 2-b. The sealed cut ends of the intestine were then released back into 
the abdomen. 
v. Samples were placed immediately on new, clean, labelled plastic or expanded polystyrene 
trays and passed to an assistant for processing for histological and bacteriological 
examination Cross-contamination was avoided by using separate instruments for each 
sample. 
2.6.3 Animal procedures 
2.6.3.1 Oral inoculation experiments 
A. Neonatal lambs 
The lambs had pre-inoculation faeces samples taken at four days of age which were 
cultured for E. coli 0157 by the IMS procedure (Section 2.2.9). 
Crossbred lambs were allowed to suckle immediately after parturition and received milk 
replacer by bottle over the ensuing five days. At six days of age, animals were each 
inoculated orally by syringe with a four-strain mixture of E. cola 0157: H7. Animals were 
observed at intervals of four hours. Rectal temperatures were determined at the time of 
inoculation, at 15 hours p. i. and at 24-hour intervals thereafter. Rectal swabs were taken 
from these lambs at four days of age, prior to inoculation, and also at 6 and 12 hours p. i., and 
thereafter approximately Ig of faeces were obtained from lambs alive at 36,60 and 84 hours 
p. i. The faeces samples were either freshly-voided or taken directly from the rectum by 
digital retrieval using a clean glove. 
Tissues were sampled under terminal anaesthesia from the lambs at time points between 
12 and 84 hours p. i. On each occasion, the lamb was anaesthetised with a 200 mg/ml 
pentobarbitone euthanasia preparation given intravenously to effect. When unconscious, the 
lamb was placed in left lateral recumbency and the right flank and inguinal area was soaked 
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with a chlorhexidine-based surgical scrub (Hibiscrub, SSL). A disposable clean surgical 
drape with a 10 x 10 cm hole in the middle was placed over the right flank and secured with 
sterile towel clips. U-shaped incisions were made in the skin and then in the underlying 
abdominal musculature, starting from the dorsocaudal quadrant of the flank and coursing in 
succession ventrally, cranially and dorsally. The cutaneous and muscular flaps so created 
were reflected dorsally and secured with a sterile towel clip. The caecum, lying across the 
exposed abdominal viscera, was grasped and the ileocaecal junction was located. Samples 
were taken using the clean technique (Section 2.6.2) in the following order: ileum, jejunum, 
duodenum, tip of caecum, proximal loop of ascending colon ('Colon 1'), spiral colon 
(junction of centripetal and centrifugal parts, 'Colon 2'), terminal colon ('Colon 3') and 
mesenteric lymph nodes. The lamb was then euthanased with an intracardiac injection of 
pentobarbitone and placed in dorsal recumbency. The skin was reflected bilaterally from the 
inguinal area and, using fresh instruments, the pubic symphysis was cut with a scalpel and 
the pelvic cavity plus retroperitoneal tissues were exposed. The rectum was sectioned 
transversely immediately cranial to the anus and at the cranial limit of the pelvic cavity, and 
removed for examination. The submandibular tissues and tongue similarly were dissected 
and reflected to expose the pharynx for excision of the tonsils. Finally the rumen wall and 
pieces of liver, kidney and spleen were sampled. The sites of intestinal samples are shown in 
Figure 2-c. 
B. Six- to 11-week old lambs 
Crossbred animals from the VLA Weybridge or University of Bristol Langford flocks, 
were faeces sampled on one (Langford flock) or two (Weybridge flock) occasions. The 
faeces samples were subjected to the E. coli 0157 IMS and culture procedure (Section 
2.2.9). The animals were then housed in groups of four in the Aerobiology Unit containment 
facility at Langford, and were sheared on the right flank and given one week to adjust to the 
new environment and a complete pelleted diet (Ewbol Lambwena, BOCM) with water, 
provided ad libitum. Each animal was then inoculated orally by syringe with 
E. coli 0157: H7. Each group was inoculated either with the four-strain mixture or with a 
single strain. Animals were observed twice a day and faeces samples were collected daily 
from each animal for bacteriological analysis, either by digital retrieval from the rectum or 
by collection of freshly-voided faeces. One animal was anaesthetised with intravenous 
pentobarbitone, tissue-sampled and euthanased as described in Section 2.6.3.1 A, on each 
sampling day. Following aseptic preparation of the right flank, samples were collected and 
euthanasia was performed as described for the neonatal lambs. For these older animals the 
pelvic symphysis was cut using a small, sterile hacksaw following cutting and reflection of 
the skin using a scalpel and forceps. At this stage it was possible to pull apart by hand the 
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two halves of the pelvis, exposing the pelvic cavity. In one group of animals, mesenteric 
lymph nodes and tonsils were not sampled. 
Two uninoculated ten week-old animals (Weybridge flock) and two six-week old animals 
(Langford flock) were selected at random, and tissues were sampled under terminal 
anaesthesia, as described for the inoculated animals. 
C. Six-month old lambs 
Ten six-month old Merino-cross lambs from the VLA Weybridge flock were faeces- 
sampled on two occasions and the samples subjected to E. coli 0157 IMS and culture 
(Section 2.2.9). Two lambs were selected at random and were euthanased by intravenous 
injection of a proprietary pentobarbitone euthanasia preparation. Tissue sampling, as 
described in Section 2.6.3.1A but omitting the pelvic splitting and rectal samples, was 
performed rapidly, using the clean technique described in Section 2.6.2. The remaining eight 
animals were inoculated orally with the four-strain E. coli 0157: H7 mixture by calibrated 
drenching gun. The lambs were housed in pairs and were observed twice daily. Rectal 
temperatures were taken daily from all animals. One pair was euthanased and tissues were 
sampled similarly to the uninoculated animals at each of four time points. Since two animals 
were sampled on each occasion, samples from the second animal were homogenised in PBS 
containing 15 % glycerol for snap freezing followed by slow thawing, IMS and culture on a 
subsequent day. 
2.6.3.2 Intestinal loop experiments 
Four crossbred lambs, of four to six months of age, were used. Faeces were collected 
from all animals on three occasions between birth and surgery. The faecal samples were 
cultured selectively for E. coli 0157 using IMS as described in Section 2.2.9. After shearing 
the ventral abdomen and overnight feed withdrawal, each animal was premedicated with 
0.2 mg/kg xylazine (Rompun 2 %, Bayer) given by deep intramuscular injection, and then 
anaesthetised using a combination of diazepam (Valium, Roche) and ketamine (Ketaset, Fort 
Dodge) given intravenously to effect. Following intubation, anaesthesia was maintained by 
inhalation using isoflurane (Isoflurane RM, Merial) in oxygen via a circle circuit. During 
anaesthesia, lactated Ringer's solution (Animalcare) was administered by intravenous 
infusion at 5-10 ml/kg/hour. Anaesthetic monitoring included the measurement of rectal 
temperature, arterial blood pressure, P02 and pCO2 in the anaesthetic circuit, and an 
electrocardiograph. Using an aseptic surgical technique, a ventral midline laparotomy was 
performed and the spiral colon was exteriorised. Ligated intestinal loops, each approximately 
10 cm long and separated by a short intervening segment, were created by tying pairs of 
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encircling braided nylon ligatures around the spiral colon, preserving the mesenteric blood 
supply to each segment. A2 ml volume of inoculum containing a single bacterial strain 
(Section 2.2.6) was then introduced into alternate loops by transmural injection using a 25- 
gauge needle. Intervening loops served as controls with inoculation of 2 ml of the sterile 
carrier medium (PBS or DMEM, according to that used in the bacterial inocula) alone. The 
injection site in each loop was sealed on the serosal surface by thermocautery. 
Following inoculation, the intestine was replaced in the abdomen and the laparotomy 
incision was closed. The animal was maintained under anaesthesia in dorsolateral 
recumbency, with venting of rumen gas via a paracostal rumenostomy. Six hours after 
inoculation the ligated intestinal segments were re-exteriorised and excised for fixation. The 
animal was then euthanased, without regaining consciousness, using intravenous 
pentobarbitone. 
2.7 Pathological techniques 
2.7.1 Fixation 
Tissues were fixed by immersion in 10 % neutral buffered formalin (Appendix 1) at room 
temperature for at least 24 hours. Tubular pieces of intestine were opened longitudinally with 
blunt-ended scissors for about half their length before immersion, except for excised ligated 
colon loops which were opened along their whole length. All intestinal tissues were placed 
into labelled individual pots of formalin and were gently dipped several times in the fixative, 
to dislodge loosely adherent intestinal contents, before being left to fix. The time between 
death or excision and immersion in fixative was considered to be of prime importance due to 
the rapidity of intestinal mucosal autolysis, and efforts were made to observe the length of 
this period on a representative series of occasions. 
For some experiments, small samples of intestinal tissues were also fixed in 2.5 % 
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2-7.4) at room temperature, 
potentially for processing for electron microscopy. 
2.7.2 Histopathological studies 
Formalin-fixed intestinal tissues were trimmed into strips and embedded in paraffin wax 
using an automatic processor (Citadel 2000, Shandon) on a long (3-day) cycle. In one 
experiment, glutaraldehyde-fixed tissues were processed similarly. One long edge of each 
tissue strip was orientated towards the cutting face of the wax block, such that 
conventionally-orientated sections of the intestinal wall including all layers and 
perpendicular to the plane of the mucosal surface, were obtained. Additionally, some large 
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intestine sections in some experiments were embedded with the mucosa presented parallel to 
the sectioning face. Two or more sections were prepared from each anatomical sampling site, 
as detailed in chapters 4,5 and 6. In some cases multiple sections were prepared by cutting at 
different levels from the same wax block. Representative pieces of liver, kidney, spleen (and 
of tonsil and mesenteric lymph nodes where collected) were also embedded and sectioned. 
Sections were cut at 4 µm on a sledge microtome (Leitz), placed onto glass microscope 
slides coated with glycerin-albumen (R A. Lamb), dried, and baked on a 60 'C hotplate for 
20-30 min to ensure adequate adhesion. The sections were then dewaxed in a clearing agent 
(Histo-Clear, National Diagnostics) for at least 6 min and stained with haematoxylin and 
eosin (H&E) by hand according to the protocol in Appendix 2. 
Intestine sections were examined, and remarks recorded, for several features: 
" Tissue preservation, assessed mainly by the condition of the mucosa including the degree 
of any epithelial detachment. 
" Villus morphology, including the villus: crypt length ratio, in the small intestine. 
Villus: crypt ratios representative of the section overall were estimated by eye. 
" Cell population and overall cellularity of the lamina propria. 
" Density and type of leucocytes within the mucosal epithelium. 
" Presence and nature of adherent organisms or luminal contents at the mucosal surface. 
In addition, other features were noted and recorded when it was considered to be relevant. 
Generally, one section from each anatomical site was examined in detail using the above 
assessment criteria, and subsequent sections from the same site were surveyed in detail only 
for features of the epithelial mucosa, such as attached bacteria. 
When appropriate, to characterise or clarify bacterial features, additional sections were 
cut and were stained by Gram-Twort, Giemsa or Warthin-Starry methods (Appendix 2). 
2.7.3 Immunohistochemical studies 
Wax-embedded 4 µm sections of tissue were prepared from the same blocks as the H&E- 
stained sections, for immunoperoxidase (ipx) immunohistochemistry. Tissues were selected 
for this procedure either on the basis of features noted on H&E-stained sections, or as a 
comparative technique to H&E-stained sections for screening (intestinal loop studies), in 
which case similar numbers of H&E- and ipx-stained sections were prepared. 
To maximise adhesion, tissue sections for ipx were floated onto glass slides which had 
been coated with the adhesive 3-aminopropyltriethoxy-silane (organo-silane, Sigma). Slides 
bearing sections were then baked on a hotplate at 60 °C for 20-30 min and held overnight in 
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a 37 °C oven. Immunostaining was performed using the peroxidase-antiperoxidase (PAP) 
complex method (Sternberger et al. 1970; Appendix 2). The primary antibodies used were 
polyclonal rabbit antisera specific for a particular E. coil `0' antigen, produced by the VLA 
Weybridge E coli typing unit by inoculating rabbits with heat-treated E coli preparations, 
and intended for use in somatic antigen typing of cultures. Working dilutions of between 
1: 500 and 1: 4000, depending on individual antisera, were found to be optimal when used on 
control positive sections. 
The staining process was verified using the test antiserum on a positive control section, 
and the lack of non-specific staining of organisms by the primary antiserum was 
demonstrated using the test antiserum on a negative control section containing E. coif 
organisms of an alternative serogroup. The absence of non-specific staining by any other 
element in the process was demonstrated by using, for each tissue block, a section stained 
with an unrelated primary antiserum. This control antiserum was either a VLA rabbit 
polyclonal antiserum for another serogroup, diluted to its normal working immunostaining 
strength, or normal rabbit serum (Sigma) diluted 1: 1000 in PBS. 
The positive control material comprised tissue sections of calf intestine from a natural 
clinical case of E coif 026 enteritis, an agar-embedded, cultured E coif 026 strain and an 
agar-embedded, cultured E cola 0157: 117 strain. No intestinal material containing E. cola 
0157: H7 organisms at a sufficiently high density for reliable control material was available. 
The agar-embedded preparations were generated from an overnight broth culture of the 
appropriate serogroup which had been fixed by mixing with an equal volume of 3% neutral 
buffered formalin. The fixed suspension in a 1.5 ml microcentrifuge tube (Eppendorf) was 
sedimented by centrifugation at 13 000 rpm (Biofuge 13, Heraeus Sepatech) for 3 min and 
the supernatant was removed. AI% solution of high strength agar (Agar powder - high gel 
strength, BDH Ltd. ) in distilled water was melted in a microwave oven, the microcentrifuge 
tube was filled with the molten agar when it was at approximately 60 °C and the bacteria 
were resuspended using a pipette. The tube was accelerated to 13 000 rpm for 30 seconds to 
concentrate the bacteria at the bottom of the tube as the agar set. When cooled, the agar plug 
was removed from the tube using a mounted needle and the tapering cone-shaped tip 
containing the concentrated bacteria was cut off. It was bisected along its long axis and each 
half was wax-embedded routinely, with the flat cut face presented at the sectioning face of 
the wax block. When sectioned at 4 µm, a roughly triangular sample was obtained, with 
bacteria concentrated at the apex and along the two adjacent sides, and with an even, lower- 
density distribution of bacteria present throughout the rest of the section. 
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2.7.4 Electron microscopy 
2.7.4.1 Scanning electron microscopy 
SEM of infected cell monolayers was performed on glutaraldehyde-fixed specimens by 
the VLA Weybridge Electron Microscopy Unit. Monolayers on coverslips were fixed for 
16 hours in 3% (v/v) glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, washed in 
phosphate buffer and post fixed in I% (w/v) osmium tetroxide in the same buffer. 
Specimens were rinsed in six changes of phosphate buffer, dehydrated in ethanol, immersed 
in acetone and subjected to critical point drying with liquid CO2. Dried specimens were fixed 
to aluminium stubs with conductive silver paint, sputter coated with gold and examined 
using a Cambridge Stereoscan S250 Mark III scanning EM at 10-20 kV. Scanning electron 
micrographs were recorded as black and white photographic prints. 
2.7.4.2 Transmission electron microscopy 
A. Wax block retrieval of tissue 
The technique was described by Skuse (2002a). Features suitable for TEM were 
identified using light microscopy (LM). By comparing the glass slide section with its 
corresponding tissue block, the area on the cutting face of the block most likely to contain a 
part of the feature seen in the section was identified and marked. Using a mounted razor 
blade, a pyramidal piece of wax and tissue was carefully excavated from the face of the 
block, with the base of the pyramid comprising the cutting face of the block in the area of 
interest and being approximately 2 mm square (Figure 2-d). This excised tissue was then 
dewaxed, hydrated, post-fixed in osmium tetroxide, dehydrated and embedded in epoxy 
resin, according to the protocol in Appendix 2. Great care was paid to the orientation of the 
tissue in the resin embedding capsule, in order to get the face taken from the cutting surface 
of the wax block again at the cutting surface of the resin block. 
Once embedded, I µm semi-thin sections were cut using an Omu3 ultramicrotome 
(Reichert), stained with I% toluidine blue in I% borax solution for I min on a hotplate at 
80 °C, and examined under the LM. If features likely to be of interest were seen, thin 
(approximately 90 nm) sections were prepared, mounted on thin-bar 300 mesh copper grids 
and stained with saturated methanolic uranyl acetate for 10 min, then with Reynold's lead 
citrate for 5 min, according to the protocols in Appendix 2. The sections were examined in a 
Philips 201 transmission electron microscope. Photomicrographs were taken of features of 
interest. 
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B. Retrieval of tissue from light microscope sections 
When the lesion of interest was too small to be found in tissue removed from the wax 
block, an alternative technique was used (Skuse 2002b; Appendix 7), adapted from previous 
reports (Glauert 1975; Bretschneider et al. 1981). The area of interest was ringed on the 
reverse of the slide with a diamond tipped pen. The coverslip was removed by soaking the 
slide in Histo-Clear until the DPX mountant was loosened, and the slide was then soaked in 
Histo-Clear for a further few hours. The slide was placed in 100 % alcohol for two or three 
changes of 30-60 min each, and then placed in a sealed container of acrylic resin (LR White 
resin, London Resin Company) for two or three changes of at least 12 hours each. One 
plastic EM processing capsule was completely filled with liquid resin with added 
polymerisation accelerator, so that the meniscus was convex. The slide was removed from 
the resin container and as much excess resin as possible was drained off. The slide was 
placed section side down on top of the resin-filled capsule with the marked area of interest in 
the centre of the resin, and the resin was allowed to polymerise over several minutes. The 
reverse of the slide was then sprayed liberally with freezing spray (Cool-Jet, R. A. Lamb 
Ltd. ). When a crack was heard, indicating partial separation of the resin from the slide, the 
capsule, including an embedded piece of the tissue section, was snapped away from the slide 
by hand. After removal of the resin block from the capsule, the cutting face was trimmed to 
permit thin sections of the area of interest to be cut. 
With this technique, only a4 gm thickness of tissue, well-orientated at the cutting face of 
the resin block and very probably containing the feature of interest, was available for thin 
sectioning, and so semi-thin sections were not prepared as a preliminary step. Thin sections 
were cut, with extreme care being exercised in respect of the orientation of the face of the 
block to the knife. This was done immediately after detachment of the tissue from the glass 
slide, because otherwise slight contraction of the embedding resin led to concavity of the 
cutting face of the block. 
2.7.4.3 Immuno-electron microscopy 
Immunogold labelling (Faulk and Taylor 1971) of bacteria in some TEM sections was 
performed, using the same primary 0157 antiserum that was used for ipx staining (Section 
2.7.3). A two-layer staining technique, using a gold-labelled anti-rabbit secondary antibody, 
was performed (Skuse 2002c; Appendix 2) using a high concentration (1: 5 dilution) of 
primary antibody. A negative control procedure, using either normal rabbit serum (Sigma) in 
place of the primary antibody, or omitting the primary antibody, was performed in parallel. 
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Figure 2-a: Aerobiology Unit category 3 containment animal facility 
1 I 
1 
i. The operating 
chamber (middle) is 
linked via hatches to 
the animal room 
(background, 
darkened) and the 
workstation 
(foreground, left) The 
airspace in the animal 
room connects only 
with the internal 
airspace of the rest of 
the apparatus. 
ii. Operating 
chamber. The half- 
suit is sealed to the 
edge of a horizontal 
aperture at waist 
level, thus the 
operator (starred) can 
stand in the aperture 
and work on the 
animal (arrowed) 
whilst remaining in 
the external airspace. 
iii. Workstation. 
Material passed 
through the hatch on 
the right is 
manipulated using 
integral sleeves and 
gloves. 
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Figure 2-b: Clean sampling technique demonstrated on a dead animal 
w3ý, 
i. After disinfecting and draping, the body wall on 
the right flank is opened in two lasers. 




'! It' iv. The intestinal loop is cut between the clips and processed immediately. The remaining cut 
ends are carefully held to avoid contamination. 
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iii. The duodenum is located, a loop is freed from 
its mesentery and double-clipped. 
I ... ' % .. h 
H. The caecum is located and exteriorised. 
v. A clean plastic hag for lute. glove) is placed 
carefully over the clip-sealed cut ends 
vi. The cut ends and clip arc scaled «ithin the bag 
using another clip (blue) before being released 
and the process repeated with the next sample 









A (purple) duodenum; B (orange) jejunum; C (pink) ileum; D (blue) caecum; E (cyan) proximal loop of 
ascending colon; F (bright green) spiral colon; G (dark green) terminal colon; H (red) rectum. 
Adapted from Dyce et al. (1987). 
Figure 2-d: Technique of tissue recovery from wax block for electron microscopy 
f- excised pyramid 





of wax block 
block cassette 
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Chapter 3- IN VITRO STUDIES 
3.1 Introduction 
In order to be confident that the test strains of E. coli 0157: H7 used in the present studies 
were comparable to those in the field, it was decided that appropriate human and animal 
sources for strains should be used, and that screening of several candidate strains for known 
and putative virulence and persistence factors should be performed. Thus, it was intended 
that test strains were recently derived from relevant natural environments, possessed the 
normal complement of factors of'typical' EHEC 0157: H7, as defined by Nataro and Kaper 
(1998), and reflected some of the diversity, in terms of Shiga toxin genes, acid tolerance and 
sources, to be found in E. coli 0157: H7 strains. Four E. coli 0157: H7 strains were selected 
for use in in vivo studies on the basis of certain genotypic and phenotypic features (Section 
3.6), and on the ability to generate spontaneous antibiotic resistance marked derivatives 
which would grow acceptably in mixed culture (sections 3.4 and 3.5.4), which would enable 
their retrieval, identification and enumeration after inoculation of animals. The four E. coli 
0157: H7 strains and their antibiotic resistance marked derivatives selected for in vivo 
studies were subjected to further phenotypic tests in an attempt to discern correlations 
between strain behaviour in vitro (present chapter) and in vivo (chapters 4,5 and 6). These 
subsequent in vitro studies also included two strains not included in the original 
characterisations: an E. coli 026: H11 (EC1537), used as a control strain in the intestinal 
loop studies (Chapter 4), and a non Shiga toxin-producing E. cola 0157: H7 (NCTC 12900), 
used in a later in vivo experiment (Experiment 6/4, Chapter 6). In addition, characterisation 
of a naturally-occurring bovine AEEC (Strain 85440, Section 2.2.1.2) was undertaken, in 
view of its potential role as a control organism. The control strains used (EPEC B 171, 
bovine EPEC 85440, bovine EHEC-like EC1537 and E. coli K12 DH5a) are described in 
Section 2.2.1.2. 
3.2 Strains examined 
The E. coli 0157 strains examined are summarised in Table 3-A. 
3.3 Genotypic characterisation of experimental strains 
PCR was used to detect genes using specific primer pairs and template DNA extracted 
from the strain under examination (Section 2.3). The presence of the gene was inferred if a 
PCR product of the expected size was seen, using agarose gel electrophoresis and ethidium 
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bromide staining, and if the negative control reaction, lacking template DNA, yielded no 
product. For the E. coli 0157: H7 strains, the chromosomal genes of the two Shiga toxin 
types (stxl and stx2) plus the LEE gene eaeA encoding intimin were amplified together in a 
multiplex PCR (Cookson et at. 2002a). The strains were also examined for the presence of 
the virulence plasmid genes katP, espP and etpD plus the EHEC-hly gene cluster, encoding 
respectively: catalase peroxidase, serine protease, part of a putative type II secretion system 
and enterohaemolysin (Section 1.4.2.2E). In addition, amplification of the rpoS gene, 
encoding the RpoS stationary-phase RNA polymerase sigma factor (Section 1.4.2.2C) was 
performed. A functional rpos gene is associated with expression of virulence factors in 
E. colt (Loewen and Hengge-Aronis 1994), acid resistance in E. coli 0157: H7 (Cheville et 
at. 1996) and a high level of excretion of E. coli 0157: H7 from inoculated calves (Price et 
al. 2000). 
Table 3-A: E. co/i 0157: H7 strains examined in vitro 
Strain Source Supplier Clinical features stx genes Phage type 
131567 Human LEP Not stated 1 8 
134107 Human LEP Diarrhoea 1 8 
138345 Human LEP Diarrhoea 1+2 2 
139229 Human LEP Bloody diarrhoea 1+2 4 
139579 Human LEP Diarrhoea, abdominal pain 2 4 
139969 Human LEP Not stated 2 21/28 
140019/0 Human LEP Diarrhoea 1+2 14 
140065 Human LEP Asymptomatic in-contact of 2 2 
symptomatic child 
NCTC Human NCTC Human diarrhoea (Willshaw et al. - 54 
12900 1994) 
EC157 Bovine VLA 
Traced isolate with identical 1+2 1 PFGE pattern to fatal HUS strain. 
EC218 Bovine VLA - 1+2 54 
EC222 Bovine VLA -2 32 
LEP: Laboratory of Enteric Pathogens, Central Public Health Laboratory. 
NCTC: National Collection of type Cultures 
For Strain 85440 the genes eaeA and bfpA were sought, the latter encoding the BFP of 
typical human EPEC (Section 1.1.3.1). This strain was reportedly non Shiga toxin-producing 
on Vero cells (Pearson et at. 1989), therefore Shiga toxin genes were not looked for. 
The results from all strains are summarised in Table 3-B and typical ethidium bromide- 
stained gel electrophoresis images are shown in Figure 3-a. All gene products were of the 
expected molecular mass. It can be seen that one E. coli 0157: H7 strain (138345) lacked two 
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of the four V irulence plasmid (pol 57) genes, suggesting either that the genes involved had 
been lost from the plasmid or had lesions at the primer binding sites, rather than the genes 
being lost due to loss of the plasmid from the strain. The Shiga toxin PCR reactions were in 
agreement 'v ith those reported for the strains from the LEP. The 85440 strain, being non 
Shiga toxin-producing, possessing the LEE gene tested for and lacking the hfpA gene, 
genot\picall\ resembled an atypical human EPEC. 
Table 3-B: Summary of genotypic strain characterisation 
Strain stx eaeA hlyA-C katP espP etpD rpoS bfpA 
111567 I + -t + + 
134107 1 + + + + + + 
138345 1K2 + - + - + + 
139229 I&2 + + + + + + 
139179 2 + + + + + + 
v-, 
O 139969 2 4- + + + + + 
1400190 1 K? + + + + + + 
41 14006S 2 + + + + + 
ECI57 1&2 + + + + + + 
EC? 18 1g2 + + + + + + 
EC222 2 + + + + + + 
85440 
Shaded cells indicate that the PCR test was not performed for that strain/gene combination. 
3.4 Generation of spontaneous antibiotic resistant mutants 
Antibiotic resistant strains ýýere generated as described in Section 2.4. The following 
were made: EC218 rit' (rifampicin resistant), EC222 nal` (nalidixic acid resistant), 
139579 spec` (spectinomycin resistant) and EC 157 str` (streptomycin resistant). However, 
Strain 139579 spec' failed to grow acceptably in mixed culture (Section 3.5.4), with a 
one log10 unit lov%er'FVC achieved by this strain than by other strains in the mixture. A spec` 
mutant of an alternative strain (140065) had an untypical, small colonial morphology, 
therefore Strain 139579 spec` was substituted with Strain 140065 nal' and a double-marked 
E: C222 nal`rill mutant as generated, which grew acceptably (no marked growth arrest and a 
final 'IVC Within one log10 unit of the other strains) both alone and in mixed culture (Section 
3.5.4). The final set of strains used in the mixed inoculum (Chapters 5 and 6) therefore was: 
218 rit', 222 nal'rit`. 140065 naI`, and EC 157 str'. 
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3.5 Phenotypic characterisation of experimental strains 
3.5.1 Protein expression and secretion 
A. Initial strain characterisation 
Initially, all candidate E. coli 0157: H7 strains were screened for intimin expression by 
Western blotting using cultures grown in DMEM (sections 2.5.4.2A and 2.5.4.3 B). Growth 
of bacteria in DMEM promotes the expression of LEE proteins in EPEC (Knutton et al. 
1997) and EHEC (Ogierman et al. 2000; Abe et al. 2002). The results are shown in Figure 
3-b. All strains tested expressed intimin of the expected molecular weight (94-97 kDa Jerse 
and Kaper 1991; Louie et al. 1993), which was detected by the polyclonal y-intimin antibody 
as shown in Figure 3-b. However, as shown, there were differences between the amounts 
present for each strain under the conditions used. 
B. Comparison between parent and antibiotic resistance marked strains 
After DMEM induction (Section 2.5.4.1A), comparison between the parent and antibiotic 
resistance marked derivative strains was made of protein secretion (Section 2.5.4.3A), EspA 
secretion (Section 2.5.4.3B) and intimin expression (Section 2.5.4.3B). Procedures were 
performed in duplicate, and representative silver-stained SDS-PAGE gels and Western blot 
membranes are shown in Figure 3-c. It was attempted to standardise the TVC of the PBS or 
DMEM bacterial suspensions used for each preparation, and the measured TVC was 
recorded alongside gel and membrane images. This permitted an approximate comparative 
assessment of the amount of protein of interest per cfu when gels and Western blots were 
evaluated. It can be seen that, with the possible exception of strains 222/222 nal`rif, where 
secreted protein levels were low in both cases, antibiotic resistance marking was associated 
with reduced secretion of proteins under DMEM induction. The apparent molecular mass of 
the EspA (approximately 20 kDa) is lower than the 22-25 kDa previously shown for EspA of 
E. coli 0157: H7 and 026: H- (Ebel et al. 1998), although distortion of bands at the edge of 
the gel and imprecision in the marking of bands on the membrane may account for this. The 
double bands of similar apparent molecular mass which are labelled by the EspA antiserum 
have been reported by other workers (Ebel et al. 1996; Ebel et al. 1998), but the reason for 
this appearance is undetermined. The possibility that this represents partial disruption of 
disulphide bonds, resulting in molecules of differing conformation and migration 
characteristics, is discounted by the fact that the published EspA sequence for E. coli 
0157: H7 (Various 1998) lacks cysteine residues, and therefore would not contain disulphide 
bonds. 
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C. Comparison between E. coli 0157: H7 and 026: H1 1 strains 
Comparison of protein secretion, EspA secretion and intimin expression between E. coli 
0157: H7 and E. coli 026: H11 strains was made, following either one hour's exposure to 
PBS (Section 2.5.4.1 B) or five hours' exposure to DMEM (Section 2.5.4. IA). These 
preparations simulated the pre-inoculation conditions used for the same strains in the Iigated 
colon loop experiments (Chapter 4). 
Incubation in DMEM or PBS and then the concentration, electrophoretic separation and 
detection of secreted proteins was carried out, in duplicate, as described in sections 2.5.4.1, 
2.5.4.3A and 2.5.4.3B. The total viable counts, plus representative silver- and Coomassie- 
stained SDS-PAGE gels and EspA-probed Western blots resulting from one- and five-hour 
incubations in PBS and DMEM respectively are shown in Figure 3-d. The overall secretion 
of proteins, as detected by silver staining, showed enhancement with DMEM incubation for 
all the E. coli 0157: 1-17 strains. This included discrete double bands around 20 kDa 
consistent with EspA (Ebel et al. 1998), and strong bands between 30 and 45 kDa consistent 
with EspB and EspD (38 and 40 kDa respectively; Kaper et al. 1998; McNally et al. 2001). 
The EC1537 (026: H11) strain also showed an overall increase of the secretion of presumed 
Esp proteins with DMEM on Coomassie-stained gels (Figure 3-d, i), although this was 
somewhat obscured on silver-stained gels by a relatively high level of other protein bands in 
the PBS preparation. There was increased secretion of bands in the EspA mass range for all 
strains, including E. coli 026: H11, with DMEM and this was confirmed for EspA by the 
Western blots. 
An assay for intimin expression using incubation of strains in DMEM or PBS, followed 
by lysis, separation and detection by Western blotting was carried out as described in 
sections 2.5.4.2 and 2.5.4.313. The results of a single preparation (Figure 3-e) show the 
enhancement of intimin expression by a five-hour DMEM incubation when compared with a 
one-hour PBS incubation, for all E. cola 0157: H7 and 026: H11 strains tested. The degree of 
enhancement seen with Strain EC1537 (026: H11) is uncertain, as the TVC of the DMEM 
versus PBS preparations differed over a 2.5-fold range. 
3.5.2 Association with cultured cells 
3.5.2.1 HEp-2 cell line assays 
A. Quantitative association assay 
Three-hour HEp-2 cell monolayer quantitative association assay (sections 2.5.5.1 and 
2.5.5.2) results are shown in Figure M. Each data point represents counts from one well. 
Association of the AEEC with the HEp-2 cells was at least one log10 unit higher in 
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comparison with a control E. coli K 12 (non-AEEC) strain, except for the double-marked 
EC222 nal'rif strain where the count was 8.1 x higher (Figure 3-f, i). 
B. Giemsa stained preparations 
The combined observations from two preparations (A and B) of Giemsa-stained 
inoculated HEp-2 cells (sections 2.5.5.1 and 2.5.5.3) are presented in Table 3-C, and Figure 
3-g. The strongest localised adhesion (LA) phenotype predictably was demonstrated by the 
EPEC B 171 strain (Section 2.2.1.2). Strain 85440, lacking BFP (Table 3-B), demonstrated 
less dense and less frequent microcolonies. The wild-type E. coif 0157: H7 strains all 
showed the localised adhesion (LA) phenotype, albeit with some variation and with poor 
expression at the three hour stage. Attenuation of the wild-type LA pattern was seen with all 
the antibiotic resistance marked E. cola 0157: H7 strains; at its most marked this attenuation 
produced small, loose clusters of cells at six hours with Strain EC222 nal`rif . Substantial 
inter-assay variation in the observed adherence pattern was seen in the case of Strain EC222, 
the difference in the number of inoculated organisms being a possible factor in this. The 
extent of HEp-2 cell degeneration, as demonstrated by nuclear hyperchromasia and 
disintegration, was strongly correlated with time post-inoculation, and was much less 
marked with non-STEC inocula. 
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Table 3-C: Observations on Giemsa-stained infected HEp-2 monolayers 
Strain Assay TVC* 3 hour incubation 6 hour incubation 
A 1.3 Small, low density MC, 10 µm, <1/cell, Mod dense MC, 15-20 µm, <1/cell. 
EC218 ----------plus 
areas of more diffuse colonisation. Areas of more diffuse colonisation. 
B CC. Loose clusters of 
1-7 bacteria on CC, ND common. MC of 15-100 
approx. 50 % of cells. bacteria on 80 % of cells. 
EC218 B 0.82 
CC. Single or paired bacteria on <10 % CC, ND in 30 %. MC of <15 
rig of cells. organisms on <10 % of cells. 
A 1.3 2-4 scattered bacteria, <1/cell. Mod dense MC, 10-15 µm, <1/cell. 
EC222 CC. Single and paired bacteria on <1 % 
CC. Single and paired organisms on 
B 0.70 
cells approx. 
30 % of cells, plus rare MC of 
<20 organisms. 
EC222 CC. Single and paired bacteria on 1% 
CC, ND common. Loose clusters, 2 to 
nal'rif 
B 0.62 to 10 % of cells. occasionally 
20 bacteria on approx. 
50 % of cells. 
CC. Adherent bacteria are solitary, CC, ND in 20 %. Medium and large 
140065 B 0.65 paired 
and occasionally in loose 
clusters of up to 13, on approx. 20 % of 
(up to 100 bacteria), loose MC on p ý' 
cells. 
approx. 90 /o of cells. % 
CC. Adherent bacteria are solitary, CC, ND in 20 %. Bacteria typically 
140065 B 43 paired and occasionally 
in loose 
0 scattered singly or paired, on approx. 
nal' . clusters of up to 13, on approx. 10 % of 70 % of cells. Occasional MC of up to 
cells. 50 bacteria. 
A 1.0 
Occasional MC of a few scattered Low and mod density MC, 10-15µ1, 
bacteria, «1/cell. <1/cell. 
EC157 CC. Pairs and occasionally up to 6 CC, ND in 20 %. Scattered bacteria 
B 0.70 bacteria adherent to I% tol0 % of plus MC of up to 50 organisms on 
cells. 50-70 % of cells. 
CC. Adherent bacteria on I% to 10 % ND in 50 %. Scattered bacteria CC 
EC157 
`B 
of cells, typically single or paired but 0.77 , and MC of typically 10-20 organisms str occasionally loose MC of up to 15 on 30-40 % of cells. organisms. 
139579 A 0.95 Occasional low-density MC, <I/cell. 
Small and dense to large and diffuse 
MC, 10-20 µm, =1/cell. 
NCTC 
CC. Single bacteria and loose clusters minimal/no ND seen Medium or CC 
12900 B 
0.77 of up to 10 organisms present on 90 % , . large loose MC on 100 % of cells. of cells. , 
B171 A 1.8 Mod dense MC, 10-15 pm, =1/cell. Very dense MC 15-20 µm, >1/cell. 
85440 A 1.2 Low density MC, 10-15 gm, >_1/cell. Mod dense MC, 10-20 gm, ?: I /cell. 
CC. Single bacteria and loose clusters CC, ND in 20 %. Adherent bacteria 
EC 1537 B 0.35 of up to 10 organisms present on 20 % scattered, often in loose MC of up to 50 
of cells. organisms, on 50 % of cells. 
CC. Single bacteria and loose clusters, CC, <10 % ND. Adherent bacteria 
DH5a B 0.53 occasionally of 20 or 30 organisms, scattered or very loosely clustered. 
present on 20 % of cells. 70 % of cells colonised. 
None B - CC. No bacteria seen. CC, rare ND. No bacteria seen. 
* TVC: total viable count of inoculum, x 109 cfu. CC: confluent cells. ND: nuclear degeneration. 
MC: microcolonies. Mod: moderate/moderately. 'Density' refers to the density of bacteria within a 
microcolony. Size measurements refer to microcolony diameter. Bold entries are illustrated in Figure 3-g 
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C. Fluorescence actin staining (FAS) 
Initial characterisation 
FAS (sections 2.5.5.1 and 2.5.5.4) was performed to evaluate AE competence in vitro on 
HEp-2 cells. For this, all candidate E. coli 0157: H7 strains, plus antibiotic resistant 
derivatives of selected strains, were used. The results are presented in Table 3-D and Figure 
3-h. The control EPEC 8171 (Section 2.2.1.2) yielded unequivocal FAS-positive lesions by 
three hours p. i. As previously described (Donnenberg and Nataro 1995), the E. coli 0157: H7 
strains required six hours incubation for the formation of FAS-positive lesions, and the 
extent and intensity of staining was noticeably less than for the EPEC strain. The intensity of 
FAS with the bfpA-negative bovine EPEC-type strain 85440 appeared to lie between the 
Bill and E. coli 0157: 117 strains. Antibiotic resistance marking appeared to have an 
attenuating effect upon the AE capability of the double resistance marked EC222 nal`rif 
strain. The use of a control negative organism (EC218 eaeA mutant) produced the expected 
negative result at three and six hours p. i. 
Effect of DMEM pre-incubation 
A follow-up study was prompted by the observation that antibiotic resistance marking 
attenuated the FAS capability of strains, possibly to extinction in one case (EC222). 
Therefore, the four antibiotic resistance marked component strains of the mixed inoculum 
(Section 3.6) plus their parent strains were pre-incubated in DMEM for three hours to induce 
expression of LEE proteins (Ogierman et al. 2000; Goffaux et al. 2001). The cultures were 
then inoculated onto HEp-2 monolayers, incubated for six hours and FAS was performed 
(Section 2.5.5.4), in order to compare further the FAS (AE) capability of the parent strains 
and antibiotic resistance marked derivatives. The results are summarised in Table 3-E. 
A comparison between tables 3-D and 3-E shows that DMEM pre-incubation produced, 
at six hours p. i., a consistent increase in the proportion of cultured cells bearing FAS- 
positive lesions, quantified as an increase from 50 % to 100 % in the cases of strains EC218 
and 140065. There may also have been an increase in the size of colonies and the intensity of 
the FAS, but inter-assay variation makes confident comparisons difficult. The AE capability 
of Strain EC222 nal'rif was only detected in the DMEM-induced assay. Comparisons 
between parent and antibiotic resistant derived strains in the DMEM-induced assay (Table 
3-E) showed an attenuation of AE capability, to varying extents, for three of the four strain- 
pairs (140065/140065 nal`, EC157/EC157 stir, EC222/EC222 nal'rif) tested. 
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Table 3-D: Observations on fluorescence actin stained inoculated HEp-2 monolayers 
Strain TVC* 
Three hour incubation 
Scoret Observations 
Six hour incubation 
Scoret Observations 
<10 % cells FAS+ 
Most cells colonised; 
8171 1.8 + 
colonies 
+++ large, bright FAS+ 
colonies 
Occasional faint FAS+ FAS + colonies on about 85440 1.5 colonies 
4+ 50 % of cells 
131567 1.6 - + Occasional FAS+ colonies 
134107 0.98 - + Occasional FAS+ colonies 
138345 1.3 - + Occasional FAS+ colonies 
139229 1.4 - + Occasional FAS+ colonies 
139579 1.3 
Occasional small, faint + 
FAS+ colonies on a 
FAS+ colonies minority of cells 
139969 1.0 - +/- Occasional, faint FAS 
140019 1 2 
Occasional small, faint + 
Dim FAS on approx. 20 % 
. FAS+ colonies of cells 
Some fluorescent foci FAS+ colonies on approx. EC218 1.3 - but no clear colonies 50 % of cells 
EC218 1.2 
eaeA- 





140065 1.3 -+ 
Dim FAS+ colonies on 
approx. 50 % of cells 
140065 x+ 
nal` 
EC 157 -+ 
EC 157 stf X+ 
*TVC: total viable count of inoculum, x 107 cfu. 
tScore: Subjective, semiquantitative, five-point score of FAS intensity and extent 
'X' indicates data unavailable, as three-hour assays were not performed. 
Bold entries are illustrated in Figure 3-h. 
Strains in the lower part of the table are those used in subsequent animal experiments (chapters 4 -6) 
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Table 3-E: Observations on fluorescence actin stained HEp-2 monolayers incubated for 
six hours with E. co/i0157: H7 strains pre-incubated in DMEM 
Inoculum FAS-positive features Strain TVC (cfu) Score* Comments 
EC218 WT 9.8 x 107 4 Approx. 1 large microcolony per cell 
EC218 rig 7.7 x 107 4 Similar to WT 
EC222 WT I. 1 x 101 2 Small to moderate microcolonies on approx. 50 % of 
cells 
EC222 nal`rif 6.2 x 107 1 Very small, rare microcolonies, «1 per field 
140065 WT 8.2 x 107 5 Large microcolonies on virtually all cells 
140065 nal' 1.3 x 108 4 Moderate to large microcolonies on virtually all cells 
EC 157 WT 1.2 x 108 4 Moderate to large microcolonies on virtually all cells 
EC157 strr 1.2 x 10" 3 Slightly fewer and smaller microcolonies than WT 
WT: Wild-type. * Semiquantitative 6-point comparative scale of extent of FAS lesions: 0 (no FAS 
lesions) -5 (maximal extent of FAS lesions seen in this set). 
Comparison of DMEM and PBS pre-incubation upon fluorescence actin staining of 
E. coli 0157: H7 and 026: H11 strains on HEp-2 cells 
To further investigate the apparent differences between E. coli 0157: H7 and 026: H1 I 
responses to DMEM induction seen in the intestinal loop experiments (Chapter 4), FAS was 
performed using PBS and DMEM incubation prior to inoculation of HEp-2 monolayers, as 
described in Section 2.5.5.4. Results are summarised in Table 3-F. A subjective 6-point 
semiquantitative score, combining size and frequency of FAS-positive lesions, as used 
previously (Table 3-E) was assigned to each stained monolayer. Using this score and a one 
hour pre-incubation in PBS as a baseline, a three-hour pre-incubation in DMEM had a 
positive or neutral effect upon the formation of FAS-positive lesions for all E. coli 0157: H7 
strains, whereas the EC1537 026: H11 strain was not enhanced and indeed appeared to be 
inhibited by the DMEM treatment. 
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Table 3-F: Fluorescence actin staining of inoculated HEp-2 cells, comparing PBS 
and DMEM pre-incubation of E. coil 
Inoculum FAS Preparation Strain TVC*(cfu) Scoret Comments 
EC21 S 9.8 x 107 4 
Approx. I large microcolony per 
cell 
EC222 1.1 x 108 2 
Small to moderate microcolonies 
on approx. 50 % of cells 
DM EM 
140065 8.2 x 107 5 
Large microcolonies on virtually 
3 hour all cells 
8 Moderate to large microcolonies EC157 incubation 1.2 x 10 4 on virtually all cells 
NCTC 12900 7.3 x 107 5 Large microcolonies on all cells 
EC 1537 6.7 x 107 2 
Approx. 50 % of cells have small 
or moderate microcolonies 
EC218 3.2 x 107 4 Similar to EC218 DMEM 
EC222 8.0 x 107 2 
Small microcolonies on approx. 
30 % of cells 
PBS g Moderate to large microcolonies 140065 1.2 x 10 4 on virtually all cells 
1 hour 
EC157 1.75 x 108 3 
Moderate colonies on approx. 
incubation 90 % of cells 
NCTC 12900 9.7 x 107 5 Similar to NCTC 12900 DMEM 
7 Small to large microcolonies on EC1537 3.8 x 10 3 approx. 80 % of cells 
tSemiquantitative 6-point comparative scale of extent of FAS lesions: 
0 (no FAS lesions) -5 (maximal extent of FAS lesions seen in this set). 
*TVC: total viable count of the inoculum. 
The data for the STEC 0157: H7 strains in the upper part of the table is the same as in Table 3-E, as these 
assays were performed in parallel, but is presented also in this table for ease of comparison. 
D. Scanning electron microscopy 
SEM was performed on inoculated HEp-2 monolayers incubated for three and six hours 
(sections 2.5.5.5 and 2.7.4.1). The findings are summarised in Table 3-G and Figure 3-i. 
Strain B171 (EPEC) formed the most dense, rounded colonies, with microcolony formation 
clearly evident by three hours. The strains lacking bfpA did not form such compact, round 
microcolonies, and only one out of four E. coli 0157: 1-17 strains (139579) showed 
appreciable microcolony formation by three hours. All strains showed identifiable 
microcolonies at six hours. 
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Table 3-G: Scanning EM observations of inoculated HEp-2 monolayers 
Strain Inoculum Observations at three hours p. i. Observations at six hours p. i. TVC* 
Discrete, raised microcolonies on Dense, rounded, discrete microcolonies B171 1.8 most cells, plus some flattened, on all cells. 
more diffuse bacterial aggregations 
A range of colonial forms: loose 
Loose aggregates of generally fewer aggregates of approx. 
50 bacteria, 
85440 1.2 
than 20 bacteria on most cells. small 
(approx. 50 bacteria) to moderate 
(100-200 bacteria) -sized flattened or 
raised dense colonies. 
Scattered single bacteria over all 
EC218 1.3 cells, no evidence of microcolony 
formation. 
Clusters of 2-5 bacteria on some EC222 1.3 
cells. 
Scattered bacteria over all cells, 
EC 157 1.0 including loose clusters of up to 6 
bacteria. 
Loose aggregates of <_10 bacteria 
139579 0.95 on some cells, scattered bacteria on 
others. 
Small, rounded microcolonies (50-100 
bacteria) on approx. 50 % of cells, 
scattered bacteria on others. 
Small, flattened microcolonies (15-70 
bacteria) on some cells, loose aggregates 
on others. 
Small, rounded microcolonies (50-100 
bacteria) on <50 % of cells, scattered 
bacteria on others. 
Flattened, small microcolonies (5100 
bacteria) on many cells, loose 
aggregates on others. 
*TVC: Total viable count, x 107 cfu. 
Bold entries are illustrated in Figure 3-i. 
In a follow-up study, prompted as described in Section 3.5.2C for the FAS study, 
DMEM-induced cultures of the four strains in the mixed inoculum plus their parent strains 
were inoculated onto HEp-2 monolayers, in order to compare the SEM appearance of the 
parent strains and antibiotic resistance marked derivatives. The results are summarised in 
Table 3-H. Like the comparative FAS studies (Section 3.5.2C), DMEM pre-incubation 
produced an apparent increase in the proportion of colonised cells by six hours p. i. in 
comparison with non-induced bacteria (Table 3-G), although the morphology and size of the 
colonies was not markedly different. When parent and antibiotic resistance marked strains 
were compared using DMEM pre-treatment, a reduction in colonisation was observed in 
three of four marked derivatives, shown by a reduction in colony size and/or the proportion 
of cells colonised. This effect was seen with the same three strain-pairs (EC222/ 
EC222 nal`rif, 140065/140065 nal" and EC157/EC157 str) that showed attenuation in the 
DMEM-induced FAS assay, and again Strain EC222 was the most markedly affected. 
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Table 3-H: Scanning EM observations on HEp-2 monolayers incubated for six hours 
with E. coli 0157: H7 strains pre-incubated in DMEM for three hours 
Strain Inoculum NC (cfu) Observations at six hours p. i. 
EC218 WT 9.8 x 107 Flattened microcolonies on most cells, some colonies are denser and 
rounded. 
EC218 rig 7.7 x 107 Similar to WT, but no dense, rounded microcolonies seen. 
EC222 WT 1.1 x 101 Most cells are colonised with flattened microcolonies. 
EC222 nal'rif 6.2 x 107 Scattered, single bacteria across the low-power field. One deeply- 
embedded at high power. 
140065 WT 8.2 x 107 Extensive flattened microcolonies on all cells. 
140065 nal' 1.3 x 108 Microcolonies smaller than WT, but present on all cells, often dense 
and rounded up. 
EC157 WT 1.2 x 108 Large flattened microcolonies on all cells, plus dense `balls' with 
surface bacteria, resembling colonised cells which have become 
markedly contracted. 
EC157 str` 1.2 x 108 Microcolonies, smaller than for WT, present on most cells. 
WT: wild-type 
3.5.2.2 Bovine cell culture assays 
The opportunity arose during the present studies to use bovine-derived epithelial-like 
intestinal cell cultures derived from a neonatal calf (Dibb-Fuller et at. 2001), which may be 
more similar phenotypically to ovine enterocytes than are the standard laboratory cell lines. 
Some of the cell association assays which had been done using HEp-2 cells were repeated 
using the bovine monolayers and the E. coli 0157: H7 strains used in in vivo studies. Three 
cell cultures, derived from ileum, colon and rectum were chosen, reflecting possible 
colonisation sites in the ruminant host, as suggested by studies with neonatal and older 
calves (Dean-Nystrom et al. 1997; Dean-Nystrom et al. 1999). 
A. Quantitative association assay 
Quantitative association assays were performed on semiconfluent monolayers of all three 
cell cultures (sections 2.5.5.1 and 2.5.5.2). The results are shown in Figure 3-j. A consistent 
feature is the tendency for counts to increase with a distal progression from ilea] to rectal 
cells. There are however no discernible differences between bacteria, either between strains 
or between wild-type and antibiotic resistant derivatives. Furthermore, the association of a 
laboratory K12 strain (DHSa) lacking the LEE, was comparable in this three-hour assay to 
the AEEC 0157: H7 strains, suggesting that E. coli 0157: H7-specific mechanisms of 
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adherence including AE lesions and associated processes such as EspA filament adhesion, 
were of minor or no significance to the overall number of adherent bacteria at this stage. 
B. Giemsa stained preparations 
Monolayers of all three bovine cell types were inoculated, fixed and stained as described 
in sections 2.5.5.1 and 2.5.5.3. The three-hour incubation was selected, to assist comparison 
with the quantitative association assay. Observations made under the light microscope are 
summarised in Table 3-I. 
There was considerable variation in the appearance of the cultured cells, probably 
signifying a degree of degeneration before or during the assay. The main dichotomy was 
between `non-staining' cells, showing a lack of nuclear stain with or without cytoplasmic 
pallor and vacuolation but no evidence of widespread apoptosis or shrinkage, and `staining' 
cells, showing strong nuclear staining and moderate cytoplasmic staining but often appearing 
vacuolated, rounded up or disintegrating. Cells were in wide zones of one state or the other, 
with relatively narrow transitional zones, i. e. `staining' and `non-staining' cells were not 
admixed. Patterns of adhesion were varied and included diffuse, localised (microcolonial) 
and a pattern of bacterial concentration along intercellular boundaries resembling the 'log- 
jam' pattern described forE. coli 0157: H7 strains on human ileocaecal (HCT-8) cells 
(McKee and O'Brien 1995b). The latter pattern is interesting, as the cells on which it was 
seen in the present study were from a similar anatomical location to those in the original 
report. Although the viability of the cells was doubtful and no strong trend of adhesion 
patterns is discernible, only 5 of 30 E. coli 0157: H7 strain/cell-type combinations did not 
yield evidence of either clustered or'log jam'-type adhesion. By contrast, no pattern or 
evidence of preferential association with cells compared with coverslip glass was seen with 
any of the control E. coli K12-infected monolayers. 
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Table 3-I: Observations on Giemsa-stained inoculated bovine cell cultures at three 
hours p. i. 
Strain Ileum Colon Rectum 
70 % cells NS. Bacteria 30 % cells NS. Bacteria 80 % cells NS. Bacteria EC218 more on staining cells, some common, some small 
WT in loose and dense'log jam'- clusters, more on staining acommon, 
some 







70 % cells NS. Scattered 
bacteria, more on staining 
cells, sparse, small flat 
clusters. 
70 % cells NS. Bacteria 
mostly in sparse, flat 
clusters, on both types of 
cell. 
40 % cells NS. Bacteria 
common, some small 
clusters. Similar numbers on 
all cells. 
30 % cells NS. Bacteria 
scattered. Occasional small 
clusters, most on NS cells. 
90 % cells NS. Bacteria 
common, often clustered, 
and strongly cell-associated. 
80 % cells NS. Bacteria 
common, much denser over 
staining cells, no pattern. 
EC222 
nal`rif 
60 % cells NS. Bacteria 
scattered, preferentially on 
staining cells where there 
are sparse, small clusters. 
40 % cells NS. Scattered 
bacteria, sparse small 
clusters. Few on NS cells. 
80-90 % cells NS. Bacteria 
common on staining cells, 
clusters common. Few 





20-30 % peripheral cells 
non-staining. Bacteria 
predominantly scattered over 
staining cells, loose 'log jam' 
pattern. Few clusters. 
30 % peripheral cells NS. 
Bacteria scattered and small- 
large flat clusters, on 
staining cells. 
20 % NS peripheral cells. 
Others typically vacuolated. 
Bacteria locally abundant, 
no microcolonial pattern, 
fewer on NS cells. 
As 140065 WT 
70 % cells NS. Bacteria 
scattered, on both cell types 
closely cell-associated, 
clusters predominate, mostly 
on staining cells. 
70 % cells NS. Bacteria 
common, more over staining 








30 % peripheral cells NS. 
Bacteria sparse, infrequently 
clustered, no adhesion 
difference between cell 
types. 
50 % cells NS. Bacteria 
sparse, clearly more frequent 
over staining cells. No 
pattern. 
50 % cells NS. Bacteria 
mainly loose'log jam' 
pattern on staining cells, 
smaller numbers in small, 
loose aggregates on NS cells. 
50 % cells NS. staining cells 
often vacuolated. Bacteria 
sparse, mainly on staining 
cells, occasional small 
microcolonies. 
10 % peripheral cells NS. 
Bacteria locally abundant, 
tend to loose 'log-jam' 
pattern. Few on NS cells. 
50 % cells NS. Bacteria 
common, locally abundant, 
some in loose'log jam' 
pattern. Few on NS cells. 
50 % cells NS. Bacteria 
common, adhering to both 
cell types equally. Clusters 
common. Adherence closely 
cell-associated (more than 
other strains). 
>80 % cells NS or weakly- 
staining. Others shrunken 
and disintegrating. Bacteria 
common, weak'log jam' 
pattern, mostly 
uninterpretable. 
50 % NS. Bacteria plentiful, 
no pattern, similar density 
over both cell types. 
80 % cells NS / weakly- 
staining. Bacteria scattered, 
more common over staining 
cells, where occasionally 
clustered. 
>90 % cells NS. Bacteria 
common over NS, strongly 
clustered and cell- 
associated. staining cells too 
few & shrunken to assess 
meaningfully. 
80 % cells NS. Bacteria 
scattered, some clusters on 
cells, but little difference in 
density between staining, NS 
and glass. 
K12 
70 % cells NS. Bacteria >90 % NS or weakly- 100 % NS, Patchy bacteria, 
DH5a scattered across all cells - no staining. 
Bacteria common, unclustered, similar density 
pattern, not cell-associated, on cells and glass. 
NS: non-staining. See Section 3.5.2.2B for explanations of staining and non-staining. WT: wild-type 
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C. Fluorescence actin staining 
Bovine cell monolayers were inoculated with E. coif 0157: H7,026: H11 and K12 strains, 
incubated for six hours, and FAS was performed according to the protocols in sections 
2.5.5. l and 2.5.5.4. The results are summarised in Table 3-J and in Figure 3-k. 
In general, less than 50 % of coverslip area had attached cells. This was often much less, 
i. e. below 10 %. As cells were verified to be semi-confluent at the start of the inoculation 
procedure, substantial detachment of cells must have occurred at some stage(s) of 
incubation, washing and staining. The degree of cell loss and degeneration did not appear to 
be correlated with the presence of an STEC inoculum, and the rectum-derived cells were 
consistently the most markedly degenerated. The lesions were subjectively scored, as 
previously described (Table 3-E), and all AE strains proved FAS-positive on all cell types. 
There appears to be no pattern of susceptibility to FAS-positive colonisation by E. coif 
0157: H7 amongst the three cell types, and the small intestine-derived (ilea]) cells yielded 
similar scores to the large intestine-derived cells. Moreover, when considering bacterial 
strains, no positive correlation is evident between the degree of FAS-positive colonisation 
with this technique and the strain persistence characteristics in lambs (Chapter 6). 
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Table 3-J: Observations on fluorescence actin staining of inoculated bovine cell 
cultures Continued on page 98 
Strain TVC* 
Typ Scoret Comments 
e 
Ileum 4 
FAS' MC, typically 50-100 bacteria, on 100 °%% of cells. Cells 
generally well preserved. 
Colon 
Small to large FAS+ MC on 100 % of viable cells. 4 
EC2I 8 9.0 Approximately 50 % of cells are rounded up and degenerate. 
FAS, ' MC, typically medium or large (100 bacteria) on 90 % of 
Rectum 4 cells. Approximately 70 % of cells are rounded up and 
degenerate. 
FAS4 MC, typically 10-50 bacteria, some up to 100, on 70 % of Ileum ' 
cells. Cells generally well preserved. 
EC218 Colon 8 
Small and medium FAS+ MC present on 80 % of viable cells. 
' " ri1T Approximately 30 % of cells are rounded up and degenerate. 
Small or medium FAS+ MC present on 50 °/, of viable cells. 2 Rectum Approximately 80 % of cells are rounded up and degenerate. 
FAS* MC, comprising 5-20 bacteria, are rare, on «10 % of 
Ileum I cells. Approximately 50 % of cells are rounded up and 
degenerate. 
EC222 7.8 Small to medium FAS+ MC present on 30 % of viable cells. Colon Approximately 70 % of cells are rounded up and degenerate. 
Rectum <4 Fewer than 10 viable cells seen. Small FAS+ MC seen on 2 cells. 
FAS+ MC, comprising 10-20 bacteria, are present on up to 10 % 
Ileum I of cells. Approximately 50 % of cells are rounded up and 
degenerate. 
EC222 6.3 ` 
Rare FAS+ clusters of typically 5 bacteria present. Approximately 
rif Colon nal 1 50 0o of cells are rounded up and degenerate. 
Rectum I 
Small FAS+ MC present uncommonly on viable cells. 
Approximately 70 % of cells are rounded up and degenerate. 
FAS, MC, comprising up to 30 bacteria, are present on 
Ileum I approximately 10 % of cells. Approximately 50 % of cells are 
rounded up and degenerate. 
EC 157 7.0 Colon 
Small FAS+ MC present on 90 % of viable cells. Approximately 
50 % of cells are rounded up and degenerate. 
Small FAS+ MC present on 50 % of viable cells. Approximately Rectum - 80 % of cells are rounded up and degenerate. 
No FAS+ bacterial adherence sites seen. Approximately 50 % of 0 Ileum 
cells are rounded up and degenerate. 
EC 157 7 
.8 
Colon 
Small FAS- MC are present but very rare. Approximately 50 % 
str' of cells are rounded up and degenerate. 
Rectum (0), 
No FAS+ bacterial adherence sites seen. Poor quality samples, as 
approximately 90 °0 of cells are rounded up and degenerate. 
Notes: see page 98 
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Table 3-J continued 
Strain TVC' Type Scoret Comments 
Ileum 4 FAS i MC of up to 200 bacteria present on 100 % of viable cells. 
Approximately 50 % of cells are rounded up and degenerate. 
Small to large FAS+ MC are present, on 100 % of viable cells. 
140065 g.; 
Colon 4 
Approximately 50 % of cells are rounded up and degenerate. 
Small and medium FAS+ MC, sometimes very loose, present on 













EC 1537 4.8 
Colon 
Rectum 
FAS+ MC, typically of 10 bacteria, present on up to 10 % of 
I viable cells. Approximately 50 % of cells are rounded up and 
degenerate. 
Small FAS+ MC are rare overall, but present on up to 30 % of' 
2 cells locally. Approximately 50 % of cells are rounded up and 
degenerate. 
I 
Scattered, small FAS+ MC on viable cells. Approximately 80 % 
of cells are rounded up and degenerate. 
4 
FAS+ MC of up to 200 bacteria, on 90 % of cells. The majority of 
cells appear viable. 
Large FAS+ MC are present on 100 % of viable cells. Cells 
5 typically have multiple MC. Approximately 50 % of cells are 
rounded up and degenerate. 
Medium and large FAS- MC present on 100 % of viable cells. 
4 Slightly less florid than same strain on colon cells. Approximately 
60 °o of cells are rounded up and degenerate. 
FAS+ clusters, looser than the 0157 MC and comprising 10- 
2 30 bacteria, on 50 % of cells. The majority of cells appear 
viable. 
Small to medium FAS+ MC, looser than 0157 MC, are present 
'_ on 50 'o of viable cells. Approximately 70 % of cells are rounded 
up and degenerate. 
Small and medium FAS+ MC present on 70 % of viable cells. 
Approximately 90 % of cells are rounded up and degenerate. 
Ileum 0 
No FAS+ bacterial adherence sites seen. The majority of cells 
appear viable. 
K12 
4.8 Colon 0 The majority of cells are rounded up and degenerate. (DHScr) 
Very few cells present, typically contracted and degenerate. No Rectum 0 FAS± bacterial adherence sites seen. 
Ileum 0 
No FAS+ bacterial adherence sites seen. Approximately 50 % of 
cells are rounded up and degenerate. 
Colon 0 Feý% cells present, most are rounded up and degenerate. None - 
Very few cells present, almost all contracted and degenerate, or 
Rectum - showing dissolution of the FITC-stained cytoskeletal actin. No 
FA S. bacterial adherence sites seen. 
*TVC: total viable count of the inoculated broth. x 10" cfu/ml. 
tSemiquantitative 6-point comparative scale of extent of FAS lesions: 
0 (no FAS lesions) -5 (maximal extent of FAS lesions seen in this series). 
Score uncertain, as few cells present for evaluation. 
MC: microcolonies. implies loose but discrete aggregations of bacteria. 
Bold entries are illustrated in Figure S-k. 
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3.5.3 Acid tolerance studies 
3.5.3.1 Inorganic acid tolerance 
The stationary phase acid resistance of candidate E. coif 0157: H7 strains was assessed 
using hydrochloric acid at low pH (2.5) for 2.5 hours. This procedure was intended to 
simulate the environmental stress associated with passage through the monogastric stomach 
or the ruminant abomasum, and has been shown to discriminate between acid-sensitive and 
acid-resistant strains of enteric E. coli (Gorden and Small 1993), and stationary phase E. coli 
0157: H7 in particular (Waterman and Small 1996). A 10% survival level, following 
previously published methods (Gorden and Small 1993; Waterman and Small 1996), was 
chosen to separate resistant and sensitive phenotypes. 
The results of a single assay for each strain are presented in Table 3-K. The strains 
examined were thus markedly heterogeneous in respect of stationary phase inorganic acid 
tolerance. 
Table 3-K: Inorganic acid tolerance of 
E. co/i0157: H7 strains 
Strain % survival Phenotype 
EC218 0.0009 Sensitive 
EC222 55 Resistant 
EC157 0.04 Sensitive 
131567 1 Sensitive 
134107 4 Sensitive 
138345 5 Sensitive 
139229 42 Resistant 
139579 0 Sensitive 
139969 7 Sensitive 
140019 18 Resistant 
140065 70 Resistant 
3.5.3.2 Acidic pH tolerance in the presence of volatile fatty acids 
The inhibitory effect of VFA upon E. coli, including E. coli 0157: H7, under acid 
conditions is well established (Wolin 1969; Rasmussen et al. 1993; Lin et al. 1996). 
Proposed mechanisms for this effect include the importation of protons (H) into the 
bacterial cell, with subsequent dissociation of the VFA-proton molecule and release of H+ 
into the cytosol, and membrane disruption by the VFA molecule. These mechanisms would 
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lead to loss of internal pH homeostasis (Benjamin and Datta 1995; Booth et al. 1999) and the 
toxic intracellular accumulation of VFA anions (Russell 1992). 
Various sources, reporting analyses of ovine intestinal contents under defined feeding 
regimes (Dougherty et al. 1975; Anon 1979; Church 1979; Maloiy and Clemens 1980; Lewis 
and Dehority 1985) provide information on the range of normal pH and VFA concentrations 
in the rumen and hindgut of sheep. The ranges of values derived from these are as follows: 
Large intestine 
pH: minimum 6.0 
maximum 8.1 
Total VFA: minimum 44 
(mmol/1) 
maximum 160 
VFA composition: Acetate 




(caecum, 60% grain diet; Lewis and Dehority 1985) 
(rectum, hay diet; Maloiy and Clemens 1980) 
(rectum, grass diet; Lewis and Dehority 1985) 
(caecum, 60% grain diet; Lewis and Dehority 1985) 
71 - 85 
9.6-14.5 
2.3-17.5 
(Lewis and Dehority 1985) 
0.8-4.2 
pH: 5.5-7.0 (Anon 1979) 
Total VFA: 60-120 (Anon 1979) 
(mmol/l) 
VFA composition: Acetate approx. 60 
(molar percentages) Propionate approx. 20 
(Church 1979) 
Butyrate approx. 15 
Valerate approx. 1-6 
With reference to the above reports, it was decided to use a standard mixture of acetate, 
propionate, butyrate and valerate in a molar ratio of 77: 10: 10: 3, at three different overall 
concentrations (0,100 and 150 mmol/I) in order to span the range likely to be encountered 
within the ovine alimentary tract. Similarly, the three pH values of 6.0,6.5 and 7.0 were 
selected, to reflect the pH values quoted in the sources and to provide the mildly acidic 
conditions at which VFA-specific inhibition may be evident. Thus, for each strain tested, 
nine different combinations of VFA concentration plus pH were assessed, including the 
effects of pH alone (no added VFA) and of VFA at neutral pH. A standard, non-limiting 
nutrient source (LB-G broth) was chosen as the medium in which to create the VFA and pH 
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conditions and, as far as was practicable using gas jars, anaerobic culture conditions were 
employed, to reflect the environment in the alimentary tract. An initial bacterial 
concentration of approximately IOS cfu/ml was selected, in order to provide adequate scope 
for detectable growth or a reduction in viable bacteria over the eight hours of the assay. The 
assays were performed as described in Section 2.5.2.2, and the results for a single assay for 
each strain and VFA plus pH combination are summarised in figures 3-1,3-m and 3-n. 
In the absence of added VFA, all strains and their antibiotic resistant derivatives grew 
similarly within the pH 6 to 7 range, and the graphs are consistent with a sigmoid growth 
curve. With added VFA at 100 mmol/l, suppression of growth of all strains was evident at all 
pH values, but it was most marked at pH 6, where a reduction in growth of approximately 
two loglo units was seen by eight hours. Furthermore, the double-marked EC222 nal`rif 
strain proved most susceptible to VFA-induced growth suppression, with growth at eight 
hours being approximately one login unit lower at all pH values than that of its parent strain 
EC222. At the highest VFA concentration of 150 mmol/l the effect was more pronounced. A 
further reduction in growth at eight hours of one to two loglo units at pH 6 amounted to a 
cessation of detectable growth in some cases. Growth at a reduced rate continued at pH 6.5 
and 7. Additionally, the values at five hours suggested a prolonged lag phase in comparison 
with the previous graphs. 
3.5.4 Growth in single and mixed broth culture 
Following initial selection of strains for in vivo use (Section 3.6), the growth curves of 
each antibiotic resistance marked strain in LB-G broth were determined, initially in single- 
strain culture with photometric measurement of cell density, and subsequently in mixed 
culture with periodic TVC monitoring of cell density using antibiotic-supplemented nutrient 
agar (Section 2.5.3). The results (Figure 3-o, i. and ii. ) show that, although all strains grew 
similarly in separate cultures, in mixed culture the detected growth of Strain 139579 spec` 
ceased whilst the other strains were in mid-logarithmic phase, resulting in the final 
stationary-phase TVC for Strain 139579 spec` being more than one loglo unit lower than the 
TVC of any other strain in the mixture. Strain 139579 spec1 was therefore substituted with 
Strain 140065 nal`, and Strain EC222 nal' was double-marked (EC222 nal`rifr) to permit 
differentiation, as further discussed in sections 3.4 and 3.6. These four strains were then 
grown separately and together in broth culture (Figure 3-o, iii. and iv. respectively. ) and 
were also cross-streaked on nutrient agar plates (Section 2.5.3). The double-marked 
EC222 nal`rif strain proved to be slower-growing in both culture experiments and achieved 
a final concentration between half and one log10 unit lower than the other three strains in 
mixed culture. However, the marked growth arrest seen in mixed culture with Strain 
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139579 spec` was not seen with any strain. No growth inhibition was seen between any 
strains in the cross-streaking experiment. 
3.6 Selection of strains for in vivo studies 
In the absence of a comprehensive understanding of E. coli 0157: H7 interactions with 
the carrier host, some unknown or unsuspected bacterial factor may be of significant 
importance in the process of attachment. As such a factor may vary between strains, it was 
considered that a mixed inoculum for in vivo studies would increase the likelihood that a 
strain or strains capable of attaching in some way would be inoculated, and form 
attachments. Bovine and human-derived strains were selected in order to include, 
respectively, a source associated with persistent ruminant strains and a source of strains 
which were virulent in humans and which may successfully have passed through the human 
food chain from an animal reservoir. Persistent sheep-derived E. coli 0157: H7 were not 
readily available at the time for consideration as candidate strains. 
The possible contribution of established virulence factors of E. coli 0157: H7 to 
persistence in the field is unknown, so candidate strains were screened for established 
virulence-associated genes and for associated phenotypic characteristics. Using the results of 
genotypic and some phenotypic characterisations, four E. coli 01 57: H7 strains (EC218, 
EC222, EC157 and 139579) were selected initially for in vivo studies. Criteria for selection 
included: the presence of eaeA and four putative virulence factors located on the pO157 
virulence plasmid and encoded by the etpD, katP, and espP genes and the EHEC-hly gene 
cluster (Section 3.3); in vitro intimin expression following DMEM induction (Section 
3.5.1 A); in vitro cell association comparable with other E. coli 0157: H7 strains (Section 
3.5.2.1A); and AE (FAS) capability in the six hour HEp-2 assay (Section 3.5.2.1C). 
Following PCR amplification of the entire rpoS stationary phase sigma factor gene (Table 
2-A, Figure 3-a), none of the candidate strains were seen to have a gross lesion in this gene. 
The rpoS gene has been shown to be highly mutable in E. coli, including 0157: H7, with 
small (Waterman and Small 1996) and large (Cookson, A., personal communication) genetic 
lesions having been found to be associated with a reduction in acid tolerance. 
Variable features of the mixed inoculum were: source of the strain, inorganic acid 
tolerance and Shiga toxin subtype, these being characteristics which are observed to vary 
substantially in field strains of E. coli 0157: H7 (Griffin and Tauxe 1991; Waterman and 
Small 1996). Following initial selection, the four strains were further characterised in respect 
of cell association by Giemsa-stained preparations and SEM examination (sections 3.5.2.1 B 
and 3.5.2.1 D respectively). Thus, the strains selected had a demonstrable capacity to adhere 
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to HEp-2 cells in a localised pattern and formed AE lesions, doing both in a manner typical 
of the EHEC 0157: H7 pathotype (Nataro and Kaper 1998). 
When the antibiotic resistance marked strains were grown in mixed broth culture (Section 
3.5.4), detectable growth of Strain 139579 spec` apparently ceased when the other strains 
were in mid-logarithmic phase, resulting in the final TVC for Strain 139579 spec` being 
more than one logro unit lower than the TVC of any other strain in the mixture. Therefore, at 
this stage it was replaced by the bovine-derived Strain 140065 nal`, and Strain EC222 nal` 
was additionally labelled with rif resistance, to distinguish between the two. This was done 
in order to be able to produce a four-strain antibiotic resistance marked mixture in which 
each strain would grow to an approximately equal density. Double-marking one strain was 
performed because a single-marked 140065 spec` strain had an atypical small colonial 
appearance (Section 3.4). Cross-streaking and mixed batch culture showed no evidence of 
inter-strain growth inhibition with the combination of EC218 rif, EC222 nal'rif, 140065 naI` 
and EC157 str`. 
Following the substitution of Strain 139579 by 140065, Giemsa-stained (Table 3-C) and 
SEM (Table 3-H) preparations of the latter strain were examined. Strain 140065 had similar 
characteristics to the other three mixed inoculum strains in these assays. The shared and 
variable features of the strains in the mixed inoculum are summarised in tables 3-L and 3-M. 
Table 3-L: Shared features of the component strains of the four-strain mixture 
Strain p0157 rpoS2 
Infmin FASO HEp-2 pattern 
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1&2: Section 3.3; 3: Section 3.5. IA; 4: Section 3.5.2C; 5: Section 3.5.2B; 6: Section 3.5.2D. 
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Table 3-M: Variable features of the component strains of 
the four-strain mixture 
Strain Source stx type' Acid tolerance2 
EC218 Bovine 1&2 Sensitive 
EC222 Bovine 2 Resistant 
EC157 Human 1&2 Sensitive 
140065 Human 2 Resistant 
1: Section 3.3; 2: Section 3.5.3.1 
3.7 Discussion 
The aims of the present in vitro studies were: the selection and characterisation of E. coli 
0157: H7 strains for in vivo studies, and the further characterisation of these and additional 
strains to complement findings from orally inoculated lambs and ligated ovine large 
intestinal loops. 
Adhesion to HEp-2 cells, as measured by the three-hour quantitative association assay, 
was similar between all E. coli 0157: H7 strains tested. Previous studies (Sherman et al. 
1987; Donnenberg et al. 1989; McKee and O'Brien 1995b; Dibb-Fuller et al. 2001) have 
shown that E. coli 0157: H7 does not invade HEp-2 cells to a significant degree, when 
compared with invasive bacteria such as EIEC and Salmonella species. Therefore, the 
quantitative association assays may be considered a reasonable reflection of the cell- 
adhesion qualities of the test E. coli 0157: H7 strains. Some reports indicate that a three-hour 
incubation time is inadequate for the characterisation and quantification of EHEC adherence 
to cell cultures (Karch et al. 1987; Donnenberg and Nataro 1995). However, these reports 
concern assays using the microscopic examination of stained monolayers for adherent 
bacteria, not the cultural method for quantification used in the present studies. For the 
microscopic technique, the detection and counting of colonies is optimised by a three-hour 
initial adhesion incubation followed by washing (to preserve the integrity of the monolayer; 
Francis et al. 1991) and a three-hour colony-development stage. For quantifying adhesion by 
culture, the second three-hour incubation following washing merely results in multiplication 
of bacteria already adherent and is unlikely to aid the discriminating power of the assay. 
Examination of certain strains including a human EPEC (B171), a bovine EPEC (85440) 
and various human- and bovine-derived E. coli 0157: H7 strains on inoculated HEp-2 
monolayers by light, fluorescence and electron microscopy yielded results which correlated 
closely between the different techniques. Strain B 171 consistently formed dense 
microcolonies, which were FAS-positive (indicating AE lesion formation) by three hours p. i. 
Strain 85440 formed less dense, more flattened colonies at a slower rate and on a smaller 
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proportion of cells. The E. coli 0157: H7 strains all exhibited the type of LA typical of the 
pathotype (McKee and O'Brien 1995b; Tatsuno et al. 2000) and characterised by the 
relatively slow formation (over more than three hours) of microcolonies which were of low 
density in comparison to those formed by typical (EAF-encoding) EPEC. Indeed, the E. coli 
0157: H7 LA resembles the `poor LA' (Knutton et al. 1991) or `LA-like' (Scaletsky et al. 
1999) phenotype reported by other workers for atypical EPEC which lack EAF and, by 
inference, BFP also. The weak LA pattern seen with E. coil 0157: H7 at three hours p. i. with 
the light microscope was generally not apparent at the higher magnification afforded by the 
scanning electron microscope. Adherence of the E. coli 0157: H7 strains at three hours p. i. 
typically was not associated with detectable FAS. 
The process of initial strain characterisation and selection has been discussed (Section 
3.6). In the light of previous experience with an E. coli 0157: H7 experimental strain 
(Cookson, A., personal communication), the rpoS stationary phase sigma factor genes of 
candidate strains were checked for lesions by PCR, whilst recognising that small changes 
undetectable by this method may still have rendered the gene non-functional in any 
particular strain. It was not originally intended to include in the mixed inoculum a strain 
(EC222 nal'riff) for which no detectable FAS (AE) capability was evident in the standard 
assay. However, FAS studies using the marked E. coli 01 57: H7 derivatives were conducted 
in parallel with the in vivo studies, and it became apparent that Strain EC222 nal'rif was 
substantially attenuated in respect of an AE capability in comparison with its parent strain 
only after first use of the four-strain inoculum. For consistency, the mixed inoculum 
continued to be used as originally constituted, and the range of AE capabilities amongst the 
four marked strains, which became evident following standard and DMEM pre-incubated 
FAS, was potentially of value to attempt correlations with strain persistence in vivo. 
Although double resistance marking may have been significant in the degree of attenuation 
of the AE capability of Strain EC222 nalTrift, the findings of the protein expression studies 
(sections 3.5.1 B and 3.5.1 C) demonstrate that the wild-type Strain 222 secreted low 
quantities of proteins, including EspA, in comparison with the other strains. Thus it appears 
that the double antibiotic resistance marking was applied within an already weak AE 
background. 
The attenuation of the colonising and AE capability in vitro of the antibiotic resistance 
marked derivatives of strains EC222,140065 and EC157 varied according to the 
strain/resistance marker combination, and Strain 218 appeared to be little affected by 
marking for rif resistance. The protein expression studies comparing wild-type and derived 
antibiotic resistance marked strains showed a pattern of protein secretion and intimin 
expression which correlated with that observed in respect of in vitro colonising and AE 
capability. Detailed comparison shows that, of the protein profiles examined, intimin 
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expression most closely paralleled the phenotypic findings, i. e. Strain 218 (least attenuation 
under FAS and SEM examination associated with antibiotic resistance marking) showed 
least apparent reduction in intimin expression when resistance marked, and Strain 222 (most 
attenuation under FAS and SEM examination associated with antibiotic resistance marking) 
showed the most marked apparent reduction in intimin expression when resistance marked. 
The reduction in protein secretion seen in the antibiotic resistance marked strains 
appeared to affect most of the protein bands present and not just the identifiable proteins 
encoded by the LEE, suggesting that the observed attenuation was not due to mechanisms 
specifically targeting regulation of the LEE. Likely mechanisms of spontaneous single-step 
resistance in the marked strains used are: mutations in the rpsL ribosomal protein S12 gene 
for streptomycin (Bryan 1984), mutations in the rpoB DNA-dependent RNA polymerase 
gene for rifampicin (Reynolds 2000), and mutations in gyr DNA gyrase genes for nalidixic 
acid (Piddock 1999). There is commonly a `fitness cost' associated with the acquisition of 
antibiotic resistance by a bacterium, at least initially (Schrag et al. 1997; Reynolds 2000), 
which may be associated with a reduction in the efficiency of DNA replication (gyr), of 
transcription (gyr, rpoB) or of translation (rpsL). As the fitness cost incurred may vary 
between different mutants (Reynolds 2000) it is perhaps unsurprising that the reduction in 
protein expression and the phenotypic attenuation varied substantially between the 
experimental strains. 
When strains were grown in DMEM before the various cell association assays, 
colonisation and the formation of AE lesions, as assessed by SEM and FAS, were increased. 
This parallels the previously reported effect of DMEM in the promotion of LEE protein 
expression (Ogierman et al. 2000). Indeed, in the case of Strain EC222 nal'rif , pre- 
incubation in DMEM restored an AE capability to a detectable level in the HEp-2 FAS 
procedure. 
One-hour PBS and five-hour DMEM incubation was performed on five E. coli 0157: H7 
strains and one E. coli 026: H 11 strain, and an increase in the concentration of the LEE 
proteins EspA and intimin was observed with the latter treatment relative to the former, 
although the effect on intimin with E. coli 026: H11 was unclear, due to substantial variation 
in the bacterial cell concentrations between assays. For E. coli 0157: H7 strains this effect 
was seen also when overall protein secretion was assessed. However the 026: H 1l strain 
appeared to behave differently, as the level of many supernatant proteins with PBS 
incubation was equal to or higher than that with DMEM incubation. Nonetheless, this effect 
did not include the proteins tentatively identified as EspB and EspD on the Coomassie- 
stained gel, which were increased in the DMEM preparation. The difference in the secreted 
protein profiles between E. coli 0157: 1-17 and 026: H11 strains without DMEM induction 
parallels the finding that FAS lesion formation on HEp-2 cells was unaffected or even 
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enhanced by PBS pre-incubation for the E. coli 026: H11 strain, in contrast to the E. coli 
0157: H7 strains which were generally enhanced by DMEM pre-incubation (Table 3-F). 
These studies comparing PBS- and DMEM-incubated bacteria were prompted by 
findings in vivo (Chapter 4), which also suggested a possible difference between E. coli 
0157: H7 and 026: H11 responses to DMEM incubation. The resulting FAS data reinforces a 
hypothesis, generated after reviewing the results of the intestinal loops studies, that the AE 
phenotype of E. coli 0157: H7 is enhanced to a greater degree than that of E. coli 026: H 11 
(Strain EC1537) by DMEM pre-treatment. However, the protein expression studies do not 
support a specific role for Esp secretion in this proposed effect, despite showing a difference 
between the serotypes in terms of overall supernatant protein levels without DMEM 
induction. These were, however, limited studies and inter-strain comparisons are restricted 
by, for example, consideration that the growth phases of the strains were not monitored, and 
that protein expression at different stages of growth were not considered. Furthermore, such 
effects as cell contact-dependent secretion of Esp proteins (Beltrametti et al. 1999) were not 
examined. The relative contributions of media and temperature are also unclear in these 
studies, as temperature has been shown to affect markedly the secretion of EspB, and 
probably EspA, by E. coli 026: H- (Ebel et al. 1996) and EPEC 0127: H6 (Kenny et al. 
1997a). 
The use of standard laboratory epithelial-like cell lines, of both intestinal (e. g. Caco-2) 
and non-intestinal (e. g. HEp-2, HeLa) derivation is well established, and provides a degree 
of standardisation with which to compare the findings of different workers. However, the 
surface properties and physiological apparatus of cells from different species and body 
locations differ. Where an in vitro approach is being used to investigate an in vivo interaction 
between micro-organisms and host, it may be helpful to use cells which are as closely related 
to the host as possible. Using bovine intestine-derived cell cultures, no differences were 
observed between E. coli 0157: H7,026 and K12 strains in an association assay. The use of 
a mannose-free incomplete medium for this assay may have complicated interpretation, as 
the control K12 strain may have expressed type-1 fimbriae whereas the E. coli 0157: H7 
strains would be unlikely to have done so (Section 1.4.2.2D). A difference between the cell 
types in the level of bacterial association was seen. However, as the cell cultures have 
proved more fragile in Giemsa-stained and FAS procedures than established cell lines such 
as HEp-2, this difference may have been due to differences in cell viability rather than in the 
adhesion characteristics of the cells per se. 
When Giemsa- and FAS-stained bovine cell monolayers were examined three and six 
hours respectively after inoculation with E. coli 0157: H7 strains, neither showed a 
correlation between adherence or AE lesions and the in vivo persistence characteristics of the 
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inoculum strain. Furthermore, a natural E. coli 026: H11 pathogen proved no more adherent 
to these bovine cells than did the E. coli 0157: H7 strains. 
The results comparing strain tolerances to VFA at acidic pH show the expected pattern, 
based upon previous work (Rasmussen et at. 1993), and do not demonstrate that one strain is 
clearly more tolerant of VFA at physiological alimentary pH values than another. The 
pronounced susceptibility of the double-marked Strain EC222 nal`rif in the 100 mmol/I VFA 
assay is further evidence that such marking procedures places bacteria at a competitive 
disadvantage in some environments. 
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Figure 3-a: PCR reaction products for gene detection 
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I. Multiplex PCR. Bands of the expected size are present, indicating that all 
strains possess eaeA. two possess stx2 and one possesses six! and stx2. 
'A'. 'ß' and 'C' indicate different PCR buffers. 
ii. PCR for rpaS. All test strains. %%ith both butters, yield a product of the 
same (expected) size. 'A' and'B' indicate different PCR buffers. 
product with two out of three PCR buffers, whilst the test (85440) strain 
yields no product. 'A', '13' and 'C' indicate different PCR buffers. 
Figure 3-b: Western blot of intimin from E. co#0157: H7 strains 
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110 
Figure 3-c: LEE protein expression from E. col/0157: H7 strains, following DMEM 
induction 
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Figure 3-d: Secreted protein profi 
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L Silver (above) and Coomassie (right) -stained 
polyacrylamide gels of electrophoresed secreted 
proteins preparations. The lanes to the left of the 
divider above are from Figure 3-c. 
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TVC: 5 67 183 500 6.17 567 550 3 83 400 
(w10"cf m4) 
ii. Western blot membranes of secreted protein preparations probed with EspAo, 57 antibody. Double 
bands of approximately 20 kDa are present with three of the strains to the left and with two strains 
on the right (arrows). The lanes to the left of the divider are from Figure 3-c. 
Notes: Strains were incubated either in DMEM at 37 °C for 5 hours, or in PBS at room temperature for 
one hour. before secreted proteins were concentrated by centrifugal ultrafiltration. The final TVC of 
each preparation after incubation is given at the bottom of each lane. Strain EC1537 (far right) is 
E. coli 026: H 11; all others are E. coli 0157: H7. 
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Figure 3-e: Western blots of E co cell lysates probed with y-intimin antibody 
Rainbow EC157 140065 218 
Mol marker 
EC157 PBS 140065 PBS 218 PBS 




























TVC (xlO'crwm): 5.67 5.17 6.00 5.67 5.00 2.00 
Notes: Strains were incubated either in DMEM at 37 °C for 5 hours, or in PBS at room temperature 
for one hour. before secreted proteins were concentrated by centrifugal ultrafiltration. The final 
TVC of each preparation after incubation is given at the bottom of each lane. Strain EC1537 
(bottom right) is E. coil 026: H11; all others are E. coil 0157: H7. The strong band 
corresponding with the 94-97 kDa intiminO157 molecule is arrowed. Substantial non-specific 
band staining is present; this is probably due to the high dilution of primary antibody used. 
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I. Comparison of E. coli 0157: H7 WT and antibiotic resistant derivative strains 
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U. Comparison of control strains B171 (0111) and 85440 
(080) using HEp-2 cells 
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0, i. Strain B171(0111), 3 hours p. i. 
_ ,, 
Microcolonies are well-established. 
'o 
X 04 '44, 
H. Strain B171 (01 11), 6 hours p. i. 
Large, dense microcolonies are 
present. 
iii. Strain EC 157 (0157), 6 hours p. i. 
A1. Low to moderate density 
microcolonics are present on most 
.I `'" cells. 
-adi 
.0 -T, It I 
0 
i"lrý ý''9 iv. Strain EC218 (0157), 6 hours p. i. 
Moderately dense microcolonies are 
j1. _ present on most cells. 
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Figure 3-h: Fluorescence actin staining of HEp-2 monolayers inoculated with E. co/i 
are common. Size. 
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i. Strain 8171,6 hours p. i. Large and frequent 
FAS-pocitiýc colonies (examples arrowed). ýýitiý e colonies. 
colonies are not clearly e%ident. colonies (arrowed) are small and scattered. 
(examples arrowed) are of moderate size and colonies (examples arrowed) are of moderate 





ý i. Mi, im 1 ', 9) 71). h hkiUI I. I. I, ý, 
aggregates of bacteria. 
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i. Strain 13 171.3 hours p. i. Distinct 
microcolonies. 
ii. titrain 11171. h hours p. i. I)cnsc. rounded 
(inset) microcolonies on all cells. 
in S5440. t, h0ui h. i. II lttcncd. 
mudieratel' dense micnxulonm. 
i%. Strain I39579.3 hours p. i. Ractrria are 
scattered, some small clusters discernible. 










Figure 3-k: Fluorescence actin staining of bovine intestinal cell cultures inoculated with 
E, w/i 
i. Strain NCTC 12900, colon, 6 hours p. i. Score: 5 ii. Strain I.. 1537. ilcum. 0 huurs h. i. Scorc: _'. 
iv. Strain E C222 nal`rir. rectum. 6 hours p. i. 
Score: 1. 
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Figure 3-o: Growth curves of E. w10157: H7 strains in single and mixed culture 
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Chapter 4- INTESTINAL LOOP STUDIES 
4.1 Introduction 
The occurrence of persistent excretion of E. coli 0157: 1-17 by some ruminants has been 
documented (Besser et al. 1997; Kudva et at. 1997a; Mechie et at. 1997; Shere et al. 1998). 
Adherence of the bacterium to the intestinal wall in vivo has been reported (since the 
completion of the present studies) in a naturally colonised steer at the recto-anal junction 
(Naylor et al. 2003). Experimentally, a high dose (109 to 1010 CFU) oral inoculum of E. coli 
0157: H7 has yielded detectable AE lesions in the large intestine of neonatal and weaned 
calves (Dean-Nystrom et al. 1997; Dean-Nystrom et al. 1998; Dean-Nystrom et al. 1999) and 
in neonatal lambs (Chapter 5), although not in the context of persistent colonisation. It is 
possible that small, sparse and as-yet undetected AE lesions occur in naturally colonised 
animals and contribute to persistence. The ligated intestinal loop technique (Williams Smith 
and Halls 1967; Frost et al. 1997) is of potential use in investigating the adherence of E. coif 
0157: 1-17 to the ruminant intestinal mucosa. It facilitates the search for bacterial attachment 
by providing a well-defined mucosal area which has been subjected to a high concentration 
of inoculated bacteria. This may be used to establish the principle of susceptibility to AE 
lesions for a host species and for a particular age group. Other benefits include the ability to 
screen several bacterial strains for host interactions in a single animal, the potential to 
analyse bacterial secretions in a single, isolated loop and the potential to examine local host 
responses. 
For the reasons discussed above, it was decided to use the ligated intestinal loop 
technique in the investigation of interactions between E. coli 0157: 1-17 and the ruminant 
host. Sheep were used as the experimental species because they exhibit the phenomenon of 
natural persistent colonisation by E. coli 0157: 1-17 in the field (Kudva et al. 1996; Kudva et 
al. 1997a), are associated with human infection (Licence et al. 2001; Strachan et al. 2001) 
and they are of convenient size for studies across a wide age range. The aims of the present 
study was: to establish effective methods for the use of this technique under hazard category 
3 microbiological containment, and to examine further the adherence phenotype of the 
E. coli 0157: H7 strains used in oral inoculation studies. The use of weaned lambs between 
five and six months old provided the opportunity to examine E. coif 0157: H7 adherence in 
an age group in which the persistent excretion of the organism has been demonstrated 
(Section 1.4.2.7). 
Four experiments were performed. The first (using Lamb 1) was a technical trial using 
sterile inocula to test, and modify if necessary, the methods which were based upon bovine 
(Frost et al. 1997) and ovine (Williams Smith and Halls 1967) small intestine loop studies, 
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and also to examine the effects of the manipulations upon the gross and histological 
appearance of the intestine. The second (using Lamb 2) was performed with category 2 
AEEC, to further refine the technique and to examine the adherence phenotype of the two 
control non-0157 organisms plus one non Shiga toxin-producing E. coli 0157: 1-17 which 
were used. The final two experiments (using lambs 3 and 4) used category 2 and 3 E. coli 
0157: H7 strains, these being the strains used in the oral inoculation studies (chapters 5 and 
6), plus a category 3 natural bovine-pathogenic E. coli (026: H11). This last organism was 
used as a comparative inoculum which had an established capability to naturally infect a 
ruminant species and to form AE lesions. A bovine-derived strain was used at that time in 
the absence of a characterised E. coli strain known to form AE lesions in sheep. In Lamb 4 
the inoculum was pre-incubated in DMEM, to promote expression of LEE genes (Kenny et 
al. 1997a). This, it was hypothesised, would increase the number of bacteria adhering to the 
mucosa within the incubation period. 
4.2 Materials and Methods 
Animal procedures 
For ethical and practical reasons, continuous anaesthesia was employed, and a six-hour 
incubation period was chosen to give the inoculated organisms adequate time to form AE 
lesions, based upon the confirmatory fluorescence actin staining (FAS) performed with these 
strains in vitro. (Section 3.5.2C). The colon was selected for the creation of the loops 
because E. coli 0157: H7 has formed lesions in the colon of calves (Dean-Nystrom et al. 
1997; Dean-Nystrom et al. 1999) and neonatal lambs (Chapter 5). The spiral colon 
specifically was used in view of its suitability in respect of surgical access and anatomical 
features, i. e. it is readily exteriorised and manipulated, is of relatively narrow calibre, and 
provides the maximum scope for multiple loops within the large intestine by virtue of its 
length. 
The technique employed is described in detail in Section 2.6.3.2, and a schematic 
illustration of the loops formed is shown in Figure 4-a. Four lambs, aged between five and 
six months, were used on separate occasions. Lamb I was inoculated with PBS only. Inocula 
for the other lambs are shown in Table 4-A. Details of the sources of the strains used are in 
Section 2.2.1. Genotypic characteristics of the Shiga toxin-producing E. coli 0157: H7 and 
the E. coli 080 strains are given in Table 3-B. Strain EC1537 possesses genes encoding Stxl 
(Gunning et al. 2001), the LEE, enterohaemolysin and a serine protease (katP) (Pearson et al. 
1999). Strain NCTC 12900 has a typical E. coli 0157: H7 genotype in respect of LEE and 
virulence plasmid genes, but lacks Shiga toxin (Dibb-Fuller et al. 2001). 
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Table 4-A: Details of inocula for ligated colon loops 
Lamb Inoculum type Strains used Serotypes 
non Shiga toxin- 
NCTC 12900 0157: H7 
2 producing AEEC in 85440 080: NM 
PBS carrier B 171 0111: NM 
EC1537 026: H11 
AEEC in PBS EC218 0157: H7 
(Lamb 3) or DMEM 
(Lamb 4) carrier. EC222 0157: H7 3 and 4 Strains for Lamb 4 140065 0157: H7 
pre-incubated in 
DMEM EC157 0157: H7 
NCTC 12900 0157: H7 
Pathological procedures 
Tissues were fixed, processed and examined as described in sections 2.7.1,2.7.2,2.7.3, 
and 2.7.4.2A respectively. 
Bacteriological procedures 
Bacteriological procedures are described in sections 2.2.9 (screening faeces for E. coli 
0157: H ), 2.2.6 (preparation of inocula) and 2.2.8 (TVC determination). The wild-type 
unmarked E. coli 0157: H7 strains were used in lambs 3 and 4 in preference to their 
antibiotic resistance marked derivatives. This was because there was no need for recovery 
and differentiation between strains in the protocol used, and therefore any phenotypic 
alterations associated with antibiotic resistance marking could be avoided. 
4.3 Results 
Animal procedures 
All four lambs survived the anaesthetic and surgical procedures until euthanasia 
following excision of the colon loops. It proved possible to create twelve loops of 
approximately 10 cm length in the spiral colon, providing six test loops inoculated with 
bacteria plus six control loops inoculated with carrier medium only, each control loop being 
immediately proximal to its respective test loop. Only 10 loops were created in Lamb 1. The 
inoculation procedure was associated with minimal leakage of the inoculum from the 
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injection site, and thermocautery assisted in limiting this. The colon loops were opened and 
placed in fixative within two minutes of excision. 
Bacteriological findings 
E. coli 0157 was not detected in faecal samples taken from any of the test animals on any 
of the three occasions over a four month period prior to the experiments. 
For lambs 3 and 4, inoculated with STEC, TVC were performed on the inoculum 
preparations, and these are listed in Table 4-B. 
Macroscopic pathological findings 
Upon removal from the animal, the serosa of the ligated loops appeared reddened and was 
often mildly oedematous. The luminal contents were mucoid and frequently were 




The loops, all inoculated with PBS only, were numbered from I to 10 in sequential 
progression from proximal to distal spiral colon. Five loops (1,3,5,7 and 9) were examined. 
The epithelium was uniformly well preserved, with no evidence of detachment or 
degeneration. The lamina propria appeared mildly oedematous in the more distal loops. 
Small, focal haemorrhages and more extensive areas of haemorrhage were common in the 
lamina propria. In addition, locally extensive haemorrhages were observed on the serosa, 
there was a small amount of free blood in the lumen and haemorrhages were occasionally 
seen in mucosa-associated lymphoid tissue. Mild or moderate apoptosis was common in 
lymphoid follicles. In the serosa and muscularis externa, acute inflammatory changes, 
comprising moderate neutrophil margination, extravasation and migration, were widespread. 
Lamb 2: 
Details are presented in Table 4-C. Tissue preservation was uniformly excellent, and 
haemorrhages were rarely seen. Inflammatory and apoptotic changes similar to Lamb I were 
seen in the outer layers of the colon wall and in the mucosal lymphoid tissue respectively. 
The bacterial populations at the mucosal surface varied considerably, in both inoculated and 
control sections. Some loosely-attached bacteria were seen in the NCTC 12900-inoculated 
loop. No AE-type lesions were seen in any section. 
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Lambs 3 and 4: 
Details are presented in tables 4-D and 4-E. Since the same strains were used in both 
animals, these two animals are considered together and the twelve bacteria-inoculated loops 
have been lettered consecutively (Table 4-B) for reference. The order of inoculation of loops, 
from the cranial to the caudal end of the spiral colon, follows alphabetical sequence in each 
animal, i. e. each strain was inoculated into the same relative position in the colon in each 
animal. As these lambs were inoculated with E. coli 0157: H7, more extensive scrutiny of the 
tissues was performed than with the previous two lambs. Fifteen to 21 sections per loop were 
examined, and these were prepared from between six and 11 pieces of embedded tissue, with 
several sections taken from each piece using different levels in the wax block. When 
measured macroscopically, the microscope sections ranged in length from 11 to 59 mm. 
Preservation of the mucosa was generally good, with only one loop (L) exhibiting 
detachment of short sections of the epithelium. AE-type lesions were found in H&E-stained 
sections in several loops inoculated with bacteria. Similar lesions were not observed in 
control loops. The occurrence of lesions is summarised in Table 4-B. Lesions were 
extremely sparse and typically were small, covering one or two adjacent enterocytes, with 
individually distinguishable bacteria (Figure 4-b). Some lesions were found on detaching 
enterocytes (Figure 4-c), although only in Loop D was this exclusively the case. The mean 
frequency of occurrence of AE lesions per section was 0.21 (82 lesions / 389 sections). 
However, a tendency for clustering of lesions was observed in some loops, with up to seven 
lesions being observed on a single section (Table 4-B), which is 33 times greater than the 
mean. Clusters of lesions were not associated with areas of visibly damaged epithelium. 
The epithelial morphology appeared abnormal in four out of 12 loops in Lamb 3, two of 
which were controls not inoculated with bacteria, and in 11 out of 12 loops in Lamb 4. The 
mucosal surface in affected loops had a ragged profile in a multifocal pattern. In Lamb 4, 
this was often accompanied by rounding up and detachment of enterocytes, both singly and 
in small clusters. Additionally, in Lamb 4, small foci of epithelial necrosis were present in 
two control loops. A number of other histological features, including focal mucosal 
haemorrhage, neutrophilic serositis, and apoptosis in mucosa-associated lymphoid tissue, 
were commonly seen in both inoculated and control loops, similarly to lambs I and 2. In 
loops L, K and J in Lamb 4, localised colonisation of the (subepithelial) lamina propria by 
bacteria was evident near some areas of epithelial erosion. In Loop Ea modest increase in 
the number of neutrophils in the lamina propria and several foci of neutrophils within the 
luminal epithelium were seen. In Lamb 4 both inoculated and control loops contained 
slender organisms of spiral morphology, in moderate or large numbers, occupying crypts and 
the intestinal lumen. Loose aggregations of such organisms were frequently present on the 
mucosal surface (Figure 4-e), but there was no evidence that these organisms were attached 
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to or invading the host intestinal wall, and no specific association with areas of epithelial 
abnormality was detected. These bacteria stained positively with a Warthin-Starry silver 
stain. 
Immunohistochemical findings 
The ipx technique proved sensitive and specific using the primary antisera for E. coli 
0157 and 026 at dilutions of 1: 1000 and 1: 4000 respectively. The 080 antiserum was not 
tested with a positive control preparation and was used at a 1: 500 dilution, this having not 
yielded any non-specific staining of 0157 organisms in a control section. Details for 
individual sections are included in tables 4-C, 4-D and 4-E. 
Lamb 2: 
Immunostaining for 080 and 0157 antigens was performed on tissue from two loops, 
wherein bacteria loosely-attached to the mucosa had been seen in H&E-stained sections. 
Positive staining was not observed. 
Lambs 3 and 4: 
Ten to 20 sections per loop were immunostained, and the results are presented in Table 
4-B. AE-type lesions were found in five of the six loops in which lesions had been detected 
in H&E-stained sections. In addition, AE lesions were found in four loops in which such 
lesions had not been detected in H&E-stained sections. Positive staining confirmed that the 
lesional bacteria were E. coli 0157 (Figure 4-d) or 026 (Figure 4-e), as appropriate to the 
inoculum. A few non-staining closely adherent bacteria were seen in association with 026 
lesions. In a number of loops, single positively-staining bacteria were seen lying on the 
mucosal surface. As the nature of the attachment, if any, of these single organisms to the host 
cells was uncertain, the recording of an AE lesion required the identification of a cluster of 
two or more positively-staining bacteria in close apposition to the mucosa, i. e. evidence of 
multiple attached organisms in a single focus. Occasionally, positively-staining attached 
bacteria were seen where, upon initial examination of a corresponding H&E-stained section, 
only surface debris had been observed (Figure 4-g). 
Substantial numbers of bacteria expressing 0157 antigen (Figure 4-1) were detected in the 
subepithelial lamina propria of the three loops (J, K, L) in which lamina proprial colonisation 
had been detected using H&E-stained sections, and additionally in Loop I. The concentration 
of 0157 organisms in the lamina propria was high (i. e. dense, uncountable masses of 
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Electron microscopic findings 
Nine pieces of tissue (detailed in tables 4-D and 4-E) were processed using the wax block 
retrieval technique from lambs 3 and 4, seven from loops demonstrating light microscopic 
evidence of AE lesions. Three of these seven specimens yielded sections containing bacteria 
which had formed AE lesions. These were: two from Loop A, containing E. coli 026 (Figure 
4-h), and one from Loop H, containing E. coli 0157: H7 (Figure 4-i). From one of the two 
resin blocks prepared from areas where lamina proprial colonisation by bacteria had been 
seen, organisms with a morphology consistent with E. coli were seen around and within the 
basal portions of crypt cells and in areas of haemorrhage. In addition, curved or spiral 
bacteria were seen (Figure 4-j). In sections from the other block, bacteria were seen within a 
goblet cell secretory vacuole and a neutrophil. 
4.4 Discussion 
E. coli 0157: 117 formed AE lesions within six hours in ligated spiral colon loops of 
weaned lambs and, where examined, the light microscopic appearance of AE lesions was 
confirmed by TEM of tissue retrieved from wax blocks. Electron microscopy proved 
demanding in the face of small and sparse lesions and only three of seven attempts to extract 
lesions for examination were successful. Lesions were not seen with strains B 171 (E. coil 
0111: NM, human EPEC) and 85440 (080: NM, bovine EPEC), but relatively few sections of 
these loops were examined, in comparison with the E. coli 0157: H7-inoculated loops. The 
blood supply to the loops appeared to be sufficient to preserve the mucosa adequately for six 
hours, but changes that may have been caused by circulatory compromise include the 
morphological alterations to the mucosa, observed in both control and test loops, and the 
limited mucosal haemorrhage. 
There was no evidence of a loop-dilating effect of any inoculum, nor of morphologic 
alterations specifically associated with any STEC inoculum. The effect of Shiga toxin upon 
the bowel has been shown to vary between species (Tzipori et al. 1987; Richardson et al. 
1992), and this includes changes observed in ligated loops (Williams Smith et al. 1983; 
Mobassaleh et al. 1988). It is consistent with the observed lack of clinical disease in naturally 
(Kudva et al. 1996; Kudva et al. 1997a) and experimentally (Kudva et al. 1995; Kudva et al. 
1997b; Cornick et al. 2000; Wales et al. 2001) STEC-colonised sheep that the ovine colon 
appeared to be resistant to Shiga toxin-induced changes for the six-hour exposure used in the 
present studies. However, the elaboration of Shiga toxins was not assessed. Current models 
of the formation of AE lesions do not propose a role for Shiga toxin (Frankel et al. 1998b) 
and there is no evidence from the present study that Shiga toxins are directly involved in the 
formation of AE lesions. This does not however preclude a role for the toxin in the 
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colonisation of animals, and indeed other workers (Dean-Nystrom et al. 1999) have 
suggested that they might facilitate colonisation. 
The sensitivity of ipx staining for the detection of AE lesions appeared to be superior to 
H&E, but this was not amenable to statistical analysis with the present data, given the 
variability in sizes of the sections examined. Numerous sections potentially containing small 
and sparse lesions were being screened, and it proved easier to detect specifically-stained 
bacteria at the mucosal surface in ipx-stained sections than to detect non-specifically stained 
intimately-adhering bacterial clusters in H&E-stained sections. Therefore, it is not surprising 
that the number of AE lesions detected per H&E-stained section (0.11) was substantially 
lower than the corresponding number for immunostained sections of a similar size (0.34). 
Different patterns of lesion formation were seen between strains and between inoculation 
regimes in lambs 3 and 4. However, the low incidence of lesions in this instance means that a 
great many more sections would need to be examined to provide unequivocal evidence of 
differences. Comparisons between findings in the two lambs are aided by the fact that the 
strains were placed in the same locations relative both to each other and to the colon in the 
two lambs. For the 0157: 1-17 strains in lambs 3 and 4, a similar number of lesions were 
recorded, but in the former lamb these were predominantly formed by one strain (EC218), 
with few or no lesions by the others, whereas in the latter the lesions were more evenly 
distributed between strains. In addition, there was a marked difference in the number of 
E. coli 026: H 11 lesions between the two lambs whereby, in contrast to the E. coli 01 57: H7- 
inoculated loops, the PBS inoculation regime yielded more 026-associated lesions. Overall, 
there is no evidence that the E. coli 026: H 11 bovine pathogen formed lesions more readily 
than did the E. coli 0157: H7 strains, nor that there was a consistent difference between the 
two serotypes in response to DMEM induction. Indeed there appears to be as much variation 
amongst E. coli 0157: H7 strains as between the two serotypes. No consistent effect of 
variation in the inoculum dose (albeit over only a fourfold range) was seen. 
The potential distorting effect of the clusters of lesions seen in some loops upon the total 
numbers of lesions detected is difficult to quantify with the modest numbers involved, but 
the clustering effect limits useful comparisons between loops. The clusters were not 
associated with any visible predisposing features, such as mucosal damage, and may have 
formed consequent upon localised high concentrations of inoculated organisms. 
The identity of the numerous slender, spiral organisms seen in crypts and at the mucosal 
surface in Lamb 2 is unknown, but Campylobacter-like organisms have been seen on the 
mucosa of sheep naturally-infected with Campylobacter fetus (Jopp and Orr 1980). Although 
there was no evidence for associated pathological change, these spiral organisms remain a 
potential confounding factor when comparing data from the two lambs, and further studies 
comparing inoculation regimes within the same animal would be required to address this. 
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The present data is insufficient to speculate about a possible role of these organisms in 
colonisation by E. coli 0157: H7 and other AE bacteria. 
The bacterial colonisation of the lamina propria, with electron microscopic evidence of a 
host response of phagocytosis, was only seen in one experimental animal (Lamb 4) and it did 
not correlate specifically with the presence of AE lesions. It was associated with the 
inoculated E. coli 0157: H7 organisms, of both Shiga toxin-producing and non Shiga toxin- 
producing strains but was not observed in E. coli 026-inoculated loops. The high 
concentration of 0157 organisms in the lamina propria suggests that the 0157 bacteria 
colonised the tissue more avidly than did other bacteria present in the lumen, although spiral 
bacteria were also seen in the tissue in EM preparations. Pre-incubation in DMEM may have 
promoted the expression of bacterial factors in Lamb 4 that were necessary for colonisation. 
In addition, the occurrence of observed epithelial abnormalities was highest in this lamb and, 
furthermore, this was the only lamb in which the Campylobacter-like organisms were seen. 
However, the significance of these two observations in relation to the lamina proprial 
colonisation is undetermined. Colonisation of the lamina propria in animals inoculated 
experimentally with STEC 0157: H7 has been reported in the caeca of chicks at 14 and 28 
days p. i. (Beery et al. 1985) and of gnotobiotic piglets at 5 days p. i. (Tzipori et al. 1986). 
The immune status of the animals was not investigated in this study. Other workers (Li et 
al. 2000) have demonstrated that strong serological responses to proteins involved in the 
formation of the AE lesion occur in humans clinically affected with E. co/i 0157: H7 and it 
follows, therefore, that the immune status of the sheep may have played a role in limiting 
intimate adherence. Although the sheep were young and were demonstrated to be free from 
E. coli 0157: 117, it remains possible that previous exposure to heterologous AEEC (such as 
those reported Experiment 6/3, Chapter 6) may have induced cross-protective immunity. 
Conclusion 
The present ligated loop studies have demonstrated the potential susceptibility of weaned 
lambs to the attachment and formation of AE lesions in the large intestine by E. coli 
0157: 117. There is no convincing evidence that, in this experimental system, the bovine 
pathogen E. coli 026: 1111, strain EC1537, formed AE lesions more readily than did E. coli 
0157: H7. It was shown that extensive, detailed examination of tissues was required for the 
reliable detection of specific bacterial attachment, and there was an indication of the relative 
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Ligated intestinal loops were created in both the centripetal (red loops) and centrifugal (blue loops) parts 
of the spiral colon. 
Figure adapted from Dyce et al. (1987). 





Loop A. inoculated with Strain EC1537. Bacteria 
are closely adherent to the apical membrane of an 
enterocyte (arrow), which protrudes above the 
intestinal surface. H&E, bar =8 µm. 
l 
40 
Figure 4-c: AE lesion, Lamb 4, E. coil 
0157: H7 
iL 
Loop H, inoculated with Strain EC218. 
Degenerating and detaching enterocytes are 
colonised by bacteria (arrows). Toluidine blue 
stained resin-embedded section, bar = 10 µm. 
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I. 4x>p A. inoculated with Strain F(' 1537. 
Immunostained bacteria (black arr)w) are closely 
adherent to the apical membrane of enterocytcs. A 
few unstained bacteria (white arrow) are also 
present. 026 ipx. bar =8 µm. 
Figure 4-f: E. co//0157: H7 in lamina 






Loop L. inoculated with Strain NU IC 12900. 
Positively-stained bacterial masses (white arrows) 
are present in the lamina propria. underlying an 
area of epithelial disruption (black arrow). 0157 
ipx, bar = 13 µm. 
Figure 4-g: H&E- and Ox-stains, Lamb 4, 








IA)Op I. Inis. uldtei ith Strain 1. ('222.1 pp r 
(11&E) and lower (ipx) pictures arc of close 
(almost consecutive) sections from the same tissue 
block, and are from corresponding locations in the 
respective sections. Possibly adherent bacteria are 
present in the II81 -stained section (arrows), but 
only the ipx stain highlights the location and 
identity of 0157 organisms (hn)H n) amongst the 
debris at the mucosal surface. I IKI: / ipx. 
bar= 10 µm. 
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Loop J, inoculated with Strain 140065. A mucosal 
depression, lined with closely-adherent bacteria 
(black arrow) which are positively immunostained 
(inset). An aggregation of spiral bacteria, stained 
with Mayer's haematoxylin, is present in the lumen 
(white arrow). 0157 ipx, bar =8 µm. 
Figure 4-h: AE lesion, Lamb 3, E. co/i 
026: H11 
ýj ý bs. 






loop A. inoculated %%ith Strain 1. ('1537. Micro\illi 
(m) are effacai around a pedestal Ipl tu \kfiich a 
bacterium (b) is intimateR attached. liar = 500 nm. 
Figure 4-j: Base of intestinal crypt, Lamb 4 
Lapp H, inoculated with Strain EC218. Same 
lesion as Figure 4-c. AE bacteria (arrows) are 
present on two adjacent, degenerating enterocytes 
(asterisks). There is also possible invasion of one 
of the enterocytes by a bacterium (b). 













" +ýr :. r 
4d 
Loop K. inoculated with inoculated with E. co/i0157: 117 Strain : C157. Bacteria of L. co/imorphology 
are present beneath (long arro%%s) and apparently within (arrowheads) crypt epithelial cells (C). Spiral 
bacteria (short ano\%s) are also present in the lamina propria. L: crypt lumen. Bar =4 µm. 
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Chapter 5- NEONATAL LAMB STUDIES 
5.1 Introduction 
The contribution of mucosal adherence to the persistence of E. coli O157: 1-17 in ruminants 
is the primary focus of the present studies. E. coli 0157: H7 possesses the well-defined AE 
capability (Sherman et al. 1987) plus other potential adhesins including: outer membranes 
(Sherman and Soni 1988b), lipopolysaccharide (Paton et al. 1998), exopolysaccharide 
(Junkins and Doyle 1992) and the IrgA homologue adhesin (Tarr et al. 2000). There are also 
14 putative fimbrial operons identified on the genome of an E. coli 0157: H7 outbreak strain 
(Hayashi et al. 2001). Adhesion of E. coli 0157: H7 to the recto-anal mucosa of a persistently 
colonised steer has recently been demonstrated (Naylor et al. 2003). In cattle the principle of 
intestinal susceptibility to E. coli 0157: 117 AE lesions has been shown experimentally using 
a high inoculum dose of 1010 cfu in young animals, either neonates (Dean-Nystrom et al. 
1997; Dean-Nystrom et al. 1998) or fasted three- to four-month old calves (Dean-Nystrom et 
al. 1999). It may be that such lesions do occur in persistently-colonised animals, but that 
detection is currently only possible when young animals, likely to be more susceptible to 
lesion formation due to the immunological and/or physiological immaturity of the alimentary 
tract, and a high-dose inoculum are used. Studies examining potential E. coli 0157: H7 
adhesion in the intestine of neonatal lambs have not been reported. Reports of experimental 
investigations into E. cola 0157: 117 interactions with sheep are summarised in Section 
1.4.2.7. 
In initial studies using six-month and six- to 11-week old lambs inoculated with E. coli 
0157: 117 (experiments 6/1 and 6/2, Chapter 6), evidence of attachment of the experimental 
strains to the intestinal mucosa was not found. Therefore, studies using E. coli 0157: 117 
inocula were undertaken in neonatal lambs. Six-day old colostrum-fed (CF) lambs were 
used, as this represented a reasonable compromise between susceptibility to colonisation by 
E. coli 0157: H7 and susceptibility to naturally-acquired infectious diseases of the new-born, 
which might adversely affect the experiments. Colostrum feeding should provide protection 
against neonatal infection in a non-gnotobiotic environment without precluding detectable 
E. coli 0157: 117 adherence, as both colostrum-deprived and CF neonatal calves developed 
AE lesions when inoculated orally with E. coli 0157: H7 (Dean-Nystrom et al. 1997). The 
primary aim of the studies was to establish in principle whether E. coli 0157: 117 can 
associate with the intestinal mucosa in orally inoculated sheep. Therefore, potentially highly 
susceptible individuals and a high dose inoculum were used, in a short-term experiment. 
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5.2 Materials and methods 
Animal procedures 
The housing, inoculation, monitoring and sampling of lambs are detailed in sections 2.6.1 
and 2.6.3. IA. Four lambs were used and one lamb was tissue-sampled and euthanased on 
each day p. i. Alimentary tissue sampling was comprehensive, including the tonsils, small 
intestine and mesenteric lymph nodes. All alimentary sites sampled, including duodenum 
and jejunum, were examined by light microscopy. 
Bacteriological procedures 
The lambs used were screened at four days of age by faeces culture for E. coli Ol 57: H7 
via IMS, as detailed in Section 2.2.9 although without the preparation of a dilution series 
before pre-enrichment. 
The preparation of inocula is described in Section 2.2.7. A four-strain mixture of Shiga 
toxin-producing E. coli 0157: H7 was used, comprising two bovine-derived and two human- 
derived strains. Candidate strains were screened for established virulence-associated genes 
(Section 3.3) and for associated phenotypic characteristics (Section 3.5). The selection 
process is described in Section 3.6, and the shared and variable features of the four strains 
are summarised in tables 3-L and 3-M respectively. 
The recovery and the analysis of bacteria are described in sections 2.2.9, and 2.2.10 
respectively. The sites from which samples were cultured were: rumen, distal small intestine 
(ileum), large intestine, tonsils and mesenteric lymph nodes. 
Pathological procedures 
Details of tissue fixation and the preparation, staining and examination of LM sections 
are given in sections 2.7. land 2.7.2 respectively. For immunostaining (Section 2.7.3), 
sections were prepared from seven pieces of embedded tissue, comprising caecum from 
Lamb 5 (12 hours p. i. ) and terminal colon and rectum from Lamb 8 (84 hours p. i. ). 
Following examination of tissues by LM, small pieces of tissue were cut out of the paraffin 
wax blocks and processed for TEM, as detailed in Section 2.7.4.2A. Immunogold staining 
(Section 2.7.4.3) was performed on sections from one resin-embedded specimen. 
5.3 Results 
Clinical findings 
All lambs remained normal throughout the experiment. Daily rectal temperatures were 
within the normal range. 
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Bacteriological findings 
Pre-inoculation faeces screening of the lambs did not detect E. co/iO]57: H7. The 
inoculated mixture provided 9x 108 cfu/animal. 
Faeces culture 
The inoculated animals had a low and irregular level of excretion at six and 12 hours p. i., 
and a higher level of excretion of most strains thereafter (Table 5-A). In the later samples, at 
60 and 84 hours p. i., the EC157 str` and EC222 nal`rif strains were detected at lower levels 
than the two other strains, but no clear pattern can be discerned. 
Table 5-A: Logarithmic counts of E. co/i0157: H7 recovered from rectal swabs and 
faeces of orally inoculated neonatal lambs 
Lamb 5678 
Strain nrs nr nrs nr nrs nr nrs nr 
6 hours p. i. ----1 1- II 1- 14414 
12 hours p. i. --------II-- ?6 ?64 >6 
36 hours p. i. >6 26 >6 >6 >6 26 26 >_6 >6 >_6 26 >6 
60 hours p. i. >_6 >_6 24 >6 26 4 2: 6 
84 hours p. i. >_7 ?7 >7 - 
Lambs 5,6,7 and 8 were inoculated with a mixture of 140065 nal' (n), EC218 rig (r), EC 157 str` (s) 
and EC222 nal'rif (nr). Faeces samples (swabs at six and 12 hours, Ig of faeces thereafter) were 
taken from all lambs alive at the time points in the table. Values are log10 of the most probable 
number cfu/g in an ascending 10-fold dilution series. - indicates E. coil 0157: H7 not detected. 
Tissue and intestinal contents culture 
E. coli 0157 was isolated from the majority of cultured samples of the gastrointestinal 
tract (Table 5-B). In all cases high numbers were recovered from the caecum and spiral 
colon (colon 2). In Lamb 6, high numbers of all inoculated E. coli 0157 strains were 
recovered from terminal colon (Colon 3) tissue and contents, despite no such organisms 
having been cultured from the rectum. Both the terminal colon and rectum were well 
colonised by E. coli 0157 in lambs 7 and 8, at 60 and 84 hours p. i. respectively. The ileum 
of all animals yielded modest numbers of E. coli 0157, and low numbers were recovered 
from the rumen. Low numbers of organisms were recovered from the mesenteric lymph 
nodes of one animal and from the tonsils of three. 
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Table 5-B: Logarithmic counts of E. co/i0157: H7 recovered from tissues and intestinal 
contents of orally inoculated neonatal lambs 
Lamb 5 (12 h. p. i. ) 6 (36 h. p. i. ) 7 (60 h. p. i. ) 8 (84 h. p. i. ) 
0157: H7 strain nrs nr nr s nr n r s nr nrs nr 
Mes. lymph nodes ---- -- -- I I I I --- - 
Tonsil 22-- 22 22 2 2 2 - -- 
Rumen 2422 22 22 2 2 2 2 4 1- - 
Ileum 4424 44 22 >-6 4 4 1 >6 >-6 >6 4 
Caecum >-6" >-60 >_6# >-6" >-6" >6" 4# >6# >6 >6 >_6 4 >6 44 2 
Colon 2 2: 6 2: 6 2: 6 >_6 >-6 >_6 1 >_6 2! 6 2_6 2! 6 4 >-6 >6 4 - 
Colon 3 tissue 4424 2: 6 2: 6 - >_6 >-6 2 - 2 >-6" >6" 44 2" 
Colon 3 contents -2-- >6 >6 - >6 >-6 >_6 - 4 >-6" >6" >6" 4" 
Rectum tissue 44-4 -- -- >6 2 - 2 >6# 4# 2" -0 
Rectum contents 22-2 -- -- ?6 >_6 - ?6 >_6" >6" >6" 2# 
Lambs 5,6,7 and 8 were inoculated with a mixture of 140065 nal' (n), EC218 rig (r), EC 157 str' (s) and 
EC222 nairrif (nr). Samples were collected and cultured as described in Section 2.2.9. Values are loglo 
of the most probable number cfu/g in an ascending 10-fold dilution series. #: sites where AE lesions were 
detected histopathologically. h. p. i. = hours post inoculation. 
Macroscopic pathological findings 
Macroscopic abnormalities were not observed in any tissue. Tissues typically were placed 
in fixative within one minute of excision from the lamb. 
Histopathological findings 
Detailed LM observations are presented in Table 5-C. Intestinal tissue preservation was 
excellent (no appreciable epithelial detachment) in the large intestine and excellent or good 
(slight epithelial separation with or without minor epithelial loss) in the small intestine. 
In the small intestine, mild to focally moderate infiltration of the lamina propria by 
eosinophils and/or neutrophils was present in the duodenum and ileum of Lamb 5, the 
jejunum and ileum of Lamb 6, the ileum of Lamb 7, and the jejunum and ileum of Lamb 8. 
Neutrophils were present in the mucosal epithelium in some sections. 
From each sampling site in the large intestine, six to 11 sections were examined. When 
measured macroscopically, the total length of the mucosal edge of the sections examined 
from each site was between 75 and 200 mm. Small, focal areas of closely-adherent bacteria 
resembling AE lesions were seen at the mucosal surface in the caecum of lambs 5 and 6, 
sampled at 12 and 36 hours p. i., and in the terminal colon and rectum of Lamb 8, sampled at 
84 hours p. i. Lesions were not observed in the tissues of Lamb 7. Only seven AE-type 
lesions were detected in 191 large intestine H&E-stained sections. Each lesion extended over 
3 to 15 adjacent enterocytes which usually protruded slightly, either singly or as a group, 
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above the surrounding mucosal surface (figures 5-a and 5-b). Affected enterocytes often 
appeared to have rounded up, and some showed condensation of nuclear material. One 
caecal lesion was accompanied by an overlying clump of neutrophils, some of which 
appeared to contain bacteria (Figure 5-c). Detachment of a colonised enterocyte from the 
mucosa was also observed. 
Mild to focally moderate infiltration of the lamina propria by eosinophils and neutrophils 
was present throughout the large intestine in a pattern which varied between animals and 
which showed no apparent association with the presence of visible AE lesions. Occasionally, 
neutrophils were seen in the intestinal epithelium. Pathological changes were not observed in 
sections of rumen, liver, kidney, tonsil, mesenteric lymph node and spleen from any animal. 
Immunohistochemical findings 
Five of the seven pieces of tissue selected for the preparation of ipx-stained sections were 
chosen because AE lesions had been observed in H&E-stained sections prepared from the 
same piece. In view of the low incidence of lesions seen in the H&E-stained sections overall, 
it was anticipated that these selected pieces of tissue would be most likely to yield sections 
containing lesions. The two other pieces of tissue which were used were embedded in the 
same wax blocks as two of the five pieces described above, and so were sectioned and 
stained alongside them. 
None of the five lesions that had previously been identified (in H&E-stained sections) 
were seen. However, one further lesion was found in a section of rectum from Lamb 8. This 
piece of tissue had not shown any AE lesion in H&E-stained sections. The adherent bacteria 
were positively and specifically labelled by the 0157 antiserum (Figure 5-d). In a section of 
caecum from Lamb 5, intestinal contents were seen to contain a large number of specifically- 
labelled 0157 organisms. 
Electron microscopy 
Pieces of the caecum of Lamb 6 (36 hours p. i. ) and the rectum of Lamb 8 (84 hours p. i. ) 
were processed for TEM. These tissue pieces lay directly beneath AE lesions detected in 
H&E-stained sections taken from the same blocks. Only the lesion seen by LM in the rectum 
of Lamb 8 was seen in resin-embedded tissue sections. Several bacteria were seen in this 
lesion, forming typical AE lesions with intimate attachment to the enterocyte plasma 
membrane, formation of pedestals and effacement of the host cell microvilli (Figure 5-f). 
There were a few bacteria which were dividing whilst attached to the mucosal surface. The 
immunogold technique using the 0157 antiserum specifically labelled the cell wall of 
adherent bacteria in the lesion (figures 5-g and 5-h). 
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5.4 Discussion 
When approximately 109 cfu of a four-strain mixture of E. coli 0157: H7 was 
administered orally to four six-day old conventionally-reared lambs, the animals remained 
clinically normal throughout the experiment. All inoculated strains were excreted in faeces, 
with uniformly high excretion at 36 hours p. i., and all strains were recovered from the ileum 
and caecum of all lambs when one lamb was euthanased at each of 12,36,60 and 84 hours 
p. i. The detection of experimental strains was frequent but variable at other alimentary tract 
sites. The str` and the nal`rif strains generally were recovered in lower numbers than either 
the nal` or the rif strains. Strain differences related to colonisation of the ovine host, or 
attenuation due to the antibiotic resistance marking, may have contributed to the differences 
in the ability to recover bacteria. 
A four-strain mixture of Shiga toxin-producing E. coli 0157: H7 was used, comprising 
two bovine-derived and two human-derived strains, for the reasons outlined in Section 3.6. 
To avoid the complicating effects of an endogenous E. coli 01 57: H7 flora, lambs and their 
dams were screened for the excretion of the organism prior to inoculation. 
Resources available under category 3 containment permitted four animals to be used, and 
it was decided to examine one lamb on each day p. i., in order to observe the possible 
development of adherence over time. The inoculum dose aimed for (109 cfu) was chosen to 
provide a reasonable opportunity for the detection of bacteria-host interactions. The dose-to- 
bodyweight ratio was similar to that which was used in neonatal calf studies by Dean- 
Nystrom et al. (1997,1998) and in a suckling lamb study by Kudva et al. (1995). It was 
higher than the doses of 105 and 107 cfu which had proved inadequate to induce reliable 
excretion of E. coli 0157: 147 in suckling lambs (Kudva et al. 1995) and young adult cattle 
(Cray and Moon 1995) respectively. It was anticipated that the size of dose given would not 
cause such extraneous effects of a high bacterial load as massive Shiga toxin or endotoxin 
release; such phenomena would be unlikely to occur in the field and might confuse the 
results if they occurred experimentally. The dose given produced no clinical effects and only 
sparse lesions. This is consistent with the findings of Cray and Moon (1995), who did not 
observe any clinical signs following the oral inoculation of calves with 10'°cfu of 
commensal E. coli. 
Oral inoculation was selected as being the most suitable method for introducing the 
bacteria to the alimentary tract, since it potentially exposed all structures from the mouth, 
including the tonsils, to the rectum. The sites selected for culture (rumen, ileum, large 
intestine, tonsils and mesenteric lymph nodes) were chosen in view of the fact that in one 
report (Dean-Nystrom et al. 1997) the ileum and large intestine, but not the proximal small 
intestine, were identified as the preferential sites for E. coli O157: 147 AE lesion formation. 
Other reports also have shown the rumen, ileum and large intestine of ruminants to be 
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colonised by E. coli 0157: H7 in preference to the intervening small intestine (Cray and 
Moon 1995; Brown et al. 1997; Cornick et al. 2000; Tkalcic et al. 2000; Fischer et al. 2001). 
Whilst a high, sustained level of E. coil 0157: H7 was seen in the small intestine of calves in 
one study (Woodward et al. 1999), this was in a gnotobiotic background. Mesenteric lymph 
nodes and tonsils have been culture-positive in calves inoculated with E. coli 0157: 1-17 (Cray 
and Moon 1995; Woodward et al. 1999). 
To obtain tissue samples which were of the highest possible quality for bacteriological 
and histological examination, the sampling technique employed aimed to fulfil the following 
criteria: 
a) Minimal time between loss of in vivo intestinal tissue perfusion and immersion in 
fixative, as autolysis is rapid in the intestine (Fell 1961). 
b) Minimal potential for bacterial cross-contamination, as sensitive bacteriological 
detection methods were being used to detect potentially low numbers of bacteria in each 
site. 
As the experiments were performed in the Aerobiology Unit apparatus, only one person 
could manipulate the animal and tissues when sampling, owing to constraints of the 
equipment (Figure 2-a). For this reason, and to further improve on the tissue quality obtained 
in a pilot experiment (6/1), tissues were sampled with the lambs under terminal anaesthesia 
rather than immediately after euthanasia. The bacteriological and histological results, 
exhibiting generally good tissue preservation and marked variation in bacterial recovery 
from site to site, indicate that the objectives of the sampling technique were met. 
There was poor correlation between culture results for faecal excretion and alimentary 
tissue samples. For example, at 36 hours p. i., all inoculated strains were detected at high 
levels in the faeces of Lamb 6, but when nearly contemporaneous (i. e. during the same 
morning) tissue samples were collected from the same lamb, E. coli 0157: H7 was not 
detected in the rectum, despite there being a large number of organisms in the adjacent 
terminal colon. Some of these unexpected findings may be artefactual, and possible 
mechanisms for this include: entrapment of IMS beads by debris associated with tissue or 
intestinal content (this was regularly observed in neat samples), inhibition of bacterium-bead 
association by substances in the intestinal contents or released from the disrupted tissue, and 
direct inhibition of E. coil 0157: H7 growth by substances present in particular parts of the 
alimentary tract. 
Although three inoculated strains were present in the tonsils for up to 60 hours p. i., there 
was no histological evidence of E. coli 0157: H7 colonisation of the associated mucosa or 
tissues. The detection of a low level of all experimental strains in the mesenteric lymph 
nodes of one lamb, in the absence of histological evidence of colonisation, may represent 
contamination at the time of sampling. Occasional recovery of an orally inoculated E. coil 
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0157: 1-17 strain from mesenteric lymph nodes has been noted in other reports (Cray and 
Moon 1995; Woodward et al. 1999). 
AE lesions were detected at 12,36 and 84 hours p. i. and were confirmed to be associated 
with E. coli 0157: H7 by immunolabelling. The restriction of lesions to the large intestine is 
consistent with the 7-intimin subtype of E. coli 0157: H7 which, in the piglet, appears to be a 
significant factor in the site-specificity of AE lesions (Nataro and Kaper 1998). Despite the 
culture evidence of high numbers (frequently >_106 cfu/g) of E. coli 0157: H7 in the intestinal 
lumen, AE lesions were observed in only five out of 197 H&E or ipx stained large intestine 
sections examined, with a total of eight lesions overall. The identity of the particular strain(s) 
forming the AE lesions was undetermined. The E. coli 0157: H7 counts in the locations 
where AE lesions were detected were all at or above 106 cfu/g, a concentration which Dean- 
Nystrom et al. (1999) has suggested is the lower Iimit for histopathological detection of such 
lesions. The lesions, and in one case a demonstrable local inflammatory response (Figure 
5-c), were established by 12 hours p. i., and showed no tendency to increase in number and/or 
size over the following three days. 
Sections selected for ipx staining were from blocks which had already provided AE 
lesions in H&E-stained sections. Furthermore, as the sections for immunostaining were taken 
from tissue closely adjacent in the wax block to that in the corresponding H&E-stained 
sections, it was possible that parts of lesions already observed in the H&E-stained sections 
would also be present in the immunostained sections. This proved not to be the case, as the 
lesions were too small to span many 4 pm section thicknesses. Indeed, the single 
immunostained lesion that was found was from a piece of tissue which had not yielded 
lesions in previous H&E-stained sections. 
The AE lesions seen were small and sparse, necessitating LM-targeted tissue retrieval 
from wax blocks for EM examination, which was necessary to confirm the nature of the 
lesions. Although the appearance of AE lesions by LM is generally characteristic, other types 
of adhering E. coif, such as ETEC (Figure 5-e), may produce lesions which appear similar by 
LM and which cannot definitively be categorised until the ultrastructure of the host- 
bacterium interface is examined with EM. Once lesional material was in a resin block, the 
advantage of reliably cutting sequential thin sections of the lesion, as opposed to the chance 
incorporation of a tiny lesion in a4 µm LM section, was a major reason for attempting to 
label the AE organisms using the immunogold technique. In the event, both ipx- and 
immunogold-labelling, with LM and EM respectively, proved successful in the specific 
detection of E. coil 0157-associated AE lesions. 
The success of the immunogold procedure with tissues which had been extensively 
processed, firstly to wax infiltration and then to epoxy resin infiltration via post-f ixation in 
osmium tetroxide, may have been in large part due to the stability of the 0157 
147 
polysaccharide antigen epitopes. It is likely that a protein antigen would have been 
substantially or entirely denatured by such a procedure. It is fortunate that, given the small 
and sparse nature of the lesions involved, all four detection and staining techniques 
attempted (i. e. H&E, ipx, TEM, and immunogold) worked successfully, to locate and 
characterise the lesions. This range of techniques is valuable, to provide several options for 
the rigorous characterisation of such elusive lesions. 
In the present experiment the attachment of E. coli 0157: H7 to the ovine mucosa was 
demonstrated and was shown to be AE in nature. There was no evidence of an alternative 
mode of E. coli 0157: 1-17 attachment to the intestinal mucosa. The lesions in this model 
appeared to be near the limit of detection by conventional histopathological and 
immunohistochemical means. Whilst the observed frequency and size of AE lesions is, of 
necessity, based upon examination of a small proportion of the mucosal surface, it is possible 
that intimate association between E. coli 0157: H7 and the ovine intestinal mucosa is in some 
way less effective than in cattle. In neonatal CD calves inoculated with a single strain of 
E. coil 0157: H7 at less than 12 hours of age, extensive AE lesions were observed, and fewer 
lesions were reported from similarly-inoculated CF calves (Dean-Nystrom et al. 1997). The 
relative paucity of lesions detected in the present study may therefore partly reflect the 
protective effect of colostrum. However, even in the CF neonatal calves described above AE 
lesions covering between 10 and 50 % of the caecal mucosal surface were reported, which is 
considerably more extensive than in the present study. This difference between the calf and 
lamb studies may be due to differences between any or all of. host species, host age, dose 
sizes and inoculum strains. Whether inoculation of younger lambs or more prolonged 
exposure would lead to establishment of more and/or larger lesions is unknown. However, 
there was no evidence in the present experiment of an increasing incidence or size of lesions 
over the 84 hours of the study. The calves reported were inoculated at less than 36 hours of 
age, in comparison with six days for the lambs. It may be that over the first few days of 
neonatal life the intestine's resistance to AE lesion formation increases substantially, 
possibly due to alterations in the mucosa, in motility or in the intestinal flora. The inoculum 
of E. coli 0157: 117 given to the neonatal calves was 1010 cfu, in contrast to approximately 
109 organisms used in the present experiment, although the initial concentration of inoculated 
organisms in the intestine was probably similar in both cases as there is an approximately 
tenfold difference in body mass between a neonatal calf and a neonatal lamb. The abilities of 
the non ovine-derived E. coil 0157: H7 strains used in this work to colonise the ovine 
mucosa, when compared with other experimental strains and ovine field strains, are 
unknown. Finally, a possible effect of inter-strain competition on the formation of AE 
lesions in the present study cannot be discounted, although in vitro tests (Section 3.5.4) did 
not show any inter-strain effects upon growth of any of the inoculated strains. 
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In conclusion, the neonatal lamb study demonstrated that in principle E. coif 0157: H7 
will form AE lesions on the ovine large intestinal mucosa, and that extensive examination of 
tissues may be necessary for the detection of such lesions. This study provided further 
evidence of a host-bacterium adherence phenomenon, forming a basis with which to assist 
interpretation of persistence and colonisation characteristics of the same E. coli 0157: H7 
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Figure 5-a: Attaching-effacing lesion 
Rectum, Lamb 8 (84 hour-, p. i. ). AtTected 
enterocytes (arrow) protrude from the mucosal 
surface. Closely-adherent bacteria are evident at 
higher magnification (inset). H&E, bar = 60 µm. 
Figure 5-b: Attaching-effacing lesion 
h 
.ý. 
` 'I Rectum, Lamb 8 (84 hours p. i. ). One of the larger 
lesions seen. Enterocytes are colonised on either 
side of a mucosal cleft. Some mucosal cells appear 
to be degenerate and detaching (arrow). H&E, 
bar = 20 µm. 
Figure 5-c: Attaching-effacing lesion with Figure 5-d: Immunoperoxidase-stained 
inflammatory cells attaching-effacing lesion 
4K '! _ ", W 
__ ._-. 
Caecum. Lamb 5 (12 hours p. i. ). A mass of 
polymorphonuclear inflammatory cells (black 
arrow) overlie a bacterial mass (asterisk) associated 
with intimately attached bacteria (white arrow). 
H&E. bar = 16 pm. 
Figure 5-e: Enterotoxigenic E. co/i 
" LL 
'Zl 
+ir y -"ý r. /ý 
1 
Rectum, Lamb 8 (84 hours p. i. ). The lesion 
protrudes from the mucosal surface. Specifically- 
labelled E. co/i cells are evident at higher 
magnification (inset). 0157 ipx, bar = 60 µm. 
F. coli 0101, calf, distal small intestine. Bacteria 
(arrows) are attached closely to the ileal mucosa. 
The precise nature of the attachment is not evident 
under the light microscope. H&E, bar = 10 µm. 
Section material courtesy of Dr G. R. Pearson. 
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Figure 5-f: Attaching-effacing lesion 
"4D Rectum, Lamb 8 (84 hours p. i.. 
>º same lesion as Figure 5-a). Bacteria 
E adhere intimately to the enterocyte 
P (E) surface. Microvilli are effaced 
and some bacteria are on pedestals 
E (P). A normal microvillous border 
P (M) is present on uncolonised 
j., adjacent enterocytes. Bar =I µm. 




Figure 5-h: Immunogold-labelled E. coil 0157 
P 
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Rectum. Lamb 8 (84 hours p. i. ). 
Gold-labelled E. coli 0157 
organisms (asterisks) are intimately 
adherent to the apical surfaces of 
host cell pedestals (P). 
Bar = 3(X) nm. 
Rectum, lamb 8 (84 hours p. i. ). A 
bacterium is intimately attached to 
a pedestal (P). Gold particles are 
localised to the bacterial cell 
membrane. Anti-O 157 immunogold 
label, bar = 100 nm 
Chapter 6- WEANED LAMB STUDIES 
6.1 Introduction 
The characterisation of factors important in the persistence of E. coli 0157: H7 in 
ruminants is likely to be aided by suitable animal models of persistent colonisation. These 
models may be used to: characterise the persistence phenomenon using detailed longitudinal 
studies; look for specific events (such as adherence) at the host-bacterium interface; evaluate 
the effects of different diets or feed additives; determine the effects of bacterium or host 
modification, including immune responses, upon persistence. Where persistence specifically 
is being investigated an inoculated whole-animal approach is likely to prove suitable, as it 
may permit the interaction of factors known and unknown over an extended time period. 
Ruminants inoculated orally or by stomach tube with E. coli 0157: H7 have been used by 
several workers in persistence studies. Most reports concern cattle (Cray and Moon 1995; 
Brown et al. 1997; Cray et al. 1998; Harmon et at. 1999; Hovde et al. 1999; Sanderson et al. 
1999; Akiba et al. 2000; Buchko et al. 2000a; Magnuson et al. 2000; Tkalcic et al. 2000; 
Wray et al. 2000; Besser et al. 2001; Grauke et al. 2002; Naylor et al. 2003), fewer involve 
sheep (Kudva et al. 1995; Kudva et al. 1997b; Cornick et al. 2000; Lema et al. 2001; Cornick 
et al. 2002; Grauke et al. 2002) or deer (Fischer et al. 2001). Sheep were used as the model 
ruminant in the present studies because of their association with the exposure of the human 
population to E. coli 0157: H7. They are a species in which natural excretion of the organism 
has been documented (Kudva et at. 1996; Chapman et al. 1997; Kudva et al. 1997a; 
Heuvelink et al. 1998a; Chapman 2000b; Synge and Paiba 2000), and there are reports of 
E. coli 0157: H7 in sheep meat and milk products (Doyle and Schoeni 1987; Rubini et al. 
1999; Chapman et al. 2000b) and of human E. coli 0157: H7 disease associated with 
exposure to sheep (Chapman 2000b) and sheep faeces (Ogden et al. 2001). There are six 
reported studies, detailed in Section 1.4.2.7, of weaned sheep experimentally inoculated with 
E. coli 0157: H7. In none of these, using total E. cola 0157: H7 doses of up to 2x 1010 cfu per 
animal, were adverse clinical signs reported. 
The aim of the present studies was to use orally inoculated sheep as a model for 
investigating the persistence of E. coli 0157: H7 in ruminants, in order to provide data on 
possible mechanisms of persistence, and on mucosal adherence in particular. The intestinal 
loop and neonatal lamb studies reported in chapters 4 and 5 were allied experiments in which 
the AE capability of E. coli 0157: H7, in inoculated ovine colon loops and orally inoculated 
neonatal lambs respectively, were investigated. Oral inoculation was selected as being the 
most suitable method for introducing the bacteria to the alimentary tract in the present 
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weaned lamb persistence studies, since potentially it exposes to the inoculated bacteria all 
structures from the mouth (including the tonsils) to the rectum. 
An initial pilot experiment at VLA Weybridge (Experiment 6/1) used six-month old 
lambs to investigate the distribution and maintenance within the alimentary tract of orally 
inoculated E. coli 0157: H7 from a four-strain mixture (discussed in Section 3.6), and to seek 
evidence of bacterial adherence to the intestinal mucosa. In addition the procedures of. 
inoculum preparation and administration, clean and rapid tissue sampling, and sensitive 
semi-quantitative bacterial culture from tissues were evaluated. 
Due to the availability of experimental resources, subsequent experiments were 
performed at Langford, using the Aerobiology Unit facilities. Two of these (experiments 6/2 
and 6/3) examined the persistence characteristics of strains in the four-strain mixture, and 
sought evidence for sites and mechanisms of persistence. They were therefore longer-term 
experiments than 6/1, extending over three (Experiment 6/3) or four (Experiment 6/2) weeks, 
and incorporating faeces sampling in the protocols. 
A final experiment (6/4) used a non Shiga toxin-producing E. coli 0157: H7 strain, 
NCTC 12900. The aim of this experiment was to evaluate further the suitability of the 
NCTC 12900 strain, a category 2 pathogen and therefore potentially of particular value for 
experimental handling, for use in persistence studies. The capacity for persistent excretion by 
weaned sheep of this strain over several weeks had been demonstrated previously at VLA 
Weybridge, by faecal excretion for up to 48 days p. i. (LaRagione, R., personal 
communication). For this experiment the wild-type strain was used in preference to an 
antibiotic resistance marked derivative, as a rifampicin-resistant strain had been shown to be 
markedly attenuated in respect of AE capability in vitro (Best, A., personal communication). 
Experiment 6/4 was done in the category 3 Aerobiology Unit apparatus despite its category 2 
status because the experimental set-up in this system had proved successful and relatively 
straightforward to run. The sampling time points for this experiment were selected to include 
potential early events in establishing persistence. 
6.2 Materials and methods 
6.2.1 Six-month old lambs 
Animal procedures 
The study was performed at VLA Weybridge, where a post mortem room with category 3 
containment was available. Animals were inoculated orally and then sampled for 
histopathological and bacteriological examination, using a protocol of euthanasia followed 
by rapid sampling to achieve good intestinal tissue preservation. Sections 2.6.1 and 2.6.3.1C 
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describe housing, inoculation and post mortem sampling. Samples were taken at four time 
points over two weeks, with an emphasis on the early post-inoculation period (one and three 
days p. i. ). 
Bacteriological procedures 
The pre-inoculation screening of animals for excretion of E. coli 0157: H7 is described in 
Section 2.2.9. A four-strain inoculum, detailed in Section 3.6, was used. The dose aimed for 
was a total of 109 cfu per animal. Preparation of the inoculum and the recovery and analysis 
of bacteria are described in sections 2.2.7,2.2.9 and 2.2.10 respectively. As two animals 
were being sampled, sequentially, on each of four days, the bacteriology samples from the 
second animal to be euthanased on each occasion, i. e. animals 12,14,16 and 18 (Table 6-A), 
were frozen as described in Section 2.2.9 for culture the following day. 
Pathological procedures 
The fixation, sectioning and staining of tissues for light microscopic examination are 
described in sections 2.7.1,2.7.2, and 2.7.3. 
6.2.2 Six- to 11-week old lambs 
Animal procedures 
Two experiments using STEC E. coli 0157: H7 inocula (experiments 6/2 and 6/3, using 
mixed and a single-strain inocula respectively) were performed, using four inoculated 
animals each (designated 19 to 22, and 23 to 26 respectively). Sections 2.6.1 and 2.6.3.1 B 
detail housing, inoculation and sampling under terminal anaesthesia. Two uninoculated 10- 
week old animals (27 and 28), from the same group from which animals in Experiment 6/3 
were taken, were euthanased for histopathological control tissues. 
A further experiment (6/4) used a non Shiga toxin-producing E. coli 01 57: H7 (Strain 
NCTC 12900) inoculated orally into four lambs (designated 29 to 32) housed in the 
Aerobiology Unit category 3 containment apparatus. Tissue samples were taken from two 
seven-week old animals (33 and 34) from the same group under terminal anaesthesia, to 
provide control histopathological tissues. Details of housing, inoculation and sampling are 
given in sections 2.6.1 and 2.6.3.1 B. All animals were examined twice daily, but rectal 
temperature monitoring was not performed (no deviation from normal had been observed in 
the previous experiments 6/1,6/2 and 6/3). 
Bacteriological procedures 
Pre-inoculation screening of animals for excretion of E. coli 0157: H7 is described in 
Section 2.2.9. Details of inoculum preparation are given in Section 2.2.7, with methods (a) 
156 
and (c) being used for experiments 6/3 and 6/4 respectively. The culture and analysis of 
bacteria from experimental samples are detailed in sections 2.2.9, and 2.2.10 respectively. 
During Experiment 6/4, samples of rectal contents collected at six days p. i. from Lamb 23 
were submitted to the University of Bristol School of Veterinary Science bacteriology 
department to screen for Salmonella and Campylobacter by the laboratory's standard cultural 
methods. 
In Experiment 6/3, in addition to the standard pre-enrichment / IMS procedure for 
bacterial recovery, for some samples non-IMS culture was performed in parallel. Two 
methods of non-IMS culture on CHROMagar 0157 supplemented with nal (15 'g/ml) were 
used. Both techniques involved spread-plating an aliquot of each of the neat primary 
preparations and the 10-, 103- and 105-fold dilutions (Section 2.2.9) directly on to the 
CHROMagar. One technique was a TVC, using a 20 µl aliquot of each mixture prior to pre- 
enrichment incubation. The colonies with an E. coli 0157: H7 morphology and colour 
resulting from overnight incubation were counted and a TVC was derived. The other 
technique used a 100 µl aliquot of the pre-enriched mixtures following a six hour incubation. 
As the mixture was incubated before subculture, the results were recorded as a most probable 
number estimate, in a 10- and 100- fold series, based upon the presence or absence of E. coli 
0157: H7 following overnight incubation of the plates. The TVC was performed on most 
faeces samples, whilst the latter technique was performed for the tissue and intestinal 
contents samples, in Lamb 25 only. 
In Experiment 6/3, a non-E. coli 0157: H7 isolate, recovered via the non-IMS pre- 
enriched technique, was serotyped (Section 2.5.1) and genotyped in respect of eaeA, stxl, 
stx2, hly, espP, elpD, katP and bfpA genes (Section 2.3). 
Pathological procedures 
The fixation, sectioning and staining of tissues for light microscopic examination are 
described in sections 2.7.1,2.7.2, and 2.7.3. Electron microscopy, used in experiments 6/3 
and 6/4, was performed as described in Section 2.7.4.2A. In Experiment 6/4 a 'pop-off 
technique (Section 2.7.4.28) was also used, for retrieving microscopic lesions from LM slide 
sections for ultramicrotomy and TEM. 
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6.3 Results 
6.3.1 Six-month old lambs (Experiment 6/1) 
Clinical findings 
All animals remained clinically normal throughout the experiment and their faeces were 
firm to solid with no evidence of diarrhoea or blood. There was no loss of appetite. 
Bacteriological findings 
E. coli 0157: H7 was not detected from any animal on either of two sampling occasions, 
four and two weeks prior to inoculation. A total dose of 9x 108 cfu of the four-strain mixture 
was given to each animal. 
The results from tissue samples taken post mortem from each inoculated animal are 
summarised in Figure 6-a. At one day p. i., inoculum strains were recovered from a wide 
range of sites (all anatomical locations sampled, including tonsil, rumen and small intestine) 
from both animals. However, isolation was variable in respect both of the positive sites in a 
particular animal and of the experimental strains recovered at a particular site. Beyond one 
day p. i., inoculated strains were not recovered from sites other than the caecum and colon. A 
low level of three of the inoculum strains was detected in one animal at three days p. i. 
Neither animal sampled at seven days p. i. yielded any of the strains. A single strain (140065 
nal) was detected at 15 days p. i., at a low density in the caecum and colon, but not the 
rectum, of animal 18. 
Macroscopic pathological findings 
There was evidence of endoparasitism, with a localised mural haemorrhage associated 
with tapeworm seen in the colon of one lamb, euthanased at 15 days p. i. Other lesions were 
not observed in any animal at any site examined. The time between euthanasia and placing 
all small intestinal samples in fixative was less than 6 min, and for large intestinal samples 
the corresponding time was less than 13 min. 
Histopathological findings 
Detailed observations are presented in Table 6-A. When control and inoculated lambs are 
considered together, autolytic changes were observed in 10 out of 20 duodenal and jejunal 
samples. Samples from the ileum were uniformly well preserved. In the large intestine there 
were large areas of excellent preservation. However, in some areas early autolytic changes 
were observed, and in a few sections there was autolytic sloughing of most of the epithelium. 
The preservation of the mucosa from the terminal colon was uniformly good. In order to 
ensure examination of a representative portion of the large intestinal mucosa, criteria for 
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large intestinal sample quality were adopted. Tissues from a particular site were judged to be 
adequate if there was 80 % or more epithelial coverage in either of the two sections 
examined, or if both sections demonstrated continuous epithelium covering 50 % or more of 
the luminal surface. On this basis, five large intestine sites (caecum of lambs 10 and 15, 
proximal ascending colon of Lamb 12 and spiral colon of lambs 11 and 17) failed to yield 
samples of adequate quality. In general, when two or more sections from the same intestinal 
site in an animal were compared, the quality of preservation of the sections was similar. 
However, in two sites (proximal and spiral colon of Lamb 15) this was not the case, as at 
each site one of two sections was markedly better preserved than the other. 
A luminal bacterial microcolony was associated with epithelial necrosis in the caecum of 
Lamb 17. Close adherence of bacteria to the luminal surface of enterocytes was not seen in 
any section. Slender organisms were seen in the crypts of the caecum and colon of three 
inoculated animals. These were Gram-negative, were shown to be spiral and argyrophilic by 
the Warthin-Starry silver stain and therefore resembled Campylobacter or Helicobacter 
organisms (Figure 6-b). Dense accumulations of neutrophils were present in a few caecal 
crypts of one animal. Scattered, microscopic foci of necrosis were seen in the large intestinal 
lamina propria of two inoculated animals (11 and 14). A microscopic focus of epithelial 
necrosis and sloughing with localised acute inflammation, but without associated bacteria, 
was seen in the rectum of one inoculated animal (14). The tonsils of inoculated animals 
frequently showed exudation of neutrophils into crypts around entrapped vegetable matter. 
Several focal inflammatory and necrotic lesions were seen in the pharyngeal and crypt 
epithelium. Occasionally these had associated bacteria in the tissue, which in Lamb 18 were 
shown to be Gram-negative. 
Changes which were observed in both control and inoculated animals included: 
generalised mild blunting, fusion and atrophy of villi in the small intestine and a mild to 
moderate, diffuse eosinophilic inflammatory infiltrate within the lamina propria of the small 
and large intestine. Encysted nematodes were present in the mucosa of the duodenum and 
caecum of some animals. Mucosal structures, resembling coccidian parasites of the genus 
Globidium, and luminal tapeworm segments were also seen. 
In the liver, mild chronic portal tract inflammation was seen commonly in both control 
and inoculated animals. The mesenteric lymph nodes, spleen and kidneys of all animals had 
a normal appearance. 
Immunohistochemical findings 
The 0157 antiserum proved to be sensitive and specific for E. coli 0157 over a broad 
range of dilutions when used to stain control sections of cultured E. coli 0157. Similar 
sections of cultured E. coli 026, used as negative controls, did not stain with the antiserum. 
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Control stains using 026 antiserum and normal rabbit serum on 0157 organisms were also 
negative. The bacterial microcolony associated with epithelial necrosis in the caecum of 
Lamb 17 and Gram negative bacteria in the tonsils of Lamb 18 did not stain with the 0157 
antiserum. 
6.3.2 Six- to 11-week old lambs 
6.3.2.1 Four-strain inoculum (Experiment 6/2) 
Clinical findings 
All lambs remained clinically normal throughout and their faeces were firm, with no 
evidence of diarrhoea or blood. There was no evidence of pyrexia, loss of appetite or 
dehydration. 
Bacteriological findings 
E. coli 0157: H7 was not isolated from any of the pre-inoculation faeces samples from 
any animal. A total dose of 5x 108 cfu of the four-strain mixture was given to each animal. 
The results of daily faeces culture and culture of intestinal samples taken under terminal 
anaesthesia are summarised in Figure 6-c. All lambs excreted all four inoculum strains for at 
least four days p. i. Detectable excretion of three of the strains (EC 157 str`, EC222 nal`rif, 
and EC218 rif) ceased between four and nine days p. i. in all lambs; in each animal this 
happened at least one day before euthanasia of the lamb. Strain 140065 nal` was excreted, at 
concentrations between 10land 106 cfu/g, by Lamb 19 until euthanasia at eight days p. i., by 
Lamb 20 until 12 days p. i., and by lambs 21 and 22 until euthanasia at 21 and 28 days p. i. 
respectively. There was no evidence of intermittent excretion of any strain. Of the four 
inoculated strains, only strain 140065 nal`was recovered from tissues, in low numbers from 
the caecum and spiral colon of Lamb 19 at eight days p. i. 
Macroscopic pathological findings 
Macroscopic abnormalities were not seen in any inoculated lamb. The two control lambs 
(27 and 28) were clinically normal at the time of euthanasia. Their mesenteric lymph nodes 
were prominent and were of even shape and consistency. The contents of the terminal colon 
and rectum of the control lambs were in one case solid and in pelleted form, and in the other 
a semi-solid unpelleted mass. 
Tissues typically were placed in fixative within one minute of excision from the lambs. 
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Histopathological findings 
Detailed observations are presented in Table 6-B. From the four inoculated animals, eight 
ruminal, 40 small intestinal and 98 large intestinal sections were examined. Preservation of 
the tissues generally was excellent. Occasionally slight autolysis was evident. Features of the 
small intestine included a mild or moderate, diffuse eosinophil infiltrate in the lamina propria 
of all animals, including controls, and a localised acute inflammation, with neutrophil 
infiltration, in the duodenal lamina propria of Lamb 19. Similarly, eosinophilic inflammation 
was present in many large intestinal samples from both inoculated and control animals. 
Luminal debris, including bacteria, was commonly seen adhering to the mucosa of the small 
and large intestines, including in the control lambs. Rod-shaped bacteria were seen in the 
tonsils of lambs 19,20 and 21. Significant pathological changes were not seen in other non- 
intestinal tissues. Slender organisms resembling Campylobacter or Helicobacter were seen 
in some large intestinal crypts of the control animals. 
Immunohistochemical findings 
Representative sections of intestinal sites where bacteria were seen adhering to the 
mucosa were immunostained for the presence of 0157 antigen (Table 6-B). Positive staining 
of bacteria was not observed. Bacteria in the tonsils of lambs 19 and 20 also were not 
labelled by the 0157 antiserum. 
6.3.2.2 Single-strain Shiga toxin-producing inoculum (Experiment 613) 
Clinical findings 
Lamb 23 had mild diarrhoea at 5 days p. i. and soft faeces on day 6 p. i. when it was 
euthanased. Lambs 24 to 26 had soft faeces from day 5 p. i. until they were euthanased. There 
was no loss of appetite or evidence of dehydration in any of the inoculated lambs. 
Bacteriological findings 
E. coli 0157: H7 was not isolated from any of the pre-inoculation faeces samples from 
any animal. Samples tested for Salmonella and Campylobacter, in view of the clinical signs 
manifested by Lamb 23 ('Clinical findings' above), proved negative for both organisms. A 
total dose of 9x 108 cfu of strain 140065 nal` was given to each animal. 
The bacteriological findings, using both IMS and direct cultural methods, in respect of 
E. coli 0157: H7 are summarised in Figure 6-d. Strain 140065 nal" was recovered from daily 
faecal samples from all lambs until day 6 p. i., when Lamb 23 was euthanased. Bacteria were 
recovered (101 to_103 cfu/g tissue) throughout the alimentary tract from rumen to rectum 
from this lamb. In Lamb 24, variable excretion of strain 140065 nal' was observed. It was not 
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isolated from faeces by IMS on days 10,11,13 or 17 p. i., or from any tissue sites when the 
animal was euthanased at day 17 p. i. Lamb 25 excreted the inoculated strain each day until 
euthanasia on day 18 p. i. On examination of the tissues from this lamb the 140065 nal' strain 
was only recovered from the contents of the terminal colon, and only by pre-enriched direct 
subculture, when IMS was negative. From Lamb 26 strain 140065 nal` was recovered 
consistently in high numbers (>_ 106 cfu/g) from the faeces, and was recovered from alI sites 
between the ileum and rectum inclusive, and in high numbers (103 to? 105 cfu/g) from the 
large intestine. 
Where TVC were performed in parallel with the semiquantitative IMS procedure, results 
generally correlated well, with IMS usually producing lower values. From the colon and 
rectum of Lamb 25 (Figure 6-d, shaded) a few lilac colonies which resembled E. coli 
0157: H7 were isolated using direct culture of the pre-enriched broths on nal-supplemented 
CHROMagar 0157. However, these colonies proved to be negative for 0157 antigen with 
the latex agglutination test. A representative sample of these bacteria from each location was 
serotyped (Section 2.5.1) and found to be non-motile E. coif 0115. Genotyping by PCR 
revealed that both strains possessed the eaeA gene (epsilon subtype) but neither six] nor stx2 
genes (Cookson et al. 2002b). The direct culture method was trialled with Lamb 25 
following zero recovery of E. coli 0157 from the tissue and intestinal contents samples of 
Lamb 24. 
Macroscopic pathological findings 
Macroscopic abnormalities were not seen in any lamb. Tissues typically were placed in 
fixative within one minute of excision from the lambs. 
Histopathological findings 
Detailed observations are presented in Table 6-C. From the four inoculated animals, a 
total of eight ruminal, 42 small intestinal and 120 large intestinal sections were examined. 
Preservation of the intestinal mucosa was generally excellent or good. Mild autolytic 
changes were present at about half of the sites examined, and comprised detachment and loss 
of a few epithelial cells from a minority of villus tips in the small intestine, and small areas 
of epithelial detachment and single epithelial cell loss at the luminal surface in the large 
intestine. Four sites in the large intestine demonstrated more marked autolysis focally. 
The small intestine of the diarrhoeic lamb (Lamb 23) had a typical villus: crypt ratio 
(length: depth, Section 2.7.2) of 1: 1 at all sites, in contrast to that of the control lambs, which 
ranged between 1: 1 and 3: 1 from site to site. In Lamb 25, euthanased at 18 days p. i., many 
AE lesions were seen in the caecum, proximal loop of the ascending colon and rectum. The 
lesions were small or of moderate size, often covering numerous adjacent enterocytes in a 
section (Figure 6-e), but did not extend to cover large areas of mucosa. Encysted and luminal 
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nematodes and small crypt abscesses were present occasionally in some sections from 
inoculated animals. A bacterial colony was seen in a mesenteric lymph node from one 
inoculated animal. A single focus of acute biliary tract necrosis, restricted to one vessel, not 
accompanied by inflammation and of unknown cause, was seen in Lamb 26. 
Some features were noted in tissues from both the control and the inoculated animals. In 
several large and small intestine sections, loosely adherent luminal contents including 
bacteria were present on the mucosal surface. The distribution of low or moderate numbers 
of plasma cells, polymorphonuclear neutrophils, and eosinophils was similar between 
inoculated and control animals. Small numbers of coccidial schizonts and gametocytes were 
present in the epithelium of the small intestine of inoculated and the large intestine of control 
animals. The tonsillar crypts of control and inoculated animals contained adventitious 
vegetable matter with accompanying bacteria and inflammatory cells. 
Immunohistochemical findings 
Sections of caecum and rectum from Lamb 25 containing AE lesions, plus sections of 
ileum from Lamb 24 containing loosely adherent luminal bacteria and debris, and sections of 
tonsil from Lamb 26 were stained for 0157 antigen (Table 6-C). Neither the bacteria 
forming AE lesions in Lamb 25 nor the adherent bacteria in Lamb 24 stained positively for 
0157. The bacterial colony detected in the H&E-stained section of tonsil from Lamb 26 was 
not seen in the corresponding immunostained section. 
Because E. coli 0115 had been isolated from the large intestine of Lamb 25, in which the 
AE lesions were found, further sections of caecum and rectum from this animal were 
immunostained using an 0115 antiserum (VLA E. cola polyclonal typing serum). The 
specificity of this antiserum at a working dilution of 1: 500 was established by demonstrating 
that this did not label control sections of cultured E. coli 0157 or 026 organisms. All of the 
AE lesions seen in immunostained sections of Lamb 25 were specifically labelled by this 
antiserum (Figure 6-f), establishing them to be E. coli 0115. 
Electron microscopic findings 
Using the method of targeted retrieval of tissue from a wax block (Section 2.7.4.2A), a 
bacterial lesion from the caecum of Lamb 25 was examined. The lesion proved to have a 
typical AE appearance, with bacteria closely adherent to the host cell membrane, and 
frequently on pedestals, in areas of microvillus effacement (Figure 6-g). 
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6.3.2.3 Single-strain non Shiga toxin-producing inoculum (Experiment 6/4) 
Clinical findings 
All lambs appeared clinically normal throughout the experiment. 
Bacteriological findings 
E. coil 0157: H7 was not isolated from any of the pre-inoculation faeces samples from 
any animal. A total dose of 4x 109 cfu of strain NCTC 12900 was given to each animal. 
Bacteriological findings post-inoculation are summarised in Figure 6-h. Excretion of 
E. coli 0157: H7 was undetectable in Lamb 31 at seven days p. i. and in Lamb 32 at nine days 
p. i. The recovery of 0157: H7 organisms from the alimentary tract also decreased with time 
following inoculation. The organism was recovered from all sites of the alimentary tract of 
Lamb 29, sampled at one day p. i. Thereafter, fewer sites were positive: the organism was 
recovered from the large intestine on days 3 (Lamb 30) and 5 (Lamb 31) p. i. but was not on 
day 9 (Lamb 32). E. coli 0157: H7 was recovered from the rumen of all animals. The 
representative lilac and 0157 latex-agglutination positive colonies which were subcultured 
and subjected to the multiplex eaeA, stxland stx2 PCR test all had the NCTC 12900 
genotype, being eaeA positive and six negative. 
The use of 0157 IMS and a selective E. coli 0157: H7 culture medium (CHROMagar 
0157), reduced the growth on culture plates by other intestinal flora. However the use of a 
strain which was not antibiotic resistance marked, and the consequent lack of an antibiotic in 
the culture medium, did result in a substantial growth of non-0157 intestinal flora on some 
CHROMagar plates at all pre-enrichment dilutions. These colonies were pale blue, or 
colourless with a blue centre, and were negative in the 0157 latex agglutination test. In 
lambs 31 and 32, a mass of discrete or semi-confluent blue or colourless colonies were 
present from all pre-enriched dilutions of faeces samples taken on the days of euthanasia, 
thereby potentially obscuring any E. coli 0157: H7 which may have been excreted. 
Furthermore, on some plates from tissue and intestinal contents samples from Lamb 32 
(marked 'f in Figure 6-h) the overgrowth of colourless colonies was also sufficient 
potentially to obscure lilac E. coli 0157: H7 colonies. Representative examples of'blue' and 
'colourless' colonies were identified, serotyped (Section 2.5.1) and subjected to a multiplex 
PCR test for eaeA and Shiga toxin genes, by the VLA Weybridge E. coli and Salmonella 
serotyping unit. A faeces-derived 'blue' colony from Lamb 32 proved to be an E. coli 
026: K'60' strain encoding eaeA and stxl, and two 'colourless' colonies, one from the rectum 
of Lamb 29 and one from the faeces of Lamb 32, were both non Shiga toxin-producing and 
encoded eaeA, but were untypable for somatic (0) antigen. 
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Macroscopic pathological findings 
Macroscopic lesions were not seen in any lamb. Tissues typically were placed in fixative 
within one minute of excision from the lambs. 
Histopathological findings 
Detailed histopathological observations are recorded in Table 6-D. From the inoculated 
lambs, eight ruminal, 56 small intestinal, and 109 large intestinal sections were examined. 
The preservation of the intestinal mucosa was excellent or good (i. e. in the latter category 
some lifting of the epithelium with no or minimal epithelial cell loss was observed) in all 
sections except one. In this, the jejunum of Lamb 32, more extensive loss of epithelial cells 
had occurred, in an area which corresponded with a part that had not been opened with 
scissors before immersion in fixative, and where it was therefore presumed that penetration 
of the fixative had been delayed. 
Numerous (up to 100) AE-type lesions, were observed in the caecum and colon of lambs 
29,31 and 32, euthanased at 1,7 and 9 days p. i. respectively. Lesions were small or of 
moderate size, multifocal, and covered between one and 20 adjacent enterocytes within a 
section. No areas of coalescing or confluent lesions were seen. AE lesions were detected 
only in those lambs (29,31 and 32) from which colourless bacterial colonies (Section 
6.3.2.3) were isolated. 
Sections from the control and inoculated animals had similar features, in particular the 
villus morphology and the mononuclear and polymorphonuclear cell populations in the 
intestinal epithelium and lamina propria were similar. In both groups of animals the 
following features were identified: coccidial schizonts and gametocytes in the small and 
large intestinal epithelium, inflammatory debris in a few crypts, luminal debris and bacteria 
loosely adherent to the mucosa, and occasionally nematode worms on or in the mucosa. In 
the ileum and caecum of Lamb 32, there were foci of polymorphonuclear neutrophils in the 
lamina propria, extending into the intestinal lumen and associated with bacterial colonies in 
the lumen (ileum) and lamina propria (caecum). 
Immunohistochemical findings 
Detailed ipx results are included in Table 6-D. Pairs of sections from all four inoculated 
lambs were stained for 0157 and 0115 antigen, using each antiserum as a negative control 
for the other. The slides comprised: Lamb 29, caecum and rectum; Lamb 30, rumen; Lamb 
31, caecum and proximal ascending colon; Lamb 32, caecum, proximal ascending and spiral 
colon and rectum. In addition pairs of sections were immunostained with 026 and 0157 
antisera, comprising: Lamb 29, caecum and terminal colon; Lamb 31, caecum and proximal 
ascending colon; Lamb 32, caecum and proximal ascending colon. 
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E. coli 0157 organisms were identified in six AE-type lesions of Lamb 29, in the caecum 
and rectum. These 0157-positive lesions were all small, covering either single, or a few 
adjacent, enterocytes in a section, and were seen separately from (Figure 6-i), adjacent to 
(Figure 6-j), and apparently on the edge of (Figure 6-k) non-staining AE type lesions. The 
non-staining (i. e. non-0157) AE-type lesions formed the large majority of lesions in 
Lamb 29, and all of the lesions seen in Lambs 31 and 32. Two of the non-0157 lesions seen 
in Lamb 29 were shown to be formed by E. coli 026 by specific immunolabelling (Figure 
6-1). 
Electron microscopic findings 
Attempted examination of the largest observed 0157 lesion using the wax block retrieval 
method proved unsuccessful, as the lesion still was too small to be present in the EM 
preparation. Therefore the'pop-off technique was used to retrieve lesional material from 
glass microscope slides. Lesions examined in this fashion were: the ipx-stained lesion from 
the caecum of Lamb 29 in Figure 6-i and a non-immunostained lesion also from the caecum 
of Lamb 29, which was the negative control slide of a positively-immunolabelled 0157 
lesion. The former lesion was successfully thin-sectioned and, as shown in Figure 6-m, had a 
typical AE appearance and corresponded morphologically with the LM appearance. 
Furthermore, the bacteria exhibited a coating, which was presumed to be diaminobenzidine 
reaction product precipitate, specifically laid down by the 0157 ipx technique. Another, 
incidental and unattached, bacterium found in the same thin section did not possess such a 
coating. The second, non-immunolabelled slide also yielded AE lesions in thin sections, 
which were positively labelled using the immunogold technique with 0157 antiserum 
(Figure 6-n). 
6.4 Discussion 
A series of experiments were conducted to investigate the persistence and localisation of 
E. coli 0157: H7 in sheep, and to seek evidence of an association between the bacterium and 
host at the intestinal mucosa. In Experiment 6/1, eight six-month old lambs were inoculated 
with 10° cfu of a four-strain mixture of antibiotic resistance labelled STEC 0157: H7 strains. 
In this pilot experiment, the times of tissue sampling were biased towards the early post- 
inoculation phase, as it was considered that adherence may more readily be seen soon after 
inoculation, when the intestinal concentration of E. coli 0157: H7, which is an apparent 
determinant of the ability to detect AE lesions (Dean-Nystrom et al. 1999), was likely to be 
highest. As the primary interest in this experiment was the distribution and behaviour of 
E. coli 0157: 117 within the animal, faeces sampling was not performed. For reasons of 
166 
experimental licenses and the availability of suitable facilities, the technique of rapid tissue 
sampling post mortem was used, rather than an ante mortem sampling technique. 
In view of the limited persistence and limited histopathological findings in the six-month 
old animals (Section 6.3.1), subsequent weaned animal experiments at Langford were 
performed on younger animals, inoculated at approximately seven weeks of age. In each of 
experiments 6/2 and 6/3, four seven-week old lambs were inoculated with 109 cfu of STEC 
0157: 117; in the former experiment a four-strain mixture was used and in the latter the 
inoculum was a single, apparently persistent, component strain of the mixture (140065 nal`). 
In a final experiment (6/4) a wild-type non Shiga toxin-producing E. cola 0157: H7 strain 
(NCTC 12900) was inoculated into four seven-week old lambs at a dose of 6x 109 cfu per 
animal. Experiments 6/2,6/3 and 6/4 were performed in the Aerobiology Unit containment 
apparatus, with faeces sampling throughout each experiment and tissue sampling under 
terminal anaesthesia. 
Inoculum dose and experimental technique 
The inoculum dose aimed for in experiments 6/1,6/2, and 6/3 (109 cfu/animal) was 
chosen for the reasons discussed in Section 5.4. In the absence of clinical signs attributable 
to this dose, the inoculum aimed for in Experiment 6/4 was increased to 1010 cfu/animal. The 
terminal anaesthetic tissue sampling technique used in experiments 6/2,6/3, and 6/4 and the 
clean sampling technique (Section 2.6.2) appeared to have provided well-preserved, 
uncontaminated samples, as discussed in Section 5.4. The higher incidence of autolysis, 
sometimes of an unacceptable degree, in tissues from Experiment 6/1 using a post mortem 
sampling technique, suggests that, by comparison, terminal anaesthesia provides superior 
quality samples. The observation that occasionally enteric mucosal autolysis may be 
markedly variable at a single sampling site (Lamb 15) suggests that optimal preservation also 
requires attention to rapid exposure of the mucosa to fixative, by opening the intestinal 
sample and dislodging any loosely adherent mucosal contents before leaving the sample to 
fix. 
Following few isolations of inoculated strains from the large intestine of inoculated lambs 
in experiments 6/1 and 6/2, the tissue samples in experiments 6/3 and 6/4 were expanded to 
include the intrapelvic rectum to the recto-anal junction. 
Clinical signs 
Clinical signs, of mild diarrhoea and persistent soft faeces, potentially attributable to the 
experimental inoculum were seen in only one experiment (6/3, single STEC inoculum). The 
most severely affected animal appeared to have a degree of villus atrophy in comparison 
with control animals. Despite the temporal correlation between inoculation and the changes 
in faecal consistency, the cause of the clinical signs is unclear, as no E. coli 0157: H7- 
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associated lesions were observed, and in only one of the four affected animals were any 
bacterial lesions detected. A luminal toxin may have been responsible in whole or in part for 
the clinical signs. A contribution by other agents, such as coccidia (also observed in the 
control animals) cannot be excluded. It is consistent with the reports detailed in the General 
Introduction (Section 1.4.2.7) that there is no convincing evidence from these studies that 
STEC 0157: H7 is pathogenic in sheep under normal circumstances. 
Persistent excretion of inoculated strains 
The present studies demonstrate substantial variations, both between E. coli 0157: H7 
strains and between individual host sheep, in respect of persistent excretion. One strain 
(140065 nal`) proved to be persistently excreted by most animals during the period up to four 
weeks p. i., whether inoculated at 1.3 x 108 cfu/animal as part of a mixed inoculum, or at 
9x 10" cfu per animal as the sole inoculum. A marked difference between strain 140065 nal` 
and the three other strains in the mixed inoculum is evident from Experiment 6/2, and the 
bacteriological findings of Experiment 6/1 are also consistent with this. Interpretation of this 
data suggests that a reasonable working definition of persistence in this model would be 
excretion beyond two weeks p. i. This is a criterion independently adopted by other workers, 
examining excretion of E. cola 0157: H7 by experimetally-inoculated calves (Naylor et al. 
2003). The issue of whether any or all of the other three strains in the mixture would prove 
more persistent when inoculated alone was not addressed by the present studies. Although 
in vitro experiments have shown that all strains grew similarly together in mixed culture 
(Section 2.53), this is unlikely to model accurately their relative growth in vivo, when in 
competition with each other and with the endogenous flora over a period of days. There is no 
evidence that the less persistent three strains in the faeces-monitored mixed inoculum 
experiment (6/2) were subsequently excreted after initially becoming undetectable. The 
marked difference in vivo between strains which appear similar in vitro (Chapter 3, and 
discussed below), emphasises the value of using a mixed strain inoculum in initial 
experiments. 
The excretion data from the non Shiga toxin-producing strain NCTC 12900 (Experiment 
6/4) suggests a `non-persistent' phenotype, i. e. excretion did not last for two weeks or more, 
under similar environmental and dietary conditions as Experiment 6/2, where non-persistent 
strains were eliminated in less than a fortnight. However, given the animal-to-animal 
variation observed with the STEC inocula, the number of animals examined beyond the 
initial post-inoculation phase of three days is too few to support a firm conclusion. 
Furthermore, the alimentary tract samples from this experiment demonstrated the presence of 
the organism in animals at seven and nine days p. i. despite no detectable excretion, and work 
by others (Section 6.1) indicates a capacity for persistence by this strain. Any low-level 
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excretion of E. coli 0157: H7 by lambs 31 and 32 at seven and nine days p. i. respectively 
may have been obscured by overgrowth of the endogenous flora on the selective culture 
plates. 
The in vivo persistence behaviour of the inoculated strains may be compared with those 
characteristics of their phenotypes which were investigated in vitro, as detailed in tables 3-L 
and 3-M and also: quantitative cell association (figures 3-f and 3-j), protein secretion and 
intimin expression (figures 3-c, 3-d and 3-e), and organic acid resistance (figures 3-1,3-m 
and 3-n). However, these comparisons do not reveal any in vitro characteristics by which 
strains designated `persistent' and `non-persistent', by the criterion of excretion for less or 
more than two weeks, may be distinguished. In particular, the degree of strain tolerance to 
inorganic acid stress, which might be expected to influence abomasal transit, does not appear 
to affect the time or the concentration at which E. cola 0157: H7 appears in the faeces 
following oral inoculation. 
Whereas antibiotic resistance marking may attenuate some features of E. coli 0157: H7 
strains (Section 3.7), such as their AE capability (Section 3.5.2C), from the evidence of the 
present studies and of other reports (Cray and Moon 1995; Brown et al. 1997; Comick et al. 
2000; Cornick et al. 2002) it does not appear uniformly to abolish a capacity for persistence. 
Because of variations in mechanisms and target genes, any attenuating effect on persistence 
is likely to vary between antibiotic resistant mutants according to the antibiotic used, the 
method of resistance labelling (e. g. selection of spontaneous mutants versus gene disruption 
by insertion of a resistance cassette by allelic exchange) and the use of single- or multiple- 
resistance mutants. In view of the fact that experimental persistence studies of E. coli 
0157: H7 require sensitive detection of, and discrimination between, inoculum strains in the 
background of the endogenous intestinal flora, antibiotic resistance marking was a useful 
tool in the present studies. Problems were encountered where it was not used and the 
inoculated organism might have been excreted in low numbers, as with Lambs 31 and 32 in 
Experiment 6/4, as there appears to be the potential for substantial carry-over of non-0157 
organisms onto culture media when 0157 IMS is used. 
The animal-to-animal variation in culture results observed in experiments 612 and 6/3, 
using mixed and single STEC 0157: H7 inocula respectively, suggests the existence of 
animals with `high', `medium' and `low' susceptibilities to persistent excretion of E. cola 
0157: 117. For example lambs 26,25 and 20 fit these three categories respectively. A similar 
divergence in the excretion profiles of individuals following oral inoculation of E. coli 
0157: 117 has been suggested for cattle (Grauke et al. 2002), whereby the authors suggested 
that four groups of animals could be discerned. These were: animals which were not 
colonised (i. e. did not excrete beyond two days p. i. ), those that excreted for less than one 
week, those that excreted for approximately one month, and those that excreted for two 
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months or more. Of 18 inoculated animals, there were two, three, nine and four individuals 
respectively in these categories. Field studies of bovine excretion, for example Conedera et 
al. (2001), have also identified individuals in a group which apparently excrete the organism 
more persistently than most of the others. Whether these observations reflect simply a 
continuous, possibly Normal, distribution of persistence phenotypes, or a genuine 
discontinuous clustering of phenotypes is unclear, given the limited data available. Statistical 
analysis of possible distributions would require persistence data from many more animals 
experimentally inoculated with a persistent strain, under standardised conditions. 
As the sheep used in the present experiments were all crossbred, of a similar age, from 
the same flock and were on the same diet, some factors potentially influencing susceptibility 
to E. coli 0157: H7 persistence, such as age, breed and diet, seem unlikely to have 
significantly affected the results. Genetic variation, previous exposure to E. coli 0157: H7 or 
related organisms with consequent immunological or physiological responses, individual 
endogenous flora and pre-existing alimentary pathological processes are possible underlying 
causes of variation in animal responses to inoculation with E. coli 0157: H7. Whilst systemic 
immune responses to E. coli 0157: H7 LEE components have been demonstrated in humans 
(Li et al. 2000), the effects of previous exposure to the organism upon subsequent excretion 
of orally inoculated E. coli 0157: H7 are unclear (Sanderson et al. 1999; Wray et al. 2000). 
How persistent excretion of E. coli 0157: H7 occurs in ruminants remains undetermined. 
One important question is whether ruminants are true reservoirs of the organism, due to 
persistent colonisation of the alimentary tract, or whether the observed phenomenon of 
persistence in ruminants is due to continuous recycling of E. coli 0157: H7 from the animals' 
environment (Hancock et al. 1998a; 1998b). Evidence that the organism does to some extent 
establish itself in the intestine includes the observation that the inoculum dose in sheep 
appears to affect the duration of subsequent excretion (Kudva et al. 1997b; Cornick et al. 
2000). Studies examining the location of E. coli 0157: H7 in persistently-excreting weaned 
ruminants have consistently found it to be present in the large intestine (Cray and Moon 
1995; Brown et al. 1997; Harmon et al. 1999; Cornick et al. 2000; Tkalcic et al. 2000; 
Fischer et al. 2001). The same workers also have frequently found the organism in the rumen 
for an extended period after inoculation, although others have not (Buchko et al. 2000a; 
Grauke et al. 2002). Recently (since completion of the present studies), good evidence has 
been presented that the recto-anal junction is a principal site of colonisation in many 
persistently-excreting cattle (Naylor et al. 2003). 
A survey in the UK has shown that phage types 4 and 32 of E. coli 0157: H7 are heavily 
predominant amongst sheep presented for slaughter, whilst types 2,8,21/28 and 32 
predominate in bovine-derived samples (Paiba et al. 2002). In the mixed inoculum, only one 
strain (EC222, phage type 32) was of a `common' ovine phage type, and this proved to be 
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non-persistent when inoculated as a double-marked antibiotic resistant mutant in a mixture. 
Conversely, strain 140065 (phage type 2) was not of a common ovine phage type, yet proved 
persistent in a single and a mixed inoculum. If susceptibility to, or the carriage of, particular 
bacteriophages are associated with phenotypic traits (e. g. receptor binding factors) that 
contribute to the host bias of E. coli 0157: H7, then the findings in the present studies 
indicate that these traits are not of overriding importance in determining persistence. 
Location of E. coli 0157: H7 in the alimentary tract 
In the present experiments, the excretion of strains on the day of tissue sampling did not 
correlate closely with recovery of the same strains from the alimentary tract. In lambs 21 and 
22, recovery was not made from any site despite near-contemporaneous faeces samples 
proving culture-positive. Recoveries from the large intestine of excreting animals were most 
comprehensive when excretion was at a high concentration, within the range of excretion 
concentrations detected in the present and previous (Sanderson et al. 1995; Grauke et al. 
2002), studies (>_10S cfu/g, lambs 26 and 29). The same sites in lambs excreting at a 
similarly-defined moderate level, i. e. 103 to 104 cfu/g, ranged from uniformly positive (lambs 
30 and 23 to uniformly negative (Lamb 21). In Lamb 31, E. coli 0157: H7 was isolated in 
low numbers from the caecum and rectum, when a faeces sample taken immediately prior to 
terminal anaesthesia and tissue sampling proved negative. 
E. coli 0157: H7 was recovered less frequently from the ileum than from the large 
intestine, but the organism was still found in the ileum at up to 19 days p. i. (Lamb 26). Other 
sites in the small intestine, where cultured (Experiment 6/4), were positive for E. coli 
0157: H7 only up to three days p. i. The rumen was culture-positive for Shiga toxin- 
producing E. coli 0157: H7 only in the early post-inoculation period, of Experiments 6/1 and 
6/3. The non Shiga toxin-producing NCTC 12900 strain was detected in the rumen 
throughout Experiment 6/4 although this experiment only extended to nine days p. i. 
Interestingly, however, the organism was cultured from the rumen in two lambs (31 and 32) 
when faecal excretion was not detected, and it was the sole positive site in the latter lamb. 
None of the `non-persistent' component strains of the mixed inoculum were recovered from 
the alimentary tract after three days p. i. In the oldest animals (Experiment 6/1), the only 
strain recovered from the latest tissue sampling at 15 days p. i. was 140065 nal`, which was 
shown in the later experiments to be persistently excreted. 
Consideration of the faeces and tissue sample culture data (see `Sensitivity of detection', 
below) suggests that the sensitivity of the cultural methods used has affected the pattern 
which is seen. Nonetheless, from Experiment 6/3 the large intestine (but no particular site 
within it) and the ileum are the areas from which recovery was made from animals (lambs 25 
and 26) which were excreting persistently, i. e. for two weeks or longer. There is no evidence 
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from the six animals sampled at or after two weeks p. i. that the rumen maintains a persistent 
E. coli 0157: H7 population, or that it is constantly re-colonised by the organism from a 
contaminated environment. The bacteriological findings of the present studies are consistent 
with those of previous reports of E. coli 0157: H7 in ruminants (Cray and Moon 1995; 
Brown et al. 1997; Harmon et at. 1999; Cornick et at. 2000; Tkalcic et al. 2000; Fischer et al. 
2001; Grauke et al. 2002) and pigs (Francis et at. 1986; Tzipori et al. 1986) inasmuch as 
colonisation of the large intestine was seen and there was no evidence of sites of colonisation 
outside the gastrointestinal tract. The data from the present studies do not point to a specific 
region within the large intestine for colonisation and do not support suggestions from reports 
of calf experiments (Cray and Moon 1995; Brown et al. 1997; Harmon et al. 1999; Tkalcic et 
at. 2000) that the rumen is an important site of persistence. There may be an age effect in the 
persistence of E. coli 0157: H7 in the bovine rumen as, by contrast, studies in older 
(yearling) cattle (Buchko et at. 2000a; Grauke et at. 2002) have not found the rumen to be a 
site of persistence. Nonetheless, the rumen may be significant at any age in affecting the 
transit of E. coli 01 S7: H7 in sufficient numbers and for a sufficient duration to permit 
colonisation of the large intestine. The recent propsal that the recto-anal junction is a 
principal site of colonisation in cattle (Naylor et at. 2003) is consistent with the present 
bacteriological findings in lambs. The possible role of the terminal large intestine was 
investigated in the present studies by sampling, culture and histopathological examination of 
the intrapelvic rectum in experiments 6/3 and 6/4. However, these investigations did not 
yield evidence of a tropism of E. coli 0157: 117 for this area. 
Sensitivity of detection 
The method of culture from experimental animals adopted in the present studies, i. e. non- 
selective pre-enrichment in BPW followed by IMS and subculture on CHROMagar 0157, 
would be expected to be a sensitive technique for the isolation of E. coli 0157: H7, based 
upon previous reports (Section 1.4.2.5). However, these same reports indicate that it may be 
unreliable in detecting the organism in faeces or intestinal samples at initial concentrations 
below 100 cfu/g. 
The freeze-thaw process before culturing used for some samples in Experiment 6/1 would 
be expected to lower the sensitivity of the IMS-culture technique, due to the 10-fold dilution 
in PBS-glycerol before pre-enrichment in BPW (Section 2.2.9) and the potential killing of 
bacterial cells by the freeze-thaw cycle. There is, however, insufficient data to detect such a 
trend but the semiquantitative counts obtained from previously frozen samples (on the right 
side of the columns for one and 15 days p. i. in Figure 6-a) are consequently likely to be 
under-estimates of the true values. 
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In Experiment 6/3 a comparative TVC culture technique was used with faeces samples, in 
addition to the standard pre-enrichment IMS and subculture. This was done to assess the 
accuracy of the semiquantitative IMS method, and to address the possible problem of a 
lowered sensitivity of detection associated with entrapment of IMS beads by faecal solids 
(with consequent loss of the beads in discarded material) in low dilution pre-enrichment 
broths. The data from Experiment 6/3 (Figure 6-d) suggests that IMS provided semi- 
quantitative results of acceptable accuracy and, on two occasions (lambs 24 and 25, both at 
15 days p. i. ), detected excretion of E. coli 0157: H7 when the direct culture method did not. 
It is possible that unexpected negative culture findings, such as in tissue and intestinal 
contents samples of lambs 21 and 22, were due to inadequate sensitivity of detection. Grauke 
et al. (2002) reported that culture for E. coli 0157: H7 using non-IMS enrichment was 
negative for the large majority of samples from the large intestine of sheep which had been 
excreting the organism for three to six weeks. The culture methodology reported did not 
involve IMS and, therefore, it is unlikely that the anomalous findings in the present studies 
were caused entirely by interference with mechanisms specific to IMS. As an alternative to a 
problem with culture sensitivity, it may be that the organism persists only in the extreme 
distal portion of the large intestine, close to or at the anus, and good evidence has emerged 
subsequent to the present studies that in cattle this is indeed the case (Naylor et al. 2003). 
An approach to comparing the sensitivity of detection of IMS with another technique was 
tried with the intestinal contents samples of one lamb (25), following zero recovery from the 
intestinal tract of Lamb 24. In this trial, a 100 µl aliquot of the pre-enriched primary 
preparation was directly subcultured onto a nal-supplemented agar plate, in addition to the 
standard IMS procedure. Whereas this alternative procedure produced negative results in 
concordance with the IMS results in the caecum, colon I and 2 and rectum, it did yield 
recovery of the inoculated organism from the terminal colon (Figure 6-d) when IMS failed to 
do so. By serendipity, it also permitted recovery of an E. coli 0115 which was coincidentally 
forming AE lesions in the same animal. Such findings suggest that, when a highly selective 
solid medium (in this case antibiotic-supplemented CHROMagar 0157) can be used, 
enrichment or pre-enrichment plus direct subculture may be as sensitive or more sensitive a 
technique than IMS. However, in studies or surveys where there is no antibiotic resistance 
marking of the E. coli 0157: H7, the competing flora on the agar plates may well render IMS 
the most sensitive detection technique. 
Association of E. coli 0157: H7 and other organisms with the intestinal mucosa 
In only one of 20 inoculated weaned sheep (Lamb 29) were 0157 antigen-bearing 
bacteria seen to be adherent to the intestinal mucosa. Despite significant technical obstacles, 
these bacteria were shown to be forming AE lesions. In this instance the'pop-off technique 
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has demonstrated its potential to characterise lesions which are so small that they may not be 
present in adjacent sections of the same piece of tissue. The 0157 immunogold staining was 
weak, possibly because of the extensive tissue processing which was required to obtain the 
lesion in a resin section, and this result should be interpreted with caution. However, when 
the light and electron microscopical findings are considered together, there is satisfactory 
evidence of E. coli 0157 AE lesions in Lamb 29. 
The lesions were seen in tissues where the luminal concentration of bacteria was probably 
in excess of the 10" cfu/g detection limit suggested by Dean-Nystrom et al. (1999), although 
interestingly the tissue sample from one affected site (caecum) yielded a bacterial 
concentration of just 103 cfu. Importantly, these lesions demonstrate for the first time the 
susceptibility of the intestine, and the large intestine (caecum and rectum) in particular, of 
weaned lambs to AE adherence by orally administered E. colt 0157: H7. This complements 
similar observations made in fasted weaned calves (Dean-Nystrom et al. 1999). There is, 
however, no evidence currently that such lesions occur in persistently excreting animals. 
Only one persistently excreting animal in the present studies (Lamb 26) might be expected to 
have detectable AE lesions if a minimum bacterial concentration of 105.5 cfu/g in the large 
intestine is required. Indirect evidence of a role for intimin, and therefore possibly for AE 
lesions, in persistent excretion of E. coli 0157: H7 in ruminants comes from Cornick et al. 
(2002) in which an intimin-deficient human-derived E. coli 0157: H7 mutant proved 
significantly less persistent in cattle and sheep than the parent strain. Nonetheless, it appears 
that the mutant strain was still excreted by one yearling ox at 60 days p. i. Similarly, Dean- 
Nystrom et al. (1999) demonstrated that, in comparison with an isogenic intimin-deficient 
mutant, a wild-type E. coli 01 57: H7 achieved a higher density in the large intestines of 
orally inoculated weaned calves in a short-term experiment. 
An interesting feature in two experiments (6/3 and 6/4) was the detection of non- 
E. coli 0157 AE organisms in inoculated lambs. Identification of lesions formed by E. coli 
of serogroups 0115 and 026 was possible by the use of immunostaining with selected 
antisera, following bacteriological isolation of these serogroups. E. coli 0115 possessing the 
intimin gene was presumably present in Lamb 25 in high enough numbers that spontaneous 
nal-resistant mutants were isolated on some nal-supplemented CHROMagar 0157 plates, 
and therefore this was a logical serogroup with which to stain the tissues. Intimin-encoding 
E. coli 026 was isolated from a lamb in Experiment 6/4 which exhibited AE lesions, and so 
026 also was a logical choice for a test antiserum on corresponding tissues. The majority of 
lesions in this latter experiment stained with neither 0157 nor 026 antisera and may have 
been formed by the untypable eaeA-positive E. coli which formed abundant 'colourless' 
colonies on the CHROMagar 0157 plates. One of the animals with non-0157 AE lesions 
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(Lamb 25) had soft faeces, in common with the rest of its cohort, but the three other lambs in 
which similar lesions were observed (29,31 and 32) showed no clinical abnormalities. 
The fact that naturally-acquired field strains of AE organisms, some of which were 
identified as serogroups of E. coli, spontaneously formed AE lesions suggests that sheep may 
be colonised without clinical disease by non-0157 AEEC, assisted by intimate attachment. 
Such a mechanism has been hypothesised in the persistent excretion of E. coli 0157: H7 
(Gyles 1998; Cornick et al. 2002), and this hypothesis is supported in the present studies by 
the demonstration that E. coli 0157: H7 has a spontaneous AE lesion-forming capacity in 
weaned lambs. The apparent association between 0157 organisms and non-0157 AE lesions 
in Lamb 29 is of particular interest. Given the scattered nature of the non-0157 lesions and 
the marked scarcity of 0157 AE lesions, the observation of these two phenomena in close 
proximity, or apparently within the same lesion, suggests a specific association. Mechanisms 
which might promote co-colonisation by E. coli 0157: H7 and other AE bacteria include 
quorum sensing (Sperandio et al. 1999) and the attachment of intimin-bearing E. coli 
0157: H7 to enterocytes bearing Tir secreted by another AE organism. A possible example of 
the latter occurring in vitro has been reported (Ismaili et al. 1998). Conversely, there remains 
the possibility that other AE bacteria in the intestine may reduce the opportunity for E. coli 
0157: H7 to attach to the intestinal mucosa, for example by inducing specific immunological 
host responses to LEE proteins. There are no reports of the effect of defined systemic host 
immune responses upon colonisation by E. coli 0157: H7, but anti-intimin immunoglobulin 
supplied to suckling piglets via colostrum was associated with reduced colonisation of the 
piglets' intestinal tract by orally inoculated E. cola 0157: H7 (Dean-Nystrom et al. 2002). 
Conclusions 
The present studies have shown that E. coli 01 57: H7 may be excreted persistently from 
orally inoculated weaned lambs, but that there is substantial variation in this phenomenon 
between bacterial strains and between animals. A two-week cut-off between 'persistent' and 
'non-persistent' strains is suggested on the basis of the excretion patterns seen. 
The correlation between detection in faeces and in alimentary tract samples is poor, 
which may be due to the sensitivity of the cultural methods used, despite them being 
generally accepted as sensitive and discriminatory. The large intestine appears to be the 
primary site of persistence. E. coli 0157: H7 was shown to be capable of spontaneously 
forming AE lesions in the large intestine, although not in the context of persistent excretion. 
The possibility that E. coli 0157: H7 may be assisted by other AE organisms to colonise the 
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Notes for tables 6-B to 6-D: 




EP/GP: Excellent/good preservation. 
ipx: immunoperoxidase stain. 
Low/mod: Low/moderate (density). 
LPC: Lamina propria cellularity. 
PMN: Polymorphonuclear neutrophils. 
NAD: no abnormalities detected. 
V: Cr. villus: crypt ratio. 
Green text highlights deviations from excellent tissue preservation. 
Red text highlights histological features of potential interest. 
Olive text highlights ipx findings. 
Blue text highlights electron microscopic findings. 
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Figure 6-a: Bacteriological findings from tissue samples in Experiment 6/1 
Days p. i. 137 15 
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Strains: - EC218 rif 
= EC222 nal`rif EC 157 str` 
_ 140065 nal` 
Numbers are estimates of the concentration of the particular experimental strain, in cfu/g tissue, made 
using the semiquantitative Most Probable Number technique described in Section 2.2.9. 
Figure 6-b: Spiral bacteria in colon 
Lamb 18, colon. Silver-stained spiral bacteria 
(examples arrowed) are present in a crypt lumen. 
Warthin-Starry, bar = 10 µm. 
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Figure 6-c: Bacteriological findings from faeces samples (left) and tissue plus intestinal 
contents samples (right) in Experiment 6/2 
+E-06 Lamb 19 -140055n. ß 
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Days post inoculation 
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ýEC157 Irr 
222 n. ý, mx Colon 3 
16*00 - -*-*-*-*-*-*- -*-*-*-*-*-*-*-*-*-*-*-* Mesenteric lymph nodes 0 246a 10 12 14 1e to 20 22 24 26 26 
Days post inoculation 
Notes: One (1) has been added to all excretion data points to allow a logarithmic plot of data which 
includes zero values. Detection was via a semiquantitative IMS technique. Many data points at and above 
103 cfu/g represent the maximum dilutions tested for that sample, i. e. a higher value might have been 
obtained if more dilute samples had been tested. Asterisked points represent samples where a dilution 
series was not prepared and detection was from a neat sample only. 
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Figure 6-d: Bacteriological findings from faeces samples (left), and tissue and intestinal 
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Notes: One (1) has been added to all excretion data points to allow a logarithmic plot of data which 
includes zero values. Faecal E. co/i 0157 were enumerated by semiquantitative IMS (red), and by direct 
culture of a dilution series (green), in parallel. Asterisked data points represent the maximum dilutions 
tested for that sample, i. e. a higher value might have been obtained if more dilute samples had been 
tested. (0115): E. co/i 0115: H- isolated. #: Results of pre-enriched direct subculture. AE lesions seen. 
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Days post-inoculation 
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Caecum, Lamb 25. Host enterocytes (H) 
have lost their microvillous surface and 
bacteria (B) are intimately attached to the 
plasma membrane. Some pedestals (P) 
have formed. Bar = 750 nm 
Caecum. Lamb 25. Bacteria are closer adherent to 
enterocytes at the intestinal surface. Some bacteria- 
coated enterocytes are detaching (arrows). H&E, 
bar = 15 pin. 
Rectum, Lamb 25. Immunolabelled mass of E. coli 
0115 organisms (arrow), adhering to the luminal 
aspect of enterocytes. 0115 ipx, bar = 10 µm. 
Figure 6-g: Ultrastructure of attaching-effacing 
lesion 
Figure 6-h: Bacteriological findings from faeces samples (left), and tissue and intestinal 
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Lamb 29. caecum. Closely-adherent immuno- 
labelled organisms (arrow) are on the luminal 
surface of three adjacent enterocytes. 
0157 ipx. bar = 10 µm. 




Figure 6-j: Attaching-effacing lesion with 
adjacent 0157 bacteria 
Irk A 
Lamb 29. caecum. A small cluster of immuno- 
labelled organisms (arrow) is adherent to the 
mucosa, adjacent to an unlabelled AE lesion 
(asterisk). 0 157 ipx, bar = 10 pm. 






Lamb 29, rectum. Immunolabelled organisms 
(arrow) are present associated with non-labelled 
organisms (arrowheads) in an AE-type lesion. 




Lamb 29, caecum. A mass of immunolabelled 
organisms (arrow) is closely adherent to the 
luminal surface of two adjacent enterocytes 
(asterisks). 026 ipx, bar =4 gm. 
Figure 6-m: Ultrastructure of E. co/i 0157 attaching-effacing lesion 
V 








Lamb 29. caecum. 'popped-off lesion previously shown in Figure 6-i. 
Adherent bacteria have formed AE lesions (arrows). Microvilli (arrowheads) 
ha%e been effaced in the area of the lesion. Inset enlargement: Adherent 
bacteria have an irregular coating of presumed diaminobenzidine (DAB) 
reaction product. 
0157 ipx plus lead citrate/uranyl acetate, bar =3 µm. 
Iamb 29. caccurn. Four bacteria (arrow, ) hav cl rrmed AL lesions. Inset 
enlargement: At higher magnitication. immunogold labelling of the bacterial 
cell wall is evident (examples arrowed). 0157 immunogold, bar= 750 nm. 
Chapter 7- GENERAL DISCUSSION 
E. coli persistence 
`Persistence' of E. coli in the intestines of mammals is not well defined. Some workers 
define `majority' versus `minority' strains, whilst others prefer to define `resident' versus 
`non-resident' or `transient' strains (Hartl and Dykhuizen 1984; Hinton 1985). Work in 
humans and dogs suggests that `resident' strains persist for several weeks to years in any 
individual whilst `transient' strains disappear after days to weeks (Hartl and Dykhuizen 
1984; Hinton 1985), so there appears potentially to be an overlap between the persistence 
categories. Bacterial factors that may enable the establishment of a persistent, or resident, 
status include: possession of certain fimbrial adhesins (Tullus et al. 1992; Nowrouzian et al. 
2001) and of KI and K5 capsules (Nowrouzian et al. 2001), colicin production by the 
organism and a high rate of growth in intestinal mucus (Wadolkowski et al. 1988). There is 
also evidence from murine studies that, once established in the intestine, an E. coli strain 
may have an increased ability to persist in competition with strains introduced subsequently 
(Wadolkowski et al. 1988). 
Epidemiological studies on the excretion of E. coli 0157: H7 by cattle (Section 1.4.2.6) 
suggest that the organism is not commonly isolated from any individual on consecutive 
(usually monthly) sampling occasions. However, from a small proportion of individuals the 
organism is recovered repeatedly, for three to eight consecutive months (Besser et al. 1997; 
Heuvelink et al. 1998b; Shere et al. 1998; Conedera et al. 2001; Jonsson et al. 2001). 
Therefore, the evidence indicates that E. coli 0157: H7 does not normally become a long- 
term `resident' strain in the gastrointestinal tract of cattle, although persistence of the order 
of a few months is detectable in some individuals, and persistence amongst the herd is 
typical (Section 1.4.2.6). Experimental studies have shown that detectable excretion of 
E. coli 0157: H7 by yearling and young adult cattle and by sheep typically persists for one to 
two months after oral inoculation (Cray and Moon 1995; Kudva et al. 1995; Comick et al. 
2000; Wray et al. 2000; Cornick et al. 2002). Therefore, it seems reasonable to discuss the 
persistence of E. coli 0157: H7 in ruminants as a phenomenon of excretion for several days 
or weeks to occasionally several months in any one individual. It is also reasonable to 
suggest that, in this respect, E. coli 0157: H7 may not differ greatly from many other 
`transient' E. coli strains (Hancock et al. 1998a). 
However, the long-term persistence of E. coli 0157: H7 within groups of cattle and sheep 
is a well-established feature of the serotype, and it may be hypothesised that the LEE- 
mediated capacity of E. coli 0157: H7 to adhere to epithelial cells has a role in this (Gyles 
1998). If a LEE-mediated attachment, either classical intimate attachment and/or perhaps a 
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non-intimate EspA-associated adherence (Tatsuno et al. 2000), could be shown to occur in 
the context of the colonisation of the intestine by E. coli 0157: 1-17, it would indicate that, in 
persistently-excreting groups of animals, strategies of control which target LEE mechanisms 
may have some measure of success. 
Consequently, the present studies examined the E. coli 0157: H7 persistence phenomenon 
at the level of the individual animal, focussing in particular on events at the mucosal surface. 
Attempts were made also to correlate the behaviour of E. coli 0157: H7 in vivo with features 
of the same strains in vitro. 
Critique of methods 
Lambs were inoculated orally with a mixture of strains from human and bovine sources, 
or with a single strain, at doses of between 5x 108 cfu/lamb (Experiment 6/2, mixed) and 
4x 109 cfu/lamb (Experiment 6/4, single strain). Experimental inoculation in this fashion 
differs substantially from the likely process of field exposure to the organism, but it is an 
established and practical method for short- and medium-term studies, and it permits the 
comparison between individuals of the results of ingestion of a defined quantity of viable 
bacteria. The value of examining both human- and animal-derived strains is emphasised by 
findings that when strains from bovine and human sources were examined in respect of LEE 
protein secretion (McNally et al. 2001) or octamer-based subtyping (Kim et al. 1999), 
consistent differences between bovine- and human-derived strains were evident. 
The chronological sequence of oral inoculation experiments in the present studies was: 
six-month old lambs with a mixed inoculum (Experiment 6/1), six-week old lambs with a 
mixed inoculum (Experiment 6/2), neonatal lambs with a mixed inoculum (Chapter 5), six- 
week old lambs with a single strain Shiga toxin-producing inoculum (Experiment 6/3), six- 
week old lambs with a non Shiga toxin-producing inoculum (Experiment 6/4). This order 
reflected a desire to use neonatal animals as a model to establish principle only if an effect 
(in this case mucosal adherence) was not detected in the older age groups that are more 
relevant to persistence. In the light of emerging results the emphasis of investigations shifted 
from multiple- to single-strain inoculations. Following the observation in Experiment 6/2 
that faeces culture was often positive for E. coli 0157: H7 whilst intestinal samples taken 
within hours were negative, the tissue sampling protocol was extended to include the 
intrapelvic rectum in the neonatal lamb study and in experiments 6/3 and 6/4. 
A further mode of in vivo investigation of interactions between E. coli 0157: H7 and host 
using ligated intestinal loops was prompted by the desire to make comparisons between 
multiple strains within a single animal and by the possibilities of readily examining host and 
bacterial responses in situ, as discussed in Section 4.1. 
194 
The combination of bacteriological and pathological approaches aimed to permit both 
detailed scrutiny of the mucosa and sensitive detection of the distribution and persistence of 
E. coli 0157: H7 in the host. When examining the tissues of animals that were excreting 
variable and often low concentrations of the organism, pathological techniques needed to be 
sensitive to a potentially low incidence of bacterium-mucosal interactions. Therefore, tissue 
sampling protocols were used that aimed to place the intestinal mucosa rapidly in fixative, 
and which largely succeeded in providing high quality histopathological sections. Relatively 
large numbers (for example 98 large intestine sections from four animals in Experiment 6/2) 
of H&E-stained intestine sections were then examined from each animal. Ipx was initially 
used as an ancillary technique to verify the identity of lesions detected by H&E-stained 
sections. The value of ipx staining as a complementary technique to H&E was emphasised 
following examination of the lesions in the intestinal loop experiments, where a superior 
sensitivity of ipx over H&E was evident (Section 4.4), and following experiments 6/3 and 
6/4, where non-0157 AE lesions frequently were present. 
Where adherence of bacteria to the mucosa was seen, elucidation of the mechanisms of 
attachment required ultrastructural analysis by TEM. Conventional approaches to EM 
specimen preparation working from wet fixed tissue would have been insufficiently sensitive 
to obtain lesions in section, given the rarity and extremely small size of the lesions that 
eventually were detected. Therefore, LM-targeted recovery of the lesions from the associated 
wax block and, where this failed, from the histological slide, was employed as described in 
Section 2.7.4.2. The polysaccharide 0157 antigen proved to be sufficiently robust to allow 
immunogold labelling of specimens prepared in this fashion. 
In summary, the methods employed proved appropriate but areas for improvement are 
evident. In particular, the routine use of relatively time-consuming IMS could be replaced by 
a more direct TVC approach in most samples as the data in Figure 6-d shows, with IMS of 
pre-enrichment broths only employed if the TVC proved negative. Furthermore, if antibiotic 
resistance marked strains are being recovered, enrichment in broth containing the relevant 
antibiotic has proved even more sensitive than IMS (Besser et al. 2001), whilst being less 
labour-intensive. The apparent advantages in sensitivity and ease of examination of ipx- over 
H&E-stained slides indicate that, if facilities exist for the economic preparation of many ipx- 
stained sections, this technique should be preferred as the primary stain for screening 
intestinal tissues for E. coli 0157: H7. 
Comparison of findings from differing experimental approaches 
Experiment 6/2 (in vivo oral inoculation) demonstrated a dichotomy in the persistence 
phenotype of the inoculated strains, showing that one (Strain 140065 nalT) was clearly more 
persistent than the other three. The persistence of this strain was confirmed in a single- 
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inoculum experiment (6/3). This finding suggests that a view of E. coil 0157: H7 strains as 
`transient' (Hancock et al. 1998a) may be over-simplistic, as there appears to be substantial 
bacterially-determined variation in the level and length of excretion of E. coli 0157: H7 by 
ruminants. Factors that logically may influence persistence include adhesins, including 
complex adhesion mechanisms such as the AE phenotype, and resistance to stresses of the 
gastrointestinal environment including acid pH and VFA. 
The phenotype of E. coli 0157: H7 strains in vitro and in vivo in ligated colon loops 
indicates that an AE capability cannot be the sole determinant of the persistence observed in 
the weaned lamb studies. Strains 218,218 rif, 140065,140065 nalr, EC157, EC157 str' and 
NCTC 12900 all readily formed AE lesions in vitro, both on HEp-2 and bovine intestinal 
cells (sections 3.5.2.1C and 3.5.2.2C). When strains 218 rii, 140065nalr, ECI57str` and 
NCTC 12900 were tested in vivo, two of these (218 rif and EC 157 str`) were not persistently 
excreted. (Strain NCTC 12900 has been shown by other workers (La Ragione, R. L. personal 
communication) to be persistently excreted by weaned sheep. ) Similarly, it was not possible 
to distinguish persistent from non-persistent E. coli 0157: H7 strains on the basis of their 
ability, or that of their parent strains, to form AE lesions in ligated ovine colon loops (Table 
4-B). Whilst a simple relationship between AE lesion-forming ability and persistence is not 
evident, it is certainly possible that an AE capability is important for the establishment of 
persistence. 
The density of E. coli 0157: H7 organisms in the samples from lambs where 0157- 
associated AE lesions were found (neonatal lamb study and Experiment 6/4) is consistent 
with the suggestion by Dean-Nystrom et al. (1999) that a minimum density of approximately 
106 cfu/g of E. coli 0157: H7 is required for histopathological detection of lesions. Whether 
this apparent lower limit is an effect of the sensitivity of histopathological examination or 
because the formation of lesions is a density-dependent phenomenon, perhaps mediated by 
quorum sensing (Sperandio et al. 2001), is unclear. 
Other in vitro phenotypic assessments, comparing all orally inoculated strains plus parent 
strains, yielded results that were not predictive of a strain's persistence behaviour in the 
orally inoculated weaned lambs. In secreted protein and intimin expression assays (Figure 
3-c), in three-hour quantitative adhesion assays on HEp-2 (Figure 3-f) and bovine intestinal 
(Figure 3-j) monolayers, and in VFA tolerance assays (figures 3-1,3-m, and 3-n) the 
persistent strain 140065 nal` showed no notable phenotype in comparison with the other 
strains tested. 
Whilst these findings do not help to predict a strain's persistence behaviour, they do not 
negate the possibility that intestinal adhesion or VFA tolerance are necessary, but not 
sufficient, for persistence. The findings of Cornick et al. (2002) do indeed suggest that 
intimin-mediated adhesion is significant in the persistence of E. coli 0157: H7 in sheep and 
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cattle. Furthermore, phenotypes vary with environmental conditions leading to, for example, 
an increased adhesion of E. coli 01 57: H7 to HEp-2 cells when the bacteria are grown 
anaerobically (James and Keevil 1999). Under such conditions a phenotypic distinction 
between persistent and non-persistent strains might emerge. Another example of possible 
complex effects concerns bacterial resistance to acidic conditions. The resistance to 
inorganic acid at low pH of each of the parent strains of the mixed inoculum components 
(Table 3-K) appeared to have no discernible effect upon the level of each antibiotic 
resistance marked strain's initial excretion (Figure 6-c). Whilst this might suggest that the 
inorganic acid resistance phenotype of E. coli 0157: H7 strains do not greatly affect the 
colonisation of the intestinal tract, there may be a different effect in the field, when oral 
intake of the organism is likely to be intermittent and at a lower level than in the present 
studies. 
An E. coli 026: HI I strain (BC1537), which was associated with naturally-occurring AE 
lesions and enteritis in weaned cattle, was compared with E. coli 0157: H7 strains in vitro 
and in ligated ovine colon loops. The 026 strain did not show more marked AE lesion 
formation on bovine intestinal cells (Figure 3-k) or on the intact ovine colonic mucosa 
(Table 4-B) than E. coli 0157: H7. The pattern of lesion formation in the ligated colon loops 
differed between 0157 and 026 strains, with evidence that E. coli 026: 1-111 formed lesions 
more readily without induction in DMEM than did most E. coli 0157: H7 strains. However, 
when all the cell monolayer and colon loops data are considered together, it is difficult to 
conclude that, on bovine and ovine enterocytes, the `non-pathogenic' E. coli 0157: H7 
formed AE lesions any less readily than did the `pathogenic' E. coli 026: H11. This is subject 
to the caveat that the true pathogenic status of the E. coli 026: 1-111 EC1537 strain in cattle 
and sheep is unknown in the absence of oral challenge data, but it does suggest that the 
degree of AE adhesion to the intestinal mucosa in naturally-exposed animals may be 
substantially governed by factors that are not evident in vitro or in intestinal loop assays of 
AE capability. Similarly, in ligated colon loops of neonatal calves (Sandhu and Gyles 2002), 
E. coli 0157: H7 also did not appear to adhere or form AE lesions any less readily than did 
any of three presumptive bovine-pathogenic Shiga toxin-producing AEEC (05: H-, 026: H 11, 
0111: H-) that had been isolated from diseased animals. In the present ligated loop study, 
meaningful statistical comparisons between the incidence of AE lesions formed by different 
strains were precluded by the scarcity of AE lesions, the tendency for clustering of lesions, 
the inherent variability in the length of epithelium present per section at the microscopic 
level and the possible variation in susceptibility to lesion formation within the spiral colon. 
Examination of E. coli 0157: H7 strains on cell monolayers and in ligated colon loops 
provided no evidence that Shiga toxin production altered a strain's propensity to form AE 
lesions, which is in agreement with findings from a ligated intestinal loop study in calves 
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(Sandhu and Gyles 2002). The data from the oral inoculation experiments is less clear, as the 
STEC-inoculated lambs of experiments 6/2 and 6/3, which did not have detectable 0157- 
associated lesions, were tissue-sampled later post-inoculation than was the non-STEC- 
inoculated lamb in Experiment 6/4 which did have demonstrable lesions. One report (Dean- 
Nystrom et al. 1999) suggests there may be a positive effect of Shiga toxin on the density of 
E. coli 0157: H7 achieved in the large intestine of orally inoculated weaned calves in the 
short term. Shiga toxin production might have a role in persistence, possibly by modulating 
local host immune responses. Shiga toxin has structural similarities with cholera toxin and 
ETEC labile enterotoxin (O'Brien and Holmes 1987). However, whereas cholera and labile 
toxins are potent adjuvants of mucosal immunity (Simmons et al. 2001), assays using Stxl 
in vitro on human (Cohen et al. 1990) and bovine (Menge et al. 1999) B-lymphocytes, and 
in vivo in pigs (Christopher-Hennings et al. 1993), show selective immunosuppressive 
effects. Therefore, a role for Shiga toxin in suppressing a mucosal immune response to 
colonising E. coli 0157: H7 is plausible. 
The present oral inoculation studies demonstrate that the spiral part of the ovine 
ascending colon appears to be relatively resistant to the formation of AE lesions by E. coli 
01 57: H7 and other AE organisms which form lesions spontaneously in sheep. Despite 
numerous AE lesions, formed by diverse AE organisms, having been detected in the large 
intestine (Chapter 5 and experiments 6/3 and 6/4) no such lesions were seen in any of the 
spiral colon tissues. However, the spiral colon is potentially susceptible to AE lesion 
formation, as AE lesions were observed in this location when, for technical reasons, it was 
used for ligated loop studies. Possibilities for mechanisms in the spiral colon that underlie 
this distribution include a relative lack of a mucosal surface receptor, a quantity or quality of 
mucus which prevents bacterial contact with enterocytes, and a luminal environment lacking 
appropriate signals for the up-regulation of the AE lesion-forming apparatus. 
In the present studies, two ipx-stained AE-type lesions containing a mixture of 
immunolabelled and non-immunolabelled organisms were seen, one in a ligated loop (Figure 
4-e) and one in an orally inoculated animal (Figure 6-k). It is not possible to say with 
confidence whether this uncommon feature genuinely illustrates `mixed' AE lesions formed 
by both inoculated and endogenous AE bacteria or whether it is a product of incomplete 
labelling of 026 and 0157 bacteria by the ipx technique. It is at least plausible that either or 
both illustrated lesions are mixed, as the ipx technique proved to be robust in labelling all 
organisms in all other positive lesions. However, an attempt to examine the lesion in Figure 
6-k by TEM using the'pop-off technique was unsuccessful, and the issue remains 
unresolved. 
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E. coli 0157: H7 persistence in sheep 
In the present studies, the use of a mixed oral inoculum permitted the separation of four 
E. coli 0157: H7 strains into one that was `persistent' and three that were `non-persistent' in 
weaned lambs. Under the conditions used, non-persistent strains were not excreted beyond 
eight days p. i. by any of the four weaned animals inoculated with them in Experiment 6/2, 
whilst the persistent strain was detected continuously in the faeces of four out of five weaned 
animals euthanased at between 17 and 28 days p. i., in experiments 6/2 and 6/3. The duration 
of excretion of the `persistent' strain is in line with reports of the excretion of E. coli 
0157: H7 by sheep (Section 1.4.2.7), typically of one to two months. Therefore, it may be 
hypothesised that there are factors in E. coli 0157: H7 that promote its persistence in the 
alimentary tract of sheep for periods of several weeks, and that these factors are subject to 
variations, possibly including selection for antibiotic resistance in the present studies, which 
alter a strain's persistence phenotype. Whether the persistence of E. coli 0157: H7, and its 
range of variation, differs in degree from that of so-called `transient' intestinal E. coli in 
sheep is unknown. One possible mechanism contributing to persistence is adherence to the 
intestinal mucosa. The intestinal loop (Chapter 4) and oral inoculation (chapters 5 and 6) 
studies demonstrate for the first time that E. coli 0157: H7 does have a capacity to adhere to 
the ovine large intestinal mucosa, across an age range from neonates to six months old. 
There was no good evidence from the present studies that the organism adhered to the 
mucosa by any method other than AE lesion formation, although in ipx-stained sections of 
E. coli 0157: H7-inoculated colon loops (Section 4.3, Lambs 3 and 4) there were scattered, 
solitary 0157-bearing bacteria that were associated with the intestinal mucosa by an 
undetermined mechanism. These may however have been in the early stages of AE lesion 
formation. Where sections from orally inoculated lambs containing loosely-adherent bacteria 
and debris were examined by ipx (tables 5-C and 6-A to 6-C), there was no evidence of 
adherent O 157-bearing bacteria. 
The findings of the present studies suggest that there are mechanisms of colonisation 
possessed by some E. coli 0157: H7 strains that can promote a state of intestinal persistence, 
in comparison with some other strains. The evidence also points to an AE capacity of E. coli 
0157: 1-17 in orally exposed weaned lambs. There is however no good evidence in the present 
data for a causal link between AE lesion formation and persistence, as lesions have not been 
detected in the context of persistent (i. e. for the present studies, greater than two week's) 
excretion, and there appears to be no simple relationship between a strain's tendency to form 
AE lesions, in vitro and in ligated spiral colon, and its persistence. Conversely, evidence 
from oral inoculation studies does suggest that the LEE, and therefore possibly AE 
adherence, affects the colonisation of the intestine by E. coli 0157: H7. Dean-Nystrom et al. 
(1999) reported that nine weaned calves inoculated with a wild-type E. coli 0157: H7 strain 
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had a greater density of the organism in the large intestine than did four calves inoculated 
with an isogenic intimin-deficient mutant. Cornick et al. (2002) showed that an intimin- 
deficient mutant appeared to be a poorer coloniser of sheep and cattle in respect of average 
duration of excretion. A finding by Magnuson et al. (2000), that crypt enterocyte 
proliferation indices in the large intestine of orally inoculated heifers were significantly 
negatively correlated with the duration of E. coli 0157: H7 excretion, also suggests that the 
persistence of the organism may depend to some extent on interactions with the intestinal 
mucosa. A promising recent finding is that persistent E. coli 01 57: H7 appear to attach 
preferentially to the follicular epithelium at the recto-anal junction of calves (Naylor et al. 
2003) by an as-yet undefined mechanism, which could be LEE-associated. 
There is a further, unexpected, finding of the present studies which appears to be hitherto 
unreported and which demonstrates that when commensal AE organisms colonise the ovine 
intestinal tract, AE lesion formation does occur, at least in some cases. In four of 30 
experimental lambs (13 %), AE lesions were seen in the large intestine of clinically normal 
animals, representing colonisation of the mucosa by E. coli 01 15 (Experiment 6/3), and by 
E. cola 026 and/or at least one other AE organism (Experiment 6/4). The affected animals 
were obtained from two flocks, separate in terms of geography and management. It might 
therefore be supposed that asymptomatic colonisation of the ovine mucosa by AE organisms 
is a relatively common phenomenon which has previously escaped recognition because 
extensive histopathological examination of adequately preserved intestinal mucosa from 
clinically normal sheep is not commonly performed. It might also be hypothesised that the 
demonstrable formation of many small AE lesions by these bacteria, which are apparently 
commensal in healthy weaned lambs, assists in their colonisation of the intestine, which is 
the same mechanism as has been hypothesised for E. coli 0157: H7 (Gyles 1998). In 
experiments 6/3 and 6/4, sufficient numbers of the presumptive adherent strains were present 
in faeces to provide a detectable number of spontaneous nalidixic acid resistant mutants 
(Experiment 6/3) and to yield uncountable blue and colourless colonies on agar plates 
(Experiment 6/4). This strongly suggests that these lesion-forming commensals are excreted 
in substantial numbers by colonised lambs. It is of further interest that one of these 
spontaneous lesion-forming AE organisms appears to be an STEC 026. Some Shiga toxin- 
producing members of this serogroup are important human EHEC and are believed to have a 
bovine reservoir (Bettelheim 2000). STEC 026: H II are also recognised as bovine pathogens 
(Mainil et al. 1987; Wray et al. 1989; lijima et al. 1990; Janke et al. 1990; Pearson et al. 
1999; Gunning et al. 2001). 
Therefore, the findings of the present studies are consistent with the hypothesis that the 
formation of intestinal AE lesions by E. coli 0157: H7 does have a role in the persistent 
colonisation of sheep by this organism. The in vitro, intestinal loop and mixed oral 
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inoculation studies together indicate that an AE lesion-forming capability is not the sole 
determinant of persistence, which is consistent with another report (Cornick et al. 2002) 
where an intimin-deficient E. coli 0157: H7 mutant did persist, albeit in only one of eight 
cattle, for 60 days p. i. It may be that AE adhesion to the intestine, so far only detected 
acutely in cattle (Dean-Nystrom et al. 1999) and sheep (present studies) is only of 
importance early on in the process of persistent colonisation. 
Wadolkowski et al. (1988) reported that one E. coli strain (F-18col-) was at a relative 
disadvantage to another (F-I 8) in its ability to colonise streptomycin-treated mice. However, 
F-18col- proved able to prevent colonisation by F-18 when the former was first permitted to 
colonise mice alone. This suggests that initial `success' in intestinal colonisation, by 
whatever means, confers a competitive advantage over at least some other members of the 
intestinal flora, which supports the hypothesis that an initial (but possibly transient) event, 
such as the formation of AE lesions, may be important in the establishment of E. coli 
0157: H7 persistence. The dose of E. coli 0157: H7 given orally to cattle and sheep appears 
to affect the duration of excretion in many cases, with doses of 1010 cfu being associated 
with the reliable induction of persistent excretion but lower doses, of 104 to 107 cfu, having a 
more variable outcome (Cray and Moon 1995; Kudva et al. 1995; Cornick et al. 2000). 
Again, therefore, an initial state (high density of E. coli 0157: H7 in the intestine) appears to 
affect persistence. An initial high density of E. coli 0157: H7 in the intestine of cattle is 
associated with a functional LEE (Dean-Nystrom et at. 1999; Cornick et al. 2002). The 
evidence on the role of the initial density of organisms is complicated by the finding that 
some E. coil 0157: H7 strains will establish persistence in calves, and transmit to others, 
following low inoculum doses, of the order of 200-300 cfu per animal (Besser et al. 2001). 
These strains appear to colonise gradually, with low levels of the organism appearing in the 
faeces initially. A high luminal density may be helpful for successful colonisation but it does 
not appear to be an absolute prerequisite. 
It is possible that the LEE functions at both the group and the individual level to promote 
persistence. A short-term effect of the LEE in increasing the number of organisms excreted 
following ingestion may increase the level of environmental exposure to the organism 
experienced by members of the herd or flock. This may in turn promote persistence within a 
group. 
The lack of AE lesions demonstrated to date in the large intestine of persistently excreting 
ruminants may be explained by the recent report that E. cola 0157: H7 appear to adhere 
preferentially to the recto-anal junction of cattle and are transferred to the faeces as they are 
passed (Naylor et al. 2003). It is postulated in that report that recto-anal colonisation may be 
responsible for the few animals which excrete E. coli 0157: H7 persistently at high levels, 
and who may be significant in the maintenance of the organism in any group of animals. In 
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the present studies, only one animal (Lamb 26, Figure 6-d) appeared to fit this `super- 
shedder' category and when its intestinal tract was examined, colonisation throughout the 
large intestine was found, i. e. the data supports a role for extensive rather than focal large 
intestinal colonisation in this animal. When it is appreciated that a2 cm x4 gm 
histopathological section represents approximately 0.0007 % (0.008 cm2 / 1201 cm2, 
Appendix 5) of the epithelial surface area of the ovine large intestine, it is certainly possible 
that sparse E. coli 0157: H7 AE lesions will be missed, even with extensive tissue sampling 
and the examination of multiple sections. 
There is much variation, in the present studies and in other reports (Kudva et al. 1995; 
Cornick et al. 2000; Magnuson et al. 2000; Grauke et at. 2002; Naylor et at. 2003), in the 
alimentary tract location and in the observed level and duration of excretion of E. coli 
0157: H7 in orally inoculated ruminants. The possible host factors of diet and intestinal 
epithelial turnover have been considered elsewhere (Kudva et al. 1995; Kudva et al. 1997b; 
Cray et al. 1998; Harmon et al. 1999; Tkalcic et al. 2000; Grauke et al. 2002), but the present 
findings have raised another possible influence, that of pre-existing AE lesions. Thirteen 
percent of animals in the present studies had detectable non-0157 AE lesions in the large 
intestine, and in another study 25% of ovine faecal E. coli isolates encoded eaeA (Orden et 
al. 2000). These findings suggest that AE lesions may be widespread in asymptomatic 
animals and that the opportunities for interactions between E. coil 0157: H7 and other AE 
bacteria in sheep are likely to be plentiful. Furthermore, the observation of an otherwise 
comparatively rare 0157 lesion in close proximity to a non-0157 AE lesion (Figure 6-j) and 
a possibly co-incident 0157 plus non-0157 lesion (Figure 6-k) prompts speculation that the 
attachment of E. cola 0157: H7 to the large intestinal mucosa may be facilitated by pre- 
existing AE lesions. Conversely, it might be hypothesised that pre-existing AE lesions might 
have a negative influence on the ability of E. cola 0157: H7 to attach to the mucosa, perhaps 
by stimulating cross-reactive local immunity to LEE components, or by increasing 
enterocyte turnover. 
Issues of immunological priming and responses were not addressed in the present studies, 
except for the precautionary screening of experimental animals for excretion of E. coli 0157. 
An attempt to characterise an anti-0157 humoral response of cattle colonised by E. coli 
0157: H7 did not produce clear results (Wray et al. 2000), and detailed studies of systemic 
and local immune responses to persistent colonisation of animals by E. coli 0157: H7 are 
lacking. Where sheep have repeatedly been inoculated with E. coli 0157: H7, there is no 
evidence that recent prior exposure affects the excretion of the organism (Kudva et at. 
1997b). 
The present studies have indicated that, like cattle, persistence of E. coli 0157: H7 
excretion may be observed for periods of several weeks. Apparent differences between cattle 
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and sheep have also been seen. The extent of AE lesion formation in CF neonatal lambs was 
much less than in similarly-inoculated CF calves, as discussed in Section 5.4. However, the 
differences between age at inoculation and between the strains used limits useful comparison 
between these two studies. The absence of detectable E. coli 0157: H7 in the rumens of 
persistently-excreting lambs in experiments 6/2 and 6/3 contrasts with the frequent detection 
of the organism in the rumens of persistently-excreting cattle of a similar age (Cray and 
Moon 1995; Brown et al. 1997; Harmon et al. 1999; Tkalcic et al. 2000). Such a difference 
may reflect differences in the ovine versus the bovine rumen environment, but it might also 
be associated with behavioural differences whereby calves may continually re-ingest higher 
numbers of E. coli 0157: H7 from the experimental environment than do weaned lambs. 
Future directions 
Cell monolayer and intestinal loop studies, using simultaneous and sequential dual- 
inoculation of AEEC would be appropriate initial approaches to questions, raised in the 
present discussion, regarding the co-localisation of AEEC, including E. cola 0157: H7, in 
lesions. In view of the distribution of AE lesions observed in the present lambs, it would be 
interesting, if technically demanding, to perform comparative studies in ligated segments of 
caecum and proximal and terminal colon, in addition to spiral colon, to see if a regional 
tropism for AE lesions could be demonstrated for a range of AEEC. Furthermore, the 
apparent bacterial concentration-dependence of detectable AE lesions could be addressed by 
the inoculation of a range of bacterial doses into ligated loops followed by assessment of the 
luminal density achieved by quantitative culture of the luminal contents and mucosa when 
the loops are harvested. Inclusion of the E. coli 026: HI I EC1537 strain in further intestinal 
loop experiments may clarify or negate the apparent differences between it and E. coli 
0157: H7 in terms of its propensity to form AE lesions under certain conditions. 
Having identified diversity amongst the ovine persistence phenotype of E. coli 0157: H7 
strains, further studies using mutants of persistent strains that are deficient in LEE-mediated 
adherence could be used to clarify further the role of the LEE in the level and duration of 
excretion. The contribution of each of the two established LEE-mediated adhesins (intimin 
and EspA) to persistence could be examined by the use of appropriate mutants. To this end, a 
study using an eaeA mutant in Strain NCTC 12900 has been performed at VLA Weybridge 
using the orally inoculated weaned lamb model (unpublished data) which demonstrates a 
statistically significant reduction in the level of excretion of the mutant in comparison with 
the wild-type. Dual-inoculation of animals with wild-type and mutant strains helps to control 
for inter-animal variation and reduces the number of animals required for statistical 
significance. However, such an approach also includes competition between inoculated 
strains as well as colonisation per se. Comparison should therefore also be made with 
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animals inoculated with a single strain. Studies using persistently excreting sheep should also 
seek evidence for preferential colonisation of the recto-anal area, as has been demonstrated 
in cattle. It is imperative that marked strains be assessed as fully as possible for AE 
capability in vitro, in comparison with parent strains. The use of non-toxigenic strains 
potentially permits more extensive investigations than do STEC, as the burden of 
microbiological containment with such strains is less severe than for STEC 0157: H7. 
Conclusions 
The present studies have attempted to advance the understanding of E. coli 0157: H7 
persistence in sheep across a broad front, investigating a number of strains, comparing them 
with other reference AEEC, and evaluating several pathological techniques for the in vivo 
study of bacteria-host interactions. It can be concluded that the persistence phenotype of 
E. coli 0157: H7 strains in sheep does vary and that E. coli 0157: H7 can form AE lesions in 
the large intestine of weaned lambs. However, the role of such lesions, and of other AE 
organisms, in persistence remains undefined. It appears that colonisation, perhaps by AE 
lesion formation, of the recto-anal area may be a significant mechanism of persistence in 
cattle (Naylor et al. 2003). Evidence from Naylor et al. (2003) and from the present studies 
shows that more extensive colonisation of the large intestine by E. coli 0157: H7 occurs in 
some calves and lambs, including in some high-level excreters. Extensive AE lesion 
formation in the large intestine, which has been shown in the present studies to occur for 
other commensal AE organisms, is one possible mechanism for this. Therefore, evidence 
from the present studies and other reports suggests that intervention in LEE-mediated 
adherence may reduce the persistent excretion of AEEC, including serotype 0157: H7, by 
individual sheep and within flocks. 
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Appendix I- Alphabetical list of standard laboratory solutions 
and reagents 
AEC chromogenic substrate 
3-amino-9-ethylcarbazole (Sigma) 
Dimethylsulphoxide (DMSO, Sigma) 
When dissolved, added to: 
Sodium acetate buffer (pH 5.4) 
Hydrogen peroxide 
20 mg tablet 
12 m1 
100 ml 
40 µ1, added immediately before use 
Agarose gel (0.8 %) 
Agarose powder (Promega) 8g 
lx TAE buffer to 1000 ml 
The powder was dissolved by heating the mixture in a loosely-capped glass bottle 
(Duran) within a pressure cooker at 121 °C for 15 min. The gel mixture was stored at 
60°C until cast. Gels were cast in Perspex trays using appropriately-sized combs 
(BioRad) to form wells. When set, gels were immersed in lx TAE buffer in a DNA Sub- 
Cell electrophoresis tank (BioRad). 
CAPS buffer 1 Ox concentrate 
3-(cyclohexylamino)-1-propanesulphonic acid (Sigma) 22.13 g 
Sterile distilled water to approx. 900 ml 
pH adjusted to 11.0 with concentrated aqueous sodium hydroxide 
Sterile distilled water to 1000 ml 
The working solution of CAPS buffer was made with one part lOx CAPS buffer, one part 
methanol and eight parts deionised water. 
Cell culture medium - complete 
Foetal calf serum (Gibco) 10 % 
L-glutamine 200mM (Sigma) 1% 
Non-essential amino acids, 100x (Sigma) 1% 
Gentamicin (Sigma) 0.5 % 
Eagle's minimum essential medium (Sigma) to 100 % 
Cell culture medium - incomplete 
1% L-glutamine (Sigma) 1% 
Non-essential amino acids (Sigma) 1% 
Mannose (Sigma) 1% 
Eagle's minimum essential medium (Sigma) to 100 % 
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Coomassie Brilliant Blue reagent 
Brilliant Blue R (Sigma) 0.46 g 
Methanol 160 ml 
Glacial acetic acid 90 ml 
Distilled water 200 ml 
Coomassie destaining solution 
Methanol 50 ml 
Glacial acetic acid 100 ml 
Distilled water 850 ml 
Dorset's egg medium (prepared by VLA media section) 
Contents of washed grade A hen eggs 750 ml 
Physiological saline to 1000 ml 
The mixture was homogenised, passed through a muslin filter, aliquoted in 3m1 volumes 
into bijoux and placed on a gradient in an oven set at 75 °C for 2.5 hours. After cooling, 
bijoux were stored at 4 °C. 
Luria-Bertani minus glucose (LB-G) broth (prepared by VLA media section) 
Sodium chloride 5g 
Pancreatic digest of casein 10 g 
Yeast extract 5g 
Sterile distilled water to 1000 ml 
The mixture was adjusted to pH 7.5 with aqueous sodium hydroxide and sterilised by 
autoclaving for 15 min at 121°C (15 psi). 
Neutral buffered formalin 10% (prepared at VLA and Langford by pathology technical 
staff) 
Formalin (40% aqueous solution of formaldehyde) 100 ml 
Sodium dihydrogen orthophosphate (monohydrate) 4g 
Disodium hydrogen orthophosphate (anhydrous) 6.5 g 
Distilled water to 1000 ml 
Nutrient agar (prepared by VLA media section) 
Agar 15 g 
Peptone 5g 
Sodium chloride 5g 
Yeast extract 2g 
Beef extract Ig 
Sterile distilled water to 1000 ml 
The mixture was gently heated to boiling and sterilised by autoclaving for 15 min at 
121°C (15 psi). 
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PCR loading buffer 
Bromophenol blue (Sigma) 0.25 % w/v 
Glycerol 30.0 % v/v 
Sterile distilled water to 100 % 
Phosphate-buffered saline (Prepared by VLA media section) 
Solution A 
Disodium hydrogen phosphate 5.93 g 
Sodium chloride 4.25 g 
Sterile distilled water to 1000 ml 
Solution B 
Potassium dihydrogen orthophosphate 4.53 g 
Sodium chloride 4.25 g 
Sterile distilled water to 1000 ml 
Solution A was added to Solution B until a pH of 7.2 was achieved. The mixture was 
sterilised by autoclaving at 121 °C (15 psi) for 15 min, and stored at 4 °C. 
Polyacrylamide separating gel (12 °/a) 
30 % acrylamide solution (Protogel, National Diagnostics) 4.12 ml 
4x separating gel buffer 2.5 ml 
Sterile distilled water 3.25 ml 
Tetramethyl ethylene diamine (Temed, Sigma) 10 µl 
Ammonium persulphate 10 % aqueous 100 µl 
Polyacrylamide stacking gel (5 %) 
30 % acrylamide solution (Protogel, National Diagnostics) 1.3 ml 
4x stacking gel buffer 1.9 ml 
Sterile distilled water 4.2 ml 
Tetramethyl ethylene diamine (Temed, Sigma) 7.5 µl 
Ammonium persulphate 10 % aqueous 75 pl 
SDS-PAGE 4x stacking gel buffer 
Trizma base (Sigma) 60.5 g 
Sterile distilled water to approx. 900 ml 
pH adjusted to 6.8 with concentrated hydrochloric acid 
Sterile distilled water to 1000 ml 
SDS-PAGE 4x Separating gel buffer 
Trizma base (Sigma) 181.6 g 
Sterile distilled water to approx. 900 ml 
pH adjusted to 8.8 with concentrated hydrochloric acid 
Sodium dodecyl sulphate (Sigma) 4g 
Sterile distilled water to 1000 ml 
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SDS-PAGE 10x running buffer 
Trizma base (Sigma) 30.3 g 
Glycine 144.0 g 
Sterile distilled water to c. 900m1, check pH, should be 8.3 
Sodium dodecyl sulphate (Sigma) 10.0 g 
Sterile distilled water to 1000 ml 
SDS-PAGE loading buffers 
i) 4x stacking gel buffer 2.5 ml 
10%SDS 4.0 ml 
Glycerol 2.0 ml 
IIromophenol blue 2.0 mg 
Dithiothreitol 0.31 g 
Sterile distilled water to 10 ml 
Stored at -20 °C for a maximum of six months. 
ii) Glycerol 50 % v/v 
Bromophenol blue (Sigma) 0.02 % w/v 
Sterile distilled water to 100 % 
2-mercaptoethanol added to sample/buffer mix at 5% of final volume 
Sheep's blood agar 5% (prepared by VLA media section) 
Agar 15 g 
Pancreatic digest of casein 15 g 
Papaic digest of soybean meal 5g 
Sodium chloride 5g 
Sterile distilled water to 950 ml 
Mixed thoroughly and gently heated until boiling, then sterilised by autoclaving for 
15 min at 15 psi (121 °C). The agar was cooled to 45-50 °C and then 50 ml of sterile 
sheep's blood was aseptically added, mixed in thoroughly and poured into sterile Petri 
dishes in 20 ml volumes and stored at 4 T. 
Sodium acetate buffer, pH 5.4 
Sodium acetate 82.02 g 
Sterile distilled water to 1000 ml 
TAE buffer 50x stock concentrate 
Trizma base (Sigma) 242 g 
Glacial acetic acid 57.1 ml 
Disodium ethylene diamine tetraacetic acid, 0.5 M (pH 8.0, Sigma) 100 ml 
Sterile distilled water to 1000 ml 
A working solution was prepared by diluting the stock 1 in 50 with distilled water. 
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Tris-buffered saline 1 Ox stock concentrate 
Trizma base (Sigma) 24.2 g 
Sodium chloride 292.2 g 
Sterile distilled water to approx. 900 ml 
pH adjusted to 7.8 with concentrated hydrochloric acid 
Sterile distilled water to 1000 ml 
A working solution was prepared by diluting the stock 1 in 10 with distilled water. 
Tris-EDTA buffer 
Trizma base (Sigma) 1.21 g 
Disodium ethylene diamine tetraacetic acid (Sigma) 0.37 g 
Sterile distilled water to approx. 900 ml 
pH adjusted to 8.0 with concentrated hydrochloric acid 
Solution made up to 1000 ml with sterile distilled water 
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Appendix 2 -Alphabetical list of laboratory procedures and 
protocols 
Electron microscopy heavy metal stains 
Epoxy resin thin sections 
Uranyl acetate (methanolic) 10 min 
Lead citrate 5 min 
Acrylic resin thin sections 
Uranyl acetate (aqueous) 5 min 
Lead citrate 5 min 
All staining solutions were filtered through Millipore filters before use. 
Filtered distilled water, or 50 % methanol then distilled water if using methanolic uranyl 
acetate, was used to wash between stains. 
Care was taken not to breathe on the lead citrate whilst staining to avoid a precipitate of 
lead carbonate forming and contaminating the sections 
Uranyl acetate: 
Methanolic - saturated uranyl acetate in 50 % methanol. 
Aqueous - saturated uranyl acetate in distilled water. 
Reynolds lead citrate: 
1.33 g lead nitrate. 
1.76 g sodium citrate. 
30 ml distilled water. 
Shake for 1 min. 
Allow to stand for 30 min shaking the solution occasionally. 
Add 8 ml 1M sodium hydroxide and mix. 
Dilute to 50mls with distilled water. 
Final pH should be pH 12. 
Intimin and EspA antiserum production (performed by Dr A. L. Cookson et al. ) 
Purified eaeA PCR products (962 base pair fragment at the 3' end of the gene, plus 
restriction sites added to primers) from E. coif 0157: H7 strain A84 and pET21 d were cut 
with BamHI and HindIIl and ligated overnight at 16 °C. E. coli DHSa (Life 
Technologies) were transformed with 2 µl of the ligation mix. White colonies were 
transferred from ampicillin / X-Gal transformation plates and cultured overnight in LB 
broth at 37 C. Purified plasmids were digested with BamHI and HindIII to ensure the 
correct insert size. The pET21d construct containing the 962 base-pair eaeA inserts was 
used to electroporate E. coli BL21 (DE3) in order to express the recombinant intimin 
C-terminal 310 amino acids, now with a six-histidine tag derived from the expression 
vector. 
The same procedure was used to generate a HIS-tagged recombinant EspA product 
comprising almost all of the EspA protein from E. cola 0157: H7 strain EC157. 
A 1ml aliquot of an overnight culture of the HIS-EaeA or HIS-EspA recombinant 
construct was inoculated into 200m1 LB-broth containing ampicillin and incubated with 
234 
shaking at 37 'C for 4 hrs. Expression of the HIS-EaeA / HIS-EspA recombinant protein 
was induced by the addition of 1 mM IPTG and the culture was incubated for a further 2 
to 3 hrs. Further recombinant protein purification, prior to injection into rabbits was 
performed using a nickel affinity column. Polyclonal antisera was prepared from New 
Zealand White rabbits by injecting equal amounts of recombinant protein preparation and 
Freund's complete adjuvant (100µl injected subcutaneously at 2 sites). Boosting with 
recombinant preparation antigen was performed at two-weekly intervals. Serum obtained 
was absorbed repeatedly with a plasmid-free BL21 (DE3) strain. Strains for absorption 
were grown on nutrient agar plates overnight at 37 'C (2 agar plates per ml of serum), 
harvested and incubated together with serum at 37 'C for 2 hrs with constant mixing. 
After each incubation the serum was centrifuged, the pellet discarded and another batch 
of BL21 (DE3) cells added. After each absorption the serum was titrated by ELISA using 
plasmid-free BL21 (DE3) and induced BL21 (DE3) containing the recombinant plasmid 
and the titre compared with that of non-absorbed serum. 
Miles and Misra method for viable count determination 
A 20 µl aliquot was removed from the bacterial suspension to be measured and was 
diluted tenfold by addition to 180 µl of PBS in a microtitre plate well. A serial tenfold 
dilution series was prepared in PBS on the microtitre plate. Depending upon the likely 
viable count, dilutions down to 104 to 106 were prepared. From each of the three or four 
most dilute suspensions, three 20 µl aliquots were plated onto labelled, partially-dried 
nutrient agar plates for overnight culture. After incubation, the least dilute suspension for 
which clear, separated colonies could be counted was used for colony counting, and an 
average number of colonies per 20 pl spot was determined from the three spots. The 
viable count of the original suspension was derived by multiplication using the dilution 
factor. 
Stains: Giemsa for paraffin wax sections 
i. Sections dewaxed in Histo-Clear (National Diagnostics) for 6 min minimum 
ii. Hydrated through two baths of 100 % alcohol (Industrial Methylated Spirits) and one of 
70 % alcohol, to tap water 
iii. Stained in a coplin jar in a mixture of 1 ml of Giemsa stock* plus 45 ml distilled water in 
a water bath at 56 °C - 20 min to 1 hour (maximum) 
iv. Rinsed in distilled water 
v. Differentiated in 1/1,500 acetic acid for approx. 30 seconds total, rinsed in distilled water. 
(Controlled by viewing at intervals under a microscope. Sections should have an overall 
pink colour, with the nuclei blue and eosinophil granules red. ) 
vi. Rinsed in distilled water 
vii. Blotted dry, rinsed briefly in alcohol, cleared in Histo-Clear and mounted under 
coverslips with DPX mountant (R. A. Lamb) 
* Prepared as follows: Mix 7.36 g Giemsa powder in 500 ml glycerol which is heated to 50 °C in a 
water bath. Leave for 30 min at 50 °C with periodic mixing. Allow to cool and add 500 ml 
methanol. Mix and filter. 
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Stains: Gram-Twort 
i. Dewaxed sections in Histo-Clear (National Diagnostics) for 6 min minimum 
ii. Hydrated through two baths of 100 % alcohol (Industrial Methylated Spirits) and one of 
70 % alcohol, to tap water 
iii. Stained with Lillie's crystal violet -1 min (filter stain onto slide) 
iv. Washed briefly in tap water 
v. Lugol's iodine -1 min 
vi. Drained the slide and flood with acetone to differentiate for 2-5 seconds 
vii. Rinsed in distilled water 
viii. Counterstained with neutral red/fast green -5 min 
ix. Washed in distilled water 
X. Dehydrated, through 70 % and 2x 100 % alcohol baths, to Histo-Clear. The alcohol step 
was prolonged until neutral red stopped coming out. 
xi. Mounted under coverslips with DPX mountant (R. A. Lamb) 
Lillie's crystal violet 
Crystal violet -2g 
Ammonium oxalate- 0.8 g 
95 % alcohol - 20 ml 
Distilled water - 80 ml 
Dissolve the dye in the alcohol, add the rest, stir for 3 hours and filter. 
Lugol's iodine 
Iodine -1 g. Dissolve it in a small quantity of the water then add the remainder. 
Potassium iodide -2g 
Distilled water - 100 ml 
Neutral redljast green solution 
9 ml of 0.2 % neutral red in ethanol 
I ml of 0.2 % fast green in ethanol 
30 ml of distilled water 
Mix and use immediately 
Stains: Haematoxylin and eosin 
i. Sections dewaxed in Histo-Clear (National Diagnostics) for 6 min minimum 
ii. Hydrated through two baths of 100 % alcohol (Industrial Methylated Spirits) and one of 
70 % alcohol, to tap water 
iii. Stained in Harris' haematoxylin for 10 min and wash in tap water 
iv. Differentiated in acid alcohol (1 % HCl in 70 % industrial methylated spirits) for ten 
seconds and washed in tap water 
v. Sections blue'd in Scott's tap water substitute for 45 seconds and washed in tap water 
vi. Stained in eosin (1 % eosin Y {yellowish} in tap water) for 4 min and washed briefly in 
tap water 
vii. Dehydrated, through 70 % and 2x 100 % alcohol baths, to Histo-Clear 
viii. Mounted under coverslips with DPX mountant (R. A. Lamb) 
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Stains: Immunogold 
i. Grids placed in distilled water for 10 min 
ii. Incubated in pH 7.4 TBS (Tris buffered saline) containing 5% normal goat serum for 
30 min 
iii. Incubated in specific primary antibody (rabbit anti-O 157, VLA) diluted I in 5 with 
pH 7.4 TBS, including 0.1 % bovine serum albumin, for 30 min. For negative controls, 
normal rabbit serum (Sigma) was used. 
iv. Grids washed in two changes of pH 7.4 TBS for 5 min each, then two changes of pH 8.2 
TBS for 5 min each 
v. Incubated with secondary antibody (10 nm gold-conjugated goat anti-rabbit IgG, BBI) 
diluted 1 in 50 with pH 8.2 TBS, including 0.8 % bovine serum albumin, for 1.5 hours 
vi. Grids washed in pH 8.2 TBS for 5 min x2 
vii. Grids post-fixed in 2.5 % glutaraldehyde in 0.1 M sodium cacodylate buffer for 15 min 
viii. Washed in two changes of distilled water for 5 min each 
ix. Grids stained with uranyl acetate and lead citrate 
Stains: Immunoperoxidase 
i. Sections dewaxed by soaking in Histo-Clear (National Diagnostics) for at least 6 min, 
then rinsed in 100 % alcohol (Industrial Methylated Spirits) 
ii. Endogenous peroxidase activity quenched by soaking in 0.5 % v/v hydrogen peroxide in 
methanol for 30 min at room temperature 
iii. Sections washed and hydrated by soaking in PBS, pH 7.4, for 5 min x2 
iv. Non-specific binding sites of bridge antibody blocked by applying normal goat serum 
(Sigma) diluted 1: 5 in PBS and left in humid chamber for 30 min 
v. Primary antibody applied to sections, appropriately diluted in PBS, and left in humid 
chamber at room temperature for 30 min 
vi. Washed with PBS, 5 min soak x2 
vii. Goat anti-rabbit secondary antibody (Sigma) diluted 1: 50 in PBS applied and left in 
humid chamber at room temperature for 1 hour 
viii. Washed with PBS x2 
ix. Rabbit PAP complex (Dako) diluted 1: 100 in PBS applied and left in humid chamber at 
room temperature for 30 min 
x. Washed with PBS x3 
xi. The chromogen diaminobenzidine (DAB, Sigma) 0.06 % w/v in PBS applied, with 
0.03 % v/v hydrogen peroxide added at the last moment, for I min 
xii. Colour development stopped with distilled water and sections counterstained in Mayer's 
haematoxylin for 30 seconds 
xiii. The haematoxylin was blue'd in tap water for 5 min, sections were dehydrated through 
70 % and 100 % alcohol, to Histo-Clear 
xiv. Sections mounted under coverslips with DPX (R. A. Lamb) 
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Stains: Warthin-Starry 
Using organo-silane (Sigma) treated slides. Glassware pre-washed with 10 % nitric acid 
followed by distilled water. Positive control section used. Plastic forceps used. 
i. Sections dewaxed in Histo-Clear (National Diagnostics) for 6 min minimum 
ii. Hydrated through two baths of 100 % alcohol (Industrial Methylated Spirits) and one of 
70 % alcohol, to tap water 
iii. Rinsed in pH 3.7 buffer 
iv. All solutions prepared and heated to 56 °C in a waterbath 
v. Slides placed in the 1% silver nitrate solution at 56 °C for 1 hour 
vi. 2.5 ml of the 2% silver nitrate solution added to the gelatine solution 
vii. The I% silver solution was tipped out leaving the slides in the coplin jar 
viii. 3 ml of the hydroquinone added to the silver/gelatin mixture and poured into the coplin 
jar with the slides 
ix. Slides treated in this solution until the sections were golden brown. This took 1-3 min. 
x. Slides washed carefully in warm tap water 
xi. Dehydrated, through 70 % and 2x 100 % alcohol baths, to Histo-Clear 
xii. Mounted under coverslips with DPX (R. A. Lamb) 
pH 3.7 buffer 
0.2 M Sodium acetate 1.5 ml 
0.2 M Acetic acid 18.5 ml 
Distilled water 480 ml 
I% Silver Nitrate in buffer 
2% Silver Nitrate in buffer 
Gelatin Solution 
3g gelatine in 45 ml buffer 
Hydroquinone 
0.3 g hydroquinone (quinol) in 7 ml buffer 
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Tissue retrieval from wax blocks for electron microscopy 
All steps to embedding were performed in glass vials on a rotating mixer. 
i. The tissue was placed into a glass processing vial filled with Histo-Clear (National 
Diagnostics) and left for 24 hours. 
ii. Tissue placed into 100 % ethanol for 2 changes of 1 hour each 
iii. Tissue placed into 90 % ethanol for 2 changes of 30 min each 
iv. Tissue placed into 0.1 M sodium cacodylate buffer for 2 changes of 30 min each 
v. Post fixed in osmium tetroxide in 0.2 M sodium cacodylate buffer for 1 hour (Equal 
quantities of 2% aqueous OsO4 and 0.4 M buffer mixed and used immediately) 
vi. Rinsed in 0.2 M buffer for 2 changes of 5 min each 
vii. Dehydrated in 70 % ethanol for 2 changes of 20 min each 
viii. Dehydrated in 90 % ethanol for 2 changes of 10 min each 
ix. Dehydrated in 100 % ethanol for 2 changes of 20 min each 
x. Infiltrated with propylene oxide (1,2 epoxy propane) for 2 changes of 10 min each 
xi. Infiltrated with propylene oxide/epoxy resin* mixture (50/50 v/v) for 1 hour 
xii. Infiltrated with epoxy resin* overnight with caps removed from vials, allowing any 
remaining propylene oxide to evaporate 
xiii. Tissue embedded in labelled capsules with freshly prepared resin* 
xiv. Resin polymerised at 60°C for 48 hours 
*Agar 100 resin, Agar Scientific 
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Appendix 3- Reagent, bacteria and equipment suppliers 
Agar Scientific: Agar Scientific, Stanstead, Essex, UK. 
Amersham: Amersham Pharmacia Biotech UK Ltd, Little Chalfont, Buckinghamshire, UK. 
Anachem: Anachem Ltd, Anachem House, Charles Street, Luton, Bedfordshire, UK. 
Animalcare: Animalcare Ltd. Common Road Dunnington York, UK. 
Antec: Antec International, Sudbury, Suffolk, UK. 
Bayer: Bayer plc. Animal Health Business Group, Bury St Edmunds, Suffolk, UK. 
BBI: British Biocell International, Cardiff, UK. 
BDH Ltd.: BDH Ltd, Poole, Dorset, UK. 
Becton-Dickinson: BD Diagnostic systems, BD UK Ltd., Oxford, Oxfordshire, UK. 
bioMl rieux: bioMerieux UK Limited, Grafton Way, Basingstoke, Hampshire, UK. 
Biometra: Biometra, Göttingen, Germany. 
BioRad: Bio-Rad Laboratories Ltd., Bio-Rad House, Maylands Avenue, Hemel Hempstead, 
Hertfordshire, UK. 
BOCM: BOCM Pauls Ltd., Ipswich, Suffolk, UK. 
Cambio: Cambio, Cambridge, Cambridgeshire, UK. 
CHROMagar: CHROMagar, Paris, France. 
CPHL: Central Public Health Laboratory, 61 Colindale Avenue, London, UK. 
Dako: Dako Ltd, Ely, Cambridgeshire, UK. 
DNASTAR: DNASTAR Inc., Madison, Wisconsin, USA. 
Dynal: Dynal A. S., Oslo, Norway. 
Dynex: DYNEX Technologies, 14340 Sullyfield Circle, Chantilly, Virginia, USA. 
Duran: Schott Glas Duran, Hattenbergstrasse 10,55122 Mainz, Germany. 
Eppendorf: Eppendorf UK Ltd., Cambridge, Cambridgeshire, UK. 
Falcon: BD Biosciences Discovery Labware, BD UK Ltd., Oxford, Oxfordshire, UK. 
Fort Dodge: Fort Dodge Animal Health, Southampton, Hampshire, UK. 
Gibco: Gibco Invitrogen Corporation, Paisley, Renfrewshire, UK. 
Heraeus: Heraeus Instruments, Inc., II IA Corporate Boulevade, South Plainfield, New 
Jersey, USA. 
Invitrogen: 3 Fountain Drive Inchinnan Business Park Paisley PA4 9RF, UK. 
ICT: Innovative Cell Technologies Inc., San Diego, California, USA. 
Janssen: Janssen Animal Health, High Wycombe, Buckinghamshire, UK. 
Lakeland Ltd.: Lakeland Limited, Windermere, Cumbria, UK. 
Leitz: Leitz GmbH & Co. KG, Leitzstraße 2 73443, Oberkochen, Germany. 
Life Technologies: Invitrogen Ltd, Paisley, Renfrewshire, UK. 
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London Resin Company: London Resin Company, Reading, Berkshire, UK. 
Merial: Merial Animal Health Ltd., Harlow, Essex, UK. 
MSE: Sanyo Gallenkamp PLC Monarch Way, Loughborough, UK. 
National Diagnostics: National Diagnostics, Atlanta, Georgia, USA. 
NCBI: National Center for Biotechnology Information, National Library of Medicine, 
Bethesda, Maryland, USA. Database access via URL: http: //www. ncbi. nlm. nih. gov/ 
NCTC: National Collection of Type Cultures, CPHL (above), UK. 
Nunc: Nalge Nunc International, 75 Panorama Creek Drive, Rochester, NY, USA. 
Oxoid: Oxoid, Basingstoke, UK. 
Pierce: Pierce Chemical Company, Rockford, Illinois, USA. 
Promega: Promega UK, Southampton, Hampshire, UK. 
R. A. Lamb: Raymond A. Lamb, Eastbourne, Sussex, UK. 
Reichert: Leica Microsystems (UK) Ltd, Davy Avenue, Knowlhill, Milton Keynes, 
Buckinghamshire, UK. 
Roche: Roche Products Limited, Vitamins and Fine Chemicals Division, Heanor, 
Derbyshire, UK. 
Shandon: Shandon Scientific Ltd., Astmoor, Runcorn, Cheshire, UK. 
Sigma: Sigma-Aldrich Company Ltd, Poole, Dorset, UK. 
SSL: SSL International Plc., Canute Court, Toft Road, Knutsford, Cheshire, UK. 
Syngene: Syngene (Europe), Beacon House, Nuffield Road, Cambridge, UK. 
Vivascience: Vivascience AG, Hannover, Germany. 
WPA: Unit 22 - Cambridge Science Park, Milton Road, Cambridge, UK. 
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Appendix 5- Large intestine surface area calculation 
Appendix table B: Approximate macroscopic surface area of large intestine 
Region Length* (cm) Circumference* (cm) Area (cm2) 
Caecum 22 8 176 
Proximal ascending. colon 30 8 240 
Spiral colon 260 2.5 650 
Descending colon 45 2 90 
Rectum 15 3 45 
Total large intestine 1201 
" Measurements were taken from the intestine of a clinically normal freshly-killed six- 
month old sheep at the end of a liver fluke study 
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Appendix 6- Publications arising from the present studies 
Wales, A. D., F. A. Clifton-Hadley, A. L. Cookson, M. P. Dibb-Fuller, R. M. 
LaRagione, K. A. Sprigings, G. R. Pearson and M. J. Woodward (2001). 
Experimental infection of six-month old lambs with Escherichfa coli 0157: H7. Vet Rec 
148 (20): 630-631. 
Wales, A. D., G. R. Pearson, A. M. Skuse, J. M. Roe, C. M. Hayes, A. L. Cookson 
and At. J. Woodward (2001). Attaching and effacing lesions caused by Escherichia 
coif 0157: H7 in experimentally inoculated neonatal lambs. JMed Microbio150 (9): 
752-758. 
Wales, A. D., F. A. Clifton-Hadley, A. L. Cookson, M. P. Dibb-Fuller, R. M. 
LaRagione, K. A. Sprigings, G. R. Pearson and M. J. Woodward (2002). 
Production of attaching-effacing lesions in ligated large intestine loops of 6-month-old 
sheep by Escherichia cola 0157: H7. JMedMicrobiol 51 (9): 755-763. 
Cookson, A. L., A. D. Wales, J. M. Roe, C. M. Hayes, G. R. Pearson and M. J. 
Woodward (2002). Variation in the persistence of Escherichia cola 0157: H7 in 
experimentally inoculated six-week-old conventional lambs. JMed Microbiol 51 (12): 
1032-1040. 
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Appendix 7- Contents of cited World Wide Web pages 
1) Anon, accessed 2002. VT-Producing Escherichia coli 0157 Strains Examined by 
PHLS LEP. England and Wales 1992 - 2001 quarterly. Public Health Laboratory 
Service. http: //www. phls. org. uk/facts/Gastro/ecoli/ecoliQua. htm 
VT-PRODUCING Escherichia coli 0157 Strains Examined by PHLS LEP 
England and Vales 
1992 - 2001 quarterly 
1st Quarter 2nd Quarter 3rd Quarter 4th Quarter TOTAL 
1992 38 149 205 78 470 
1993 38 94 185 68 385 
1994 33 94 220 64 411 
1995 41 143 413 195 792 
1996 44 132 300 184 660 
1997 89 215 558 225 1087 
1998 140 181 364 205 890 
1999 186 239 484 175 1084 
2000 65 248 420 163 896 
2001" 73 161 352 182 768 
" Provisional data 
Source: PHLS Laboratory of Enteric Pathogens 
2) Skuse, A. M., Accessed 2002a. Retrieval of tissue from histological wax blocks for 
E. M. University of Bristol Comparative Pathology Laboratory. 
http: //www. bris. ac. uk/Depts/PathAndMicro/CPL/emtechs. htm#Retrieval Of Tissues 
From Wax 
RETRIEVAL OF TISSUE FROM HISTOLOGICAL WAX BLOCKS FOR E. M. 
In some cases an area of interest, which may not be discovered by simply processing more tissue, 
can be retrieved from the wax block. 
1. Identify the area of interest on the microscope slide by ringing it with a marker pen. 
2. Match the area marked on the slide against the specimen in the wax block and cut around it with 
a razor blade. 
3. Cut a few millimetres into the surface of the wax block all around the marked area. 
4. Carefully lever out the piece of tissue. 
5. Cut the piece of tissue into suitable sized blocks making sure that orientation can be recognised 
later by cutting so that one dimension is greater than the other two. 
6. Place the tissue into a glass processing vial and fill it with a suitable wax solvent (Histo-Clear 
or xylene) and leave for 24 hours, (preferably on a rotating mixer). 
7. Place tissue into 100% ethanol for 2 changes of 1 hour each. 
8. Place tissue into 90% ethanol for 2 changes of 30 minutes each. 
9. Place tissue into 70% ethanol for 2 changes of 30 minutes each. 
10. Place tissue into 0.1 M sodium cacodylate buffer for 2 changes of 30 minutes each. 
11. Continue with usual processing schedule for E. M. specimens. 
12. The flat (previously cut) surface will be embedded facing the end of the embedding capsule so 
that the required area is accessible in the finished block. 
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Skuse, A. M., Accessed 2002b. Removal of tissue section material from glass 
slides for EM. University of Bristol Comparative Pathology Laboratory. 
http: //www. bris. ac. uk/Depts/PathAndMicro/CPL/emtechs. htm#PopOf f 
REMOVAL OF TISSUE SECTION MATERIAL FROM CLASS SLIDES FOR EM 
In some cases the area of interest in a histological section is so rare that finding a similar area by 
remosal of tissue from the svax block will not gi e the required result. In this case it is possible to 
rctnese the actual tissue from the glass slide for EM. 
Ring the area of interest on the top surface of the slide and then mirror that ring on the reverse 
of the slide \\ith a diamond tipped pen. This will allow the correct positioning of the slide later. 
2. Remove the coverslip by soaking the slide in Histoclear' or xylene until the DPX mountant is 
loosened. 
3 Soak the slide in Histoclear' or xylene for a further few hours to remove all the mountant. 
4 Place the slide in 100% alcohol for two or three changes of 30-60 minutes each. 
5 Place in a scaled container of LR White' resin for two or three changes of at least 12 hours 
each. 
I. ither: 
" \takc up sufficient quantity of I_R White , with accelerator to fill one or two [NI 
nheddiMg capsules. 111m1 resin :I drop accelerator is a convenient quantity. 
"i t() \O I coat the inside ofthe capsule vsith extra accelerator. 
"I ill the I. \l capsule completely to the briny with resin mixture so that it is convex at the 
, urf; tcc. 1 to diagram. 
" 'lace tvvo empty capsules either side of it on a flat surface for support. 
" ILcmove the slide from the coplin jar and drain oil as much excess resin as possible. 
" 'lace the slide section side dossn on top ofthe resin mixture making sure that the marked 
.,..: to! In: ctc t 
i, in the centre of the resin. 
" \ý , ., ý, ýr: r .: 1,11' 
I5-. 10 minutes or until hardened. 
Or: 
" ýL ! c, in vs ithoout accelerator. I his may be better for any sample that requires 
mmunocv tochemistr at a later stage as the use of accelerator generates high temperatures 
in the resin. 
" l'se a multi capsule block as single capsules tend to distort during caving and the block 
_ises more support. 
"I ill I Capsule completely to the brim with resin so that it is convex at the surface. (See 
diagram. ) 
" Remos c the slide from the coplin jar and drain oil' as much excess resin as possible. 
" Place the slide section side dovsn on top of the resin making sure that the marked area of' 
interest is in the centre of the resin. 
" I'olstttcrise at SIf'C for 12-24 hours. 
Area of interest 
i 
i 




7. Spray the reverse of the slide liberally with freezer spray. After a few seconds a crack will often 
be heard which denotes the partial separation of the resin from the slide. 
8. Snap the capsule from the slide, some force may be necessary. The section of tissue should be 
embedded in the resin. 
9. Section as soon as possible. The resin has a tendancy to distort gradually after polymerisation 
which prevents a whole section being taken. Trimming should be kept to an absolute minimum 
as the tissue is right at the surface of the block and is very thin. 
4) Skuse, A. M., Accessed 2002c. Immunogold staining technique. University of 
Bristol Comparative Pathology Laboratory. 
http: //www. bris. ac. uk/Depts/PathAndMicro/CPL/emtechs. htm#lmmunoqoid 
IMMMUNOGOLD STAINING TECHNIQUE 
1. Cut sections (preferably processed into acrylic resin) and mount on inert grids such as nickel 
or gold. 
2. Rinse grids in distilled water for 10 minutes. 
3. Incubate in pH 7.4 T. B. S. (tris buffered saline) containing 5% normal serum for 30 minutes. 
(Serum from same animal as secondary antibody). The concentration of the normal serum may 
have to be increased to up to 50% to prevent background signal. 
4. Incubate in specific primary antibody diluted 1 in 5 with pH 7.4 T. B. S., including 0.1% bovine 
serum albumin, for 30 minutes. (Check pH after preparation). 
5. Wash grids in two changes of pH 7.4 T. B. S. for 5 minutes each, then two changes of pH 8.2 
T. Q. S. for 5 minutes each. 
6. Incubate with immunogold conjugated secondary antibody diluted 1 in 50 with pH 8.2 T. B. S., 
including 0.8% bovine serum albumin, for 1.5 hours. 
7. Wash grids in pH 8.2 T. B. S. for 5 minutes x 2. 
8. Post fix grids in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer for 15 minutes. 
9. Wash grids in two changes of distilled water for 5 minutes each. 
10. Stain grids with uranyl acetate and lead citrate. (If using LR White resin stain in aqueous 
uranyl acetate. ) 
TRIS BUFFERS 
Tris buffer 0.05M 
" Dissolve 6.1 g tris(hydroxymethyl)methylamine in 50mis of distilled water. 
" Add 37mis of IM HCI. 
" Dilute to a total volume of I litre with distilled water. 
" pH should be 7.4 at 25°C, adjust with 1M HCI if necessary. 
Tris buffered saline (T. B. S. ) pH 7.4 
" 0.05M tris buffer pH 7.4 (as above) - 100mis 
" NaCI-to2.5%w/v 
" Triton X-100 - to 0.2% v/v 
Tris buffered saline (T. B. S. ) pH 8.2 
" As above but adjust pH of buffer to 8.2 with IM NaOH. 
CONTROLS 
1. Omit the primary antibody by leaving grids in the wash/block solution at step 3 and 
continuing to step 5. (Checks the secondary and substrate). 
2. Replace the primary antibody with another but inappropriate antibody. (Checks the primary). 
3. Replace the primary antibody with normal (non-immune) serum obtained from the same 
animal as the primary. (Checks the primary). 
4. For immuno-gold detection of bacterial antigens dried onto formvar grids it may be necessary 
to block at step 3. with more concentrated normal serum as the formvar may absorb proteins 
non-specifically. (Putting on concentrated normal serum blocks this capacity). 
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5) Various, Accessed 2002. TrEMBL database accession number 069412: ESPA 
ExPASy. http: //ca. expasv. orq/cqi-bin/niceprot. pl? 069412 
NiceProt View of TrEMBL: 069412 
General information about the entry 
Entry name 069412 
Primary accession number 069412 
Secondary accession numbers None 
Entered in TrEMBL in Release 07, August 1998 
Sequence was last modified in Release 07, August 1998 
Annotations were last modified in Release 21, June 2002 
Name and origin of the protein 
Protein name ESPA protein 
Synonym Secreted protein EspA 
Gene name ESPA or Z5107 or ECS4556 
From Escherichia coli [TaxID: 562] 
Escherichia coli 0157: H7 [TaxID: 83334] 




SEQUENCE FROM NUCLEIC ACID. 
SPECIES=E. coli; STRAIN=EHEC EDL933; Kresse A. U., Ebel F., Deibel C., Chakraborty T., 
Guzman C. A.; Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases. 
[2] 
SEQUENCE FROM NUCLEIC ACID. 
SPECIES=E. coli; STRAIN=EDL933; MEDLINE=98339885; PubMed=9673266; Perna N. T., 
Mayhew G. F., Posfai G., Elliott S., Donnenberg M. S., Kaper J. B., Blattner F. R.; "Molecular 
evolution of a pathogenicity island from enterohemorrhagic Escherichia coli 0157: H7. "; Infect. 
Immun. 66: 3810-3817(1998). 
[3] 
SEQUENCE FROM NUCLEIC ACID. 
SPECIES=E. coli 0157: H7; STRAIN=0157: H7 / EDL933 I ATCC 700927; 
MEDLINE=21074935; PubMed=11206551; Perna N. T., PlunkettG. III, Burland V., Mau B., 
Glasner J. D., Rose D. J., Mayhew G. F., Evans P. S., Gregor J., Kirkpatrick H. A., Posfai G., Hackett 
J., Klink S., Boutin A., Shao Y., Miller L., Grotbeck E. J., Davis N. W., Lim A., Dimalanta E. T., 
Potamousis K., Apodaca J., Anantharaman T. S., Lin J., Yen G., Schwartz D. C., Welch R. A., 
Blattner F. R.; "Genome sequence of enterohaemorrhagic Escherichia coli 0157: H7. "; Nature 
409: 529-533(2001). 
[4] 
SEQUENCE FROM NUCLEIC ACID. 
SPECIES=E. coli 0157: H7; STRAIN=0157: H7 / RIMD 0509952; MEDLINE=21156231; 
PubMed=11258796; Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K., 
Han C. -G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T., lida T., Takami H., Honda 
T., Sasakawa C., Ogasawara N., Yasunaga T., Kuhara S., Shiba T., Hattori M., Shinagawa H.; 
"Complete genome sequence of enterohemorrhagic Escherichia coli 0157: H7 and genomic 





I \IIU 1 1300S, CAA735u0. l; -. 
AF071034; AAC31501.1; -. 
AE005594; AAG58820. I; -. 
AP0025G6; ßAß37979.1; -. 
IntcrPro IPR005095; EspA. 
Ptäm PF03433; ESPA; 1. 
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